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ABSTRACT 
Background: The mandate for scale up of home-based HIV counseling and testing 
(HBHCT) is strong. To maximize the benefits of testing, prompt linkage to care and 
treatment for HIV -positive clients is essential. Timely linkage can lead to decreased 
morbidity and mortality, as well as increased quality oflife and life expectancy. Early 
treatment initiation can also reduce HIV transmission to uninfected partners. While data 
exists on the transition to care from mobile and facility-based HIV testing, less is known 
about the transition from HBHCT. 
Methods: A mixed methods study was conducted among a sample of 492 HIV -positive 
HBHCT clients in rural South Africa to: 1) determine the rate of linkage from HBHCT to 
facility-based services; and 2) identify factors that influence linkage. Clients were 
followed up to assess linkage to care, defined as providing a blood sample for a facility-
based CD4 count. Using data from a cross-sectional survey conducted among a sub-
sample of 196 clients 6-153 days after testing, Cox regression was performed to 
determine factors associated with linkage. To further explore potential barriers and 
lX 
facilitating factors, in-aepth interviews were conducted with 30 clients who were 
purposively selected based on timely versus delayed care seeking. 
Results: Among 359 illY-positive HBHCT clients, 62.1% (95% CI: 55.7%- 68.5%) 
linked to care within 3 months. For those who did not link promptly, barriers occurred at 
all levels: individual, relationships, community, and health systems. Delayed care seeking 
was influenced by poor psychological responses to the diagnosis; challenges surrounding 
disclosure and limited social support; lack of time, opportunity, and financial resources; 
and internalized negative experiences with the healthcare system. Often, barriers 
interacted and were subtly reinforced by stigma. Women and youth may be particularly 
vulnerable to these barriers. 
Conclusion: The fmdings highlight important gaps in our understanding, and provide the 
basis for policy and programmatic recommendations. Key recommendations include: 1) 
including HBHCT and monitoring of linkage to care in the role of community health 
workers; 2) offering tailored counseling and motivational interviewing; 3) conducting 
short-term intensive community-based support groups; 4) offering mobile point-of-care 
CD4 counts; and 5) piloting and evaluating community based nurse-initiated treatment. 
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CHAPTER 1: 
AIMS, BACKGROUND & RATIONALE 
AIMS 
Conducted in a rural sub-district of South Africa, the primary aims of this 
dissertation study were: 
• to determine the rate of timely linkage to care following home-based HIV 
counseling and testing (HBHCT) 
• to identify factors that influence linkage to care 
• to provide policy and programmatic recommendations to address barriers 
and facilitate timely linkage to care 
To put these aims in context and illustrate the rationale for this study, this chapter 
provides an overview of: 1) HIV I AIDS and available treatment; 2) the scale and scope of 
the global HIV/AIDS pandemic; 3) the HIV/AIDS epidemic in South Africa, the study 
setting; 4) the role ofHIV testing in addressing the epidemic; 5) the evidence regarding 
acceptability and effectiveness of home-based HIV counseling and testing; 6) the benefits 
of timely linkage to care; and 7) fmdings from studies addressing linkage to care from 
various facility and community-based HIV testing settings. 
1 
BACKGROUND 
HIVIAIDS 
The Human Immunodeficiency Virus (HIV) is a retrovirus which causes the 
Acquired Immunodeficiency Syndrome (AIDS). 1 HIV is spread through blood, semen, 
vaginal secretions, and breast milk. It is most commonly transmitted during unprotected 
anal, vaginal, or oral sex, by sharing contaminated needles and/or syringes, through 
transfusion of contaminated blood or blood products, or from an infected mother to her 
infant during pregnancy, delivery, or breastfeeding_2 
By disabling or destroying the body's CD4+ T-cells, HIV weakens the immune 
system and makes it difficult to fight off certain infections and cancers. The onset of 
AIDS, which refers to the most advanced stages ofHIV infection, occurs when an HIV-
infected individual has less than 200 CD4+ T-cells per cubic millimeter of blood 
(compared to 1,000 or more in healthy adults) and acquires one or more of26 clinical 
conditions outlined by the Centers for Disease Control and Prevention. Many of these 
conditions are opportunistic infections that do not affect healthy people. However, for 
those with AIDS, these illnesses are severe and often fatal. 3 
There is currently no cure for HIV or AIDS, however, highly active antiretroviral 
therapy (HAART) can effectively suppress the virus to undetectable concentrations. First 
introduced in 1996,4-6 access to HAART, has been fraught with many challenges, and the 
utility of the drugs has been complicated by regimen complexities, adverse effects, 
toxicities, and cost. 7' 8 However, in recent years, there have been substantial advances in 
the development ofless complex and toxic drugs to treat HIV infection.9- 11 Today, there 
2 
are 31 antiretroviral drugs (ARVs) approved by the Food and Drug Administration, 
though not all are licel)sed or available in every country.3• 12 
Global burden of HWIAIDS 
At the end of2010, a few decades into a very complex pandemic, an estimated 34 
million people worldwide were living with HIV. Despite its heavy toll, steady gains are 
now being made to halt and reverse the spread ofHIV. In fact, the global incidence of 
HIV infection has stabilized and even begun to decline in many heavily affected 
countries. In 2010, 2.7 million people were newly infected, reflecting a 21% decrease in 
the number of new infections since the peak of the epidemic in 1997. In addition, more 
people are living with HIV than are dying from it. This is primarily due to greatly 
increased access to ARVs. 13 Since 2004, there has been a 13-fold increase in the number 
of people receiving HIV treatment, an achievement that has contributed to a 19% decline 
in deaths among people living with HIV between 2004 and 2009. Despite this success, 10 
million people who are eligible for treatment are still in need. 14 
The HIV I AIDS epidemic most often affects people in their prime years, and in 
heavily affected regions has dramatically decreased average life expectancies by as much 
as 20 years. 15 Its devastating impact on human health and mortality also has a powerful 
social and economic impact. Peter Piot, former Director of the Joint United Nations 
Programme on AIDS (UN AIDS), once stated that the epidemic is not merely a health 
crisis but also poses "a major threat to development and to human society." His statement 
speaks to the fact that in many nations, the AIDS epidemic has dismantled the societal 
3 
infrastructure and inhibited optimal functioning of key public sectors such as education, 
agriculture, and finance, as well as private corporations. Additionally, the epidemic's toll 
is acutely felt by HIV -affected families and households, which are emotionally and 
financially burdened with the challenges of caring for the sick, losing loved ones, 
surviving following the death of a breadwinner, and raising orphaned children. 16 
HWIAIDS in South Africa 
Home to 68% of all people living with HIV, sub-Saharan Africa (SSA) is the 
most heavily HIV -affected region. AIDS has claimed at least one million lives annually 
there since 1998, and in 2010 it accounted for 70% of new HIV infections. 13 Southern 
Africa has been particularly hard hit, with South Africa having the greatest number of 
people living with HIV in the world. At the end of2009, 5.6 million South Africans were 
living with HIV, reflecting an HIV-prevalence of 17.8% among those 15-49 years. In that 
same year, an estimated 310,000 people in South Africa died of AIDS-related causes. 14 
As in most of SSA, women in South Africa are disproportionately affected by the 
epidemic. The difference is particularly pronounced among young adults, as illustrated by 
the following comparisons of HIV prevalence among males versus females, respectively: 
15-19 years (2.5% vs. 6.7%); 20-24 years (5.1% vs. 21.1%); 25-29 years (15.7% vs. 
32.7%); 30-34 years (25.8% vs. 29.1%); 35-39 years (18.5% vs. 24.8%); 40-44 years 
(19.2% vs. 16.3%) and 45-49 (8.4% vs. 14.1 %)Y 
The government of South Africa endorsed the free rollout of ARV s in late 2003 
with an initial commitment to provide ARV s to over a million people by early 2008. 18 
4 
Progress however, has been slow. By the end of2010, it is estimated that nearly 1.4 
million people were receiving ARVs. Based on the 2010 World Health Organization 
eligibility guidelines, this only represents about 55 percent of those in need. 19 
STUDY RATIONALE 
Role of HIV testing 
HIV testing plays an important role in addressing the HIV I AIDS epidemic, as it 
provides a critical gateway to other HIV -related services such as prevention, care, 
treatment, and support.20-22 For example, knowledge of HIV status could lead to 
increased condom use,23 use of prophylaxis for prevention of mother-to-child-
transmission, identification and treatment of opportunistic infections, and initiation of 
ARVs. Yet, the vast majority of people in heavily affected countries remain unaware of 
their status.24 In South Africa, for example, a 2008 survey indicated that only 24.8% of 
those aged 15-49 years received an HIV test in the last 12 months and knew their status. 17 
Low awareness of HIV status is due in part to various structural, economic, and social 
barriers such as low risk perception, stigma, and transport costs, that prevent people from 
·1· · · 1 1'. ·1· b d HIV t t. · 2s 21 26-29 uti 1zrng conventwna 1ac1 1ty- ase . es rng services. ' ' 
Recently, it has been suggested that an effective response to the HIV/AIDS 
epidemic requires universal HIV testing.30' 31 In an effort to expand HIV testing coverage, 
in April 2010, the South African government launched a national HIV testing campaign. 
By June 2011, 13.3 million people had tested, with 16% testing HIV-positive?2 Despite 
its success in raising awareness of HIV status, the campaign raised many concerns about 
5 
the adequacy of testing procedures, counseling, and importantly referrals to care and 
treatment. 33 
Given the known barriers to facility-based testing and the challenges of 
continually implementing large scale national campaigns, there is growing interest in the 
development and scale up of innovative HIV testing models. Such models would better 
address community needs and preferences,25' 28' 34-36 yet still have the potential to rapidly 
reach large proportions of the population. These models include: provider initiated 
testing, mobile or community HIV counseling and testing (HCT), integrated HCT, and 
home-based HIV counseling and testing (HBHCT)_2°, 25, 28, 37, 38 
Expansion of HIV testing is merely a means to a broader end. Thus it is important 
to understand client behavior following testing, for example, with regard to preventing 
future infection or addressing a positive diagnosis. As such, this dissertation aims to 
investigate linkage to care following one increasingly popular intervention - home-based 
HIV counseling and testing. 
Home-based HW testing 
Home-based HIV counseling and testing has been implemented and studied in 
various sub-Saharan African contexts. With regard to acceptability, uptake, and 
expansion ofHIV testing coverage, the current evidence is overwhelmingly positive. In 
one randomized controlled trial conducted in urban Zambia, individuals were randomized 
in clusters to receive voluntary counseling and testing (VCT) either at a nearby health 
facility or at an optional location. Participants randomized to the optional location (who 
6 
mostly chose home) were 4.7 times more likely to accept VCT than those allocated to a 
facility. 39 Additionally, a recent meta-analysisrepmied that uptake ofHBHCT exceeded 
70% in three-quarters of the included studies. The authors further concluded that by 
raising awareness of HIV status so substantially, HBHCT could be a valuable tool for 
HIV/AIDS prevention and treatment.40 
Table 1 outlines several studies conducted as part of an intervention or within a 
survey context, which show encouraging findings with regard to the acceptability and 
feasibility of home-based testing both in rural and urban settings.41 -47 For example, within 
a Demographic and Health Survey (DHS) in Uganda, 86% of eligible respondents took 
an HIV test at home and accepted their results.45 In a more recently published study from 
Uganda, Nuwaha et al. found that following the implementation of an HBHCT 
intervention, the proportion of people who had ever tested for HIV increased from 18.6% 
to 62% (p<O.OOl) in a period of2 years.47 Further, within the Good Start HBHCT study 
conducted in rural South Africa (the parent st_udy for this dissertation sub-study), 75% of 
clients who were approached in the home, accepted HIV testing.48 
Studies on per client costs of HBHCT also suggest that the model is economically 
viable.49' 50 Particularly promising is the fact that HBHCT reaches populations with no 
prior testing experience50-54 and identifies previously undiagnosed HIV-positive clients. 53-
55 Recent evidence also indicates that HBHCT has the potential to reach clients at an 
earlier stage of illness. This is quite important given the fact that in sub-Saharan Africa 
late entry into care at an advanced stage of disease is the nmm. 56' 57'58' 59 Late entry has 
critical negative implications for morbidity and mmiality,60' 61 ,62 incidence of 
7 
b 1 . 63 HIV . . 64-67 h . 1. . 61 1 . .c. 68 .. tu ercu os1s, transmissiOn, osp1ta 1zatwn, 11e expectancy, and ut1hzation 
of health care resources.69 
In a study conducted in Kenya, Wachira et al. found that the median enrollment 
CD4 count for clients entering HIV care from HBHCT was significantly higher than from 
other services. Those entering from HBHCT had a median CD4 count of323 cells/mm3, 
compared to 217 cells/mm3, 190 cells/mm3 and 136 cells/mm3 for those entering from 
conventional facility-based VCT, provider-initiated testing and counseling (PITC), and a 
tuberculosis clinic, respectively (p<.001).70 Another retrospective cohort study conducted 
by Menzies et al. in Uganda found that compared to three other models of HIV testing 
(i.e. stand-alone, hospital-based, and household member) door-to-door home-based 
testing reached a greater proportion of clients ( 69.3%) at a less advanced stage of illness, 
with CD4 counts> 200 cells/mm350 
Importance of linkage to care 
Linkage from HIV testing to care has clear benefits for HIV -positive individuals, 
who can be treated for opportunistic infections and initiated on ART when eligible. 
Subsequently, they can benefit from decreased morbidity and mortality as well as 
. d a1· fl".c. 7172 dl·.c. 7374 T" 1 link . "11 mcrease qu 1ty o 11e ' an 11e expectancy. · 1me y age to care IS espec1a y 
beneficial. Findings presented at the 2012 AIDS conference in Washington D.C. show 
that early versus late initiation of treatment significantly lowered the incidence of clinical 
events by 41%. Further, early treatment delayed the time to both AIDS and non-AIDS 
8 
primary events and significantly delayed the time to AIDS events, death and 
tuberculosis. 75 
Findings from other recent studies also emphasize the important prevention 
benefits of linkage to care and initiation of antiretroviral treatment. For example, Donnell 
et al. showed that HIV-infected clients on ART are less likely to transmit HIV to their 
heterosexual partners than those not currently on treatment. 76 Further, in a landmark trial, 
Cohen et al demonstrated that early versus late initiation of ART led to a 96% reduction 
in the risk of sexual HIV transmission. 67 Several mathematical models also suggest that 
ART, with high levels of access, and high adherence, can substantially reduce the global 
incidence ofHIV.77 One particularly bold ' test-and-treat' model proposed by Granich et 
al. suggests that universal HIV testing and immediate treatment with ART could virtually 
eliminate the HIV I AIDS pandemic. More specifically, within 10 years of full 
implementation of the strategy, HIV incidence and mortality could be reduced to less 
than one case per 1,000 people and within 50 years, HIV prevalence could be less than 
1%.3 1 Importantly, one key assumption of the model is 100% uptake of ART following 
HIV testing. 78 
A separate modeling exercise carried out by Granich et al. shows that a scenario 
of 90% annual HIV testing coverage among adults 15-49 years in South Africa and 
treatment initiation at a CD4 count of ::::;350 cells/mm3 could also be very cost-effective. 
Potential gains include: prevention of an estimated 265,000 (17%) and 1.3 million (15%) 
new HIV infections over 5 and 40 years, respectively; a decline in cumulative deaths by 
15%, from 12.5 to 10.6 million; a decline in disability adjusted life years (DAL Ys) lost 
9 
by 14%, from 109 to 93 million over 40 years; and a drop in costs of $504 million over 5 
years and $3.9 billion over 40 years. The model predicts that the cost of such an ART 
program would break even within 2 years. 79 
The predicted outcomes of the Granich and other models rest on many important 
assumptions and require further modeling, testing, and research.80• 81 Nonetheless, they 
underscore the importance of ensuring that expansion of HIV testing coverage is also 
coupled with efforts to promptly link HIV -positive clients to needed care and treatment. 
Linkage to care in tlte context of facility-based HIV testing 
A recent systematic review by Rosen et al. states that "the failure to link patients 
from HIV testing to HIV care and retain them until they are eligible for ART" is a major 
problem that "has just begun to be recognized in the research literature."82 As 
mechanisms to monitor and trace the movement of clients from HIV testing to other HIV-
related services are uncommon, information about linkage to care is minimal, even when 
the entry point is facility-based HIV testing. However, the available evidence indicates 
that linkage is generally not optimal. The systematic review cited above, of studies 
conducted within sub-Saharan Africa, indicates that the median proportion of clients 
retained between HIV testing and receipt of CD4 results or clinical staging was 59% with 
a range between 35% and 88%.82 The conclusion from this review and other studies is 
that there is a grave need to improve mechanisms for linkage between HIV testing and 
d 0 57 83-92 care an treatment services. · 
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The development of mechanisms to improve rates of liilkage necessitates an 
understanding of the factors that hinder clients from making the transition from testing to 
care. Much of the available literature assessing barriers relates specifically to initiation of 
treatment. Identified baniers cut across the spectrum from individual level (e.g. 
employment status, finances, perception of health, difficulties coping with the diagnosis, 
lack of time, poor nutrition, interpersonal challenges, lack of or incorrect information); 85, 
92
-
97 psycho-social or cultural (e.g. fear of stigma, belief in traditional medicine, 
disclosure );85' 92-94 structural (e.g. transport costs, distance to the facility, judgmental and 
. . d 1 1. ) 85 93 95 98 d 1. . 1 ( CD4 unresponsive prov1 ers, ow-qua 1ty care ; ' ' ' , an c m1ca e.g. count, 
1 . 92 96 symptoms of tubercu osts ). ' 
Figure 1 illustrates the complexity of stages involved in the continuum of HrV 
care. Very few studies specifically address the transition from HIV testing to obtaining a 
CD4 count, which is particularly important given that it is generally the first entry point 
to HIV care. Within a hospital setting in Durban, South Africa, Losina et al. explored 
factors related to pre-treatment loss to care (PTLC), which they defmed as failure to have 
a CD4 count within 8 weeks of diagnosis. Factors found to be associated with a greater 
likelihood ofPTLC included: living 2: 10 kilometers from the testing center, having a 
history of tuberculosis treatment, and refenal by a healthcare provider (as opposed to 
self-refenal).91 A study conducted by Kranzer et al. in a peri-urban community in Cape 
Town, South Africa, found that place of testing had an important impact on rates of 
linkage to care. Specifically, a greater proportion of clients who tested through antenatal 
care (81.3%) or sexually transmitted infection (STI) services (84.1%) completed a 
11 
facility-based CD4 count compared to only 53.5% of those who had tested within VCT 
services. 86 
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Figure 1. Continuum oflllV Care (taken from Mugavero et al84 as adapted from 
· Ulett et al.99 with permission from Mary Ann Liebert) 
Importantly, even when clients do attend a facility to obtain a CD4 count, not all 
return for their results, further disrupting the transition to needed care. Naidoo et al. 
investigated predictors of CD4 collection at a primary health care clinic in Johannesburg, 
South Africa. They found that only 65% of clients returned to collect their CD4 results. 
Predictors of collection were: age, education level, the perception that people don't care 
what their CD4 results are, and the perception that CD4 count does not matter if you have 
HIV. A large proportion (89%) of clients reported a preference for being told the results 
via telephone. 100 
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Linkage to care in the context of community-based HIV testing 
Some countries such as Uganda and Kenya have already taken home-based HIV 
1. d · 1 70 101 o· h · 1 f hi d 1 · counse mg an testmg to sea e. , 1ven t e potentia o t s mo e to mcrease access 
to testing, as well as early diagnosis and treatment, other national governments are likely 
to do the same. In fact, the World Health Organization has recently published a practical 
handbook for planning, implementing, and monitoring, home-based HIV counseling and 
. . b Sah A..-.. 102 testmg m su - aran 1nca. 
Although there is substantial evidence that HBHCT can effectively expand HIV 
testing coverage, there is a dearth of literature about the rates of linkage from home-based 
testing to facility-based care and treatment. To date, there are only two other studies that 
have specifically explored linkage to care following a home-based HIV counseling and 
testing intervention. In an abstract from the 18th Conference on Retroviruses and 
Opportunistic Infections (20 11 ), Amollah et al. presented fmdings showing that in a rural 
area of Kenya, older age, female gender, disclosure, self-reported poor health status, 
having tested as a couple/family, and living with another individual attending care were 
predictors of current attendance in care. Client-cited reasons for non-attendance of care 
included: feeling healthy, not believing the results, or concerns about confidentiality or 
stigma. Household proximity to the health facility was not predictive of attendance. 103 
Another unpublished study conducted in a rural area ofKwazulu-Natal, South 
Africa found that following home-based testing and a point-of-care CD4 count, 95% of 
clients visited an HIV clinic by 6 months, and 85% of those eligible initiated treatment. 
As a result there was a decrease in mean community viral load with a high percentage of 
13 
clients having a plasma viral load of less than 1,000 copies/mL, which indicates low risk 
of HIV transmission.1 04 
A few available studies discuss linkage to care from other community-based 
testing models such as mobile testing and community testing campaigns. In one recent 
study, Nakigozi et al. found that among a community cohort of clients in Uganda who 
had accepted VCT and who were referred for free HIV care, only 68.5% enrolled in care. 
Non-use of services was significantly greater among youth 15-24 years, males, those 
living alone or with fewer co-residents, and those with higher initial CD4 counts ( >250 
cells/mm3). 105 In another study, Govindasamy et al. explored linkage from a mobile 
testing unit to facility-based care and found that a greater proportion of those with lower 
CD4 counts, particularly those already eligible for treatment, successfully linked to care. 
The authors also found that disclosure, symptoms of tuberculosis, and unemployment 
increased the likelihood of linking to care.92 
Hatcher et al. explored predictors oflinkage to care following a community-based 
HIV testing campaign in Kenya where CD4 counts were done on-site post-testing. The 
cumulative rate of linkage to care within 3 months oftesting was 63.2%. Rates of 
enrollment in care were significantly higher for participants who were older and who 
received a follow up home visit by a trained person living with HIV I AIDS (PL WHA) 
navigator. Other predictive factors varied by gender. For males, disclosure to their spouse 
and higher perceived discrimination were associated with a higher likelihood of linkage, 
while uncertainty around ART knowledge was associated with a lower likelihood. For 
females, greater education, being widowed or single, and disclosure to family were 
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associated with higher rates of linkage. Lack of HIV knowledge or anticipation of a 
negative response from their patiner were associated with a lower likelihood of linkage to 
care. 106 
Contribution of the dissertation 
The importance of this dissertation study is evident given how little is known 
about the rates oflinkage from HBHCTto facility-based care, particularly in the absence 
of a point-of-care CD4. Further, we lack a full understanding about the factors that may 
impede or facilitate care seeking behavior among HBHCT clients. This information is 
critical for the development of effective policies and strategies to overcome barriers and 
encourage prompt linkage. 
Given that there may be important differences in the context of HBHCT 
compared to conventional VCT, there is clearly an important gap in the literature. For 
example, since HBHCT attracts clients who may not have tested in the absence of the 
intervention, they may differ with regard to personal characteristics, risk perceptions, 
health status, and motivation levels. Additionally, community-based testing models such 
as HBHCT would typically be utilized to overcome existing limitations such as a weak 
service delivery infrastructure or long distances to facilities. These inherent challenges 
will persist and could impede a successful transition to care. 
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Table 1. Summary of studies investigating home-based mv counseling and testing 
Author Country Study Population/Design Key Findings 
Fylkesnes et al. Zambia Randomized controlled trial The acceptance of testing was 11.8% among those allocated to 
200439 comparing rates of testing among VCT at the local clinic compared to 55 .8% for the group 
clients allocated to clinic-based VCT allocated to an optional location (RR, 4.7). The optional 
(n=1,102) or at an optional location location was mostly home. 
(n=1,343). 
Sample was drawn from all household 
members aged 15+ years in 1 0 
sampled clusters. 
Lugada et al. Uganda Randomized controlled trial Household members ofHIV-infected index patients who were 
2010 107 comparing uptake of home-based offered home-based VCT were 10 times more likely to be tested 
VCT (n=4,798) versus clinic-based compared with those offered clinic-based VCT. 
VCT (n=2,386) among household 
-
members of 1,453 patients receiving 
0\ ART. 
N uwaha et al. Uganda Pre-post cross sectional surveys The proportion of people who had ever tested for HIV increased 
201247 assessing population-level changes in from 18.6% to 62% (p<O.OOl). 
knowledge ofHIV status, stigma and 
HIV -risk behaviors following a home- Among people who had ever tested, the prop01tion of people 
based testing intervention. who shared HIV test results with a sexual prutner increased 
from 41% to 57% (p<0.001). The proportion of persons who 
1,402 randomly selected adults 18-49 didn't want the infection status of a family member to be 
years were interviewed in the baseline revealed decreased from 68% to 57% (p<O.OOl). 
survey; a different set of 1,562 
randomly selected adults were There were improvements in risk behavior. The prop01tion of 
interviewed in the post intervention people who: 1) exchanged money for sex decreased from 12% 
survey. to 4% (p<O.OOl); 2) used a condom when money was 
exchanged during a sexual act increased from 39% to 80% 
(p<O.OOl); and 3) reported genital ulcer/discharge decreased 
from 22% to 10% (p<O.OOl). 
Helleringer et Malawi Post-intervention survey measuring Among successfully contacted clients, 71.9% of eligible men 
al. 200952 the uptake of home-based HN testing. and 79.3% of eligible women took a test and learned their 
results. 
Comparison of testing uptake by Testing uptake was significantly higher among clients from the 
income quartile. lowest income qurutile compared to the higher income quartiles 
(aOR: 1.70, 95% CI: 1.04-2.79) 
Sample included 852 residents of 6 
villages aged 18-3 5 years and their 
spouses. 
Matovu et al. Uganda Community epidemiological survey 90% of respondents who were bled requested their HN results; 
200243 including a venous blood draw for 64.6% ofthose who requested their HIV results received them. 
HIV testing. Sample included 15,091 
adults aged 15-49 years. 
Menzies et al. Uganda A retrospective cohort study Costs per client were the least for door-to-door HCT, though the 
200950 comparing costs and effectiveness at 3rd highest per HIV-positive client identified. 
........ 
-.....) 
reaching key population groups for Door-to-door testing identified the highest percentage of HIV-four HCT strategies: stand-alone positive clients with a CD4>200 cells/mm3 • HCT; hospital-based HCT; household-
member HCT; and door-to-door HCT. 
The sample included 84,323 people 
who received HIV testing through one 
of four strategies and whose data was 
available. 
Mulogo et al. Uganda Cross-sectional study comparing Clients who received facility-based testing were less likely to be 
2011 108 predictors of facility (n=500) vs. home residents of more rural households (aOR= 0.14, 95% Cl 0.07-
based VCT (n=494) in a rural context. 0.22). 
Respondents were 18-59 years. Clients who received home-based testing were less likely to 
report having an STI symptom (aOR = 0.63 , 95% CI 0.46, 
0.86), and more likely to be worried about discrimination if they 
contracted AIDS (aOR = 1.78, 95% CI 1.22, 2.61). 
~- - ---- - - ~ -
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Mutale et al. 
201051 
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200949 
Tumwesigye et 
al. 201053 
Sekandi et al. 
2011 54 
Were et al. 
200655 
Zambia 
Kenya 
Uganda 
Uganda 
Uganda 
Population-based HN survey, where 
all participants willing to test for HN 
were offered VCT at home. 
Respondents included 5,035 adults 15-
49 years. 
Intervention study assessing the 
feasibility, acceptability, and cost of 
home-based testing. Sample 
comprised 3,180 15-49 year olds 
exposed to a community awareness 
campaign. 
Intervention survey to assess whether 
home-based testing was acceptable 
and increased uptake of HN testing. 
Sample included 28,285 residents 14+ 
years who were eligible for HCT and 
1 present at home. 
Cross-sectional survey to investigate 
the uptake of home-based HIV 
counseling and testing; HN sero-
prevalence; and factors associated 
with uptake ofHBHCT. Respondents 
included 588 residents aged 15+ years. 
The study assessed testing uptake, 
HN 
prevalence, HN discordance, and the 
rate of ART eligibility among 2,3 73 
household members of730 HIV-
infected clients who were offered 
home-based VCT. 
Overall, the proportion ever HN tested increased from 18% 
before home-based VCT to 38% after. 
Of those willing to test, 76.1% (95% CI: 74.9-77.2) were 
counseled and received the test result. 
63.9% who were exposed to the campaign agreed 
to be visited by counselors; 97.6% ofthose agreed to be tested 
and receive the results. 
The program costs were: $2.60 per community member; $5.88 
per person tested; and $84 per positive case detected . 
The intervention reached 63% of all homes in the district. Of 
those eligible and present at home, 94% accepted testing and 
received their results. 90% of those who tested had never tested 
previously. 
The cost of testing was $7.83 per previously untested client. 
69% of respondents accepted testing. 
Gender, age, marital status, and previous testing history were 
associated with HBHCT acceptance. 
30 (7.4%) previously unknown HN positive individuals were 
identified and linked to HN care. 
99% of household members accepted VCT. HN prevalence 
was 7.5% and was highest among adults aged 25-44 years. 
74% ofthe HN-positives had never previously tested, and 39% 
were eligible for ART. 
Of 120 spouses ofHN-infected clients, 43% were HIV-
negative. 
Yoder et al. Uganda The study aimed to assess the uptake 86% of respondents ultimately gave blood and also accepted I 
200645 of testing among 1,686 respondents their HIV test results. I 
aged 15-59 years who pat1icipated in a 
population-based survey. 
Amollah et al. Kenya This study used multivariate logistic Predictors of early care attendance included: older age, female 
2011 regression (adjusted for age, gender, gender, HIV disclosure, self-reported poor health, testing as a 
[unpublished] 103 marital status, and village) to assess couple/family, and having another household member. enrolled 
factors associated with early uptake of in care. 
HIV care and treatment services 
following HBHCT in a rural area. 66% of persons not in care cited good health and disbelief of 
test result as reasons for not seeking care. 
Barnabas et al. South This study evaluated the impact of 95% ofHIV -positive clients visited an HIV clinic following 
2012 Africa HBHCT (and point-of-care CD4 HBHCT and a point-of-care CD4 count. 
[unpublished]104 count) on knowledge of HIV status, 
linkage to and retention in care, and Among eligible clients, ART initiation increased from 18% at 
change in community viral load . baseline to 85% by 6 months. 
........ 
1.0 The mean community viral load decreased, with a high 
percentage of clients having a plasma viral load of less than 
1,000 copies/rnL, which indicates low risk ofHIV transmission. 
SUMMARY 
•!• There are 34 million people worldwide living with IDV/AIDS 
•!• IDV/AIDS is a public health problem and a threat to societal development 
•!• HIV testing is a cornerstone of efforts to address HIV I AIDS 
•!• Home-based HIV counseling and testing is acceptable and also effective at 
increasing HIV testing coverage in various settings 
•!• Little is known about rates of linkage to care following home-based HIV 
testing or the factors that influence linkage 
•!• Timely linkage to care and treatment can significantly affect the outcomes 
and quality of life for mv -positive individuals 
•!• Timely linkage to care and treatment has important implications for the 
prevention of mv transmission to uninfected individuals 
•!• This study aims to fill some of the gaps in our understanding about 
linkage to care following home-based mv counseling and testing 
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Chapter 2: 
Study Overview & Context 
STUDY OVERVIEW 
The benefits ofhome-based HIV counseling and testing in terms of morbidity, 
mortality, and prevention, are best realized through timely linkage to care by HIV-
positive 9lients. To better inform scale-up of the HBHCT model, more information is 
needed on rates of linkage, as well as factors that facilitate, delay, or hinder care seeking. 
Addressing this gap, this dissertation study investigated the transition from HBHCT to 
facility-based follow-up care in a rural area of South Africa. Specifically, it explored the 
initial stage of linkage to care - uptake of CD4 testing, which is a critical gateway to other 
components of HIV care and treatment. 87 
The study employed both quantitative and qualitative methods to answer key 
questions. A prospective cohort design was used to determine rates of linkage and a Cox 
regression analysis was performed to determine factors associated with linkage. The 
study also involved qualitative analysis of in-depth interviews and field notes to provide 
deeper insight about the factors that may facilitate or impede the linkage to care. The 
dissertation concludes with a synthesis of findings and policy and programmatic 
recommendations designed to improve linkage to care and optimize the benefits of 
HBHCT. A policy brief has also been developed to share the study's findings with key 
stakeholders and decision-makers. 
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STUDY CONTEXT 
Setting 
The dissertation study was conducted in the Umzimkhulu municipality, one of 
five local municipalities comprising the Sisonke District in the province of Kwazulu-
Natal (KZN).109 One of the poorest rural areas in South Africa, Umzimkhulu is 
characterized by dispersed rural settlements, difficult terrain, poor transport systems, 
great distances to health facilities, and a weak infrastructure for the delivery of public 
health and social services. The population is predominantly Black African (99%) with 
low education and employment levels. In fact, 60% of the population have either no 
formal education or have only completed primary school. Only 10% are formally 
employed, with fifty-two percent having no individual monthly income, and 35% earning 
Figure 2. Setting and homes typical of the study area 
22 
ZAR1600 (approximately US$200) or less monthly. As such, many families rely solely 
on social grants for subsistence. Impmiant1y, 91% of the population lives in rural areas 
and out-migration to urban centers for work is common. Over 60% of households in the 
. . 1' .c: 1 h d d 109 110 mumc1pa 1ty are 1ema e ea e . ' 
HIV/AIDS, treatment access, and national policies 
Notably, KZN has the highest adult HIV prevalence of any province in the 
country (25.8%); antenatal prevalence in the Sisonke district is 35.2%.111 In an area so 
heavily impacted by the epidemic, ensuring access to HIV testing is essential. Yet, a 2008 
baseline survey conducted by the South African Medical Research Council in the 
Umzimkhulu study clusters found that only 32 percent of adult men and women had ever 
had an HIV test. 112 The Comprehensive HIV and AIDS Care, Management, and 
Treatment Program (ARV rollout) was implemented in KZN in April.2004. 113 As of 
January 2009, over 200,000 children and adults in the province had been initiated on 
antiretroviral treatment ( AR T).114 
In the past few years, during the course of the dissertation study, South Africa's 
treatment guidelines have undergone several changes. Previously the threshold for 
treatment eligibility was a CD4 count of <200 cells/mm3 .115 In April 2010, the 
government issued an amendment stating that pregnant women and those with 
tuberculosis (TB) could be initiated on treatment at a threshold of 350 cells/mm3 . 116 In 
December 2011 , guidelines were again amended to align with WHO guidelines indicating 
that treatment should be initiated at a CD4 count of <350 cells/mm3 for everyone. 11 7 
23 
Task shifting has been an important strategy in South Africa for addressing health 
systems challenges. In the case of HIV I AIDS programming, task shifting means that 
nurses, rather than doctors, can initiate antiretroviral therapy; lay counselors, rather than 
nurses, can administer HIV tests, and pharmacy assistants, rather than pharmacists, can 
dispense ARVs.118 Another important and on-going shift in South African health policy is 
the process of Primary Health Care (PHC) re-engineering, which involves a three-stream 
approach comprised of: 1) a ward based PHC outreach team for each electoral ward; 2) 
strengthening of school health services; and 3) district-based clinical specialist teams 
with an initial focus on improving maternal and child health. 
Primary Health Care re-engineering aims to contribute to the achievement of four 
main outputs, one of which is "combating HIV and AIDS and decreasing the burden of 
disease from Tuberculosis." Relevant to this dissertation study, a key aspect of the ward-
based component is improving the skills and capacities of community health workers 
(CHW) to provide comprehensive home and community-based health services and 
improving the link to facility-based services. 119 While CHW duties currently include 
AIDS-related tasks such as home-based care and tracing oftreatment defaulters, they do 
not include HIV testing. However, this could change given the emergence of new 
evidence and on-going discussions at the policy level. 
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Good Start home-based counseling and testing study 
This dissertation work was conducted as a sub-study of the Good Start Home-
based HIV Counseling .and Testing Study (Good Start HBHCT). 1 In response to the need 
for further research to guide HIV policy and programing, the Good Start HBHCT study 
was implemented by the South African Medical Research Council (MRC) and the 
University of the Western Cape (UWC) in collaboration with the Sisonke District 
Department of Health. It was the first community cluster randomized-controlled trial of 
door-to-door HBHCT versus standard-of-care (mainly facility-based) HIV counseling 
and testing (HCT) in South Africa. The trial included 8 intervention clusters and 8 control 
clusters with the primary outcome being community level HIV testing rates. The Good 
Start HBHCT study was a registered trial (ISRCTN31271935) and was granted ethical 
approval by the Ethics Committee of the South African Medical Research Council 
(Protocol ID: EC009-003). 
The dissertation sub-study was conducted in Good Start's eight HBHCT 
intervention clusters and in an additional II non-trial related clusters, where HBHCT was 
implemented. These clusters were added to accommodate this sub-study as well as to 
extend coverage for the national HIV testing campaign. The implementation team 
included 1 clinical nurse supervisor, 11 lay counselors and 4 field supervisors, all of 
whom were females from the sub-district who spoke the local language - a mixed dialect 
1 The summary of the parent Good Start HBHCT study and trial outcomes is taken from 
the study team's published paper: Naik R, Tabana H, Doherty T, Zembe W, Jackson D. 
Client characteristics and acceptability of a home-based HIV counselling and testing 
intervention in rural South Africa. BMC Public Health 2012, 12: 824. 
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of Zulu and Xhosa. All staff completed a 1 0-day nationally accredited course in HIV 
counseling and testing, and the counselors spent four months gaining supervised testing 
experience at local health facilities. Additionally, they received training on couples 
counseling, family counseling, prevention of mother-to-child transmission, HIV and 
infant feeding, disclosure, TB/STI screening, and family planning. Supervisors 
participated in the general training and were further trained to monitor counseling and 
testing quality through formal counselor observations and client exit interviews. 
Extensive community mobilization and interaction with local chiefs and leaders, as well 
as collaboration with the Sisonke District Department of Health through formal and 
informal meetings, were integral parts of study implementation throughout. 
From September- December 2009 and June 2010- January 2011 , lay counselors 
systematically visited all households in the 19 HBHCT intervention clusters. After 
seeking permission from the household head, they offered free rapid HIV testing to all 
household members or guests aged 18 years and older. Adolescents aged 14~ 17 years 
were also offered testing provided they had parental or guardian consent. Counselors 
were trained to encourage couples counseling and testing when appropriate. All clients 
gave oral consent for participation in the study, and written consent for the actual HIV 
testing, in accordance with local district procedures. 
Lay counselors read a translated information sheet to all potential clients, 
outlining study and testing procedures. They also gave basic HIV I AIDS education, after 
which clients were allowed to make a choice regarding participation. Clients who agreed 
were then met individually in a private room or section of the home, where survey 
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administration, pre-test counseling, TB/STI screening, HIV testing, and post-test 
counseling took place. Post-test counseling included a brief explanation about the CD4 
count and the importance of obtaining it promptly. 
The counselors used the same rapid HIV test kits that were used by district health 
facilities during the study period - SD Bioline for screening and SENSA for confirmation 
ofHIV-positive results. As part of the Good Start quality control measures, a sub-sample 
of HIV -negative clients and all HIV -positive or indeterminate clients gave additional dry 
blood spot (DBS) samples, which were sent to a Durban-based laboratory for ELISA-
testing. Sensitivity and specificity of counselor vs. laboratory results were high. 
Sensitivity was 98.0% (95% CI: 96.3- 98.9%) and specificity was 99.6% (95% CI: 99.4-
99.7%). Attempts were made to give all clients a paper copy of the lab results. All clients 
were given at-shirt stating "I know my status." Distribution oft-shirts was aimed at 
boosting individual morale and raising community awareness about testing. 
HIV -negative clients were offered a 2nd HIV test 3-6 months following the initial 
test. All HIV -positive clients were given a referral letter and contacted periodically 
following testing to provide support and to monitor access of needed health and social 
services. These components are further discussed in Chapter 3. They were also given a 
referral brochure listing names and contact information of other organizations or 
government departments providing HIV -related services. Clients with one or more 
verbally assessed symptoms of tuberculosis (TB) or sexually transmitted infections (STI), 
or who indicated a need for family planning, were also given a referral letter for further 
assessment at a health facility. 
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Figure 3. Good Start lay counselor leaving a home with her bag of mv testing supplies 
The 19 communities where the dissertation sub-study was conducted were served 
by 9 primary health care clinics (PHC), 1 district hospital, and 1 specialized TB hospital. 
At the time of the study, all health facilities conducted CD4 counts (though blood 
samples were sent off-site for laboratory testing) and offered ARV literacy training. 
Three PHC's initiated ARVs, while the others referred to the 2 hospital-based ARV 
clinics. Distances and transport time to facilities varied by community and facility. The 
average distance (as the crow flies) from each cluster to the nearest facility was 6 
kilometers. Distances would be considerably further for clients who opted for clinics or 
private providers outside of their home catchment areas. Time needed for a clinic visit 
would be reflective of actual distances, terrain, availability of transport, and waiting 
times. Figure 4 indicates the location of intervention clusters and nearby health facilities. 
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Figure 4. Map showing HBHCT intervention clusters and nearby health facilities 
Good Start intervention trial outcomes 
The lay counselors visited 3,328 households, where they met 6,757 people aged 
14-98 years. The majority (68.0%) were in the reproductive age group of 14-49 years. 
Of these household members, 28.1% were male and 72.0% were female. Overall, 5,086 
(75.0%) of those met, agreed to participate in the study and to take a home-based HIV 
test. Nine-hundred and eighty-eight (19%) ofthe HIV-negative clients were met again 
and accepted the 2nd follow up test 3- 6 months later. 
A total of 483 clients from the first round of testing had HIV -positive results. 
Nine clients who initially tested HIV -negative and who accepted the 2nd follow up test 
sera-converted. In total, Good Start identified 492 lab-confirmed HIV -positive clients. 
This reflects a prevalence of9.5%, which is lower than expected when compared to the 
provincial HIV prevalence of25.8% among those aged 15-49 years. 17 This may be 
explained in part by the fact that we tested a substantial number of clients who were well 
beyond the conventionally reported reproductive age range and that many clients who 
declined testing reported being HIV -positive. To test these theories, we recalculated HIV-
prevalence for those aged 15-49 years, including refusals and classifying those who self-
repmied an HIV -positive status as HIV -positive, and classifying all others as HIV-
negative. This resulted in an HIV prevalence of 14.3%, which is still well below the 
provincial rate. However, this may be explained in part by the fact that some of those 
who refused testing for other reasons or who were not met in the home, could have been 
HIV -positive. Further, it could be the case that this particular rural sub-community is less 
heavily affected by the epidemic than others in the province. 
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ETHICAL REVIEW 
The main Good Start trial aimed to investigate uptake and acceptability of 
HBHCT. In order to investigate linkage to care for the HIV -positive clients, a separate 
dissertation sub-study and protocol were developed. Ethical approval for the sub-study 
was received from the Institutional Review Board ofthe Boston University Medical 
Campus. This study was also included as an addendum to the main Good Start trial and 
received ethical approval from the Ethics Committee of the South Mrican Medical 
Research Council. All 492 laboratory-confirmed HIV -positive clients identified by the 
Good Start HBHCT study were eligible for inclusion in the dissertation sub-study, which 
is described further in the following chapters. 
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CHAPTER3: 
LINKAGE TO CARE & SUPPORT 
AIM 
The overall aim of this component of the study was to investigate key aspects of 
linkage to care for clients who tested HIV -positive within the Good Start HBHCT 
intervention in rural South Africa. 
OBJECTIVES 
The primary objectives were: 
Objective 1: To determine the proportion of HIV -positive clients who linked to care 
(i.e. gave a blood sample for a CD4 count) following HBHCT 
Objective 2: To determine the proportion ofHIV-positive clients who linked to care 
within 3 months ofHBHCT 
Objective 3: To determine the median CD4 count (cells/mm3) for HIV-positive 
clients who linked to care following HBHCT 
Objective 4: To determine the proportion of eligible HIV-positive clients who 
initiated antiretroviral therapy following HBHCT 
Objective 5: To determine the proportion ofHIV-positive clients who obtained social 
support services following HBHCT 
METHODS 
Sampling frame and study design 
The sampling frame for this study was clients who obtained HIV testing at home 
during the Good Start HBHCT trial. The study utilized a prospective cohort design, 
whereby clients who tested HIV -positive within the Good Start HBHCT intervention 
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were followed up over time to monitor the linkage to facility-based HIV care. All HIV-
positive clients who were not already in pre-ART or ART care at the time ofHBHCT 
were eligible for inclusion. 
There were two primary components of the Good Start intervention aimed at 
encouraging the linkage to care: 
a. Lay counselors from Good Start conducted routine support and follow up of 
HIV-positive clients via home visits, during which they assessed issues such as 
health risks, coping mechanisms, and access to care. Though the intended 
schedule of visits was 1, 2, 3, 6, 9, and 12 months following testing, the actual 
frequency and timing of contacts deviated substantially due to difficulty reaching 
clients. Additionally, for some clients (who were either unavailable or who 
preferred not to be visited), phone calls replaced in-person visits. Follow up 
contacts were attempted through May 2012 when the study ended. Ultimately, 
clients received between 0-9 contacts (including contacts for other sub-study 
related interviews). The median number of contacts was 2 and the median follow 
up time from testing to the last point of contact was 161 days (range: 0 - 624 
days). 
b. After testing HIV -positive, all clients were given a referral letter by the Good 
Start counselors and advised to take it to the health facility of their choice 
(Appendix 1). Prior arrangements were made with staff at the 11 facilities serving 
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the catchment area to keep the letters in a designated referral box. The letters 
included the client' s unique 5-digit study ID number, name, and date of birth. 
Data collection 
We utilized the mobile data collection platform Mobenzi Researcher120 for data 
collection at various stages of this study. All data captured in the field was transmitted to 
a central web-based server, allowing it to be downloaded in an excel file, which could be 
monitored and analyzed in real time. 
At the time of testing, lay counselors from Good Start used a participant survey to 
collect demographic data for all clients (Appendix 2). They used cell phones to input data 
using the client's unique 5-digit study ID number. Demographic data collected included: 
number of adult household members, gender, age, marital status, and prior testing history. 
Data on key linkage to care outcomes was collected in the following ways: 
a. Paper-based information collected during visits/phone calls: During the follow 
up visits or phone calls, the counselors filled in a paper-based monitoring tool 
(Appendix 3). Of note, they recorded the date of the visit and the following 
information: 1) whether or not the client had visited a health facility to give a 
blood sample for a CD4 count; 2) name of the health facility where CD4 
blood was taken; 3) date CD4 blood was taken; 4) whether or not the client 
had received the CD4 count results; 5) if known, CD4 count (cells/mm3); 6) 
whether or not the client had initiated treatment; 7) date of treatment 
initiation, if applicable; and 8) name of the health facility where treatment was 
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initiated, if applicable. Most of this information was self-report, though some 
clients were in possession of an official clinic card, from which the counselor 
copied the relevant information and noted the data source. 
During the visits clients were also asked whether or not they had ever 
received any of nine social support or services (Appendix 3). Those who 
reported not having received one or more of the services were broadly asked 
for the reason (i.e. not specifically for each service). The responses were 
recorded in the monitoring tool in longhand by the counselor and later post-
coded by the investigator. Some clients did not provide any reasons, while 
others provided more than one. 
b. Tracking of referral letters: Written consent for review of medical records was 
sought at the time of testing and obtained from all clients (Appendix 4). 
Throughout the study period, the Good Start clinical nurse supervisor made 
regular visits to the 11 health facilities serving the catchment area; other non-
catchment area clinics within the district were visited only when clients 
reported attendance. At the facilities, the clinical nurse supervisor collected 
Good Start referral letters and used them to locate clients' medical records in a 
CD4 result notebook, file ofCD4lab reports, pre-ART register, or ART 
register, by matching name, age, gender, and when available the client's 
reported CD4 count or address. All relevant data points mentioned in section 
a. above were entered via cell phone into a referral tracking survey (Appendix 
5). Only the unique study ID was entered into the cell phone as a client 
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identifier. Multiple facility visits and reviews of clinic records may have been 
required to trace clients through each stage of care. 
c. Follow up on self-reports: In the event that a client self-reported having 
received care at a health facility during a phone call or visit, but the referral 
letter had not been found at that clinic, clinic records were still checked and if 
found, relevant information was recorded in the referral tracking survey as 
above. 
Depending on their circumstances, clients may have had data from one or two 
sources- either self-report or clinic records, or both. At the end of the study, data from 
all possible sources was consolidated and entered into a client outcome survey (Appendix 
6) using a cell phone. For· clients with data from only one source, that data was entered 
and the source was noted. For clients with both self-report and clinic verified 
information, only the verified information was entered and was noted as such. For those 
who self-reported not obtaining care, clinic records were not checked and the self-report 
was taken as truth. Outcomes from this consolidated dataset were used for all final 
analyses. 
Clients with data from any source were included in all analyses. Ofthose who 
sought care, 194/273 (71.1%) had clinic verified data. While it is possible that some 
clients with only self-reported data may have given socially desirable rather than factual 
responses, the decision to include all self-reports was made based on a strong impression 
that poor record keeping at the health facilities may explain why some self-reported 
infmmation could not be verified. Additionally, of the 79 self-reports, 19 (24.1 %) were 
36 
clients who reported having sought care outside the district or at a private doctor, where 
records could not be checked. Had it been possible, it is likely that at least some of these 
would have been verified. 
Figure 5. One of the 9 primary health care referral clinics (left); Good Start 
referral box placed at each clinic (right) 
Eligibility and study sample 
Four hundred and ninety-two clients tested HIV -positive within the Good Start 
HBHCf intervention . Of these, either through client self-reporting or cross-checking of 
medical records, we learned that 54 (11%) were already in pre-ART or ART care prior to 
testing within HBHCf. These 54 clients were excluded, and the remaining 438 were 
eligible for inclusion in the analysis. Of these, 8 died (none had sought care before death 
and all had less than 3 months of follow up time) and 71 were lost to follow up (Figure 
5). Of this latter group, 34 had moved from the study area and were unreachable by 
phone, 13 refused follow up visits and were unreachable by phone, and 16 could not be 
contacted despite several attempts. Three others claimed to have re-tested negative, 3 
initially had an indeterminate result and could not be contacted to be given the lab-
confirmed HIV -positive result, 1 refused to receive her results, and 1 insisted she had 
never had sex and therefore was HIV -negative. 
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Some clients who moved and/or refused follow up visits were contacted and study 
outcomes were successfully obtained either prior to that event or via phone call. 
However, for programmatic purposes, it is still important to note that ofthe 438 clients 
who were eligible for study participation, a total of 117 (26.7%) clients moved out of the 
study area and 87 (19.9%) refused follow up at some point during the study (this may 
have been after already receiving one or more contacts). Twenty-one clients both moved 
and refused visits. 
A total of359 clients, who linked to care at some point during the study or who 
did not link to care within 3 or more months remained for the analysis. This sample 
includes 20 clients who sought care either outside the district, at a private doctor, or had 
missing clinic name information. It also includes 23 clients who reported having learned 
of their HIV -positive status prior to HBHCT (a few to several years), but never having 
linked to pre-ART care. The sub-groups that comprise the 359 clients included in the 
analysis are designated by a dotted line in Figure 6. 
Data analysis 
STAT A version 11 was used for all data analysis. To describe the study sample, 
univariate analyses were performed for the following five background characteristics: 1) 
number of adult household members; 2) gender; 3) age group; 4) marital status; and 5) 
ever having an HIV test prior to HBHCT. Frequencies and proportions were tabulated for 
the full sample of HIV -positive HBHCT clients (n=492), the sample of eligible clients 
(n=438), and the final sample used for analysis (n=359). 
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Tabulations were made to determine the number and proportion of clients who 
were known to have given blood for a CD4 count at any point during the study following 
HBHCT. Additional tabulations were made to determine the proportion of clients for 
whom refetTalletters were found, and who received their CD4 count results. 
Further analyses were conducted to determine the proportion of clients who 
linked to care within 3 months of testing, and of those what proportion linked to care 
within 1 month. The cutoff of3 months (i.e., 91.5 days) was chosen based on 
recommendations by Fox et al. to create standardized defmitions of retention and 
attrition in pre-antiretroviral HIV care.121 Recorded dates ofhome-based testing, and 
clinic verified and self-reported dates ofCD4 were used for the calculation oftime from 
testing to CD4. Table 2 indicates the number of clients with available data on date of 
CD4 from each data source. For 23 clients with missing dates, the time to CD4 was 
estimated by using the midpoint between the date of testing and the first date the 
counselor learned that the CD4 had been obtained at some point prior. A sensitivity 
analysis was conducted with a sub-sample orily including clients with a clinic verified 
. 
date of CD4. Chi-square tests were also performed on categorical variables to assess the 
association between client characteristics and promptness of linkage to care. 
We calculated the proportion of clients who sought care after 3 months and their 
median time from testing to CD4. Tabulations were also made to determine the number 
and proportion of clients who self-reported not having linked to care at 6 months and 1 
year following testing. 
40 
Table 2. Number of clients with available data for each component of analysis 
Data Point Clinic Verified Self-report Estimated TOTAL 
Giving a blood 359 
sample for a CD4 
count 
194 79 --- 273 
Linked to care --- 86 --- 86 
Did not link to care 
Date ofCD4 193 57 23 273 
CD4 results 191 35 --- 226 
Initiation of ART 38 12 --- 50 
Date of ART 38 6 --- 44 
initiation 
Access of social --- 246 --- 246 
services 
Of the 273 clients who linked to care, 226 (82.8%) had a recorded CD4 count 
(Table 2). To determine the disease stage ofthese clients, we calculated the median and 
range CD4 count ( cells/mm3) at the initial point-of-entry into care. A comparative 
analysis was carried out to determine the median CD4 count for those who linked to care 
within 3 months and for those with verified data. Additional tabulations were made to 
show what proportion of clients who linked to care (within any time period) were eligible 
for treatment based on ART eligibility guidelines at the time of the study and who would 
be eligible according to current guidelines. 
Of all the eligible clients, we were able to trace 50 clients through to the stage of 
ART initiation (Table 2). Cross tabulations were performed to determine the number and 
proportion of clients within the CD4 range eligible for ART (:S 200 cells/mm3) who 
initiated treatment. Finally, we calculated the median time fi·om home-based testing to 
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ART initiation for 44 clients who had a recorded date of initiation (Table 2). 
Tabulations were performed to determine the number and propmiion of clients · 
who had obtained the following social support or services at any point following 
HBHCT: 1) joined an HIV support group; 2) received home-based care services; 3) 
received help/support/counseling from a social worker; 4) received help/support from an 
NGO; 5) applied for a disability grant; 6) received a disability grant; 7) received 
support/counseling from a spiritual/religious leader; 8) received support/counseling from 
a community group; and 9) received support/treatment from a traditional healer. An 
affirmative response during any follow up visits was counted as a "yes". Tabulations 
were also performed to calculate the self-reported reasons for not having obtained 
services. 
Results 
Sample characteristics 
Table 3 shows background characteristics for the full sample of HIV -positive 
clients identified within HBHCT and for the smaller sample included in the analysis. The 
majority of clients (82.4%) were females ofreproductive age from homes with small 
adult membership. The proportions of those who were single (43.4%) or married (40.7%) 
are similar, with a minority being widowed, divorced or separated. Approximately half 
had ever taken an HIV test prior to HBHCT. The comparison indicates that the sample 
included in the final analysis is similar to the full sample as well as those who were 
initially eligible for inclusion. 
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Table 3. Comparison of background characteristics for clients included in the prospective cohort 
analysis 
Characteristic All HIV -positive Clients eligible Clients included 
HBHCT Clients for study in final 
(N=492) inclusion prospective 
(N-438) cohort analysis 
(N=359) 
n(%) n (%) n (%) 
Household size 
<3 adult members 305 (62.0) . 274 (62.6) 227 (63.2) 
>3 adult members 187 (38.0) 164 (37.4) 132 (36.8) 
Gender 
Male 101 (20.5) 86 (19.6) 63 (17.6) 
Female 391 (79.5) 352 (80.4) 296 (82.4) 
Age Group 
16-24 110(22.4) 103 (23 .5) 73 (20.3) 
25-49 303 (61 .6) 265(60.5) 224 (62.4) 
50+ 79(16.1) 70 (16.0) 62(17.3) 
Marital status 
Single 220 (44.7) 196 (44.8) 156 (43.4) 
Married/Cohabitating 202 (41.1) 180 (41.1) 146 (40.7) 
Divorced/Separated/Widowed 70 (14.2) 62 (14.2) 57 (15 .9) 
Ever tested prior to HBHCT 
Yes 265 (53.9) 225 (51.4) 181 (50.4) 
No 227 (46.1) 213 (48.6) 178 (49.6) 
Linkage to care 
Of the 359 eligible clients, 273 (76.0%; 95% CI: 71.6- 80.4%) are known to have 
given a blood sample for a CD4 count at some point during the study period (i.e. between 
0-542 days since HBHCT). For those with verified clinic records, a referral letter was 
found at the facility for 73.2% of clients. Nearly two-thirds (64.5%) of all clients who 
linked to care reported having received their CD4 count results at some point during the 
study period. It could be the case that additional clients also received their results, but 
that this information was not captured because the event occurred after their last follow 
up contact. 
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In all, 223/359 (62.1 %; 95% CI: 55 .7%- 68.5%) of the HIV-positive clients 
obtained a CD4 count within 3 months ofHBHCT. The majority 156/223 (70.0%; 95% 
CI: 64.0% -76.0%) of clients who sought care within 3 months actually did so within 
one month of testing. A sensitivity analysis only including clients with a clinic verified 
date ofCD4 produced very similar results. In that case 169/280 (60.4%; 95% CI: 54.7%-
66.1%) obtained a CD4 count within 3 months. 
Table 4 indicates that with regard to age, marital status, and previous testing 
history, there are differences between those who linked to care promptly and those who 
did not. In particular, a greater proportion of those who did not link to care within 3 
months were in the youngest age group, single, and had tested prior to HBHCT. 
Of the 136 clients who did not link to care by the 3-month time point, 50/136 
(36.8%) did link after 3 months. The median time from testing to CD4 for these clients 
was 184 days (range: 93-542 days). The other 86 clients reported never having linked to 
care by the last point of contact. Of these, 56/86 (65%) had at least 6 months of follow up 
time, while 31/86 (36%) had a full year or more of follow up time, and still had not 
sought care by the last point of contact. 
The range of client CD4 counts at the first point of contact with the healthcare 
system for the 226 clients included in the analysis was 23 - 1468 cells/mm3 This 
indicates high variability in disease stage at the point of entry into care. The median CD4 
count for all clients who linked to care was 340.5 cells/mm3. Findings were essentially 
unchanged when only clinic verified CD4-counts were included (i.e. 340 cells/mm3). 
Table 5, which includes both the self-report and verified data, indicates that nearly 20% 
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of HBHCT clients were eligible for treatment during the study period when the eligibility 
cutoff was ~200 cells/mm3 and that over half (51. 8%) would be eligible for treatment 
according to the current eligibility cutoff of ~3 50 cells/mm3. The findings are similar for 
those who linked to care within 3 months of testing. For that group, the median CD4 
count was 333 cells/mm3 and 51.3% of clients would be eligible for treatment under 
current guidelines. 
Table 4. Characteristics oflDV-positive clients by promptness of follow up 
Linked to Did not 
n care within link to care p-value 
3 months within 3 
months 
% % 
Household Size 
<3 adult members 227 66.8 57.4 0.071 2:3 adult members 132 33.2 42.7 
Gender 
Male 63 17.9 16.9 0.804 
Female 296 82.1 83.1 
Age group 
14-24 73 15.3 28.7 
25-49 224 64.1 59.6 0.003 
50+ 62 20.6 11.8 
Marital status 
Single 156 37.2 53.7 
Married/Co-habitating 146 44.4 34.6 0.008 
Divorced/Separated/Widowed 57 18.4 11 .8 
Ever tested prior to HBHCT 
Yes 181 45.7 58.1 0.023 No 178 54.3 41.9 
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Table 5. CD4 count (cells/mm3) by ART eligibility 
CD4<=200 cells/mm3 CD4 201-350 CD4>350 cells/mm3 
cells/mm3 
HIV-positive clients 
(n=226) 45 (19.9%) 72 (31.9%) 109 (48 .2%) 
A total of 50 HBHCT clients were known to have initiated ARV treatment at 
some point within the study period. Among the 45 clients who met the eligibility cutoff 
of200 cells/mm3, 33/45 (73.3%; 95% CI: 60.4- 86.2%) initiated treatment. It is 
unknown why the other 17 clients with higher CD4 counts were initiated, however it 
could be that their health deteriorated following the initial assessment or that they met 
other clinical criteria. The median time from HBHCT to initiation for the 44 clients with 
a recorded date of ART initiation was 108 days (range: 20-468 days). The median time 
from providing a blood sample for a CD4 count to initiation was 55.5 days (range: 12-
401 days). 
Linkage to social support 
With regard to social support, 246/359 (68.5%) clients had data available from at 
least one follow up visit. Table 6 shows the number and proportion of clients who had 
ever reported receiving services by the last point of contact. Only 28/246 (11.4%) clients 
reported having received any social support services. Three of these clients reported 
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having received more than one service. The rest had not received any social support 
services by the last point of contact. 
In terms of self-reported reasons for not seeking any one of the listed support 
services, of the 246 clients: 167 (67.9%) reported having no need for the services; 85 
(35.6%) said services were not available; 22 (8.9%) did not want others to know their 
status; 53 (21.5%) hadn't yet disclosed their status broadly; 12 (4.9%) had not yet done a 
CD4 count; 5 (2.0%) were not ready; and 20 (8.1%) reported "other" reasons, including 
fear of stigma, lack of knowledge about the services, and lack of confidentiality among 
workers. Note that since some clients did not report reasons and others reported more 
than one, the percentages do not add to 100%. 
Table 6. Number and proportion of clients receiving social support and services (N=246) 
Source of Support/Service n (%) 
Joined an HIV support group 0 (0.0) 
Received home-based care services 2 (0.8) 
Received help/support/counseling from a social worker 3 (1.2) 
Received help/support from an NGO 3 (1.2) 
Applied for a disability grant 2 (0.8) 
Received a disability grant 0 (0.0) 
Received support/counseling from a spiritual/religious leader 6 (2.4) 
Received support/counseling from a community group 3 (1.2) 
Received support/treatment from a traditional healer 16 (6.5) 
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DISCUSSION 
The findings from this study and the challenges faced during implementation raise 
important points regarding the rates of linkage from home-based HIV testing to facility-
based care as well as the mechanisms for tracking clients and monitoring linkage. The 
findings indicate that a sizeable proportion of clients linked to care at some point 
following home-based testing. Particularly encouraging is the fact that the majority of 
those who sought care also obtained their CD4 count results. 
Our main study finding that approximately 62.1% (95% CI: 55.73%- 68.47%) of 
HIV -positive HBHCT clients obtained a CD4 count within 3 months following testing, is 
similar to studies in resource-rich122 as well as resource-poor settings.82• 106 A recent 
systematic review including 10 studies conducted in sub-Saharan Africa (6 in South 
Mrica), found that between one-third and two-thirds of clients testing HIV -positive 
obtained a CD4 count and/or returned for their results within 2-3 months of diagnosis. 
The review indicated that the median proportion of clients linking to care within this time 
period was 59% (range: 35%- 88%). All but one of these studies was conducted within 
an urban clinical setting. 82 
Given that 100% of clients should promptly be linked to care, and since the 
transition from testing to CD4 is only the first of several stages where clients could be 
lost before receiving needed care and/or treatment, our rate of linkage is far from optimal. 
However, given that home-based testing generally achieves higher testing coverage than 
facility-based testing, achieving similar rates of linkage could result in a net gain in the 
number of people entering treatment. Linkage rates in the upper range of those found 
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within facility-based settings is also very encouraging considering: 
• the poor, rural infrastructure of our setting; 
• the inherent challenges to linkage from the home to a health facility; and 
• the likelihood that many clients would not have tested in the absence of the home 
based intervention, and thus may have been less prepared for a positive result, and 
less inclined to seek care. 
One study conducted in another rural part of South Africa found that 95% of 
clients within a home-based HIV testing intervention linked to care. 104 In another study in 
rural Kenya, 63.2% of clients linked to care following a community-based HIV testing 
campaign. 106 Our rate of linkage is comparable to the fatter though considerably lower 
than the former. One key difference is that in both of these studies, clients had received a 
point-of-care CD4 count at the time of testing. It could be that having a clear sense of 
their current health status motivated them to seek further care, whereas in our study, 
linkage meant taking the first step to obtain the CD4 count armed only with the 
knowledge of HIV -status. 
The findings suggest that if linkage to care happens at all, it will generally occur 
very soon after testing. For example, the majority of clients who linked to care withiri 3 
months actually did so withiri 1 month. Further, the minority who linked to care after 3 
months took a median of 184 days, and a sizeable proportion of clients are known not to 
have sought care 6 months to a year after testing. It is possible that as more time from 
testing elapses, the urgency and motivation to seek care declines. Additionally, those who 
seek care late may be faced with different personal or structural barriers, or may 
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ultimately seek care for reasons unrelated to the testing intervention (i.e. onset of illness, 
hospitalization). Others may never seek care. 
The development of strategies to improve the rate of linkage from HBHCT to 
facility-based care will require a keen understanding of the target population and the 
reasons for delay or non-linkage. Further insight about these issues will be offered in 
Chapters 4 and 5. However, the findings presented here also provide useful information. 
Although there was no significant gender difference in follow up, the majority ofHIV-
positive clients identified by our HBHCT intervention were female. Thus it is important 
to recognize that culture, community context, and gender norms niay be influential with 
regard to decision-making around the linkage to care. 
Our fmdings indicate that there were meaningful differences with regard to other 
background characteristics between those who linked to care within 3 months and those 
who did not. A greater proportion of those who did not link to care promptly were in the 
youngest age group, single, and had previously tested. While the reasons for their 
behavior are not fully understood, it may be the case that those who are younger and 
unmarried have less social support and financial resources to seek care. And for those 
who have tested previously, their testing history may have led to difficulties in accepting 
the results. These issues are further investigated and discussed in the following chapters. 
The median CD4 count of 340.5 cells/mm3 found in this study is similar to 
fmdings from Wachira et al., where the median CD4 count for clients entering care from 
home-based HIV counseling and testing was 323 cells/mm3.70 This median was much 
higher than for those entering from facility-based services. Although the same 
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comparison was not made in our study, given that late entry into care is the norm in South 
Africa, we assume the findings may be similar in this setting. Still a median CD4 count of 
340.5 cells/mm3 means that according to cunent guidelines, over half of the HBHCT 
clients in our study would be immediately eligible for treatment. This finding is important 
given the aims of the test-and-treat strategy and since timely initiation of treatment is 
known to have important implications for client health, survival, and HIV transmission. It 
will clearly be important to develop mechanisms to ensure that HIV -positive clients are 
promptly linked to care and treatment following HBHCT. Clients with higher CD4 
counts will also benefit from linkage through the receipt of pre-ART care and treatment 
for other illnesses. 
Our findings indicate that 73% of the HBHCT clients eligible for treatment 
actually initiated treatment during the study period. Though not optimal, this rate is 
relatively high and in the upper range of what is found in other settings. The same 
systematic review mentioned previously found that across 14 studies, a median of 68% 
(range: 14- 84%) of clients eligible for treatment initiated treatment during the 
observation period. 82 It is encouraging that such a sizeable proportion of clients who 
tested within a pilot HBHCT intervention were able to link to care and ultimately initiate 
treatment. We did not explore the reasons for loss-to-care at this stage, since clients had 
already been transitioned into facility-based care by that time. However, it is evident that 
there is still a need for improvement within the existing healthcare system to retain clients 
through each stage of care. 
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Our fmdings also indicate that very few clients received social support or 
services. While some clients expressed not having a need for the service, fear of stigma 
and unavailability of services were also important reasons for non-access. The latter is 
not surprising considering that most communities did not have support groups for people 
living with HIV (PL WHA) and the presence of other services was minimal. Fear of 
disclosure to people in the broader community may have also inhibited clients from 
seeking care from sources such as religious leaders or community groups. There is a clear 
need for improvement in the provision and linkage to social support services for HIV-
positive clients. 
The challenges faced during implementation of the study raise a number of 
important practical considerations with regard to linkage, as well as monitoring of 
linkage to care. For example, there were a substantial proportion of eligible clients who 
moved (26.7%) or refused follow up visits (19.9%) at some point during the study. For 
the former group, mobility itself may impede care seeking behavior. If clients do seek 
care outside of their home testing areas, it may be difficult to monitor them. There may 
also be additional implications such as clients being re-tested if facility-based staff are 
unfamiliar with the HBHCT result. Additionally, the high rate of refusal for follow up 
visits indicates that stigma and fear of inadvertent disclosure of HIV status may still be 
important challenges. Again, this could have a significant impact on care seeking 
behavior and pose challenges for monitoring the linkage to care. Although we tried to 
implement phone contacts as an alternative to home visits in cases where clients had 
moved or refused visits, we also found that a considerable number of clients did not have 
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phones where they could be reached and even in cases where they did, the numbers 
provided did not work throughout the full duration of the study. This is an imp01tant 
practical challenge to consider during scale up. 
We also found that a sizeable propmtion of clients sought care without their 
referral letters, making it difficult to track their entry into care. This also means that many 
of these clients are likely to have been re-tested at the health facility, doubling the use of 
scarce resources. Another challenge we encountered is that many clients might have 
given one name when testing within HBHCT and then another when seeking care (i.e. 
Zulu name/English name), also making monitoring and accurate tracing difficult. 
Additionally, the fact that records could not be verified for 29% of clients who self-
reported seeking care highlights an important issue - either clients were not telling the 
truth or the medical records were poor. It is likely a combination of both, and each 
circumstance has important implications for accurate monitoring of linkage. 
It will be important to acknowledge and address these and other potential 
challenges that may arise with regard to the scale up ofHBHCT and efforts to monitor 
clients' transition to care. 
Limitations 
The findings from this study must be interpreted with caution and in light of some 
important limitations. First, the inclusion of unverified data may have led to an 
overestimate in the total number and proportion of clients seeking care during the 
observation period. Some clients may have given socially desirable rather than factual 
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responses. On the other hand, this proportion could be underestimated since not all clients 
had the same amount of follow up time and thus may have linked to care after their last 
point of contact. 
Second, since self-reporting of date of CD4 and actual CD4 results may be subject 
to recall bias, the proportion of clients seeking care within 3 months and the median CD4 
could be mis-estimated. However, since the sensitivity analyses including only clients 
with clinic verified data produced remarkably similar results, we can be fairly confident 
that the estimates are accurate within a reasonable margin of error. Third, selection bias 
due to the exclusion of clients who moved, refused follow up, or whose outcomes could 
otherwise not be determined prior to the 3-month mark, may have affected the analysis of 
timely linkage. The excluded clients may differ from those who were included with 
regard to health care seeking behavior and HIV disease stage. It is unclear to what extent 
and in which direction their true outcomes may have affected the results. Additionally, it 
could be the case that the contacts by lay counselors also played an important role in 
encouraging linkage to care, as this has been found in other settings. 106 However, it was 
not possible to measure this effect since it is those clients who were lost to follow up 
and/or who sought care early, who received less contacts. Finally, this study took place in 
one particular rural community in South Africa and involves a relatively small sample 
size, primarily including females. This limits the extent to which fmdings can be 
generalized to other settings. 
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Strengths 
Despite its limitations, this study has a number of strengths. Importantly, this is 
one of three studies to date investigating the linkage to care following home-based mv 
counseling and testing. It is the only one defming linkage as the transition from testing to 
obtaining a CD4 count. Given the growing interest in scale up of community-based 
testing models such as HBHCT, an understanding of linkage to care is critical. Second, 
the study was conducted in a very challenging "real world" setting with a relatively poor 
rural population, broad geographic area with weak transport infrastructure, numerous 
referral clinics, and clinic activities operating as per usual (i.e. no substantial changes in 
record-keeping or other practices were implemented to accommodate the study). Further, 
strategies to encourage linkage to care were minimal. Thus the fmdings offer a good 
indication of what can be achieved in a typical environment and highlights important 
issues to be considered and addressed when expanding or scaling up this intervention. 
Finally, another important strength of the study is the verification of outcomes. Of the 
273 clients who obtained a CD4 count, 71% had verified information. Though not ideal, 
in other similar studies, outcome information was solely based on self-report. 
Conclusion 
Overall, the findings from this study are encouraging. Current evidence suggests 
that a drastic increase in HIV testing rates is needed for the achievement of national and 
international goals to combat HIV I AIDS. Given the growing evidence about the 
effectiveness of community-based testing models to achieve high levels of population 
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testing coverage, some national govemments are already taking them to scale and in the 
coming years, many more are likely to follow suit. However, since increased testing is 
only one of many essential steps in the continuum of care, a clear understanding of the 
transition to needed facility-based care is essential. This study has shown that home-
based HIV testing can identify a substantial number of previously undiagnosed HIV-
positive clients and that half of them are eligible for treatment soon after testing. Findings 
from this study are promising, since rates of linkage to care were comparable and 
importantly no worse than those found within facility-based settings. Given that home-
based testing is known to increase testing coverage rates, this could result in considerable 
net gains in linkage. Further, this was a novel intervention for the area and minimal 
efforts were put into the linkage to care component. Thus important lessons can be 
leamed from this experience and there is considerable room for improvement. New 
strategies to strengthen the referral system, encourage clients to seek care, and improve 
client tracking and monitoring, will surely achieve even better results. Drawing from 
these findings as well as those presented in later sections of this dissertation, specific 
policy and programmatic recommendations will be discussed in Chapter 7. 
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KEY MESSAGES 
•!• 76.0% of clients linked to care at some point following HBHCT 
•!• 62.1% of clients linked to care within 3 months of HBHCT 
•!• The median CD4 count for clients who linked to care was 340.5 
cells/mm3, meaning that over half would immediately be eligible for 
ARV treatment 
•!• 73.3% of eligible clients initiated treatment during the study period 
•!• Very few clients obtained external social support services 
•!• Improvements are needed to ensure that more clients link to care 
promptly following HBHCT and receive needed social support services 
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CHAPTER4: 
FACTORS ASSOCIATED WITH LINKAGE TO CARE FOLLOWING HBHCT 
AIM 
The overall aim of this component of the dissertation study was to identify 
personal characteristics and other factors that may influence the linkage to care following 
home-based HIV counseling and testing in a rural area of South Africa. 
METHODS 
A survival or time-to-event analysis was performed to determine the factors 
associated with the rate of linkage to care following home-based HIV counseling and 
testing. The sample was drawn from the same cohort ofHIV-positive clients described 
previously. 
Data collection 
The outcome measures used for this analysis were linkage to care (defined as 
giving a blood sample for a CD4 count) and time (in days) from HBHCT to linkage. 
Methods used to collect data on the former outcome and to calculate the latter were 
described in Chapter 3. 
Data on predictor variables were drawn from two different sources: 1) a 
participant survey undertaken by clients at the time ofHBHCT and 2) a cross-sectional 
survey undertaken by clients 6- 153 days following HIV testing. The following five 
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predictor variables from the participant survey (Appendix 2) were used in the analysis for 
this study: 1) number of adult household members; 2) gender; 3) age; 4) marital status; 
and 5) ever having taken an HIV test prior to HBHCT. 
A cross-sectional survey (Appendix 7) was implemented midway through the 
Good Start study amongst HIV -positive individuals to collect data on additional 
predictors. The variables measured by this survey were developed based on the available 
literature, using a social-ecological framework. This framework aims to uncover and 
illustrate the interrelations among various personal and environmental factors. As such, 
the survey measured individual, community, relationship, and health care system level 
variables, which were hypothesized to influence follow up behavior. 
The broad themes explored in the survey included: demographic characteristics; 
life circumstances; experience of home-based testing; barriers to accessing health care; 
perceptions about the health care system; knowledge and beliefs about HIV I AIDS and 
ART; fear and stigma; social support and disclosure; mental health; and alcohol use. 
Whenever possible, specific questions were drawn or adapted from existing instruments 
that have been used in similar settings within the region. For mental health, we attempted 
to determine a change following testing. Clients were asked about a list of 13 common 
depression systems (e.g. headaches, poor appetite, difficulty sleeping, etc.). For each 
symptom, they were asked a) whether or not they had experienced it in the 3 months prior 
to HBHCT; and b) whether or not they had experienced it following HBHCT. 
The cross-sectional survey was conducted by a trained female interviewer in her 
late twenties who was separate from the counselors who conducted HIV testing. Prior to 
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the start of the study, the interviewer received extensive training from two study 
managers on how to conduct the interview and completed several pilot interviews to 
build her skills and confidence. When the study commenced, the interviewer contacted 
HIV -positive clients at their homes, where HBHCT had previously taken place. In cases 
where clients were difficult to find at home or had previously refused visits, phone calls 
were made to set up appointments. Although the intended time frame for this interview 
was approximately 1-2 weeks following testing, due to difficulties reaching clients, it 
took place anywhere from 6 to 153 days after HBHCT. The median time between HIV 
testing and the cross-sectional interview was 16 days. 
Once clients were met and taken to a private section of the home, the interviewer 
described the study, affirmed they were aware oftheir HIV-positive status, and read the 
consent form aloud (Appendix 8). Consenting clients signed the form. To conduct the 
interview, the interviewer used a paper-based questionnaire, which was translated into the 
local language, a mixed dialect of Zulu and Xhosa. The interviews lasted approximately 
45 minutes. Due to the survey's length and complexity, client responses were recorded on 
the paper-based questionnaire at the time ofthe interview and data was entered via cell 
phone by the interviewer within 1-2 days, to be transmitted to a central server. At the end 
of the study, all electronic data was cross-checked against the paper-based responses 
(which were deemed as "correct") and corrections were made when any discrepancies 
were identified. All respondents were offered a food parcel as a token of appreciation for 
their time. 
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Study sample 
Since implementation of the cross-sectional survey only began midway through 
the Good Start study and could only be conducted a short time after home-based testing, 
the potential sample of clients excluded the 218 clients who had already tested HIV-
positive by the time this sub-study began. Ofthe 274 clients who tested HIV-positive 
after the start ofthis sub-study, 18 (6.7%) were already in pre-ART or ART care, and 
thus ineligible for inclusion. Of the remaining 256 clients, 205 (80.1%) completed the 
cross-sectional survey. Reasons for non-completion for the other 51 clients were as 
follows: 16 (31.4%) had moved, 12 (23.5%) refused the visit, 12 (23.5%) could not be 
met after several attempts, 4 (7.8%) died, and 7 (13.7%) could not be interviewed due to 
other circumstances such as poor mental health or claiming to have re-tested negative. 
The final analysis required clients to have both predictor and CD4 outcome data. Of the 
205 interviewed clients, only 196 clients also had outcome data. These 196 clients 
comprised the final sample for this analysis (Figure 7). 
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Figure 7. Study flow chart showing exclusions and inclusions 
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Statistical analysis 
Survival or time-to-event analysis was used to analyze this data. The outcome was 
defined as linkage to care, or more specifically, as giving a blood sample for a CD4 
count. Person-time for those with the outcome was calculated as the number of days from 
home-based testing to CD4 count as described previously. For those without the outcome, 
person-time was calculated as the number of days from home-based testing to the last 
date of follow up. 
Cox proportional hazards regression was used to assess which candidate predictor 
variables were significantly associated with linkage to care. Variables with sufficient 
variability in response and which were associated with linkage to care (p:SO .1) in the 
bivariate analysis, were eligible for inclusion in a preliminary multivariable Cox model. 
A backward elimination stepwise procedure was then carried out to produce a final model 
in which all variables were significantly associated with linkage to care at the p<0.05 
level. The fmal model is adjusted for clustering of data within communities using shared 
frailty models. 
To ensure that the proportional hazards assumption was not violated, tests of 
proportional hazards were carried out both graphically and by using goodness-of-fit tests 
for each variable in the final model. Cox-Snell residual testing was carried out to ensure 
that no outlying observations were disproportionately affecting the outcome. 
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RESULTS 
There were 196 clients included in the analysis, of which 136 (69.4%) had the 
event (i.e. obtained a CD4 count) and 60 (30.6%) did not. The total observation time was 
12,926 person-days. Each client contributed anywhere from 1 to 373 days of observation 
time; the median time to linking to care was 33 days. Figure 8 shows the overall 
cumulative linkage to care curve. Ofthe 196 clients, 123 (62.8%) obtained a CD4 count 
within 3 months ofHBHCT. 
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Table 7 shows the basic characteristics ofthe 196 clients included in the Cox 
regression analysis. The comparison shows that the sample is similar to the full sample of 
HIV-positive HBHCT clients and of those included in the broader prospective cohort 
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analysis. This sample does however include a greater proportion of clients who are 
married and in the oldest age group, and a smaller proportion of clients in the youngest 
age group and who had ever tested prior to HBHCT. Reflective of the underlying sample 
of testers, the vast majority of clients were female. 
Table 7. Comparison of background characteristics for clients included in the Cox regression 
analysis 
Characteristic All HIV -positive Clients included in Clients included in 
HBHCT clients the prospective . the Cox regression 
(N=492) cohort analysis analysis 
(N=359) (N=196) 
n(%) n (%) n (%) 
Household size 
<3 adult members 305 (62.0) 227 (63.2) 123 (62.8) 
>3 adult members 187 (38.0) 132 (36.8) 73 (37.2) 
Gender 
Male 101 (20.5) 63 (17.6) 40 (20.4) 
Female 391 (79.5) 296 (82.4) 156 (79.6) 
Age Group 
16-24 110 (22.4) 73 (20.3) 30 (15.3) 
25-49 303 (61.6) 224 (62.4) 123 (62.8) 
50+ 79(16.1) 62 (17.3) 43 (21.9) 
Marital status 
Single 220 (44.7) 156 (43.4) 73 (37.2) 
Married/Co-habitating 202 (41.1) 146 (40.7) 89 (45.4) 
Divorced/Separated/Widowed 70 (14.2) 57 (15.9) 34(17.4) 
Ever tested prior to HBHCT 
Yes 265 (53.9) 181 (50.4) 88 (44.9) 
No 227 (46.1) 178 (49.6) 108 (55.1) 
Table 8 shows the results of the univariate analyses of predictor variables for the 
196 clients. The findings indicate that most clients were generally comfortable with 
home-based testing services (98.0%), and importantly over two-thirds would not have 
accessed testing services within that month had the counselor not visited them at home. A 
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striking 28.1% of clients either did not believe or were unsure about their results. A 
substantial proportion of HBHCT clients also reported facing challenges to accessing 
health care such as lack of financial resources for transport (62.8%) or treatment (65.8%), 
and distance to the facility (63.8%). Over 90% of clients had favorable perceptions of the 
health system with regard to staff availability and quality of treatment by staff. Nearly 
84% had a positive overall rating of services. However, only 55.9% of clients felt that 
drugs/supplies were always or mostly available at the health facility and less than half 
trust that facility-based healthcare workers would keep their information confidential. 
The findings show that while clients were familiar with HIV/AIDS, they had 
important gaps in knowledge about the illness and about ART. Furthermore, they had 
limited knowledge about where to find resources to help deal with their illness. Fear and 
stigma surrounding HIV also seem high amongst this population. A sizeable proportion 
of clients feared being blamed for their illness (77.2%), losing their friends ( 42.3%) or 
having family members hurt (38.8%) due to their HIV-status. 
The findings highlight that mental health is a serious issue for clients. Out of a 
total of 13 verbally assessed depression symptoms, the median number of reported 
symptoms prior to HBHCT was 0, while after HBHCT the median was 7. Notably 10.2% 
of clients indicated having thoughts of suicide sometime following testing. While 
excessive alcohol use does not appear to be common among this cohort, over one-quarter 
of clients indicated some level of alcohol use. 
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Table 8. Characteristics of clients included in Cox regression analysis (n=196) 
Characteristic n (%) Characteristic n (%) 
Level of Schooling Religion 
Never attended/some 96 (49.0) Christian only 14 (7.1) 
primary/completed primary Christian + traditional beliefs 161 (82.2) 
Some high school/completed 100 (51.0) Shembe 8 ( 4.1) 
high school/tertiary None 13 (6.6) 
Life circumstances 
Number of income sources Perception of health status 
0 34 (17.4) Poor/very poor/fair 92 (46.9) 
1 107 (54.6) Good/excellent 104 (53.1) 
2+ 55 (28.0) 
# people for whom Time spent away from home 
financially responsible Never away - away up to 146 (74.5) 
0-2 88 (44.9) 4months/year 
3+ 108 (55.1) Away 5+ months/year 50 (25.5) 
# people for whom a 
caregiver 
0-3 27 (13.8) 
4+ 169 (86.2) 
Experience of home-based HIV counseling and testing 
Ever tested prior to HBHCT Comfort with counselor skills 
Yes 88 (44.9) Very/generally comfortable 192 (98.0) 
No 108 (55.1) Very/generally uncomfortable 4 (2.0) 
Reason for testing Received enough information 
Suspicion of i1lriess 86 (43 .9) about follow up 
Other reason 110(56.1) Yes 191 (97.5) 
No 5 (2.5) 
Comfort testing at home Believed HBHCT results 
A lot/little more comfortable 159 (81.1) Yes 141 (71.9) 
at home No/not sure 55 (28.1) 
Same as clinic 29 (21.8) 
A lot/little more comfortable 8 (4.1) 
at clinic 
Tested if counselor hadn't Impression ofHBHCT 
visited Excellent/good 177 (90.3) 
No 109 (55 .6) Okay 16 (8.2) 
Maybe/not sure 22(11.2) Poor/very poor 3 (1.5) 
Yes 65 (33.2) 
Barriers to health care are a "big" or "small" problem (versus not a problem) 
Money for transport 123 (62.8) Availability of transport 74 (37.8) 
Money for treatment 129 (65.8) Finding time to seek care 41 (20.9) 
Distance to facility 125 (63.8) Getting permission 6 (3.1) 
Perceptions of the health care system (n=186) 
Availability of staff Drugs/supply availability 
Always/mostly 176 (94.6) Never/rarely/sometimes 40 (21.5) 
Sometimes/rarely/never 10 (5.4) Mostly/always 104 (55.9) 
Don't know 42 (22.6) 
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Quality of treatment during Extent of trust in staff 
last visit confidentiality 
Very bad/bad/fair 17 (9 .1) Completely 89 (47.8) 
Very good/good 169 (90.9) Somewhat 26 (14.0) 
Not at all 40 (21.5) 
Not sure 31(16.7) 
Rating of services Extend of trust in staff skills 
Very poor/poor 30 (16.1) Completely 126 (67.7) 
Very good/good/fair 156 (83.9) Somewhat 20 (10.8) 
Not at all 17(9.1) 
Not sure 23 (12.4) 
Knowledge about HIV/AIDS and ARVs 
There is no cure for AIDS ARVs must be taken for life 
Agree 104 (53.1) Agree 140 (71.4) 
Disagree/don' t know 92 (46.9) Disagree/don't know 56 (28.6) 
A person with AIDS may not HIV/AIDS inakes it difficult 
look or feel sick for many for the body to fight other 
years illnesses 
Agree 124 (63.3) Agree 91 (46.4) 
Disagree/don' t know 72 (36.7) Disagree/don't know 105 (53.6) 
A person's CD4 determines 
whether they get ARVs 
Agree 138 (70.4) 
Disagree/don't know 58 (29.6) 
Limiting beliefs about HIV/AIDS and ARVs 
ARVs almost always ARV treatment is not simple 
improve the lives of those Agree 59 (30.1) 
taking them Disagree 129 (65.8) 
Agree 148 (75 .5) Don't know 8 (4.1) 
Disagree 4 (2.0) 
Don't know 44 (22.5) 
People in this community Traditional medicine can cure 
can readily access ARVS HIV 
Agree 84 (42.8) Agree 19(9.7) 
Disagree 17 (8.7) Disagree 95 (48.5) 
Don't know 95 (48.5) Don't know 82 (41.8) 
If you're not feeling sick you Traditional medicine is better 
don't need ARVs than ARVs 
Agree 17 (8.7) Agree 11 (5.6) 
Disagree 109 (55 .6) Disagree 112 (57.2) 
Don't know 70 (35.7) Don't know 73 (37.2) 
ARVs can make you feel sick It is too difficult to take 
Agree 40 (20.4) ARVS for life 
Disagree 86 (43 .9) Agree 56 (28.6) 
Don' t know 70 (35.7) Disagree 133 (67.9) 
Don't know 7 (3 .5) 
ARVs are very expensive for You know where to find 
patients resources to help deal with 
Agree · 21 (10.7) illness 
Disagree 93 (47.5) Agree 108 (55.1) 
Don' t know 82 (41.8) Disagree 88 (44.9) 
68 
Fear and Stigma (related to the client's HIV- positive status) 
Fear being blamed Would avoid getting 
Strongly/somewhat/agree 44 (77.2) treatment/ services because 
Strongly/somewhat/disagree 149 (22.8) someone might find out about 
HIV status 
Strongly/somewhat/agree 20 (10.2) 
Strongly/somewhat/disagree 176(89.8) 
Feel ashamed of HIV status Fear people hurting family if 
Strongly/somewhat/agree 83 (42.3) HJV status is known 
Strongly/somewhat/disagree 113 (57 .7) Strongly/somewhat/agree 76 (38.8) 
Strongly/somewhat/disagree 120 (61.2) 
Find it difficult to disclose Fear losing friends if HIV 
Strongly/somewhat/agree 166 (84.7) status is known 
Strongly/somewhat/disagree 30 (15 .3) Strongly/somewhat/agree 113 (42.3) 
Strong! y I somewhat! disagree 83 (57.7) 
See HIV as a punishment Fear being rejected by family 
Strongly/somewhat/agree 73 (37.2) if HIV status is known 
Strongly I somewhat/ disagJ_"ee 121 (61.7) Strongly/somewhat/agree 94 (48.0) 
Refuse to answer 2 (1.0) Strongly/somewhat/disagree 102 (52.0) 
Feel moving may be 
necessary because ofiDV 
Strongly/somewhat/agree 19 (9.7) 
Strongly/somewhat/disagree 177 (90.3) 
Familiarity with HIV/AIDS 
Know someone with 152 (77.5) Know someone who's gotten 115 (58 .7) 
HIV/AIDS healthier because of ARVs 
Know someone who died of 124 (63.3) Know someone who died 30 (15.3) 
HIV/AIDS after starting ARVs 
Know of friends/family 79 (40.3) 
taking ARVs 
Mental Health (before and after HIV testing) 
Symptom Before . After Symptom Before After 
Experienced Experienced 
Often had headaches 66 (33 .7) 93 (47.5) Difficulty enjoying 6 (3.1) 95 (51.5) 
daily activities 
Appetite been poor 25 (12.8) 84 (42.9) Difficulty making 4 (2.0) 99 (50.5) 
decisions 
Difficulties sleeping 12(6.1) 98 (50.0) Daily work suffered 4 (2.0) 88 (44.9) 
at night 
Felt nervous, tense, 8 (4.1) 124 (63 .3) Loss of interest in 4 (2.0) 92 (46.9) 
worried things usually 
enjoyed 
Trouble thinking 10 (5.1) 130 (66.3) Thoughts of suicide 1 (0.5) 20 (10.2) 
clearly 
Felt unhappy 8 ( 4.1) 134 (68.4) Felt tired all the ll (5.6) 93 (47.5) 
time 
Crying more than I (0.5) 48 (24.5) Total symptoms 
usual 0 119 (60.7) 35 (17.9) 
1+ 77 (39.3) 161 (82.1) 
Alcohol Use 
Drink alcohol I 56 (28.6) I 
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In bivariate analysis, several variables were associated with time to linkage. 
Unadjusted hazard ratios, 95% confidence intervals, and p-values for all variables 
explored are shown in Appendix 9. The multivariate analysis produced adjusted 
associations of predictors oflinkage to care at the p<0.05 level (Table 9). 
The multivariate model suggests that life circumstances, positive perceptions of 
the health care system, familiarity with HIV I AIDS, and mental health status are 
positively associated with the linkage to care. Specifically, we found that believing that 
drugs/supplies are generally available at the local health facility (AHR1. 78; 95% CI: 1.07 
- 2.96); experiencing 2:3 depression symptoms post diagnosis (AHR 2.09; 95% CI: 1.24-
3.53); having 4 or more non-financial dependents (AHR 1.93; 95% CI: 1.07- 3.47); and 
knowing someone who died ofHIV/AIDS (AHR 1.68; 95% CI: 1.13- 2.49) were 
associated with an increased incidence of linkage. 
The multivariate model also suggests that large household membership, young 
age, disbelief of test results, time barriers to healthcare, limiting beliefs about ART, and 
. alcohol use are negatively associated with linkage to care. Specifically, we found that 
younger age (16-24 years) (AHR 0.5; 95% CI: 0.28- 0.91); living with 2:2 adults (AHR 
0.52; 95% CI: 0.35- 0.77); not believing or being unsure about the test results (AHR0.48; 
95% CI: 0.30-0. 77); difficulty finding time to seek health care (AHR 0.40; 95% CI: 0.24 
- 0.67); believing ART can make you sick (AHR0.56; 95% CI: 0.35- 0.89); and 
drinking alcohol (AHR0.52; 95% CI: 0.34- 0.80) were all associated with a decreased 
incidence of linkage. 
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Both the graphical and goodness.:of-fit tests show that that the proportional 
hazards assumption was not violated for any of variables included in the final model. 
Cox-Snell residual testing indicated that no outlying observations disproportionately 
affected the outcome. 
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Table 9. Multivariate associations of client characteristics and linkage to care among HIV-positive HBHCT clients 
Variable n # clients who linked Rate of linkage per Unadjusted HR 
to care I person-days 100 person-days (95% C.l.) 
Household size 
<3 adult members 123 90/6562 1.4 1 
2:3 adult members 73 46/6364 0.7 . 0.62 (0.43 - 0.89) 
Age group 
16-24 30 13/3081 0.4 0.41 (0.23- 0.73) 
25+ 166 123/9845 1.3 1 
#People for whom a caregiver 
0-3 27 13/2540 0.5 1 
4+ 169 123/10385 1.2 1.85 (1.04- 3.27) 
Believed HBHCT results 
Yes 141 112/7611 1.5 1 
No/not sure 55 24/5315 0.5 0.37 (0.24 - 0.58) 
Finding time to go to the facility 
Not a problem 155 114/9211 1.2 1 
Big/small problem 41 22/3715 0.6 0.56 (0.35- 0.88) 
Perceptions drug/supply availability 
Never/rarely/sometimes 40 21 /4310 0.5 1 
Mostly/always 104 80/5627 1.4 2.05 (1.26- 3.33) 
Don' t know/never been to clinic 52 35/2989 1.1 1.85 (1.07- 3.20) 
ART can make you feel sick 
Agree 40 25/3811 0.7 0.65 (0.42- 1.02) 
Disagree/don 't know 156 111 /9115 1.2 1 
Know someone who died ofHIV/AIDS 
Yes 124 9317817 1.2 1.42 (0.98 - 2.04) 
No 72 43/5109 0.8 1 
Total mental health symptoms after 
HBHCT 35 18/3001 0.6 1 
1-2 161 118/9925 1.2 1.69 (1.03- 2.77) 
3+ 
Drink alcohol 
Yes 56 33/3918 0.8 0.69 (0.47- 1.03) 
No 140 103/9008 1.1 1 
Adjusted HR 
(95% C.l.) 
1 
0.52 (0.35- 0.77) 
I 
0.50 (0.28- 0.91) 
1 
1 
1.93 (1.07 - 3.47) 
1 
0.48 (0.30- 0.77) 
1 
0.40 (0.24 - 0.67) 
1 
1.78 (1.07- 2.96) 
1.83 (1.03- 3.28) 
0.56 (0.35 - 0.89) 
I 
1.68 (1.13 -2.49) 
I 
1 
2.09 (1.24- 3.53) 
0.52 (0.34 - 0.80) 
I 
Discussion 
Findings from the univariate analysis of variables measured in the survey 
highlight some impmtant issues that may require further attention. Substantial 
knowledge gaps surrounding HIV and ART exist, indicating a need for greater education 
and awareness raising, possibly as part ofHBHCT or more broadly. Additionally, a 
sizeable proportion of clients indicated having barriers to seeking healthcare such as lack 
of finances or distance to the clinic. This may require implementation of strategies to 
facilitate access to services. Many clients also had concerns about the availability of 
drugs/supplies and the level of confidentiality maintained by healthcare staff, which 
could reflect actual circumstances or unfounded fears. This may require improvements at 
the facility level as well as awareness raising within the community about the quality of 
services available. Fear and stigma were also notably high and may need to be addressed 
prior to or as an integral component ofHBHCT. 
While univariate analyses identified many challenges and barriers that are 
conventionally well understood and similar to what is cited in the existing adherence 
literature,85• 86• 91 • 92• 97 the adjusted analysis identified factors specifically influencing the 
linkage to care following home-based testing. Each of the ten factors found to be 
significantly associated with linkage are discussed further below. 
Adult household membership. Clients who live with 2 or more adults are less 
likely to link to care than those living alone or just with one adult. This may be explained 
by the fact those living with more adults in the house have greater household 
responsibilities and thus less time and oppmtunity to seek care. Additionally, they may 
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find it difficult to leave the house or attend to personal affairs, without providing an 
explanation or prompting unwanted questions. Lack of disclosure to other household 
members may also inhibit care-seeking. This finding is in contrast to what was found by 
Nakigozi et al., where people living alone or in households with 1-2 co-residents were 
less likely to enroll in care following VCT. 105 Importantly, our study did not assess 
household size inclusive of children. Since having children in the house is common in 
this setting, living with less adults may not necessarily indicate the same level of social 
isolation identified in that study. 
Age group. Similar to other studies, 103' 105 adolescents and young adults are less 
likely to link to care than older adults. Youth may struggle more with acceptance and 
disclosure of their status. Additionally, some may live and attend school in areas away 
from the home, where they may be busy, unfamiliar with the setting, or generally feel 
uncomfortable seeking health services. Youth may also have less social support and 
fewer independent financial resources to seek care, and may have less freedom to leave 
the home without explanation. It should also be acknowledged that youth may have felt 
pressured to test by others in the home, and may not have been ready to deal with the 
consequences of testing HIV -positive. 
Non-financial dependents. Clients who have 4 or more people relying on them for 
something other than money (e.g. cooking, washing, shopping, care-giving, emotional 
support) are more likely to seek care than those with fewer dependent people. This may 
be explained by the fact that such individuals are more socially connected and perhaps 
also feel more "needed", providing greater motivation for self-care. People reliant on 
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them may include children, the elderly, and imp011antly people living outside the home 
such as parents or in-laws. Attending to the needs of people outside the home may also 
provide opportunities to travel and access care without questioning from household 
members. In this sample, most clients reported having several people reliant on them 
(median= 7 people), thus it may be the case that those having a small number of 
"dependents" are uniquely socially isolated. Supporting the theory that having 
dependents could positively influence care seeking behavior, Kigozi et al. found that 
having young children in the home was associated with presentation for HIV care at an 
earlier (less severe) stage of illness. 56 
Belief of test results. Clients who did not believe or were unsure about their test 
results were less likely to link to care than those who did believe their results. Field notes 
taken at the time ofthe interview indicate that this disbelief stemmed more from denial or 
non-acceptance of results based on the client's level of perceived risk or previous testing 
experiences rather than from doubt about the quality or reliability of the testing 
procedure. This is supported by the fact that the majority of clients had a favorable 
impression ofHBHCT and the counselor' s skills. Clients who have not yet come to terms 
with their HIV -positive status would naturally be unlikely to seek care. Our findings are 
consistent with other studies. For example, Fitzgerald et al. found that in Haiti, denial at 
the announcement of test results was associated with lower odds of seeking medical care 
following VCT. 123 Amollah et al. also found that 22% ofhome-based testing participants 
did not believe the test result and this was also cited by clients as a reason for not seeking 
care. 103 
75 
Difficulty finding time to seek healthcare. Clients who reported that finding time 
to seek healthcare is either a "big" or "small" problem were less likely to link to care than 
those who reported it was not a problem. In this poor, rural setting, people, particularly 
women (who comprised the majority ofthis sample) are often occupied with the daily 
tasks of living, such as fetching firewood, cooking, washing, child or elder care, and 
making home repairs. Others are also engaged in various livelihood activities, and during 
certain seasons, agricultural activities such as planting or harvesting may also occupy 
much of their time. In comparison, these daily activities are likely to seem more urgent 
than seeking care, particularly if people are not feeling ill or face difficulties accessing 
· care. Although lack of time is not specifically noted as a barrier in other studies, access 
issues in terms of long distances to facilities and long waiting times are common in sub-
Saharan Africa. 124-126 Thus this variable likely reflects clients' assessment of personal 
responsibilities coupled with knowledge of the extensive time costs involved in care 
seeking. 
Perception that drugs/supplies are not available. Clients who believe that drugs 
and supplies are generally available at their local health facility or even those with no 
knowledge about drug/supply availability, are more likely to link to care than those who 
believe that they generally are not available. Mfirming the validity of clients' negative 
perceptions, a recent report on inspections of primary health care delivery sites in South 
Mrica found that among visited sites, 64% lacked sufficient medl.cation, while 84% 
lacked sufficient medical equipment. 127 It may be that poor past experiences and 
perceptions of the health care system influence care seeking behavior when it comes to 
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addressing a new HIV diagnosis. This is not surprising considering that poor perceptions 
of the health care system appear to hinder health care utilization more generally in many 
pmts of sub-Saharan Africa. 128.124' 125' 129' 130 Lack of trust in the health system has also 
been noted as an important barrier to uptake ofHIV testing services. 131 Interestingly, 
Bakeera et al. found that in Uganda, among focus group participants from the poorest 
wealth category, perceptions of the quality of care offered by public health services were 
low, notably with regard to shortages of essential supplies. 128 
Belief that ARVs can make you sick. Clients who believe that ARV treatment can 
make you sick are less likely to link to care than those who do not hold this belief. It may 
be that clients who feel well and are anxious about the side effects of treatment avoid 
obtaining a CD4 count due to fears that they may also be asked to start treatment. This is 
in line with findings from recent studies showing that fear of side effects is an important 
barrier to both ART initiation and adherence in sub-Saharan Africa. 132• 133 
Separate from fears of illness, this finding may also be explained in part by 
cultural belief systems about illness and medicine. For example, a qualitative study in 
rural Mozambique found that people's belief that "good" medicine should be curative 
was a deterrent to ART adherence. The authors suggest that the concept of chronic 
disease management still remains unfamiliar in many communities. 129 As such it is 
conceivable why, particularly in the absence of symptoms, the prospect of having to take 
medication that would not cure you, and which may also result in the onset of illness 
would be unappealing. Given that half ofthe clients who tested within HBHCT were 
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immediately eligible for treatment, it is critical that potential fears and beliefs regarding 
treatment be further explored and addressed. 
Know someone who has died ofHIV/AIDS. Clients who know someone who has 
died of AIDS are more likely to seek care. This may be because they have experienced 
the loss of a friend or family member, and are thus motivated to avoid the same fate. 
Education about the benefits of ARV's with regard to quality and longevity of life may 
thus raise awareness among those without similar experiences and motivate them to seek 
care. An alternative explanation for these fmdings can be drawn from a recent study in 
South Africa, which assessed changes in stigma following an intervention. The 
investigators found that a decreasing stigma score was significantly associated with 
knowing someone who had died from HIV I AIDS. 134 This may particularly be the case if 
those who died were close family or friends, since HIV -related stigma is likely to be 
mitigated through such intimate relationships. 
Presence of depression symptoms following HIV diagnosis. Clients who have 
experienced 3 or more symptoms of depression following the HIV diagnosis are more 
likely to seek care than those with fewer symptoms. This may be in part because 
depression is the result of clients truly accepting and coming to terms with their illness, 
whereas those in denia! may not have internalized the diagnosis. The depression 
symptoms may also heighten the feeling of being unwell and prompt them to seek care 
and treatment. In this sample, the majority of clients reported experiencing several 
depression symptoms following the diagnosis (median = 7 symptoms), thus those with 
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significantly fewer symptoms may be different in the way they processed and coped with 
the diagnosis. They may have even still been in denial about their status. 
Recent miicles about depression among HIV -positive clients suggest that it is an 
under-recognized problem that healthcare providers should better understand and address 
as part of standard HIV care. 135-138 Further, cunent evidence indicates that depression not 
. . 1" fl"~ b - 1 dh 139 140 d only has a negative rmpact on qua 1ty o 11e, ut a so on treatment a erence, · an 
on viral suppression and retention in care. 141 Thus, while it is encouraging that clients 
with depression are seeking care, given that mental health care is not integrated within 
cUITent HIV I AIDS care in most rural areas in South Africa, these findings draw attention 
to an important gap in service delivery. 
Drink alcohol. Contrary to one study56, our findings indicate that clients who 
drink alcohol have a lower incidence of care seeking than those who do not. Those who 
drink may be less likely to seek care because of impaired judgment or drinking itself may 
be a sign of poor self-care. Although most clients who reported drinking reported social 
or fairly infrequent drinking, it is possible that alcohol use could increase as a way to 
cope with the HIV diagnosis. CUITent evidence shows that alcohol use is associated with 
poor adherence to ART142· 143 and enhanced disease progression, 144 and may also 
influence the use of drugs to treat common opportunistic infections associated with 
HIV .145 Coupled with our findings, this suggests that alcohol users may require additional 
attention and assistance to ensure successful linkage and retention in care. 
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Limitations 
The findings should be viewed in light of important limitations. Logistic 
regression using an outcome of linking to care within 3 months would have provided a 
more direct answer to the question about which factors influence timely linkage. 
However, our limited sample size and the common outcome limited the precision of 
estimates that were derived from this type of analysis. Further, there was considerable 
variation in follow up times for our clients. Thus, Cox regression was selected as the next 
best alternative, since it allowed full utilization ofthe available data with reasonable 
precision. This does, however, limit the interpretation of fmdings, which only provide an 
understanding of the factors associated with the rate of linkage to care rather than with 
timely linkage. That said, the influential factors identified by this analysis were the same 
as those identified by the less precise logistic regression. 
Another important limitation of the Cox regression analysis is the underlying 
assumption that all clients would eventually have the outcome of interest- in this case, 
obtaining a CD4 count. However, the analysis may be impacted by the fact that the 
sample is made up of HIV -positive clients, some of whom may have died at some point 
post-testing and thus would never obtain care. Offsetting this limitation, only one client 
known to have died during the study period was included in this analysis. Further, the 
likelihood of the counselor learning of a death was high given that they were either from 
the communities or would have learned of it from household members when attempting 
to meet clients for follow up visits. Additionally, the majority of clients included in the 
analysis who did not obtain care had at least 3 months of follow up time, with a sizeable 
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proportion having 6 or more months. Thus we have a reasonable amount of total 
observation time free of death. 
Due to unanticipated circumstances, the study started later and ended earlier than 
planned. Thus the sample size was less than half of what was intended, and may have 
lacked power to detect significant relationships between the outcome and all relevant 
predictor variables. This may particularly be the case for variables with more 
homogeneity. The small sample size also prohibited stratification by gender, which may 
have important implications given that different factors may be more or less influential 
for care seeking between males and females. The sample size and limitation of the study 
to one geographic area may also limit the generalizability of our fmdings. 
Although we followed HIV -positive clients prospectively from the time of testing, 
only a sub-set of clients were included in this analysis. Since only those who tested after 
the implementation of the cross-sectional survey and who could be met in person 
following testing were interviewed, this may have led to sampling bias and a consequent 
mis-estimation of'rates of linkage. Those who did not participate in the study because 
they moved, refused a visit, or could not be contacted may have different care seeking 
behavior, and in particular may be at risk of delayed or non-linkage to care due to stigma 
or other social factors. As a result, selection bias may have also led to an underestimation 
of the extent to which certain social and inter-personal factors predicted the linkage to 
care. 
Since some of the data on predictive factors was obtained after many clients had 
aheady obtained a CD4 count, it is difficult to ascertain the direction of causality for the 
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associations found. However, given their nature, most ofthe associated factors are 
unlikely to have been affected by care seeking itself. Finally, due to the methods and 
timing used to measure disclosure in this study, it was not possible to include this 
variable in the multivariable analysis, despite the fact that it is likely to be an influential 
factor with regard to care seeking. 
Conclusion 
This is the only study to date that explores factors associated with the linkage to 
care following home-based HIV counseling and testing. It addresses a broad range of 
individual, community, relationship, and health systems factors, which is important given 
the complex array of issues that HIV -positive clients may face when receiving, coping 
with, and addressing an HIV diagnosis. The fmdings highlight important gaps in our 
understanding and draw attention to critical areas where practical interventions and 
strategies may be needed to address clients' needs and improve linkage to care. Specific 
strategies will be discussed further in Chapter 7. 
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KEY MESSAGES 
•!• The following characteristics motivate clients to link to care: 
o Having a broader network of non-financial dependents 
o Believing that drugs/supplies are available at the local health 
facility or lacking knowledge about drug/supply availability 
o Knowing someone who died ofiDV/AIDS 
o Experiencing more symptoms of depression 
•!• The following characteristics hinder clients from linking to care: 
o Living with more adults 
o Being younger (i.e. youth or young adult) 
o Not believing or being unsure about the test results 
o Having difficulty finding time to seek health care 
o Believing that ART can make you sick 
o Drinking alcohol 
•!• Strategies should be implemented to address barriers to linkage 
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Chapter 5: 
Client Experiences and Perspectives on Linkage to Care 
Aim 
The primary aim of this component of the study was to gain an understanding of 
the personal characteristics and circumstances that may affect the timing and linkage to 
care following home-based HIV counseling and testing. 
Methods 
This was a qualitative study that was conducted as part of the Good Start HBHCf 
intervention trial. The sample was drawn from the same cohort of HIV -positive clients 
described previously. 
Data collection 
The study utilizes data from two key sources: 
• In-depth interviews 
• Field notes collected during the cross-sectional survey 
In-depth interviews (IDI). In-depth interviews were conducted with a sub-sample 
of 30 HIV -positive HBHCf clients drawn from the prospective cohort study described in 
Chapter 3. Throughout the study, clients were purposively selected based on their care 
seeking behavior. For example, to understand the factors that may have encouraged 
timely linkage, we interviewed clients with verified clinic records who sought care within 
three months. Conversely, to better understand the reasons that may hinder or delay the 
linkage to care, we interviewed clients who self-reported not having sought care four or 
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more months following HBHCT. Clients were drawn from 12 ofthe 19 community 
clusters comprising the full study and thus reflect potential differences such as varied 
catchment clinics and distances from health facilities. 
The interviewer was a female field supervisor, separate from the counselors 
implementing the intervention. After reviewing their records and noting the receipt and 
timing of a CD4 count, she contacted clients and invited them to participate in the 
interview. Some clients were approached in their homes, while others with working 
phones were called to set up an appointment. Since clients were already enrolled in the 
larger study, they were accustomed to contacts and visits from the study team. Five 
clients refused participation in an interview because they felt uncomfortable with the 
follow up visit. The completed sample included 30 clients, at which point the study had 
reached thematic saturation. Fifteen of these clients had also participated in the cross-
sectional survey described previously. 
Clients were met in their homes, and once they agreed to be interviewed, were 
taken to a private room or area of the home. The interviewer then read aloud a consent 
form (Appendix 1 0), translated to a mixed dialect of Zulu/Xhosa, and consenting clients 
signed the form or provided a thumbprint if they could not write. The interviewer used a 
semi-structured interview guide (Appendix 11) with open-ended questions to explore 
experiences of home-based HIV counseling and testing and the linkage to care. As is 
common with qualitative research, questioning was adjusted over time and within 
interviews as needed to explore emerging issues. All interviews were conducted in the 
mixed dialect of Zulu/Xhosa commonly spoken in the area. A digital tape recorder was 
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used to record all interviews, which generally lasted about 35 minutes. After the 
interview was complete, participants were offered a food parcel as a token of appreciation 
for their time. A few participants refused the food parcel for fear that family members 
might question it or because they felt it made them feel like a "sick person." Most others 
expressed gratitude for it. 
Field Notes (FN). As part of the cross-sectional interviews described in Chapter 4, 
the interviewer was instructed to take notes on any issues of importance that were not 
adequately captured by the survey. All notes were written in English. While these notes 
were not initially intended to be utilized as data, the investigator felt that the content was 
informative and would complement the in-depth interviews well. Thus field notes for 196 
clients were added as an additional data source for the qualitative study. These notes 
represented clients from 16 of the 19 study clusters. 
Data analysis 
The tape-recorded in-depth interviews were transcribed verbatim into their 
original language by two transcriptionists separate from the study team. To make the 
transcripts accessible to the investigator, they were then translated into English by the 
same individuals. In order to maintain participants ' confidentiality, all audiotapes and 
interview transcripts were labeled only with the cluster name and 5-digit unique study ID 
number. To monitor transcription and translation quality, a senior member of the Good 
Start study team fluent in Zulu/Xhosa, as well as English, cross-checked a sample of 
interviews throughout the process and provided feedback to the transcriptionist/translator. 
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No major discrepancies were identified. The 196 handwritten field notes were typed 
verbatim in English. Most were a few sentences to a paragraph long. 
During analysis, the investigator read through all 30 in-depth interview transcripts 
and the 196 field notes, reflected on key themes, and developed an outline of the primary 
elements emerging from the data. A second reader separate from the study team, read 
through a 20% sample of in-depth interview transcripts (n=6) and field notes (n=40), and 
independently developed an outline Of recurrent themes. The next step in the analysis 
involved sharing the thematic outlines, reflecting on key messages, clarifying emerging 
ideas, and identifying new patterns. Based on this, the investigator developed a codebook 
broadly outlining key concepts. The codebook was discussed and further modified with 
the second reader (Appendix 12). 
In order to ensure internal validity and that the codebook adequately captured all 
relevant concepts, the investigator and 2nd reader each coded another 10% sample ofthe 
same in-depth interview transcripts (n=3) and field notes (n=20). The coding schemes 
were compared and generally found to be similar. Any discrepancies were used to further 
refme the codebook, clarify key themes, and inform future coding. The investigator then 
independently coded the remainder of transcripts and field notes. Qualitative software 
Atlas.ti version 7.0.71 was used to code, sort and categorize the data. Content analysis 
was used to identify the most important emerging themes. Further analysis was 
conducted by exploring the patterns that emerged when qualitative and time-to-CD4 data 
(drawn from the prospective cohort sub-study) were paired. Key themes were written up 
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and refined after further discussions with the 2nd reader as well as the broader research 
team. 
Results 
Of the 30 clients who participated in an in-depth interview, 24 (80%) were female 
and 6 (20%) were male, reflecting the underlying population. General characteristics of 
IDI participants were similar to those included in the sub-studies described previously 
(Table 10). A total of21 IDI participants linked to care at some point during the study; 14 
linked to care within 3 months while 7 delayed and linked within 107 - 520 days. The 
other nine clients interviewed hadn't linked to care by the last point of contact, which 
ranged from 123-542 days following HBHCT. As described in Chapter 3, 123 (62.8%) 
ofthe 196 clients with field notes, obtained a CD4 count within 3 months ofHBHCT. 
The rest delayed or did not seek care. 
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Table 10. Characteristics of clients included in the qualitative analysis 
Characteristic Clients included in Clients whose field Clients who 
prospective cohort notes were included participated in 
analysis (N=359) in the qualitative the in-depth 
analysis interviews (N=30) 
(N=l96) 
n (%) n(%) n(%) 
Household size 
<3 adult members 227 (63.2) 123 (62.8) 20 (66.7) 
> 3 adult members 132 (36.8) 73 (37.2) 10 (33 .3) 
Gender 
Male 63 (17.6) 40 (20.4) 6 (20.0) 
Female 296 (82.4) 156 (79.6) 24 (80.0) 
Age Group 
16-24 73 (20.3) 30 (15.3) 6 (20.0) 
25-49 224 (62.4) 123 (62.8) 18 (60.0) 
50+ 62(17.3) 43 (21.9) 6 (20.0) 
Marital status 
Single 156 (43.4) 73 (37.2) 12 (40.0) 
Married/Co-habitating 146 (40.7) 89 (45.4) 13 (43.3) 
Divorced/Separated/Widowed 57 (15.9) 34(17.4) 5 (16.7) 
Ever tested prior to HBHCT 
Yes 181 (50.4) 88 (44.9) 14 (46.7) 
No 178(49.6) 108 (55.1) 16(53.3) 
The linkage to care appears to be affected by a variety of factors, which likely 
operate in concert. Clients each have a unique set of circumstances, which include 
potential barriers and facilitating factors, not all of which necessarily hinder or encourage 
linkage, respectively. In some cases, a combination of various difficult circumstances 
may ultimately hinder linkage, and similarly a combination of positive circumstances 
may facilitate linkage. For some clients, motivation to seek care may have been 
hampered by certain practical realities, whereas for others, such barriers were easily 
overcome. A combination of the "right" factors, different for each person, is needed to 
ultimately drive timely linkage. 
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Despite the complexity, this analysis identified four key factors that appear to 
play an important role in either hindering or facilitating the linkage to care. Difficult life 
circumstances leading to limitations on time and financial resources, and poor 
experiences with the healthcare system were clear barriers to linkage. Additionally, 
timing of linkage to care seemed to be influenced by the nature of clients' responses to 
the diagnosis, and the level of support received through personal relationships. These 
fmdings are described below using illustrative client quotations and observations from 
the cross-sectional survey interviewer. Quotations are marked as IDI, indicating their 
source as the in-depth interviews. Interviewer observations are marked as FN, indicating 
their source as field notes. 
Life hardship 
This intervention operated in a poor, rural area where most people face a rather 
harsh daily reality. Extreme fmancial hardship, coupled with numerous household and 
caregiver responsibilities are the norm. Clients generally appeared to be in a constant 
struggle for survival, trying their hardest to fulfill the important roles of caring for their 
family members and/or engaging in various livelihood activities to make ends meet. This 
often meant dedicating their days to caregiving, doing temporary jobs, moving to urban 
areas for work, or finding ways to stretch government grants. 
Given the setting and circumstances, it is not surprising that some clients reported 
limited finances as a direct cause of not seeking or delaying the linkage to care. Since 
care at government facilities is free in South Africa, fmancial challenges referred to by 
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clients generally relate to transport costs. Cost of care would, however, be of concern for 
those who desire to seek care at a private doctor. 
My sister I have been poor. I have been having problems sister. Whatever I have been 
getting I've been getting through hard work. I had to do some work before getting money. 
I was not going to take that money and go to [name of health facility] when my children 
don't have food you see that.- Female, 47 years, had not linked to care at last point of 
contact (231 days) [IDI] 
.. 1 delayed taking [the referral letter] because I didn't have money because my 
grandmother got sick. I wasted my money by taking her to Pietermaritzburg. -Female, 
24 years, linked to care in 167 days [IDI] 
She did not go for a CD4 count, she is having money problems since she only receives a 
grant. Her husband stays and works in Durban but he is not taking care of them, he went 
many years ago and he is not giving them any money. The grant that she is receiving is 
for her disabled child who is studying at Potchefstroom. She said immediately she gets 
some money she will go to [name of clinic] to do a CD4 count.- Female, 46 years, linked 
to care in 64 days [FN] 
Several clients also reported that being busy with livelihood activities or 
searching for work limited their time and were important factors in hindering or delaying 
the linkage to care. 
She didn't go for a CD4 count. She said she is busy, she doesn't have time. She is selling 
chickens so no one will take care of the chickens if she goes to the clinic but she will try 
to go to a mobile clinic.- Female, 43 years, had not linked to care at last point of contact 
(147 days) [FN] 
She said she did not go to the clinic, she said she is always busy since she is working at a 
school cooking. She said she will go immediately when school closes. - Female, 42 years, 
had not linked to care at last point of contact (74 days) [FN] 
Interviewer: Wait then baba how long did it take you to take this letter that you were 
given by the counselor to the clinic? 
Respondent: ... it took me some time because ... I have been busy, not having time .. 1 have 
been busy my sister, I have been walking up and down [looking for a job] as you can see 
that I am unemployed.- Male, 56 years, linked to care in 213 days [IDI] 
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Other clients who were not working explained that despite their desire to obtain a 
CD4 count, caregiving responsibilities and other circumstances at home limit their time 
and oppmiunities to attend a health care facility . 
... I've been staying with my grandmother the whole day ... . my mother gets off only on 
Saturdays, she works from Monday to Saturday. On Saturday she knocks off at 3pm and 
clinics don't operate on Sundays. That 's the thing that has been making me not be able to 
go to the clinic. -Female, 20 years, had not linked to care at last point of contact (146 
days) [IDI] 
She said she didn 't go for a CD4 count because she is taking care of her grandchild when 
her daughter in-law is at school, but as soon as she finishes her exams she will go to the 
clinic.- Female, 48 years, linked to care in 195 days [FN] 
.... the other thing that hits me hard is that I don't get a chance to go to the clinic since 
I'm staying with this [disabled] child while others are at school ... I'm unable to go to the 
clinic, I find that I'm really unable to go ... it 's bad even if I want to .... I find that I'm 
unable to ... no matter how much I want to but I can 't. In order for me to go to the clinic I 
have to absent one child from school because it 's difficult to leave your child with 
someone ... when you come back from the clinic he really is hungry because when you get 
to the clinic it will be full ... your child is hungry and you can see that the nappy has not 
been changed and you just get fed up. -Female, 29 years, linked to care in 131 days [IDI] 
Challenges with the health care system 
While some clients reported satisfaction with the process of accessing and 
receiving healthcare, it was far more common for them to report dissatisfaction, 
particularly with regard to waiting times, treatment by staff, and confidentiality. Clients' 
comments make it evident that seeking healthcare in this environment can often be a very 
cumbersome, challenging, and frustrating experience. 
[The clinic} becomes too full, sometimes you will go there and nothing will be done to 
you because there are a lot of people. Sometimes by the time you get there the gate is 
closed and they will say they only want 50 people. You have to wake up while it 's still 
dark and go to the clinic. By the time they open at Bam you are already waiting at the 
gate .... even now the person who woke up early in the morning she went at 4 am in the 
dark, she is not back yet. -Female, 48 years [IDI] 
92 
She said she doesn't trust [name of clinic} staff. .. because ... they don 't have 
confidentiality. They talk about people's illnesses ... -Female, 58 years [FN] 
Given this context, it is not surprising that several clients cited negative 
experiences at a healthcare facility as a reason for non-linkage or delays in linkage 
following HBHCT. 
Interviewer: Where is the [referral] letter? 
Respondent: I haven't taken it to the clinic [laughing]. 
Interviewer: Why haven't you taken it to the clinic? 
Respondent: It's just that the nurses there they like shouting, that's what scares me they 
like shouting. -Female, 20 years, linked to care in 107 days [IDI] 
I once went to the clinic because I had a headache and [name of nurse] was rude 
towards me ... she just became rude towards me and because I'm short tempered I told 
myself that I will never go there again and up until today I have never been there ... I'm 
not educated but I have feelings too and I will never go there. - Female, 4 7 years, had not 
linked to care at last point of contact (231 days) [IDI] 
Some clients also expressed a general disinterest in care seeking, regardless of the 
nature of the health issue. Their sense of not being a "clinic person" or having a general 
aversion to the healthcare system seemed to carry over to the current situation as well. 
It's just that sister I don 't want to lie, when I'm pregnant I don't even go to the clinic at 
all. It always eats me up to know that I must go to the clinic as it is now discovered that 
there is something wrong with my blood. You see? ... Ijust become lazy, I really don 't like 
the clinic. -Female, 38 years, had not linked to care at last point of contact (226 days) 
... it 's just that the clinic is not something that I value much because even if I have flu I'm 
not a person who likes going to the clinic.- Female, 32 years, had not linked to care at 
last point of contact (542 days) [IDI] 
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Given the tight social networks in these communities, circumstances such as 
knowing staff at the clinic and not necessarily wanting to disclose to them also pose 
challenges to care seeking. 
She didn 't go for a CD4 count. She said at [name of clinic}, the nursing sisters there are 
rude, at [name of another clinic}, the counselors know her so she can 't risk her 
friendship with them by re-testing with them, because before doing a CD4 she wants to 
re-test ... - Female, 25 years, had not linked at last point of contact ( 146 days) [FN] · 
Respondent: ... I don't want to go to the local clinics, I'm going to go to [name of another 
more distant clinic}. 
Interviewer: What makes you not to attend local clinics that are here ... ? 
Respondent: No, they know me and they also know my aunt and everybody knows her and 
she may know this issue just like that. -Female, 20 years, had not linked to care at last 
point of contact ( 146 days) [ID I] 
While some clients express a desire and manage to seek care at other facilities, 
attending a private doctor or a preferred clinic outside of their own communities may 
require additional time and fmancial resources that are not always readily available. 
Respondent: I haven 't done anything with [the referral letter} .. . because staff at the local 
clinic don 't have confidentiality ... I've heard them talking about other people ... I have to 
use money to go to the clinic that I like but then I don't have money yet. -Female, 22 
years, had not linked at last point of contact (192 days) 
She said she did not go for a CD4 count. She is planning to go and do it at a private 
doctor. She said she doesn't like the clinic because they don't have confidentiality. -
Female, 37 years, had not linked at last point of contact (202 days) [FN] 
Importantly, a substantial number of clients reported attempting linkage, however, 
encountering a problem in the process. Only some clients tried again, and others delayed, 
resulting in a considerable number of missed opportunities. Some challenges were related 
to facility closings. 
94 
She did not take the referral letter to the clinic because there was a strike ... she said as 
soon the strike ends she will go and do a CD4 count at [name of clinic}.- Female, 73 
years, linked to care in 126 days [FN] 
She said she went to the clinic on the 2F1 December, 2010 (13 days after testing) but the 
clinic was closed for Christmas. She is now planning to go in the coming weeks.-
Female, 52 years, had not linked to care at last point of contact (187 days) [FN] 
Others were related to poor treatment or shortages in staff or supplies . 
.. . she went for a CD4 count at [name of clinic}, and they told her that they don 't have 
forms to fill in that must be attached with the blood for the lab ... a nurse called the 
counselor who works in the clinic who lives in her area and told her that when the forms 
for CD4 count arrive you must tell this lady to come to the clinic.- Female, 19 years, 
linked to care in 140 days [FN] 
She said she went to [name of clinic} to do a CD4 count in January (same month as 
testing) but they didn 't do a CD4 count, she was told that they don't have needles ... 
Female, 18 years, linked to care in 53 days [FN] 
She went to [name of clinic} on the 1 i 17 January 2011 (3 days after testing), but they read 
her referral letter and gave it back to her because the sister-in-charge was not there to do 
a CD4 count.- Female, 63 years, linked to care in 53 days [FN] 
Meanwhile some clients encountered logistic challenges. 
[The nurse} told me to go and join the queue and it was full ... I could see that time was 
against me and there was no transport and there was nothing that I was sitting there for. 
That is when I came back with that [referral] letter that later got lost and burnt with the 
goods.- Female, 26 years, had not linked at last point of contact (521 days) [IDI] 
Given the already challenging nature of attending the clinic - with regard to time, 
money, effort, and motivation, it is not difficult to imagine that clients who have poor 
experiences with the healthcare system feel disillusioned about the whole process, which 
may result in further delaying or not even re-attempting to seek care. The following 
clients clearly illustrate the sense of deflation that can arise from such frustrating 
expenences. 
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I tried to take [the referral letter J to [name of clinic} where I wanted to take it to because 
at [name of local clinic} I'm avoiding my neighbors on certain things, only to find that in 
this clinic ... they say, why have we left the [name of local clinic]? !was then annoyed and 
came back because they said 'why do you come here and leave your clinic? ' I told [name 
of counselor] what I have encountered at the clinic ... ! said 'well! need to take a break 
for now, I will go another time' .. . it is just that I was disappointed that day since I was 
keen to know my CD4 count and !lost interest and I said 'well, I will go back again '. -
Female, 43 years, had not linked to care at last point of contact (176 days) [IDI] 
No, I'm not satisfied with treatment at the clinic because you get there and test, do you 
hear? They tell you that you are going to get assistance ... and when you get there saying 
that I'm here to check my results they will say that no there is no one. Or else you will 
say I want to draw blood, they will tell you that the person who draws blood is not 
here ... you just lose hope because you come from far ... you come dragging yourself 
because you also don't like what you are there to do it's just that you have to. Then you 
get there and find that there is no one that encourages you. No, the person who checks 
results is not there, no, we don't draw blood today, no, we are busy, you see that? You 
then again tell them that you are suffering from something and they have to take care of 
you. They have to sit down and think about it especially when they know your health 
status .... yes now you just become lazy if you have to go back ... -Female, 29 years, 
linked to care in 131 days [IDI] 
The clinic is far and I 'm not working, I found only one nurse you see, I was pregnant with 
this child and she said she is not checking pregnant people. She then read and read the 
[referral] letter I gave her and she said just come back on Tuesday because other nurses 
are not here. 
When the same client was asked whether she had tried again to take the referral letter to a 
health facility, she said: 
I haven 't returned back, the clinic issue is tiring, it's not a pleasing one. Even if you 
have arrived there you don't get help. Even now I forgot I didn't go back with it. -
Female, 38 years, had not linked to care at last point of contact (226 days) [IDI] 
Response to the diagnosis 
Clients' response to the diagnosis seems to play an important role in the linkage to 
care. The response is characterized by both their reactions to and their attitudes about the 
diagnosis. Although clients' reactions were naturally on a continuum, with thoughts and 
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emotions changing over time, they generally fell into two groups - those who were 
relatively quickly able to accept and believe their results versus those who grappled with 
and/or did not believe their results. Clients' attitudes could also be grouped into two 
general categories - motivated versus apathetic. Although most clients did not explicitly 
identify these issues as affecting their care seeking behavior, very distinct patterns 
emerged when pairing the qualitative information with the time-to-CD4 data. 
Positive reaction: acceptance and belief of HIV status 
Although they may have felt upset, disturbed, or even struggled with acceptance 
for a period of time, a common response to the diagnosis among clients who quickly 
linked to care was an expression of acceptance or at the least, resignation about their HIV 
status. Thus it seems that having come to terms with an HIV -positive diagnosis is an 
important factor in facilitating timely linkage to care. 
Because we managed to accept our situation, our status, I think that is what helped us to 
go [to the clinic] quickly. So that we can know how far are we with our health status as a 
whole. -Male, 27 years, linked to care in 5 days [IDI] 
I didn't have a problem when I received my results because I had decided that I'm going 
to accept everything that is going to be said because I had already agreed. [The 
counselor] also asked me what I am going to do when I receive my results and I said that 
I'm going to be free because I want to live. -Female, 45 years, linked to care in 7 days 
[IDI] 
I was fine because if something has happened it has happened, even if I get hurt the virus 
is not going to go away from me.- Female, 44 years, linked to care in 13 days [IDI] 
I'm still the same like other people. I always give myself comfort about that. I always 
listen to Linda Sibiya on the radio in the morning saying that if you are HIV-positive it 
doesn't mean that you have come to an end .... this is something that I mostly hold on to.-
Female, 29 years, linked to care in 15 days [IDI] 
Since acceptance is a process, even clients who initially had very negative 
responses to their diagnoses were able to come to tenns with it over time. This is clearly 
97 
illustrated by one client who had suicidal thoughts, but later accepted the situation, and 
even sought care promptly. 
She was worried when she got her results. She even thought of committing suicide but 
then she had some thoughts that who will take care of her children, and then she realized 
that she is not the only one with HIV So there are other people who are really sick but 
who don 't kill themselves, so she saw herself that she is still strong and healthy. She will 
go and do whatever the nurses tell her to do .- Female, 28 years, linked to ~are in 29 days 
[IDI] 
Acceptance of an HIV -positive diagnosis is likely the result of various factors, 
however, it seems that reasons for testing and readiness to receive the results may play a 
particularly important role. For example, many clients reported having tested due to 
concerns about their health or because of their current or former partners' health status or 
behavior. These circumstances may have conditioned them to expect a positive result. 
She said she tested because she was sick, she was having abdominal pain and she was 
losing weight. -Female, 30 years, linked to care in 2 days [FN] 
She said she tested because she was very sick and her children encouraged her to go to 
[the clinic} to test but our counselor visited her and she took that opportunity.- Female, 
65 years, linked to care in 6 days [FN] 
She said her mother told her that there is a lady who tests people for HIV, so she became 
interested because her husband was very sick.- Female, 39 years, linked to care in 11 
days [FN] 
She said she tested because she was involved in risky behaviors and her partner has 
multiple partners.- Female, 37 years, linked to care in 5 days [FN] 
Others had a more general interest in testing or specifically mentioned that they 
felt it would be a gateway to receiving needed help, implying a concerted interest in and 
likelihood of care seeking following testing. 
[Referring to the counselor and HBHCT] ... Ifelt happy and thought that I now have 
someone who is going to make me feel healthy because I could feel that I was not well. -
Male, 69 years, linked to care in 7 days [IDI] 
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... they used to say a person must just test himself .. he must just test if he is not feeling 
well and hear what is going on .... because you may sometimes not test while this thing is 
spreading ... !just thought let me just do it, maybe I am going to get help.- Female, 55 
years, linked to care in 10 days [IDI] 
Negative reaction: difficulty with coping/acceptance or disbelief ofHIV status 
On the other hand, clients who delayed linkage to care clearly had difficulty 
coping with prospect of being HIV-positive. Some were clearly more focused on the 
potentially negative outcomes of their illness rather than on how care seeking could 
facilitate their well-being. 
I cry sometimes ... I sometimes get very hurt .. . I just imagine myself being sick suffering 
from this illness ... yes that's the thing that brings back my tears because there's another 
aunt from next door ... ! was still very young by then I was 15 years old when she was 
sick .... she was suffering from it, I saw her when she was sick and .... her picture just comes 
back to my mind .. .! just say that one day I'll be like her.- Female, 20 years, had not 
linked to care at last point of contact (146 days) [IDI] 
Interviewer: .. . you mentioned among other things that one of the reasons you didn 't take 
the letter to the clinic is that you have fear about going there, can you explain to me the 
cause of this fear? 
Respondent: ... it is just scary because a person who is irifected can just die, those are the 
things that scare me.- Female, 36 years, had not linked at last point of contact (123 days) 
[IDI] 
Although not commonly mentioned, some clients' difficulty accepting and coping 
with their newfound status was associated with excessive alcohol use. 
Interviewer: Okay, does your status lead you to take alcohol? 
Respondent: Very much, I drink the whole week and I even see that people can see that 
I 'm now crazy because ji-om early in the morning around 8 and 9 AM, I have started 
drinking. I drink and drink so that I may just forget a bit but after that I will be told that 
yesterday you were complaining a lot.- Female, 38 years, had not linked in 226 days 
[IDI] 
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Everything in his house has gone fi'OJn bad to worse, he is now drinking everyday 
because his wife is not talking to him and he always thinks about this HIV thing. .. - Male, 
44 years, had not linked at last point of contact (71 days) [FN] 
Other clients struggled to accept and come to terms with the diagnosis. 
She is still trying to deal with the fact that she is positive so she said she doesn 't think she 
will go to the clinic anytime soon. She said .she just wants to get some other results to 
convince herself that she is really positive, so she is still going to do an HIV test 
somewhere before she does a CD4 count. She said she doesn't want to be visited because 
talking about HIV is stressing her so she doesn't want anyone who will visit and ask her 
about being positive.- Female, 66 years, had not linked to care at last point of contact 
(139 days) [FN] 
I don't know then how it happened as I was least expecting it .... I'm still in denial, I 
haven't accepted it, I still don't believe it yet.- Female, 22 years, had not linked to care at 
last point of contact ( 192 days) [ID I] 
Several other clients completely refused to believe the results, putting it out of 
their minds or sometimes expressing intentions to re-test. 
[The counselor] kept on coming back to ask if I've been to the clinic and I would say no I 
have never been. She will ask me why and I would tell her that I still don't believe that. 
She said that I have to go and I would say I am going to go and I willletthat pass and go 
to sleep.- Female, 17 years, linked to care after 520 days [IDI] 
Clients' reasons for disbelief of their results were often related to views about 
their behavior and perceived risk. 
What made me not to believe [my results] my child is that ... my husband passed away in 
2004 ... and I have never had sex with any man. If what [the counselor] says is real! will 
wonder where I got it. Does it mean that I got it from my husband because this thing 
hides in one's blood? Does it mean that he was infected before he died? No sister, I don't 
believe it and I still don't believe it even today ... where did I get it because I'm a widow 
and I don't go around taking other women's men but then where did I get it?- Female, 47 
years, had not linked to care at the last point of contact (231 days) [IDI] 
She was still unsure if she must believe [the results] because she said she slept with one 
man ever since she started to be intimate.- Female, 44 years, had not linked to care at 
the last point of contact (86 days) [FN] 
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She said she did not believe her results. She said she is a virgin, she doesn 't know how 
she got HIV That is why she doesn 't believe her results. -Female, 17 years, had not 
linked to care at the last point of contact (111 days) [FN] 
Others had difficulty believing the results because of previous testing experiences. 
She said she didn 't believe, or she was not sure about her results because the last time 
she tested she was negative and that was two years back. But she said she never used 
protection. - Female, 22 years, had not linked at last point of contact (139 days) [FN] 
She said she did not believe her results because she tested several times when she was 
pregnant. She tested at Bloemfontein when she was one month pregnant, and when she 
was four months pregnant she did her window period She said she then tested again at 
eight months in Johannesburg and after giving birth, and she was negative all these 
times. Even when she tested with us she was negative, but on her second test with us she 
tested positive, this was her window period She is still waiting for her lab results to 
ensure that she is really positive. - Female, 25 years, had not linked at last point of 
contact (167 days) [FN] 
Though not common, a few clients mentioned that their hesitance or disbelief 
stemmed from problems that arose during the testing procedure. 
She did not believe her results because the counselor said you are negative and suddenly 
changed and said there is a dot next to the line and asked to prick her again for another 
test. Then on the second test there was one strong line and one faint line, so she did not 
believe her at all. She will go to [name of clinic] to re-test when she gets money.- Female, 
4 7 years, had not linked at last point of contact (231 days) [FN] 
Attitude: motivated 
Another aspect of clients' responses that appears to play an important role in 
linkage to care is their general disposition and attitude toward the diagnosis. Clients who 
linked to care promptly took the diagnosis seriously and demonstrated a desire to be well. 
They were generally also strong-minded and unconcerned about stigma or others' 
op1mons. 
She said nothing will stop her from getting medical help because she wants to stay strong 
and healthy.- Female, 42 years, linked to care in 2 days [FN] 
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She said she went for a CD4 count at [name of clinic 1 in early January. She is still 
waitingfor her results. She said she will do everything they tell her to do at the clinic 
because she doesn't want to bother other people when she is sick.- Female, 28 years, 
linked to care in 24 days [FN] 
There is nothing that prevented me because I knew that since I was sick, that my help is 
only at the clinic. I also didn 't want that to affect my mind. !just told myself that I am 
going to live, I just didn't want to hurt myself and make myself suffer from stress, no. -
Female, 39 years, linked to care in 2 days [IDI] 
For many ofthese clients, awareness of their status was sufficient to motivate 
care-seeking. 
I was encouraged by the condition that I had learnt that I'm in so that they can 
see how much my CD4 count was so that they can see what they can do ... 1 must not sit 
and accept this thing .. .I quickly went [to the clinic 1 because I had learnt that I have the 
virus.- Female, 41 years, linked to care in 5 days [IDI] 
Interviewer: Now I would like to know what helped you to go quickly to the clinic. 
Respondent: What helped me are those people who were testing from Good Start ... it is 
them who have helped me a lot in that. Because .. . I saw that .. . I was really going to be 
sick ... and people wouldn 't know what 's wrong and even myself I was not going to know 
what 's wrong with me.- Female, 35 years, linked to care in 54 days [IDI] 
Other clients clearly recognized the importance of seeking help. 
Interviewer: Is there maybe something that could have made it difficult and prevented 
you from going to the clinic? 
Respondent: There was none, after you have learnt about your status you have to stand 
up and go to the clinic because if you don't go to the clinic you are killing yourself 
Female, 45 years, linked to care in 25 days [IDI] 
Interviewer: .... please tell me what encouraged you to take this [referral1letter ... to the 
clinic? 
Respondent: It was because I wanted to know ... I want to know everything. I was not 
afraid when I took it, I didn 't have stress, I thought let me take it to the clinic, maybe I am 
going to get something.- Female, 44 years, linked to care in 13 days [IDI] 
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Attitude: apathetic 
Clients who significantly delayed linkage to care commonly expressed apathy 
regarding the diagnosis. They had an air of nonchalance and even "laziness" when it 
carne to addressing their health condition. Such clients generally felt well and had a 
limited sense of urgency regarding the HIV diagnosis. 
He was part of couples testing and the results were concordant positive. He only 
disclosed to his wife. He said he didn't go to the clinic to do a CD4 count. He said his 
wife went to the clinic but he doesn 't think he will go to the clinic anytime soon, because 
he sees himself as fit as ever, so he just doesn't see any reason to stress himself by going 
to the clinic. - Male, 3 9 years, had not linked to care at last point of contact (162 days) 
[FN] 
Interviewer: ... let 's talk about your life, what do you think after you have tested and 
discovered that you are HIV positive? 
Respondent: Nothing so far, I'm just relaxing for now. 
Interviewer: Why are you relaxing? 
Respondent: Let me just relax, I will see some other time. 
Lat~r in the same interview, this respondent also said: 
I will see whenever but I won 't be keeping myself busy ... my beloved ones, I 'm not sick 
yet, the truth is I can 't be going up and down like this ... it 's not something that I should 
stress about. -Female, 32 years, had not linked to care at last point of contact (542 days) 
[IDI] 
Explaining why they kept the referral letter without seeking care, other clients 
said: 
There is nothing really, it 's just that I didn 't think about taking [the referral letter] to the 
clinic but I will take it there now ... it 's just that it never came to me that I must take it and 
I never thought about it. -Female, 36 years, had not linked to care at the last point of 
. contact (123 days) [IDI] 
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... it was just laziness ... .it 's just that they are going to keep on telling me about this issue 
you see. They are going to tell me that I must go to the clinic and come back all the time. 
So now Ijustfeellazy to go there.- Male, 32 years, had not linked to care at last point of 
Qontact (244 days) [IDI] 
Although most clients either reported not knowing much about ARVs or had a 
positive view about it (i.e. felt that it was helpful and had no problem with it), there were 
a few who expressed reservations about ART and. cited that as a reason for their 
reluctance to seek care . 
. . .I'm lazy to go [to the clinic] because they might say I should take ARVs and I know 
myself that when it comes to time I'm not strict, I can 't take ARVs now, it 's better I focus 
on eating things that will boost my immune system and use protection in other 
ways ... because it will happen that I start taking them and then along the way maybe I 
will fee/lazy to continue and stop taking them. When maybe I decide to take them again 
that 's when I will cause more damage to myself, those are the kind of things I'm 
avoiding .. . no, I can't take pills for a long time, pills it's just not my thing when I'm sick, I 
just don't believe in pills. -Female, 20 years, linked to care in 107 days [IDI] 
She didn 't take the referral letter to the clinic. She said she went to the clinic and asked 
them to give her sputum jars because she is coughing a lot. She suspected TB then and 
now she is still waiting for the TB results. She said she did not give them the referral 
letter. She doesn 't want to take ARVs so if she gives it to them, they will do a CD4 and 
maybe initiate her and she doesn't want that. She will treat the TB if she has it and drink 
traditional medicine. She doesn 't want to take tablets for HIV. Female, 28 years, linked to 
care in 242 days [FN] 
Interviewer: Okay, how will you feel if the time comes for you to go to the clinic and take 
this treatment? 
Respondent: No, sister, I can take it, but it will be difficult, but this is something that I 
can do. 
Interviewer: Please explain to me about the difficulty. What can make it difficult? 
Respondent: My God, I have never thought of taking pills all the time .... because a pill is 
something that I take sometimes ... my God I don't know how I will do it. I can take them 
but then because I am nauseous, because even if I take Panado for a headache ... .!feel 
nauseous. -Female, 26 years, had not linked to care at last point of contact (521 days) 
[IDI] 
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Most clients also reported that they would not use traditional medicine for HIV 
and that they were aware that traditional medicine and ARVs should never be mixed. 
However, a few clients did report not seeking care due to a preference for traditional 
medicine. 
She said she did not go for CD4 count because she is using the traditional medicine that 
she was given. She said she believes that she is going to be better because most people 
are highly recommending these bottles that she is using, so she doesn't think going to the 
clinic will help her. -Female, 30 years, had not linked at last point of contact (121 days) 
[FN] 
This client illustrates how multiple barriers might come together to prevent care 
seeking. A preference for traditional medicine appears to be one among several other 
issues hindering linkage to care. 
He said he did not go to the clinic for a CD4 count. He said he is a busy man so he can't 
stop his work and go to the clinic, because he is not sick. Even if he is sick he won't go to 
the clinic because he believes in using traditional herbs for any flu or sickness that 
bothers him. So for this one he is just taking his traditional medicine everyday twice a 
day to keep himself strong, so he just doesn't see a need to go to the clinic. He said he is 
a van driver so he doesn't have free time to go to the clinic to be treated badly by nurses. 
He only disclosed to his wife since they tested together. He refused to take the food parcel 
and he said food parcels are given to sick people and he is not sick so he won't take it. -
Male, 51 years, had not linked to care at last point of contact ( 68 days) [FN] 
Relations/tips and support 
Encouraging relationships 
The presence of active support and encouragement from family, friends, and even 
the counselor play an important role in facilitating clients' linkage to care. 
Something that made me to go [to the clinic} is that I kept on meeting [the counselor] on 
the way and each time we meet on the way she will ask me ... asking if I have been to the 
clinic and I will say no I haven 't been and she will say she's getting worried. You see 
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each time she says that I will just say let me just hand myself over and just go ... I just 
went then ... it 's that lady, I kept on meeting her and she will encourage me such that she 
will go to my place and ask me to go outside and discuss this ... she just kept on 
encouraging me. - Female, 29 years, linked to care in 15 days [IDI] 
My sister is giving much support she is like a parent to me, she is just like my mother. -
Female, 39 years, linked to care in 2 days [IDI] 
Receipt of support from spouses and partners seemed particularly helpful. 
She said her husband is so supportive to her. He is the one who gives her money to travel 
to Johannesburg and to do all these things ... CD4 and pap smear.- Female, 30 years, 
linked to care in 2 days 
She was part of couples testing. She said the counselor explained everything to them 
before testing and when they got positive results she comforted them and gave them hope. 
She said she did not feel very bad because her partner was there, so she was relieved that 
she was not going to think of the ways of telling him. Her husband was so supportive to 
her. He is the only one who knows her status.- Female, 36 years, linked to care in 29 
days [FN] 
[My girlfriend} didn't take it badly, she never had a problem.- Male, 32 years, linked to 
care in 8 days [IDI] 
On the other hand, clients who delayed linkage to care commonly experienced 
challenges related to disclosure, leading to a concerted lack of support. Some were unable 
to disclose their status to anyone. 
Her husband passed away in 2003 in an accident and now she is having a partner who 
doesn 't stay with her. She said her partner is having a wife. She did not disclose to him or 
anyone but she thinks she will disclose to her mother when the timing is right. She won 't 
disclose to her partner because he will blame her and tell her she is the one who gave 
him HIV.- Female, 47 years, linked in 95 days [FN] 
He said he will never disclose unless he can be very sick.- Male 32 years, had not linked 
to care at last point of contact ( 1 07 days) [FN] 
A strongly emerging pattern among those who delayed linkage to care was 
difficulty with disclosure to members of their own households. Despite possibly having 
told others, this situation may have a particularly prominent impact on clients' daily lives 
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and decision-making, as it could affect the logistics of leaving the house to seek care, and 
the feeling of being "alone" may also make it difficult to adequately cope with the HIV 
diagnosis. Notably, clients in this situation were often young adults. 
Yes, something that made me to get hurt .. .I'm still unable to tell other people here in the 
household. I'm still unable to tell my mother and I don't know how I am going to tell her 
and there are a lot of people here in the household .. . I'm unable to accept it. So I don't 
know, my life ... I'm unable to accept it.- Female, 22 years, had not linked to care at last 
point of contact (192 days) [IDI] 
She doesn't know how to tell her parents her status. She said someone who will maybe 
understand her is her grandmother, but she is staying at [name of another community] in 
her brother's house. She said she doesn't know how she will tell her. -Female, 20 years, 
had not linked to care at last point of contact (146 days) [FN] 
... I would have told my friend but I'm not going to tell anyone here in the household, I 
don't want to lie I will never. People from this household are talkative. This will make me 
to be always embarrassed because I know how the situation is here in the household. -
Female, 24 years, linked to care in 167 days [IDI] 
A substantial number of clients tested alone despite having a spouse or partner. 
Oftentimes this occurred due to the context of this community, where people may live 
away from home for extended periods for work, possibly only returning once or twice a 
year. Although many clients reported having sought care despite not even having 
disclosed to a partner or spouse, several who found themselves in particularly difficult 
intimate relationships or who received pointedly negative responses upon disclosure also 
did not link to care promptly. These clients appear to feel "stuck" in a sense, as they may 
be willing to address the diagnosis and seek care, but lack the support to do so, and feel 
afraid to jeopardize their relationships. 
She said her husband died in 1992, he was sick, but now she is having a long term 
partner who stays in Johannesburg. She said she won 't disclose to her partner because 
he is rude, he can even kill her if she can tell her results.- Female, 37 years, had not 
linked to care at last point of contact (202 days) [FN] 
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I said [to my husband] I have checked [my status} ... you must also go. He said you have 
checked and what did they say? I said no that is my secret what they said, you must also 
go and check. He said no never. I said they said I have got AIDS. He said no, you can 't 
infect me with AIDS and kill me. Now where can you start with that person who gives 
such responses? How much more when you speak the truth? I tried to show him by just 
speaking but if I can decide to tell him the truth there might be conflict I don 't know. -
Female, 38 years, had not linked to care at last point of contact (226 days) [IDI] 
She disclosed to her partner but he acted negatively by blaming her. She said they 
quarrel so much in such a way that even now when she calls him he tells her that she is a 
hypocrite, doing things behind his back because he told her not to test until he is ready to 
test with her. She was emotionally disturbed, crying, blaming herself for doing the test. 
She said she had some thoughts of ending her life especially after she disclosed to her 
boyfriend, but as I explained things to her she was better and she promised to go for a 
CD4 count. She said her boyfriend tore apart the referral letter the way he was angry. -
. Female, 32 years, had not linked to care at last point of contact (186 days) [FN] 
Although many clients felt enabled to seek care in their partners' absence, a few 
explicitly reported this as a reason for the delay. 
I will indeed go [to the clinic} but I'm still waiting for my husband and we will go 
together as well as talk about it, I won 't say anything on the phone. Things like this you 
can't just say it anyhow ... about going to the clinic, I'm not saying I will not go but when 
the time is right and I feel it's time for me to move on with my life ... my stand is, we need 
to go together. For now I won't do anything, I'm waiting for him ... -Female, 32 years, 
had not linked to care at last point of contact (542 days) [IDI] 
He didn't disclose to anyone. He didn't go to the clinic to do a CD4 count. He said he is 
waiting for his wife to come home and disclose to her and then ask her which clinic she 
thinks is the best for them because he doesn 't want to go to [name of clinic]. - Male, 34 
years, had not linked to care at last point of contact (38 days) [FN] 
She said she didn't take the referral letter to the clinic. She is waiting for her husband to 
come home and she said she will tell him that she is positive and take him to the clinic to 
do couple's testing. -Female, 28 years, had not linked to care at last point of contact (1 0 
days) [FN] 
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Discussion 
These fmdings underscore the importance of understanding HBHCT clients and 
the context of their lives and communities. While most people-may agree to testing, their 
unique dispositions and life circumstances play an important role in determining what 
happens afterward. Thus, to ensure that the benefits of HBHCT are realized through 
timely linkage to care, it is important to understand clients' emotional make up, living 
situations, relationship dynamics, responsibilities, and personal resources. Potential 
barriers can then be addressed and facilitating factors encouraged by specific 
interventions. 
The basic tasks of earning a livelihood and caring for families are clearly strong 
priorities in this community. In this environment, these activities alone can be 
challenging; people find themselves consumed with the tasks of daily living and the 
"hustle to survive." Thus any additional task, even something as beneficial as care 
seeking, may feel burdensome. Fmihermore, clients living under such hardship may have 
limited emotional and mental "space" to deal with yet another "problem." Some clients 
mentioned that they would disclose or seek care at the "right time" though they couldn't 
necessarily describe when that might be or what that might require. They may even 
intentionally put off seeking care to an unknown point in the future when they feel better 
equipped to handle the situation. 
It is evident that in this community, barriers such as lack oftime and finances play 
an important role in the linkage to care. These factors may not be firm logistic 
constraints, but rather contextual elements that work to subtly push care seeking further 
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down on the list of personal priorities. It is not that people do not have money at all, but 
rather that they are forced to make difficult choices about how to use their limited 
finances. For example, items such as food, transport to work, attending to the needs of 
other family members, or purchasing children' s school uniforms are likely to take priority 
over care seeking. These "more important" items may repeatedly displace care seeking, 
diminishing its urgency over time, particularly if clients are still feeling well and 
unhindered by their illness. 
Since care at government facilities is free in South Africa, fmancial challenges 
referred to by clients generally relate to transport costs, which would be approximately 
$2.50 to/from a health facility. This amount could buy a loaf of bread, milk and tea or 
2.5kg of sugar or maize meal. Most households in this area rely on child support grants, 
which are valued at about $32.50/month. Given that these grants are generally used to 
support a minimum of two household members, using up nearly 8% of the grant on one 
trip to the clinic would understandably be a burden to the household. Even those who are 
employed would face similar challenges. The burden is further increased when additional 
clinic visits are required to obtain results, or transition to treatment. 
The role of limited finances in decision-making regarding linkage to care supports 
fmdings from a recent study comparing health seeking behavior among rural and urban 
communities in South Africa. In this study, the authors found that rural participants, 
primarily due to lack of employment had significantly less funds to dedicate to healthcare 
(including transport) than their urban counterparts. 146 Another study in rural Malawi 
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found that increased transport costs were significantly associated with a lower likelihood 
of ART acceptance. 147 
With regard to the banier oftirne, it is important to acknowledge that this 
challenge relates more to lacking "opportunity" rather than lacking hours in the day. For 
those who are working, particularly in temporary jobs, each day counts, and wages or the 
position itself may be jeopardized by absence or lateness. And even for those who are 
unemployed, finding the right time and oppmtunity can be challenging. Such clients may 
spend time looking for work, lack independent resources for transport, have difficulty 
ananging alternate sources of care for children or the elderly, and particularly if they 
haven't disclosed, may face challenges explaining to household members why they need 
to be away from horne for most of the day. In all of these circumstances the "costs" of 
care seeking are high, making it evident how this "task" could easily slip down the list of 
personal priorities. The challenges of finding time and opportunity are especially 
pertinent in an environment where care seeking is generally very time-intensive. 
Ironically, the health care system in this setting seems to serve as its own banier. 
Clients clearly internalized poor previous experiences with government health services 
ranging from facility closures to poor treatment to lack of confidentiality to shortages of 
staff or supplies. Already faced with a host of logistic and personal constraints, and the 
likelihood of feeling anxious or fearful of stigma, the prospect of unresponsive or 
demeaning care is enough to deter even those with a desire to seek care. Particularly 
disheartening were the findings that many who actually made the attempt at linkage still 
did not receive the needed services. As some clients so aptly described, these experiences 
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can be extremely deflating. Since care seeking in this environment is so burdensome, 
overcoming the challenges seems to require several factors to converge: time, fmancial 
resources, strong will, motivation, and household support. When these factors rarely 
converge, some may lose motivation entirely. 
It is important to keep in mind that community-based models of testing would be 
implemented precisely to overcome known structural, economic, and social barriers to 
facility-based HIV testing services?1• 25-29 Thus it can only be expected that clients would 
still face these same barriers when linking to care at these facilities. Some of the barriers 
to linkage following HBHCT articulated in our interviews were similar to those identified 
by other studies on barriers to ART adherence, or even health services utilization in 
general. 
In a recent publication, Kagee et al. suggests that the role of structural barriers to 
ART adherence in Southern Africa have been poorly emphasized. The challenges 
experienced by our clients very closely mirror many of the factors outlined by the 
authors, including, poverty-related barriers (lack of transport funds, lost wages and threat 
of losing employment, absence of social support), institution-related factors (inadequate 
medical services, logistical barriers to accessing health services), and political and 
cultural barriers (migration, stigma, and gender inequalities). 148 Similarly, in a review of 
studies of ART adherence, Reda and Biadgilign report the influence of socioeconomic 
factors , health care systems, and factors related to patients and their farnilies. 149 
The prominence of health systems factors in influencing health-seeking behavior 
is pmticularly notable m1d disturbing. Various studies on health services utilization in 
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sub-Saharan Africa have cited factors such as poor health worker attitudes and practices, 
poor quality of care, drug and supply stock outs, and low reliability at the point of care 
(i.e. possibly not fmding someone there to assist you) to be important barriers to health 
· ·1· . . 1 128 130 Th 1· b . HIV . ART services uti Izatwn m genera . ' e Iterature on arriers to testmg, 
adherence and HIV care seeking in sub-Saharan Africa also notably cites negative 
experiences with clinic staff as important baniers. 124, 125, 129, m , 148 
While logistic, structural, and health systems barriers may be more commonly 
understood, this study also identified important individual level and psychosocial factors 
that affect care seeking. A 2013 literature review by Mukolo et al highlights the dearth of 
literature examining the role of such factors in presentation for HIV I AIDS services. As 
such, the authors strongly recommend further exploration of the role of factors such as 
personality, disposition, cognitions, emotions, psychological distress, and coping.150 All 
of these were noted in this study. 
Structural baniers may hinder those who desire to seek care from doing so, 
however, psychosocial factors can prevent people from even desiring to seek care. For 
example, HBHCT clients who expressed apathy regarding the diagnosis, or psychological 
distress and difficulty accepting, coping with, or believing the results were disinclined 
toward care seeking. Similarly, fears regarding lifelong medication, also identified in 
other similar settings,94 can dampen interest in obtaining needed care and treatment. 
The variation in clients' attitudes toward the diagnosis also suggests that the 
health locus of control may have an important role to play. This term refers to whether 
people perceive that they are in control of their health or that control lies with external 
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circumstances, people, or powers. The literature indicates that those with an internal 
locus of control put more energy toward learning about their health status and engaging 
in health care and treatment. 151 In our study, clients for whom awareness of status was 
enough to motivate linkage, who recognized the importance of seeking help, and who 
expressed that nothing could prevent them from seeking care, clearly demonstrated a 
strong internal locus of control. Meanwhile, the locus of control for those who had 
difficulty accepting their status and who focused on potential negative outcomes was 
external. Together, these findings regarding the individual and psychosocial factors that 
influence linkage, suggest the potential utility of improvements in counseling or the 
implementation of other behavioral interventions. 
The findings from this study also draw attention to important issues surrounding 
interpersonal relationships and social networks. It is evident that the complex structure 
and dynamics within relationships can affect care seeking in different ways. For example, 
disclosing to someone may not necessarily provide adequate support, particularly if 
confidants live far away or have minimal influence on clients' daily lives. On the other 
hand, positive and active sources of support from family members or a counselor can 
even overcome the absence of a spouse or partner. Meanwhile, a concerted lack of 
support from the closest individuals, such as household members or spouses, can 
negatively affect care seeking. Interpersonal dynamics can also have a strong influence. 
For example, while some clients with absent spouses felt comfortable seeking care alone, 
others strongly felt the need to wait for, consult, and/or take action together. These 
findings suggest the need for interventions to enhance social support for those who need 
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it and to mitigate potential harms that could arise from unsupportive relationships. 
While not explored in-depth, these findings also draw attention to important 
issues such as alcohol abuse and mental health challenges related to an HIV diagnosis 
that may require further attention or research. Additionally while stigma was not 
identified as an independent factor affecting the linkage to care, it was clearly a prevalent 
issue in this setting. Its impact appeared to be interconnected with other relevant issues 
such as willingness to be followed up, disclosure and preference for non-local healthcare 
facilities. 
Importantly, since this research was conducted primarily among females in an 
area with conventional gender and social norms, it also uncovered various gender-related 
issues that warrant attention. For instance, there are clearly important implications of 
females testing in the absence of their partners or spouses. Though it did not always 
appear to be a problem, for some women this may lead to difficulties with disclosure, and 
even worse, put them at risk of maltreatment or violence. Females may also be at greater 
risk of delayed linkage due to factors such as waiting on partners, not believing results 
based on perceived risk, lacking independent fmancial resources, having more care giving 
responsibilities, and having more limited mobility. Further research may be required to 
understand the extent to which these issues can be a problem. Implementers of 
community-based interventions such as HBHCT should also be cognizant of such 
possibilities and implement measures to avert and address any adverse outcomes. 
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Limitations 
The findings from this study should be interpreted with caution due to various 
limitations. Firstly, it should be acknowledged that we often do not necessarily know why 
we do what we do. This made it difficult to elicit straightforward responses from clients. 
The sensitivity and complexity of this topic further added to this challenge. As such, 
some clients seemed unable to clearly identify or explain the reasons for their care 
seeking behavior. It is conceivable that when "pressed" they gave responses which may 
not have reflected their true circumstances but rather something that more readily came to 
mind or which they believed the interviewer wanted to hear. In otht?r cases, clients may 
have offered surface level "excuses" when in fact their behavior may have been 
influenced by other potentially more deep-rooted factors. Additionally the patterns 
observed when pairing the qualitative and time-to-CD4 data, may not necessarily reflect 
causal associations. Regardless, they highlight important contextual factors that must still 
be acknowledged and addressed in order to improve HBHCT and related services. Also, 
as with the quantitative sub-studies, this study only included a sub-sample of clients, and 
excluded many who could not be contacted or who refused to participate. It is possible 
that the views and experiences ofthose not interviewed were different. Finally, since this 
study took place in only one rural South African community with a primarily female 
sample, the findings cannot be broadly generalized. However, the findings and principles 
are transferable to similar populations and settings in South Africa as well as in other 
countries in the region. 
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Strengths 
Despite its limitations, this study has many strengths. It is the first qualitative 
study to date exploring the linkage to care following HBHCT. Further, its placement 
within an ongoing intervention and prospective cohort study enabled a real time 
investigation, which may have allowed clients to better recall and more accurately 
describe the most relevant and current circumstances in their lives related to testing and 
follow up. Third, the inclusion of both in-depth interviews and field notes provided a 
unique perspective and broader scope of information from which to draw. Fourth and 
quite importantly, this study addresses psychosocial factors impacting late presentation 
for HIV/AIDS services, which are less well understood and difficult to assess using only 
quantitative research methods. Fifth, the purposive sampling and pairing of actual time-
to-CD4 data with qualitative information (despite its limitations), provided a very 
powerful illustration of the salient characteristics and factors that are likely to have 
influenced the linkage to care. In patiicular, this method enabled us to identify patterns 
surrounding attitudes and personal relationships that clients themselves were not 
necessarily able to articulate. Sixth, the interviews achieved thematic saturation, with no 
new information emerging toward the end of the interviewing process. Further, the in-
depth interviews addressed all relevant issues that were hinted at in the much larger 
sample of field notes. Finally, the fmdings from this study are likely to be broadly 
applicable to settings outside of home-based testing, and to various points oflinkage 
along the continuum of engagement in HIV care. 
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KEY MESSAGES 
•!• Various factors influence the linkage to care following HBHCT 
•:• Life hardship, including poverty and unemployment limit finances that can 
be dedicated to care seeking (i.e. for transport costs) 
•!• Living arrangements, formal employment, informal livelihood activities, and 
caregiving responsibilities limit time and opportunity for care seeking 
•!• Common among those who promptly seek care are: 
o Positive reactions and attitudes toward the diagnosis (i.e. acceptance, 
motivation to be well, understanding the importance of seeking care) 
o Receipt of social support from partners, family, and others 
•!• Common among those who delay care seeking are: 
o Negative reactions and attitudes (i.e. disbelief of the results, apathy 
regarding the diagnosis, lack of acceptance, or difficulty coping) 
o Challenges with disclosure and negative responses from others such as 
intimate partners 
•!• Poor experiences and perceptions of the health care system are widespread 
and lead clients to devalue and put off care seeking 
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Chapter 6: 
Synthesis of Findings 
A synthesis of the quantitative and qualitative findings from each of the 
dissertation sub-studies provides a holistic understanding of the complexities involved in 
the linkage to care following home-based HIV counseling and testing. The prospective 
cohort data informs us that 62.1% of HIV -positive HBHCT clients link to care within 3 
months of testing. Comparable and even higher to what is found in many facility-based 
settings ,82 this rate of linkage is very encouraging. However, it still means that a 
substantial proportion of clients delay or put off care seeking entirely. Of those who 
sought care, most did so within one month, and about half were immediately eligible for 
treatment at the time of presentation to a facility. This further underscores the importance 
of timely linkage. The prospective cohort study also drew attention to the fact that very 
few clients linked to external community or social services for support, assistance, or 
further counseling with regard to their HIV status. 
Operational challenges faced during study implementation also highlight areas 
requiring further attention. For example, there is a need to improve referral, record-
keeping, and monitoring mechanisms so as to streamline the transition from HBHCf to 
facility-based care. The study also uncovered important challenges that should be 
acknowledged and addressed as part of scale up, including difficulty tracking clients due 
to high levels of mobility, refusals for follow up, and difficulty contacting clients via 
phone. 
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Importantly, the regression analysis identified key socio-demographic and other 
personal characteristics that may hinder, delay, or facilitate care seeking. Further 
supplementing these findings, the qualitative data provides insight about the 
interrelatedness of these factors and the mechanisms through which they may affect the 
linkage to care following HBHCT. Drawing from client perspectives and experiences, the 
qualitative fmdings also highlight the influential role of interpersonal relationships, 
psychosocial factors, and the subtle impact of stigma. 
· The findings from the Cox regression and qualitative analyses are synthesized and 
described below using a social-ecological framework adapted from a recent paper by 
Mugavero et al (Figure 9). 84 It is evident that factors that facilitate, hinder, or delay care 
seeking occur at all levels: individual, relationships, community, and health systems. 
Relevant frequencies and cross-tabulations from the cross-sectional survey (n=196) are 
also reported to supplement the discussion. 
INDIVIDUAL RELATIONSHIPS 
Figure 9. Socio-ecological framework 
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Vulnerable groups 
At the individual level, the findings highlight two demographic groups which may 
require particular attention: youth and women. We found that clients below 25 years of 
age had a 50% lower incidence of linkage to care than their older counterparts (AHR 
0.50; 95% CI: 0.28- 0.91). Although the qualitative analysis was not stratified by age, an 
in-depth look at the fmdings does suggest that some of the identified challenges to 
linkage were more commonly faced by young adults. This is further supported by 
frequencies and chi square test results from the cross-sectional survey. 
In the qualitative interviews, younger clients often expressed difficulty with 
acceptance ofthe diagnosis and belief in the test results. This is corroborated by 
univariate findings indicating that a greater proportion of young adults < 25 years . 
compared to older clients (43 .3% vs. 25.3%; p=0.043) did not believe or were unsure 
about their results. The qualitative findings also revealed that young adults were more 
reluctant to disclose to family or household members, another factor which hindered 
linkage. Supporting this fmding, the univariate analysis showed that among those who 
had disclosed their status by the time of the cross-sectional interview (n=11 0) 31.3% of 
those < 25 years compared to 22.3% (p=0.44) of older adults reported that nobody within 
their households knew their status. During the qualitative interviews, youth also more 
commonly expressed fears about poor treatment and exposure of their status upon 
seeking care at a health facility. Similarly, when rating facility services, a greater 
proportion of young adults (23.3%) selected very poor/poor/fair compared to older clients 
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(14.7%) (p=0.24). Together, these findings suggest that youth and young adults may have 
unique concerns and life circumstances, and thus require more focused and tailored 
attention from the point of testing through to follow up. Importantly both the cross-
sectional and qualitative samples included no young males, thus the findings cannot be 
extrapolated to this sub-group. 
Since the vast majority ofHIV-positive clients and respondents were female, this 
limited the option to stratify both the quantitative and qualitative analyses by gender. 
However, it is still important to acknowledge that gender may play an important role in 
the linkage to care and that the specific challenges to linkage may vary between males 
and females. The barriers identified in this study are likely to be most applicable to 
impoverished rural females. This sub-group may be particularly vulnerable following an 
HIV diagnosis given prevalent gender and cultural norms, and a context where male 
partners may be away for long periods oftime. For example, they may lack emotional 
support, and be particularly constrained by a lack of independent finances and caregiver 
responsibilities, which limit time and opportunity to seek care. Difficulties with partner 
or family disclosure may also cause them to delay or avoid care seeking. 
Jewkes et al. who conducted research in a rural part of South Africa very similar 
to where the Good Start study took place, found that power inequity and intimate partner 
violence within relationships were associated with increases in HIV incidence among 
young South African women. 152 Amaro and Raj also suggest that women's HIV risk must 
be understood within the important context of oppression and the role of power in 
intimate sexual relationships. 153 Thus it should be acknowledged that challenging 
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interpersonal relationships may be realities for many HIV -positive female clients of 
HBHCT, and could potentially impact their ability to effectively cope with the diagnosis 
and seek appropriate care. The design of any home-based or community-oriented HIV 
testing intervention should acknowledge and accommodate such gender-related 
eventualities. 
Response to HW diagnosis 
Importantly, both sub-studies identified important individual level responses to 
the HIV diagnosis that affect the linkage to care. The most consistent theme was that care 
seeking was often delayed or put off due to reluctance or refusal to believe the HIV test 
results. The regression analysis indicates that those who did not believe or were unsure of 
their results had a 52% lower incidence of linkage to care compared to those who did 
believe the results (AHR 0.48; 95% CI: 0.30- 0.77). The same theme was echoed in the 
qualitative fmdings, which also added further insight as to the reasons for disbelief, such 
as low risk perception, previous testing experiences, and abnormalities that occurred 
during the testing session. Importantly, refusal to believe the test results did not seem to 
be a result of failure to trust or respect the professionalism of the home-based lay 
counselors. This was never mentioned in the qualitative interviews and is further 
supported by the fact that 98% of clients reported being very or generally comfortable 
with the counselor's skills. Further, 90.3% of clients reported that the overall HBHCT 
experience was either "excellent" or "good". However, disbelief oftest results may be a 
more common problem in community-based testing settings since many clients may not 
have tested in the absence of the intervention. Such clients may not be sick or have any 
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suspicions about their status, and thus a positive test result could be more shocking and 
unexpected. The fmding regarding belief of test results suggests that early intervention 
post testing may be needed to help counsel clients through this barrier. 
The qualitative findings indicated that even among those who did believe their 
results, difficulties accepting and coping with the diagnosis also led to delays in linkage. 
For some clients, readiness to test and anticipation of the results appeared to facilitate 
acceptance. Although only 28 .6% of clients reported any use of alcohol, the qualitative 
findings hinted at the idea that among users, alcohol abuse may be a sign of poor coping. 
For example, some clients mentioned using alcohol so that they could forget about their 
status or because their home life had become difficult after disclosing. This may in part 
explain the Cox regression finding that alcohol users had a 48% lower incidence of 
linking to care compared to non-users (AHR 0.52; 95% CI: 0.34 - 0.80). 
Though only speculation, it could be that those who already drink are more likely 
to turn to alcohol as a coping mechanism when faced with a problem. Thus alcohol use 
could be a proxy for the true root cause of the delay in linkage - difficulty with 
acceptance or coping. Alternatively alcohol use may independently inhibit the desire or 
faculties to seek care. Since the mechanism of action is unclear, additional research is 
needed to fully understand alcohol's role in the linkage to care. Overall, the fmdings 
regarding difficulty with coping and acceptance suggest that early intervention may be 
needed to help clients come to terms with their status, identify positive coping 
mechanisms, and mitigate negative ones. 
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Clients' attitudes toward the diagnosis were also an important factor with regard 
to linkage to care. Despite both believing and accepting their results, some clients were 
notably apathetic about the diagnosis. In fact, many expressed a lack of urgency with 
regard to the importance of care seeking. Although many clients who expressed this 
attitude were not yet ill, their health status did not appear to be the sole reason for their 
indifference. Other healthy clients had entirely different reactions, expressing a clear 
understanding regarding the severity of their diagnosis and the importance of timely care 
seeking. 
Although the study did not fully unmask the reasons for apathy, a few clients did 
mention a general lack of value in the healthcare system. Some clients spoke more 
specifically about an aversion or disinterest in starting ARV s, because of side effects or 
the reluctance to take pills for life. The latter may explain the finding that those who 
believed that ART could make you feel sick had a lower incidence oflinkage (AHR 0.56; 
95% CI: 0.35- 0.89) than those who disagreed or were unsure of that statement. Others 
may have lacked awareness about the gravity of their diagnosis and the importance and 
benefits of timely linkage to care and treatment initiation. The overall finding implies that 
it may be useful to assess and address client attitudes toward the diagnosis soon after 
testing, and provide relevant education about the effectiveness of treatment and the 
benefits of early care seeking. 
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Mental health 
Findings from the cross-sectional survey showed that an HIV -positive diagnosis 
was often met with the onset of depression symptoms. In fact, out of 13 symptoms, 
clients self-reported an increase in the median number of symptoms from 0 in the few 
months before testing to 7 soon after testing. Notably, 10.2% of clients indicated having 
thoughts of suicide after testing HIV -positive. Contrary to the original hypothesis, the 
Cox regression findings indicated that depression did not hinder the linkage to care. In 
fact, the analysis showed that compared to those with fewer symptoms, clients with 3 or 
more depression symptoms after testing had over a 2-fold greater incidence of linkage to 
care (AHR 2.09; 95% CI: 1.24- 3.53). These findings were not strongly corroborated or 
explained by the qualitative data, perhaps because poor mental health is likely to have a 
more subconscious impact such that clients would not necessarily be able to identify or 
articulate it. 
Some of the qualitative findings do suggest that depression may be reflective of 
an initial stage of the coping process, and may be a strong indicator of true acceptance of 
the diagnosis. For example, those in denial or apathetic about their HIV status may not 
feel upset or worried, while those who fully believe and acknowledge it, may experience 
a range of emotions as they struggle to come to terms with the diagnosis. Ultimately, it 
may be this acceptance that that drives care seeking. Supporting this view, the qualitative 
fmdings revealed that even clients who expressed having suicidal thoughts, managed to 
overcome them, and still linked to care promptly. Additionally, depression symptoms 
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may exacerbate the feeling of being unwell and further drive clients to seek care and 
assistance. 
While it is encouraging that clients who experience depression post diagnosis still 
seek care, the prevalence and .severity of depression following the HIV diagnosis strongly 
suggests that attention to mental health needs is a clear priority. This is particularly so 
given that the current health system in this part of South Africa is poorly equipped to 
address widespread mental health issues related to HIV. For example, in the study area, 
there was only one psychologist available for the entire district, and this person was 
located in a semi-urban town, quite far from most of the intervention communities. This 
setup made it impractical to provide HBHCT clients with useful mental health assistance. 
Further, the local hospitals could only provide assistance in the form of a "suicide watch" 
once someone had already attempted suicide. Despite the fact that depression does not 
appear to hinder linkage to care, the fmdings indicate that that the successful 
implementation of HBHCT will require further attention to the mental health needs of 
newly diagnosed HIV clients. 
RELATIONSIDP FACTORS 
Dependents 
Both the quantitative and qualitative findings indicate the important role that 
interpersonal relationships and dynamics play with regard to linkage to care. The Cox 
regression indicated that those who had four or more non-financial dependents (people, 
including children and non-household members who depend on them for something other 
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than money, e.g. cooking, washing, shopping, emotional support) had a higher incidence 
oflinkage to care (AHR 1.93; 95% CI: 1.07- 3.47) compared to those with fewer non-
fmancial dependents. Although the qualitative findings did not fully elucidate the reasons 
for this, some clients did say that the need to continue raising children or grandchildren 
provided motivation to seek care. Having more dependent adults may also indicate a 
larger social network with more potential sources of support. The median number of non-
financial dependents among this sample was 7, so those with 3 or less may be uniquely 
socially isolated, and may have other unique circumstances that provide a disincentive for 
care seeking. 
Social support 
Personal relationships also seemed to play an important role in the way clients 
addressed the HIV diagnosis. The qualitative fmdings revealed that positive 
encouragement from friends, family, spouses, partners, and the counselor all appeared to 
help clients accept and cope with the diagnosis. This subsequently influenced prompt 
linkage to care. Importantly, having a source of emotional support often also translates to 
financial support, since partners or other confidants can assist by providing the resources 
needed to attend a health facility. 
The source of social support is important. For example, having support from those 
with a more proximate or strong influence on clients' daily lives is more likely to 
facilitate care. Conversely, difficult relationship dynamics and challenges with disclosure, 
particularly with partners and household members, negatively affected linkage. For 
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example, those whose intimate partners responded angrily to disclosure, others who could 
not even bring themselves to disclose, or those who decided to wait until partners 
returned from an extended stay away, may have felt logistically and emotionally 
disempowered to further address their diagnoses through care seeking. Our qualitative 
fmdings support those reported by Hatcher et al. , which show that disclosure to a spouse 
or family members was associated with higher rates of linkage, while anticipation of a 
negative response was associated with a lower likelihood of linkage to care following 
community-based HIV testing. 106 
These findings suggest that clients' prospects for social support may need to be 
assessed at the point of testing and at various intervals afterward. Those who experience 
challenges may require further assistance and intervention. 
Knowing someone who died of HIV/AIDS 
The regression model showed that clients who knew someone who died of 
HIV/AIDS had a greater incidence oflinkage to care (AHR 1.68; 95% CI: 1.13- 2.49) 
compared to those who did not know someone who died ofHIV/AIDS. Although the 
qualitative study did not provide further insight with regard to this finding, it could be 
that for those with the motivation to live and avoid a similar fate, this knowledge may 
have provided an additional impetus for timely care seeking. Stigma may also have a role 
to play in the interpretation of these fmdings. Investigators of a recent study in South 
Africa found that a decreasing stigma score was significantly associated with knowing 
someone who had died from HIV/AIDS.134 Thus it may be that clients who knew 
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someone who died of HIV I AIDS were less hindered by the impact of stigma and more 
readily sought care. 
COMMUNITY FACTORS 
Stigma 
Stigma was not identified by the quantitative analysis as an independent factor 
affecting the linkage to care. This may have been due in part to the way stigma was 
measured- e.g. using variables such as fear of being blamed, fear oflosing friends or 
family, or seeing HIV as a punishment. However, it was apparent from the qualitative 
work and the general study context that stigma was a prevalent issue. Numerous clients 
requested not to be visited due to concerns about the neighbors making inquiries or 
possibly being identified as HIV -positive. And although not reported here, many clients 
described HIV -related stigma in their communities as being quite severe, with people 
even being isolated or given their own food and utensils at social events. It is possible 
that this level of stigma was internalized and experienced differently than the way it was 
measured. For example, a client may not fear losing their friends but may still feel 
embarrassed about others knowing their status. 
The impact of stigma appeared to be interconnected with other influential factors 
such as difficulty with acceptance, challenges with disclosure, and preferences for non-
local healthcare facilities where staff were unknown to them or their family members. 
Programmers should acknowledge that the overall aims of any community-based 
intervention such as HBHCT may be adversely impacted when set within a context of 
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prevalent stigma. Thus specific anti -stigma interventions or other stigma reducing 
program components may need to be implemented in concert with HBHCT. 
Structural barriers 
The qualitative findings clearly underscored the importance of structural factors 
common to this community such as poverty, and livelihood and family responsibilities 
that can hinder care seeking. While the significance of financial difficulties was not 
specifically identified by the regression findings, this may be due in part to the small 
sample size and the relative homogeneity of this poor community. However, it was 
evident from the qualitative findings that fmanciallimitations posed a significant barrier 
to linkage. For example, several clients mentioned not having or needing to wait to obtain 
money to seek care. 
Clients who reported that finding time to attend a health facility was a problem 
had a 60% lower incidence (AHR 0.40; 95% CI: 0.24- 0.67) of linkage to care compared 
to those who reported that it was not a problem. The qualitative findings made it apparent 
that clients' time was usually occupied by earning a livelihood or caring for family 
members, limiting their opportunities to seek care. Overall the logistic barriers of lack of 
finances, time, and opportunity were generally reflective of personal priorities and 
responsibilities. For example, clients said that despite having a desire to seek care, money 
may be needed for other purposes such as buying food or caring for others. Similarly, 
clients' time may need to be spent earning a livelihood or caring for children or the 
elderly. Interestingly, a qualitative study conducted in Uganda, Tanzania, and Nigeria 
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exploring reasons for disengagement in HIV care similarly found that competing 
demands on time stemming from family, cultural, or economic obligations were 
prioritized over clinic appointments. 154 
The fmdings also highlight the potential interaction of factors. For example, we 
discussed earlier the individual level finding that those who believed that ART could 
make you feel sick had a 44% lower incidence of linkage to care (AHR 0.56; 95% CI: 
0.35- 0.89) compared to those who disagreed with or who were unsure about this 
statement. It may be that clients with this belief, particularly those who were feeling well, 
were reluctant to seek care for fear ofbeing started on ARVs, becoming sick, and being 
unable to fulfill their livelihood and caregiving responsibilities. 
Living arrangements 
Regression results showed that clients who live with 2 or more adults have a 
lower incidence oflinkage to care (AHR 0.52; 95% CI: 0.35- 0.77) compared to those 
who live alone or with one adult. The qualitative findings suggest that "who" clients live 
with may explain this association. For example, there may be more adults in a household 
because there is someone elderly who requires caretakirlg, thus limiting time and 
opportunity to seek care. It could also be the case that those living with more adults, 
perhaps youth living with siblings and parents or married females with husbands and in-
laws, do not necessarily disclose to all of their household members. At the time of the 
cross-sectional survey, only 1101196 (56.1%) clients had disclosed their status to anyone. 
Among those who did, 26/110 (23 .6%) reported that nobody in the household knew about 
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their status and 2 additional clients reported that no household members were supportive 
of them as a person with HIV/AIDS. Coupled with existing fmanciallimitations and 
power inequities, lack of awareness or support from household members may make it 
particularly difficult to find opportunities to seek care freely. 
Initially, it may seem that the findings regarding the number of household 
members and non-financial dependents are at odds, since larger household size hinders 
care seeking, while having a greater number of dependents promotes it. The difference 
may be explained by the fact that the household size variable only includes adults. As 
explained previously, living with and being accountable to more adults can pose 
important logistic challenges to seeking care. Meanwhile, non-fmancial dependents could 
include children as well as others living outside the home. This is likely the case given 
that the median number of dependents was 7 compared to a median adult household size 
of 2. Such dependents may be representative of a larger social network or increased 
responsibility, which may provide the client with a greater feeling of self-importance and 
more motivation to be well. Further, living with a greater number of people may be more 
reflective of daily limitations on time and opportunity, whereas non-residential 
dependents may only require periodic attention. 
HEALTH CARE SYSTEM FACTORS 
Although the univariate analysis showed that overall perceptions of the healthcare 
system were favorable, the qualitative findings gave a contrary picture. This may be due 
to the nature of inquiry. For example, it may be easier to be more frank and honest during 
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an open-ended discussion. However, when pushed to select a definitive response for a 
survey, clients may feel reluctant to give a "bad review." It may also be the case that 
when responding to the quantitative survey, clients focused specifically on services 
received during the last visit. Meanwhile, in the qualitative interview, they focused more 
generally on difficulties in obtaining services and the lack of reliability in delivery of 
services. Further, problems with the health system were predominantly mentioned by 
those who delayed or did not seek care, and this sample of clients may have unique 
perceptions and experiences. Regardless, these perceptions clearly hindered care seeking 
for some clients. 
The qualitative interviews highlighted how issues such as long travel and waiting 
times, poor staff attitudes and lack of discretion, and limited availability of staff and 
supplies to provide needed services, all contribute to making the process of care seeking 
cumbersome and frustrating for clients. Further, limited operating hours and inconsistent 
practices (such as turning away clients from non-catchment areas) were also a hindrance 
to linkage. As described in the previous chapter, these findings strongly mirror those 
found in other parts of Africa with regard to utilization of general health services as well 
as those more specifically related to HN I AIDS. 
Thes qualitative findings offer clear insight about the regression results showing 
that clients who believe that drugs and supplies are generally available at their local clinic 
have a 78% greater incidence of linkage to care (AHR 1. 78; 95% CI: 1.07 - 2.96) than 
those who believe that they are generally not available. Skepticism about drug and supply 
availability may be a proxy for poor expectations and lack of faith in the reliability of the 
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health care system. As such, given the context and cumbersome nature of obtaining 
health care, people may subconsciously weigh the costs and benefits, and be less inclined 
to attempt linkage if they feel uncertain about whether or not they will receive needed 
services. It was also apparent that clients who have poor experiences with the healthcare 
system involving lack of staff or supplies often lose motivation to re-attempt care 
seeking. 
Overall, the qualitative findings suggest that clients' views and values regarding 
the health care system are strongly internalized and can dampen clients' inclination to 
seek care. The logistic difficulties of care seeking and the prospect of poor service also 
work to reinforce other challenges to linkage. Interestingly, the findings from our study 
regarding structural barriers related to poverty and health systems factors were strikingly 
similar to those from a qualitative study conducted in the same municipality. This study 
aimed to explore influences on healthcare seeking during fatal infant illness, and found 
that poor access due to financial limitations, as well as caregiver assessments of 
insufficient staff and medicines, limited operating hours, and long waiting times also 
influenced care seeking decisions. The findings also highlighted the important role of 
past experiences and poor healthcare worker attitudes in deterring caregivers from 
seeking care for their infants, despite the severity of the circurnstances. 126 The 
comparison serves to validate our findings and also highlights the fact that certain 
barriers to care seeking are not necessarily illness specific. 
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In order to maximize the full potential of community-based interventions such as 
HBHCf, and encourage care seeking, there is a need for more general infrastructure and 
health systems improvement. 
SUMMARY 
Taken together, the quantitative and qualitative findings paint a holistic picture of 
the factors that affect the linkage to care following HBHCT (Figure 10). It is evident that 
no one factor serves as a primary barrier and that various individual, relationship, 
community, and health systems factors subtly interact, sometimes reinforcing one 
another, to delay linkage or ultimately prevent care seeking altogether. Poor responses to 
the diagnosis including disbelief, difficulty coping, or apathy may inhibit the desire for 
care seeking. Adding to this, lack of social support, or concertedly negative responses 
from intimate partners or others can leave clients feeling isolated, confused, and 
ultimately disempowered to take the necessary steps to address their HIV diagnosis. 
Meanwhile, even for clients with an interest in care seeking, structural barriers such as 
limited finances and personal responsibilities that limit time and opportunity often 
displace this task from the list of personal priorities. Finally, negative past experiences 
with the healthcare system or personnel, are strongly internalized and clearly dampen 
clients' inclination toward care seeking. For vulnerable groups such as women and youth, 
all of these factors may be particularly burdensome. Importantly, environmental factors 
such as prevalent stigma can exert a subtle yet powerful influence on how these factors 
interact and ultimately affect client behavior. 
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The findings have highlighted numerous factors and potential mechanisms 
through which they influence the transition from HBHCT to facility-based care. Overall 
it appears that there are two primary types of barriers - 1) psychosocial barriers, 
stemming from poor responses to the diagnosis, difficulty with disclosure and lack of 
support; and 2) access barriers stemming from lack of fmances, time, or opportunity and 
poor perceptions of the healthcare system. Appropriate interventions are needed to help 
clients overcome these barriers and promptly link to care. 
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Figure 10. Socio-ecological factors influencing the linkage to care 
Chapter 7: 
POLICY AND PROGRAMMATIC RECOMMENDATIONS 
Given the growing body of evidence about the acceptability and effectiveness of 
community-based HIV testing models such as HBHCT, the likelihood of scale up 
throughout sub-Saharan Africa is high. In order to maximize the benefits of such 
interventions, timely linkage to care is critical. The fmdings from this study elucidate 
some of the primary barriers to linkage and as such provide a basis for the development 
of policy and programmatic strategies to encourage prompt linkage. 
Much of the current evidence base around effective practices to improve linkage 
to HIV care comes from the United States, where considerable efforts have been made to 
address known shortfalls. One key output of the US-based work has been the 
development ofTesting and Linkage to Care Plus (TLC+), a framework for a 
comprehensive initiative that integrates key aspects in the continuum ofHIV care, 
including testing, care and treatment, social services, and prevention-with-positives. 155 In 
light of the clear need to expand HIV testing in sub-Saharan Africa and the shift toward 
mixed community- and facility-based models of testing in resource constrained settings, 
it is recommended that the South African National AIDS Council (SANAC) in 
collaboration with other key stakeholders develop a contextually appropriate guidance 
document such as TLC+. 
Based on the findings from this study, this chapter offers recommendations that 
could be included in such guidance. Though many are evidence-based, it will be 
necessary to pilot and evaluate the suggested strategies to ensure feasibility and 
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effectiveness within context. These recommendations aim to: 1) create a supportive 
infrastructure for HBHCT and the linkage to care; and 2) overcome key psychosocial and 
access barriers to linkage. 
Creating a supportive infrastructure for HBHCT and the linkage to care 
Add HBHCT and facilitation of linkage to CHW scope of work 
South Africa is currently restructuring its health care system, with an emphasis on 
the re-engineering of primary health care (PHC). An integral component of these efforts 
is the utilization of a uniform cadre of community health workers (CHW) who. can 
provide comprehensive home and community-based health services and improve the link 
to facility-based services. 119 Although a national policy allowing fmger prick testing by 
lay health workers was passed in 2010,156 HN testing is not currently included as one of 
the CHW roles. Based on current evidence regarding the acceptability and effectiveness 
ofHBHCT, it is recommended that HIV testing be added to the CHW scope of work. 
Rapid HIV testing is quick and should fit well within the duration of a usual home visit. 
It is further recommended that CHW take on the role of monitoring and 
facilitating linkage to care following HBHCT. This is in keeping with recently developed 
guidelines for improving entry into and retention in HIV care, which recommend the use 
of two evidence-based strategies: 1) the use of paraprofessional patient navigators and; 2) 
intensive outreach to clients not engaged in care at 6 months. 157 The CHW would fulfill 
these roles, which would also ensure continuity of care, and make it easier to identify 
clients with special needs or challenges. CHWs will already be making visits to their 
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catchment households and conducting non-HIV related duties with various household 
members. Thus, it will be logistically feasible and easier to identify and address the needs 
of HIV -positive clients without raising suspicions or inadvertently disclosing their status. 
This may naturally reduce many stigma related challenges. The data from this study show 
that a majority of HIV -positive clients will not need additional support to facilitate 
linkage, so the workload will not necessarily be too burdensome for CHWs. 
Streamline referral, record-keeping, and monitoring 
IfHBHCT is scaled up and incorporated within existing PHC services, there is a 
need to make improvements in streamlining the transition from testing to facility-based 
care. Based on experiences from this study, the following issues should be addressed: 1) 
facility-based staff should be familiar with HBHCT services and staff; 2) consistent 
policies should be implemented regarding clients seeking care within the district but 
outside their home catchment areas; 3) referral letters from all external services and from 
all districts should be uniform and indicate the point of origin; 4) CHW should strongly 
emphasize to clients the need for taking referral letters to the facility when seeking care 
and provide replacements if needed; 5) retesting at the facility should not occur if the 
client is in possession of a referral letter, unless specifically requested by the client; 6) 
clients should be entered into facility records with a notation regarding their point of 
origin to facilitate data analysis and tracking; 7) data capturers should be employed at all 
facilities to ensure that client records are accurately entered; and 8) a system should be 
put in place, using CHW s to track referrals and follow up on clients who have not entered 
care. 
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Engage communities to reduce stigma and normalize HIV I AIDS 
In order to help people better deal with their individual HIV diagnoses, it is 
critical that HIV I AIDS be nonnalized at the community level and that the community is 
actively engaged in supporting HIV -positive members. In fact, recent evidence from 
Malawi indicates that community support can positively influence ART outcomes and 
may be a particularly underused resource. 158 It was apparent that stigma, lack of 
information about HIV I AIDS, and general unease regarding the illness were still 
commonplace in our study setting. Thus it is recommended that community engagement 
and anti-stigma interventions be implemented prior to and in concert with HBHCT. A 
supportive community environment can go a long way to promote linkage among 
members. 
To this end, community leaders could be engaged to utilize culturally appropriate 
channels of communication to share information and empower their constituencies. This 
may involve: 1) providing basic information about HIV I AIDS and treatment; 2) . 
addressing issues such as stigma, disclosure, the importance of supporting family and 
community members, and encouraging people to get needed care and treatment; and 3) 
mobilizing communities to provide support for those living with HIV, for example in the 
form of spiritual counseling or child/elder care to enable people to attend to their health 
needs. Community engagement activities could take on any number of forms, including 
speeches given at local meetings or imbizos, church-oriented events, sporting events, or 
even using creative media such as dance, music, or film. Importantly, PL WHA who are 
willing to openly share their experiences should be active participants in as many 
142 
community events as possible, to help reduce stigma and other fears regarding life with 
HIV/AIDS. 
Specific anti-stigma interventions may also be useful. One particularly promising 
intervention was identified by a 2011 systematic review, and may be suitable for 
adaptation in the South African context. The key components of this intervention, 
conducted in Thailand, were empowering communities, reducing resource constraints, 
and increasing interactions between PL WHA and other community members. The 
intervention had a significant effect on decreasing HIV/AIDS-related stigma. 159 
Addressing key barriers to linkage 
The findings from this study identify the complex influence of individual, 
relationship, community, and health systems factors on linkage. The following 
recommendations aim to assist clients in overcoming personal and relationship challenges 
and reducing the environmental and logistic burdens of care seeking. The use of these 
strategies should be tailored to meet clients' individual needs. The general aim is to equip 
the CHW to handle as many basic scenarios as possible and to put in referral mechanisms 
and more intensive strategies for complex cases. 
Interventions to address psychosocial barriers 
Offer tailored counseling and motivational interviewing 
At the individual level, some clients were apathetic about their diagnosis, and 
demonstrated a lack of interest/motivation to seek care, as well as disbelief of their test 
results. To address these immediate reactions, CHW should be trained to quickly identify 
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key client barriers and deliver scripted messaging that can help address commonly 
experienced issues such as reasons for disbelief of status (i.e. previous test experiences, 
low risk perception), aversion to starting treatment, and a limited sense of urgency 
regarding the diagnosis. Messaging should emphasize technical information regarding the 
accuracy of test results, why/how results may be different at different points in time, the 
importance of early care seeking, and the benefits of timely linkage and treatment on 
survival, and quality and length of life. Additional media such as posters and radio should 
also be used to reinforce key messages. Focus group discussions could be conducted to 
help develop and pilot appropriate messaging. 
As part of their routine counseling, CHWs could also be trained to conduct 
motivational interviewing (MI), an evidence-based technique designed to facilitate 
specific types of behavior change. This approach has been successfully adapted for use in 
various healthcare settings. 160 Recent studies demonstrate tentative though promising 
results in improving ART adherence in HIV -positive individuals, 161 and promoting HIV-
related behavior change among youth. 162 A pilot trial to maintain youth and young adults 
in HIV care showed that peer outreach workers could provide MI with comparable 
quality to masters level staff given adequate training and supervision. 163 Recent 
. £ b 1 1 . S h A-1': . . 1 . . 164-1 66 adaptatiOn or use y ay counse ors m out .mea 1s a so prom1smg. 
Conduct repeat test if needed 
A strong finding from this study was that disbelief of test results can hinder 
prompt linkage to care. During implementation of this study, we also found anecdotally, 
that conducting the lab-based test and offering the official paper-based results helped 
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clients to trust and believe their rapid test results. It seemed that both the repetition and 
formality of the lab test provided needed affumation. Drawing from this, it is 
recommended that clients who still do not believe their results after extensive counseling 
and education, be offered a repeat test. While tllis would seemingly imply additional 
costs, our qualitative fmdings revealed that many clients had intentions to retest, and we 
also know that retesting in much of sub-Saharan Africa is common. Thus clients who 
seek this affumation would likely obtain one or more repeat tests. However, they may not 
do so in a timely fashion, leading to missed opportunities to ensure timely linkage. The 
PHC team leader, a professional nurse, could be called upon to conduct the second test so 
that clients can receive affirmation from someone different and at a higher level of 
professionalism. 
Encourage couples counseling and testing 
Many clients in this study, particularly females reported difficulty with disclosure 
to their partners or delays in linkage due to negative responses from their partners. 
Further Amollah et al. found that couples counseling and testing was a predictor of early 
care attendance. 103 Thus it is recommended that couples counseling and testing strongly 
be encouraged and accommodated whenever possible. 167 Endorsed by the World Health 
Organization, this strategy can eliminate challenges with disclosure and issues such as 
blame from partners or feelings of isolation when testing alone. It also allows couples an 
opportunity to discuss their results with the support of a counselor or health worker. With 
all of these benefits, clients are more likely to better cope with the diagnosis, and 
subsequently seek care promptly. Importantly, since in this environment, partners may be 
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away for extended periods of time, it may prove beneficial for some clients if CHW 
recommend delaying testing until partners retum home and/or testing has been explicitly 
discussed with them. Merely testing as a couple would not necessarily alleviate all of the 
potential repercussions of one or both partners testing positive. Thus, pre-test counseling 
should strongly emphasize the importance of readiness to test, willingness to support 
each other, and fostering positive interpersonal communication regarding results and the 
way forward. 
Conduct short-term intensive community-based support groups 
Difficulty coming to terms, accepting, and coping with the HIV diagnosis were 
identified as key barriers to linkage. Further, the first month following testing appeared to 
be a critical time period when most clients either sought care or did not. Evidence in 
South Africa shows that support groups can be effective in improving disclosure, positive 
coping, and self-esteem, and in discouraging avoidant coping. 168• 169 Participation in 
support groups has also been shown to positively affect ART outcomes. Importantly, a 
recent review highlights the vital role of psychosocial care, client empowerment, and well 
organized community support initiatives in supporting public sector ART programs. 170 
Based on the existing evidence, it is recommended that short-term post-test 
wellness groups be set up within each CHW's catchment community to help clients learn 
more about HIV/AIDS and adjust to their diagnosis. In order to facilitate better 
participation, consideration should be given to offering child care services and to hosting 
groups at times that are most suitable for clients. As the groups will be held in multiple 
short sessions within sub-communities, where clients can walk, time and financial 
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concerns should not pose significant barriers. Efforts to overcome stigma-related barriers 
may need to be implemented. The format for this group could draw from the model 
currently being implemented by the IACT (Integrated Access to Care and Treatment) 
program following facility-based testing. This model comprises a participatory 
curriculum of 6 sessions covering HIV basics, treatment, acceptance of status, confidence 
for disclosure, healthy living, and prevention strategies. Such groups generally involve 10 
-15 participants who are encouraged to commit to attending all 6 sessions and forming a 
. h 171 supportive co ort. 
The IACT curriculum has proven successful in quickly getting clients to a place 
of acceptance and moving forward with needed care and treatment. Further, post-test 
support services were an integral component of Project Accept, a successful community-
based voluntary counseling and testing intervention implemented in Tanzania, 
Zimbabwe, South Africa, and Thailand. Post-test support included information-sharing 
group sessions, psychosocial support groups, crisis counseling, coping effectiveness 
training workshops, stigma reduction workshops, and referrals to external agencies when 
needed. 172 
All clients should be encouraged to attend the post-test support groups so that 
their needs can be addressed more efficiently. IACT is currently funded by the United 
States President's Emergency Plan for AIDS Relief (PEPF AR) and works in close 
partnership with the National Department of Health. The TB/HIV Care Association in 
collaboration with the Sisonke District Department of Health are currently piloting this 
approach and lessons learned can inform more widespread scale up. 
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Implement a brief disclosure intervention 
For some clients, challenges related to disclosure and the subsequent lack of 
support hindered care seeking. While some of these clients may receive needed assistance 
from the one month support group, for others, disclosure and partner-related challenges 
may hinder attendance. For such clients, it is recommended that the CHW be trained to 
implement an individual brief disclosure focused intervention. The PHC team leader 
should be called upon..to address particularly challenging cases. Development of this 
intervention could be adapted based on experiences from other areas of the world. For 
example, a team in Thailand is currently developing a family focused disclosure 
intervention based on qualitative interviews with PL WHA and health care workers. Key 
components of the intervention address readiness for disclosure, assessment of risks and 
benefits, and skills-building sessions to assist PL WHA with disclosure to family 
members. 173 
Another source from which to draw is the Brief Disclosure Intervention (BDI), 
which was developed in the USA to assist HIV -positive African Americans face 
challenges that may be addressed through increased social support. The BDI format is 
based on the structure of brief motivational interviews (BMis ), which can include single 
or multiple sessions of motivational discussions lasting anywhere from a few minutes to 
an hour. The BDI places emphasis on analyzing options, techniques for sharing, 
identifying potential reactions, and maximizing positive responses. In one New Jersey 
study, participants of the BDI reported increased disclosure efficacy and decreased 
d. 1 . d 174 1sc osure anx1ety an worry. 
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Refer difficult cases to the Sukhuma Sakhe 
Extreme difficulties coping with the diagnosis will naturally hinder care seeking. 
While counseling from the CHW, supp011 from family or friends, or lessons learned in 
the short-term support group will be enough for many clients to overcome this barrier, 
there may be serious cases which require additional professional assistance. For 
example, it would be beyond the capacity of the CHW to counsel clients with suicidal 
ideations, domestic conflict, or severe depression. Other clients may require further 
assistance with disclosure or obtaining services such as home-based care. The CHW 
should initially refer such cases to the PHC team leader. If the problem is still beyond 
his/her scope, the case should be reported at the war room, which is part of Operation 
Sukuma Sakhe ("Let us stand and build"). This is a multi-sectoral approach whereby 
information on the health, social and economic needs of households in a given 
community are collected and discussed by a committee at a clinic-based "war room." 175 
Once cases are presented at the war room, relevant government departments are 
called upon to deliver needed services. For example, a clinical social worker from the 
Department of Social Development could be contacted to help clients resolve a domestic 
dispute related to HIV testing or counsel a client with thoughts of suicide. The war room 
approach is currently being used in Kwazulu-Natal, however, the South African National 
AIDS Council has endorsed it and intends to adopt the model for use nation-wide. 176 The 
PHC team leader can be responsible for collating the needs ofHBHCT clients and 
reporting to the war room infrastructure to ensure that they receive appropriate services. 
Since stigma and disclosure of status may be of concern, measures to ensure client 
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petmission and confidentiality should be incorporated (i.e. requirement of signature or 
thumbprint for release of information to the war room). 
Interventions to address access barriers 
Offer community-based point-of-care CD4 counts 
The study identified a number of logistic barriers to care including lack of time 
and fmances, as well as poor perceptions of the health care system. To overcome these 
barriers, it is recommended that point-of-care (POC) be conducted within the short term 
support group environment. Current evidence shows that point-of-care CD4 counts can 
substantially decrease the time from enrollment to ART initiation, 177 increase the total 
number of life years saved (L YS), and decrease costs per L YS compared to traditional 
flow cytometry.178 While these outcomes were achieved in facility-based settings, 
evidence from community-based settings also encouragingly shows that point-of-care 
CD4 counts result in high rates oflinkage to care. 104' 179 Further, there are existing CD4 
cell testing technologies that are accurate, inexpensive, and suitable for use in low level 
health facilities or community outreach. 180 
A set of machines could be purchased for use by districts, and a roving mobile 
team could bring services to any of the 6 planned sessions of the support group. This 
way a number of clients' needs could be met in one session. Further, results would be 
available immediately and could be incorporated into the discussion. Non-group 
participants can also be informed of the date of the mobile CD4 count so that they are 
able to utilize the services. In extenuating circumstances, plans could also be made for the 
POC CD4 count to be offered at the household level. 
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Pilot and evaluate community-based nurse-initiated treatment 
As part of the efforts toward task-shifting, South Africa has recently implemented 
nurse-initiated managementof antiretroviral treatment (NIMART). Although it will still 
take some time for a critical mass of nurses to be trained, it is recommended that 
NIMAR T at the community level be piloted and considered for future implementation. 
For example, the PHC team leader could attend the later sessions of the short-term 
community-based support groups to initiate eligible clients. Plans for re-prescription and 
retrieval of medications by clients would need to be further developed and piloted. This 
could include community depots or rotational systems whereby one person obtains 
medications for all members of the support group. 
Engage communities to improve the quality of health services 
Negative experiences with the healthcare system were commonly identified as 
barriers to linkage. Although some of the aforementioned recommendations would limit 
clients' engagement with conventional facilities, for some, linkage at a facility may still 
be most suitable. Further, treatment services will still remain facility-based for the time 
being. Thus, it is recommended that district health departments undertake a local exercise 
to improve the quality of health services. The aim of such an exercise would not be to 
overhaul the health system, but to identify key problems and bottlenecks, and implement 
immediately feasible and simple solutions. This exercise should involve a means of 
directly soliciting client feedback, giving them an opportunity to feel more invested and 
empowered in effecting change. A special task team could be developed to review client 
concerns and develop appropriate solutions. Asmembers ofthis team, Primary Health 
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Care (PHC) Supervisors could then provide feedback to facilities and implement needed 
changes. As part of these efforts, particular emphasis should be placed on the issue of 
improving staff attitudes and ethical codes of conduct. Local training sessions could be 
developed to address topics particularly relevant to HIV/AIDS services such as 
professional ethics, provision of sensitive and empathetic care, and the link between 
health and human rights. 
Over time, by engaging clients in the process and increasing quality of care, client 
perceptions and attitudes would shift. When clients report challenges with the healthcare 
system as a reason for not linking to care, CHW can respond by informing them of the 
quality improvement process and by soliciting their participation. The process of quality 
improvement could utilize the Partnership Defmed Quality methodology developed by 
Save the Children to "improve the quality and accessibility of ser\rices with community 
involvement in defining, implementing, and monitoring the quality improvement 
process." The methodology links quality assessment and improvement with active 
community engagement and mobilization. It has been used successfully in various 
countries including Uganda and Rwanda, and in settings beyond healthcare. Save the 
children has developed a practical handbook that can be used to guide the process step-
by-step.181 
Strategies to address the needs of youth 
Develop partnerships with the school health team and youth-focused organizations 
The findings clearly showed that youth struggle with linkage and may have 
unique needs and concerns. One best practice identified to help youth with linkage to care 
152 
is the employment of a youth linkage worker. 182 Further, recently published guidelines 
recommend: 1) intensive-youth focused case management and 2) adolescent-focused 
therapeutic support interventions using a problem-solving approach and addressing 
h . 1 157 psyc osocm context. 
Drawing from these guidelines, it is recommended that partnerships be developed 
with the school-based health team as well as with youth-focused organizations such as 
Love Life. Staff from these entities who are well versed in approaches and 
communication strategies best suited to youth, could be called on to assist the CHW with 
youth and young adults when appropriate. For example, they might facilitate youth-
focused support groups or provide individual counseling to clients on denial or 
disclosure. Partnership with the school health team may also help accommodate the needs 
of learners by coordinating services and offering them at more convenient times and 
locations. 
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Table 11. Policy and programmatic solutions to address key challenges regarding linkage to care following HBHCT 
Identified needs Practical solutions 
Creating a supportive • Add HBHCT and facilitation of linkage to CHW scope of work 
infrastructure for HBHCT and the • Streamline referral, record-keeping, and monitoring 
linkage to care • Engage communities to reduce stigma and normalize HIV I AIDS 
Addressing barriers to care 
Psychosoci Poor responses to • Offer tailored counseling and motivational interviewing 
al Barriers the diagnosis (i.e. • Offer a repeat test when needed 
poor coping, apathy, • Encourage couples counseling and testing 
lack of motivation, 
• Conduct short-term intensive community-based support groups 
and disbelief) or 
• Implement a brief disclosure intervention 
difficulties with 
• Refer difficult cases to the Sukhuma Sakhe 
disclosure and lack 
of social support 
Access Lack of time, money, • Offer community-based point-of-care CD4 counts 
Barriers and opportunity or • Pilot and evaluate community-based nurse-initiated treatment 
poor quality and 
perceptions of health 
• Engage communities to improve the quality of health services 
services 
Addressing the unique needs of • Partner with the school health team and youth-focused organizations 
youth and young adults 
Receiving a positive HIV diagnosis is a deeply personal experience which is 
affected by a host of environmental factors. Just as no one barrier hinders people from 
seeking care, no one solution will facilitate linkage. Thus, the menu of recommendations 
presented in this chapter aims to offer a range of options from which CHWs or PHC team 
leaders can draw to meet clients' unique needs and circumstances. While cost and 
feasibility concerns are inevitable, districts are encouraged to implement or adapt 
interventions that will best meet the needs of their communities given available 
resources. 
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POLICY BRIEF 
BACKGROUND 
Timely linkage to care and treatment by HIV -positive individuals can lead to 
significant decreases in morbidity and mortality as well as increases in life expectancy 
and quality oflife.72• 73 Further, there are significant prevention benefits as early initiation 
on antiretroviral treatment (ART) can significantly reduce HIV transmission to 
uninfected partners. 76•67 Modeling exercises also suggest that universal HIV testing 
coupled with immediate treatment could decrease HIV incidence and virtually eliminate 
the HIV/AIDS pandemic. To achieve this, the rate oflinkage to care must be 100%.31 
This underscores the importance of understanding and addressing barriers to linkage. 
Little is known about such barriers, particularly for newer community-based models of 
testing such as home-based HIV counseling and testing (HBHCT). Current evidence 
suggests that HBHCT is acceptable and effective in raising HIV awareness.40• 48 Thus the 
mandate for scale up is strong, and the next step is to ensure that appropriate measures 
are put in place to maximize the benefits of timely linkage. 
STUDY METHODS 
This study employed a mixed methods approach to: 1) determine rates oflinkage 
from HBHCT to the first point of contact with the health system - defined as obtaining a 
CD4 count; and 2) identify predisposing and other factors that may hinder or facilitate timely 
linkage. The study was conducted in the Umzimkhulu municipality, a poor rural area in 
Kwazu\u-Natal, South Africa. It comprised a predominantly female sample of 492 HIV-
positive HBHCT clients. 
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KEY FINDINGS 
Linkage to care 
• 62.1% of HBHCT clients linked to care within 3 months, which is a rate comparable 
to what is found in many facility-based settings82 
• The median CD4 count for those who linked to care was 340.5 ce11s/mm3, indicating 
that over half were immediately eligible for treatment 
Factors influencing linkage 
Client experiences following HBHCT are complex and barriers to linkage occur at all 
levels: individual, relationships, community, and health care system (Figure 1). Delayed care 
seeking is more likely when clients respond poorly to the diagnosis; have difficulty with 
disclosure and limited social support; lack time, opportunity, and financial resources; and 
have internalized negative experiences with the healthcare system. For example: 
• Clients who did not believe their test results had a 52% lower incidence of linkage 
• Clients who reported that finding time to seek healthcare is a problem had a 60% 
lower incidence of linkage 
• Clients who believed that drugs/supplies are generally available at the local clinic 
had a 78% greater incidence of linkage 
The qualitative analysis . offered deeper insight about the interrelatedness of these 
fmdings and the mechanisms through which they may affect the linkage to care. In 
particular, the qualitative findings highlight the influential role of interpersonal 
relationships, psychosocial factors, and the subtle impact of stigma. Importantly, youth 
may be particularly vulnerable to each of these barriers and subsequent delays in care 
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seeking. Clients aged 16-24 years had a 50% lower incidence of linkage to care compared to 
their older counterparts. 
Client Voices 
What made me not to believe [my results} ... is that ... my husband passed away in 2004 ... and 
I have never had sex with any man ... does it mean that I got it .from my husband because this 
thing hides in one 's blood? Does it mean that he was infected before he died? No sister, I 
don't believe it ... where did I get it because I'm a widow and I don't go around taking other 
women 's men. -Female, 47 years, had not linked to care at the last point of contact (231 
days) 
I will indeed go [to the clinic} but I'm still waitingfor my husband and we will go together ... ! 
won 't say anything on the phone. Things like this you can't just say it anyhow .... I will wait 
for him. I'm not saying I will not go but when the time is right and !feel it 's time for me to 
move on with my life ... my stand is we need to go together. For now I won 't do anything, I'm 
waiting for him ... -Female, 32 years, had not linked to care at last point of contact (542 days) 
... I've been staying with my grandmother the whole day .. .. my mother gets off only on 
Saturdays, she works from Monday to Saturday. On Saturday she knocks off at 3pm and 
clinics don't operate on Sundays. That's the thing that has been making me not be able to go 
to the clinic. -Female, 20 years, had not linked to care at last point of contact (146 days) 
I haven't done anything with [the referral letter] ... because staff at the local clinic don 't have 
confidentiality ... I 've heard them talking about other people ... I have to use money to go to the 
clinic that I like but then I don't have money yet. -Female, 22 years, had not linked at last 
point of contact (192 days) 
RECOMMENDATIONS 
To promote a supportive infrastructure for HBHCT and linkage: 
• Add HBHCT and facilitation oflinkage to CHW scope of work 
• Engage communities to reduce stigma and normalize HIV I AIDS 
To address psychosocial barriers to linkage: 
• Encourage couples counseling and testing to facilitate partner support 
• Conduct short-term intensive community-based support groups 
• Implement a brief disclosure intervention 
• Offer a repeat test when needed to quickly avert disbelief of results 
• Offer tailored cmmseling and motivational interviewing 
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To overcome access barriers to linkage: 
• Offer community-based point-of-care CD4 counts 
• Pilot and evaluate community-based nurse-initiated treatment 
To address the unique needs and concerns of youth: 
• Partner with the school health team and youth-focused organizations 
Figure 1. Socio-ecological factors influencing the linkage to care 
• Refusal to believe the test results 
• Apathy regarding the diagnosis and care seeking 
• Difficulty coping and accepting the results 
• Lack of interest or motivation to seek care 
Difficulty with disclosure 
Lack of support or negative reactions from: 
• Intimate partners 
• Household members 
• Other family, friends, and community members 
• Stigma 
• Poverty (i.e. lack of finances for transport) 
Factors leading to lack oftime and opportunity: 
• Living with numerous people to whom the client 
has not disclosed 
• Employment or other livelihood activities 
• Caregiving responsibilities 
Poor perceptions of the healthcare system based on 
negative past experiences including: 
• Lack of drugs/supplies 
• Demeaning treatment 
• Lack of discretion or confidentiality 
• Unavailability of staff 
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LINKAGE TO CARE FOLLOWING HOME-BASED 
HIV COUNSELING AND TESTING 
BACKGROUND 
Timely linkage to care and treatment by HIV-positive individuals can lead to 
significant decreases in morbidity and mortality as well as increases in life 
expectancy and quality of life.'·' Further, there are signifi cant prevention benefits 
as early initiation on antiretroviral treatment (ARn can significantly reduce HIV 
transmission to uninfected partners' ' Modeling exercises also suggest that 
universal HIV testing coupled with immediate treatment could decrease HIV 
incidence and virtually eliminate the HIVJAIDS pandemic. To achieve this, the 
rate of linkage to care must be 1 00%' This underscores the importance of 
understanding and addressing barriers to linkage. Litt le is known about such 
barriers, particularly tor newer community-based models of testing such as 
home-based HIV counseling and testing (HBHCn. Current evidence suggests 
that HBHCT is acceptable and effective in raising HIV awareness'·' Thus the 
mandate for scale up is strong, and the next step is to ensure thai appropriate 
measures are put in place to maximize the benetits of timely linkage. 
STUDY METHODS 
This study employed a mixed methods approach to: 1) determine rates 
of linkage from HBHCT to the fi rst point of contact with the health system 
- defined as obtaining a CD 4 count; and 2) identify predisposing and other 
factors that may hinder or facilitate timely linkage. The study was conducted in 
the Umzimkhulu municipality, a poor rural area in Kwazulu-Natal, SouU1 Africa. 
It comprised a predominantly female sample of 492 HIV-positive HBHCT 
clients. 
KEY FINDINGS 
Lillkage to care 
52. 1% of HBHCT clients linked to care within 3 months, which is a rate 
comparable to what is found in facility-based settings' 
The median CD4 count for those who linked to care was 340.5 cells/mm' . 
indicating that over half were immediately eligible for treatment 
F{(ctors influencing linkage 
Client experiences following HBH CT are complex and barriers to linkage 
occur at all levels: individual, relationships, community, and health system 
(Figure 1). Delayed care seeking is more likely when clients respond poorly 
to the diagnosis; have difficulty with disclosure and limited social support; 
lack time, opportunity, and financial resources; and have internalized negative 
experiences with the health system. For example: 
Clients who did not believe their resuns had a 52% tower rncidence of linkage 
Clients who reported that finding time to seek health is a problem had a 60% 
lower incidence of linkage 
Clients who believed that drugstsupptres are generally available at the local 
ctrmc had a 78% greater rncrdence of linkage 
The qualitative analysis offered deeper insight about the interrelatedness of 
these findings and the mechanisms through which they may affect the linkage 
to care. In particular, the qualitative findings highlight tl1e influential role of 
interpersonal relationships, psychosocial factors. and the subtle impact of 
stigma. Importantly, youth may be particularly vulnerable to each of these 
barriers and subsequent delays in care seeking. Clients aged 16-24 years had 
a SO% lower incidence of linkage to care compared to their older counterparts. 
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CLIENT VoicEs 
What made me not to belteve {my results}. . .ts 1/la/ ... my husband passed 
aw,1y in 2004 .. . and 111ave never 11ad sex wt/11 any l/liln ... does it mean/hall 
goltl from my husband bec,?use this lhmg hides in ones blood? Does it mean 
/hal he was infected before he died? No stsler. I don 'I believe it ... where did I 
geltl because nn a widow and I don 'I go around taking other women's men. -
F€male. 47 years, had not linked to care at the last pomt of contact (231 days) 
lwtlltndeed go flo /he clwcj but rm slt/1 wal/ing for my husband ,md we wt/1 
go together ... 1 won't say anything on the phone. Thmgs like /his you can't 
JUS/ say 11 anyhow ... .I wt/1 watt for htm. I'm not saying ! will not go but when 
/l1e ltme is rig/11 and I feel tl's ttme for me to move on wt//1 my life ... my stand 
ts we need to go together. For now /won 't do anythmg. I'm waitmg tor him ... 
-Female. 32 years. had not linked to care at last point of contact (542 days) 
.. .I've been staymg with my grandmother the whole day. ... my mot11er gets 
ott only on Saturdays. she works from Monday to Saturday. On Saturday she 
Anocks ott at Jpm and clinics don't operate on Sundays. That's 111e thing that 
has been making me not be able to go to the clime. -Female. 20 years. had 
not linked to care at last point of contact (145 days) 
I haven 'I done anythmg wtth [the referral letter}. .. because st,?tt at the local 
clinic don 't have confidentiality .. .rve 11e.1rd them talking about other people .. .I 
h,1ve to use money to go to the cltmc thai IItke but then I don 't have money yet. 
-Female. 22 years. had not linked at last po1nt of contact (1 92 days) 
Figure 1. Socto-ecologlcal factors Influencing the linkage to care 
Refusal to believe the test resulls 
Apathy regarding the diagnosis and care 
seeking 
Difficulty coping and accepting the results 
Lack of mterest or motivation to seek care 
• Difficulty wrth disclosure 
Lack of support or nevative reactions from: 
Intimate partners 
Household members 
other family, fnends, and community 
members 
• Stigma 
• Poverty (i.e. lack of finances for transport) 
Factors leading to lack of time and opportunity: 
Living with numerous people to whom the 
client has not disclosed 
Employment or other livelihood activities 
Caregiving responsibilities ) 
~-----~ 
~~erceptlons of the healthcare system based 
on negative past expertences including: 
Lack of drugstsupplres 
Demeaning treatment 
Lack of discretion or confidentiality 
Unavailability of staff 
REcoMMENDATIONs 
To promote a supportive infrastructure for HBHCT and linkage: 
- Add HBHCT and facilitation of linkage to CHW scope of work 
- Engage communities to reduce stigma and normalize HIVIAIDS 
To address psychosocial barriers to linkage: 
Encourage couples counseling and testing to facilitate partner support 
Conduct short-term intensive community-based support groups 
Implement a blief disclosure intervention 
Offer a repeat lest when needed to QUickly avert disbelief of results 
Offer tailored counseling to address common concerns 
To overcome access barriers to linkage: 
- Offer community-based point-of-care CD4 counts 
• Pilot and evaluate community-based nurse-mrtiated treatment 
To address the unique needs and concerns of youth: 
- Partner with the school hea/lh team and youth-focused organizations 
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Appendix 1. 
Referral Letter 
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Good start Q~know "y status 
Good Start III Home-based HIV Counselling and Testing 
Medical Research Council/University of the Western Cape 
11 Moodie Street, Harding; Ph: 039-433-2532 
Date: Counsellor: 
Cluster: Counsellor Supervisor: 
Client name: Clinical Nurse Supervisor: 
ClientDOB: Clinical Nurse Supervisor Contact: 
Client Study ID (barcode): 
Dear health care provider, 
This letter is to inform you that a trained Good Start counsellor has conducted the following with the above 
mentioned client: 
TB screening 0 STI screening o HIV testing o 
We would like to refer the patient to you for additional follow up services. 
Results of the TB screening are as follows: 
no symptoms o ; a cough o ; night sweats o ; weight loss o ; chest pain o ; loss of appetite o ; fatigue o ; other 
specify: ____ ____ _ 
Results of the STI screening are as follows: 
no symptoms o ; vaginal discharge o ; urethral discharge/dysuria o ; genital ulcers o ; lower abdominal pain o ; 
genital sores/warts o ; other specify: _____ ____ _ 
Results of the HIV test are as follows: 
Screening Test (SD Bioline): Reactive o; Non-reactive o; 
Confirmatory Test (SENSA): Reactive o ; Non-reactive o ; Not done o; 
It would be most appreciated if you could put this letter into the Good Start box in your clinic, so that our home 
based counsellors can easily follow-up on the clients ' progress. If you are unaware of the Good Start Project, 
please keep this letter and contact the Clinical Nurse Supervisor mentioned above. 
Please feel free to contact the Clinical Nurse Supervisor if ever you have any questions or concerns. 
We hope that this letter will help facilitate your work. 
Sincerely, 
Good Start III Project Team 
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Appendix 2. 
Participant Survey 
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Participant Survey 
Last Modified by: ClyTal SUpport on 01 Nov 2010 16:39:08 Revision number: 197 F ield Count: 35 
Section 1. Household Identification 
1.1 Cluster Name 
Please select the name of the cluster: 
r: Mvoti [1] 
r Phumamuncu [Z] 
C Cacadu [ 3] 
c Vuka (4] 
C Mthwana [5] 
c Senti [ 6 } 
r James [7] 
C Mantunzeleni [S] 
c Mfulamhle [9] 
C Matsheni (10] 
C Sphahleni [11] 
C G<:ebeni (12] 
r Summerfield {13] 
C Ncambele [14 ] 
c Readsdale [ iS] 
c Dumisa [16] 
c St. Barnabas [17] 
c Mahobe f :t S] 
r Ingele (19] 
c Skhulu [ 20] 
1.2 Household Code 
Please fill in household code: 
Expects a n umeric ,-esponse (requir·ed) 
P:e:;po.-:::e rn.:.;:..-:t: be Greaf.er7han .,_.,r-Equ :!l"OOO" 
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t..l Couns@llor Nilm@ 
Please select the cousellor's name: 
r Nobuhle Somcho ~ i: 
r :X:cJisWil Sthul.un 
r Xali.s~ Mdil [..;; 
r Hlaniphile I'Izolo f 'i j 
r Busis"tn Tshu.i ( S] 
r Juqaeline I'Iazillr;iu ['] 
r CeliWt! N&idi [S] 
J:' htie.D.~I! Njobe ~ l ii j 
r Millit:i!Dt ZO:ad.i [ 11) 
Please specify the date: 
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Section 2. Participant Identification 
2.1 Visit Attempt 
Is this a follow up visit (i.e. did they refuse to participate last time)? 
r Yes :: . 
0 No ~j 
2.2 New PID lnstrucUon 
Please select the next available PID that bas all the stickers in place. Take this sticlr.er and place it on the Household Identification Form. The ne.'<t 
question will ask you to enter this PID number. 
2..3 Unique Participant number 
Please enter the participant identification nnmher. 
Exp-ect!'; a valid GSJ. identifier {reqUired) 
2.4 Partidpant Gender 
Is the paticipant male or female? 
E::;:pe-:l::: a :;lngle option t ·e~p·:m~e (re41Uiredl) 
C Male [l ] 
C Female [0] 
2.5 Partldpants Age 
Wbat is your age? 
Ccn!itr.Jints 
!<e:;por1!1:! m~t be Gt't!;:;t~r nlim or-Er;u.1/ '14' 
Sefirw.;s.~ mu:;t be Lt,."!i.S Tluw or £qua1'100' 
2.6 Study Partlci!>lltlon 
Would the participant like to take part in this stncy? 
E)';r.ect:.; a .:.fngle option re!'punei: (required) 
L YeS [! } 
C No ["] 
Branches 
H r!:!.l~!)n=:e Sot Equal •y~ (l]' t h -en ~~i p ~o Vflw No Pcrticip.ltion (4.1) 
2-7 Marital Status 
What is your marital status cm:rently? 
E"'pE!d'!l .!t r.f ngl.e o" ti on t ·e~pon~e (required} 
r:: Sin!le [ l ] 
C Murled [2] 
r Co-habltlng [3 ] 
0 Widowed [ 4] 
r Divorced/ Sepilrated :;;.J 
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2.8 Contact Number 
Please enter your contact number: 
~to:n:=tHi~i ~c~ 
.:;.:- p .·,··~·r. f';?:-:;-::::;:·nl-;; A.:~-:: (2.5) t.;r·!.Jb!rTh•~u'17' 
2.9 Parental Consent 
Was consent obtained from a parent/guardian or is the participant married or living independently? 
C YeS [!] 
r No co] 
3r;Jnch-e!; 
I f re.ipon~o:: Equa:s 'No [2)' t he;) :. kip t•> End Instru<tiO.'l (S.3J 
2.10 Lived in House 
Have you lived in this house for at least four months over the past year? 
E:-:p<:tt!: a ~inQie option re:o:;p on::.e (required) 
C Yes [1] 
r No [ ::] 
2.11 Intends to Stay In House 
Do you intend to stay in this house for at least the next month? 
f.xpe~t!l a si rtgle .rption re~pon:;e (required) 
C Yes [!] 
L No [Z ] 
Prerequisites; 
SFp whe-n l.ivcd in HO(J$e (2.10) Net ECJuai'NQ [ 2]' 
2.12 Areas 
Are you from any of these areas? 
Expecb :a ~sngle oplion re~pon.!i e ( rcquir·cd) 
r Rietvlei [l.i 
r Dresilll [2] 
r Ibisi £3] 
C Lon~ Clove [ 4] 
C Madueni [5] 
C Fonrteen [ 6] 
C Non~idi [7 ] 
C Ntlanr;wini. (a] 
C None of these -inside district [9] 
r: None of these -outside district { l o] 
Prere::roisi~cs 
s!:::p \'of·•.:r. POJrUc.'p~nt Gem!l!'r(2A ) t.Qt Equ-31 'femal•! [2]' 
2.13 CurrenUy Pregnant 
Are you currently pregnant? 
rYes [:_ 
r No -.:· 
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Section 3- HIV History 
3.1 HIV Test 
H ave you ever had a n HIV test? 
r Yes :c: 
r No ::J 
a r.-. 1~o:h e s 
: f 1 t:;!' r;r: n :. i! Equals N-;,. [ 2 ]' th'.':- ' ! -;,.i:- to E~plain TB/Sfi (~.3) 
3..2 Amount of times been tested 
How many times have you tested? 
Ex pect::; ~ nu mt!ric I ' H~·on..:;e (re.,uired) 
Constraints 
Resp::Jt1::. e mL·:;t be Greater l"han or Equal '1' 
3.3 Test Location 1 
Where did you test on the last occasion? 
Expr:ctzo a single aptian re'.lpon:;e (required) 
r Clinic/hospital [ 1 j 
r Mobile van [Z] 
f": other non heillth fuilityfNGO [3] 
r Privote doctor [ 4] 
C Community eventfvenue (5) 
PrerequisiteS 
S~;ip w;...er. Amount of times been tested (3.2) l.e.!.s l11an '2' 
JA Test Location 2 
Where did you test the second last occasion? 
E:tr;-ecb <s :::inQie option re:JDCn~e (required) 
C ClinicfhospiW [1) 
r Mobile van (2) 
C Other non heillth facilityfNGO [,3) 
C Private doctor [ 4 J 
r Community eventfvenue [5) 
Prerequisites 
Skip v.·hrn Alno.unt of times been fu.<;ted (3.2) LJ!ss Than '3' 
3.5 Tesl Location 3 
Where did you test on the third last occasion? 
r: Clinicfhospital [l ] 
r Mobile van [~] 
r Other non heillth facill tyfNGO [3] 
r Private doctor ( •l] 
r Co mmunity even.t jvenue f SJ 
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3.6 Time of Test 
How long ago was your most recent test? 
r more than one year :1: 
r more than six months but less than one year [2] 
r between four to six months :3~ 
r within the last 3 months r 4! 
3.7 Willing to tell test result 
Are you willing to tell me the result of your most recent test? 
Expect~ a single option n:wpons.:; (requir-ed) 
C Yes (1 J 
L No [2] 
Branches 
If response Not Equal 'Yes [tr. then skip to Explain TB/STI (4.3) 
3.8 Test Result 
What was. the result? 
Expect" a ~ingle option response (required) 
C Positive ( 1 J 
C Negative [2] 
C Don't Knowj Didll.'t recieve results [3] 
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Section 4· TB/STI Screening 
4.1 Why No Participation 
Why do you not want to participate in the study? 
I Don't think they have HIV or are at risk of getting HIV. 
r Already know status . 
I Scared 
I Would prefer to test at a clinic, doctor, etc. 
I Time not convenient/ too busy. 
I Need permission from partner;family member or head of household. 
; Fear of stigma/ people finding out. 
I Don't see any benefit to participating. 
I Does not trust the study. 
I Fear of testing procedure/ finger prick . 
r Against religious beliefs. 
r Fear of ARV drugs. 
r Already know they are positive 
r Waiting to test with partner 
r Not ready/need to think about it 
r Other 
4.2 No Participation Other 
Please specfy. 
4.3 Explain TBISTI 
INSTRUCTION: Remember to ""'Plain the importance of STI and TB screening. 
4.4 TBISTI Screening 
Would you like to be screened for TB/STI? 
I Yes 
I No 
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4.5 TB Screening 
Have you experienced any of the follow-ing: 
r Cough for more than two weeks : 1] 
r Unexplained weight loss of more than 1.5Kg in the last month [:'.] 
r Fever for more than two weeks [::,] 
r Drenching night sweats [ 4} 
r TB contact in the house [5] 
r:: None of the above [ 6] 
Prerequisites 
Skip when ParticipautGender (2.4) Not Equal 'Female [21' 
4!.·6 STI Screening - Female 
Have you recently experienced: 
Expects multiple se lected options (required) 
C Discharge from vagina [1i 
C Sores on vagina [2] 
C Lower abdominal pain (3] 
r. None ofthe above [4] 
Prerequisites 
Sk ip wl en Participant Gender (2.4} Not Equal 'Ma!e [1]' 
4.7 STI Screening - Male 
Have you recently experienced: 
Expects multiple se lected options (required) 
C Discharge from penis [1] 
C Sores on penis [2] 
C Burning on passing urine [3] 
r None of the above (<!. ! 
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Section 5· End 
5.1 Refer Client forTH screening 
Did you refer the client to the clime for TB screening? 
r Yes [l~ 
r. No l::C] 
5.2 Refer Client for STI screening 
Did you refer this client for STI screening? 
Expect<> a ,sing 'le option response (.required} 
L Yes [1) 
C No [2] 
5.3 End Instruction 
Please select 'Next' to complete the survey. 
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Appendix 3. 
Monitoring Tool 
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Ongoing Counselling (Periodic Follow Up Visits) 
Participant ID: HH#: Cluster: Counsellor: Date: Follow up 
visit#: 
Client Age: Client Client marital Currently Pregnant Recent 
Gender: status: Pregnancy 
(within last 
6 months) 
Yes 
I 
No Yes I No 
How has client been coping to date? 
(Note: This section of the tool is for general program management purposes) 
How has client managed main concerns I issues from previous session? 
(Note: This section of the tool is for general program management purposes) 
Has the client disclosed his/her status? To whom? Does the client have someone to support him/her 
to manage the illness? 
(Note: This section of the tool is for general program management purposes) 
What are the client's main concerns, needs, or challenges? 
(Note: This section of the tool is for general program management purposes) 
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(Tick which of the fo llowing were covered during the session in the table below) 
PMTCT Education Family Planning [FP] Screen [Men & Women] 
Transmission Using Method: 
to baby ARVs to baby FP Yes No 
method 
Feeding Bactrim to Referred for Condom 
options baby FP Yes No N/A Use: 
ARVsto Testing of Pap smear Referral: 
mother baby Ever Yes No 
HIV/AIDS Education 
Transmission/Safer CD4/HIV TBIHIV Condom 
sexual practices Care demonstration 
Disease Positive STIIHIV Condom Progression Living distribution 
TB Symptom Screen STI Symptom Screen 
Cough for >2 weeks Yes No WOMEN MEN 
Weight loss > 1.5 kg Discharge Discharge Yes No from Yes No Yes No in last month 
vagina from penis 
Fever >. 2 weeks . Yes No Sores on Yes No Sores on Yes No 
vagina penis 
Drenching night Lower Burning on Yes No abdominal Yes No passing Yes No 
sweats pain urine 
TB contact in house Yes No Name ofPN referred to: 
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Which of the following services has the client received since testing OR since the last follow up visit? 
Health Services Where were When were 
services services 
obtained? obtained? 
1. Got a CD4 count YES NO NA 
2. Received Result of CD4 YES NO NA 
Count 
If #2 =yes, what is the CD4 CD4 Count: What is the source of Info Source: 
count? information (e.g. 
clinic card, self 
report)? 
3. TB Screening at a facility YES NO NA 
4. TB Treatment YES NO NA 
5. STI Screening at a facility YES NO NA 
6. STI Treatment YES NO NA 
7. Started using a family YES NO NA 
planning method 
8. ARV Literacy I YES NO NA 
9. ARV Literacy 2 YES NO NA 
10. ARV Literacy 3 YES NO NA 
II. ARV Initiation YES NO NA 
12. Received drugs to prevent YES NO NA 
HIV transmission to unborn 
child 
13. HIV Testing for baby YES NO NA 
14. Baby received drugs to YES NO NA 
prevent mother to child 
transmission 
15. Mental Health Care YES NO NA 
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Where were When were Social Services 
services services 
obtained? obtained? 
16. Joined an HIV support YES NO NA 
group 
17. Received home-based YES NO NA 
care services 
18. Received YES NO NA 
help/support/counselling 
from a social worker 
19. Received help/support YES NO NA 
from an NGO 
20. Applied for a social YES NO NA 
disability grant 
21. Received a social YES NO NA 
disability grant 
22. Received YES NO NA 
support/counselling from 
a spiritual or religious 
leader 
23. Received YES NO NA 
support/counselling from 
a community group 
24. Received YES NO NA 
support/treatment from a 
traditional healer 
Why did the client not obtain health services? 
(Note: This section will be post-coded) 
-
Why did the client not obtain social services 
(Note: This section will be post-coded) 
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What was done during this visit to address the client's needs? 
(Note: This section of the tool is for general program management pwposes) 
Short term strategy to address client's needs: 
(Nate: This section of the tool is for general program 
management purposes) 
Additional Comments: 
Long term strategy to address client's 
needs: 
(Note: This section of the tool is for 
general program management purposes) 
(Note: This section of the tool is for general program management purposes) 
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Appendix 4. 
Consent for HIV Testing & Medical Record Review 
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Good start I know my status 
CONSENT TO IDV TESTING 
I hereby consent to having blood taken for HIV testing. I understand the consequences of the 
outcome as I have received counselling regarding the disease. I understand I might be recalled 
for further testing. 
Ndiyavuma okokuba igazi lam lingahlolelwa isifo sengculazi (HIV/AIDS). Ndiyazi ukuba 
iziphumo zithetha ntoni kuba ndicaciselwe malunga nesi-sifo. Ndiyaqonda ukuba ndingabizwa 
liphindwe lihlolwe kwakhona. 
Abantu abangaphakathi ko 14 and 18: 
Ndiyavuma ukuba igazi lomntwana warn ongaphantsi kwe 18 lingahlolelwa isifo sengculazi 
(HIV I AIDS). Ndiyazi ukuba iziphumo zithetha ntoni kuba ndicaciselwe malunga nesi-sifo. 
Ndiyaqonda ukuba angabizwa liphindwe lihlolwe kwakhona. 
Name/Igama: 
Signature/Usayine (or thumbprint): Date/Umhla: 
Signature (or thumbprint) of parent/guardian of Date/Umhla: 
client under 18/Usayino lomzali womntu 
ongaphantsi kwe 18: 
Witness 1 (Counsellor) Name: 
Signature/U sayine: Date/Umhla: 
Participant ID: Lab ID: 
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CONSENT FOR CLINIC RECORD REVIEW 
As part of the Good Start Study, we would like to follow up on our clients to see how they are 
doing and find out which health services they have accessed. To do this, we will need to review 
the records at your chosen clinic or health facility. Will you give us pennission to do this? 
Please know that you have a right to say no, and there will be no adverse consequences if you do. 
You will continue to receive the standard services offered by Good Start and by the local health 
facilities. 
Njengoko sisenza ucwaningo le Good Start Project, singathanda ukulandela bonke abangenelele 
le projekti ukuze sithole ukuthi basebenzise maphi amaziko ezempilo. Ukuze sikwazi ukwenza 
oku, siyawudinga ukuthi sibone iinkcukacha zempilo yakho kwi kliniki okanye iziko lempilo 
olikhethileyo. Uyasinika imvume yokuba sikwenze oku? 
Nceda wazi ukuba unalo ilungelo lokuba uvume okanye unqabe, kodwa qiniseka ukuba nokuba 
isigqibo sakho sithini akukho nto imbi izakuchaphazela uncedo olufumanayo. Uzakuqhubeka 
ufumane uncedo kwumaziko empilo no Good Start njengesiqhelo. 
I give permission for the Good Start Study Team to review my clinic records at the health facility. 
Ndinika imvume kubasebenzi becwaningo le Good Start ukuba bajonge iinkcukacha zempilo yam 
kumazuko empilo. 
Client name 
Client signature/Usayine (or thumbprint) Date/Umhla 
Person obtaining consent (Printed name and signature) Date/Umhla 
Ingqina lalowo ufumana imvume 
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Appendix 5. 
Referral Tracking Survey 
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Referral Tracking 
. L:;ast Modified by: Cl)tr.I/ Support on 28 Oct 2009 1ft:Ol:28 Re:vision number:248 Field Count 41 
Section 1. Participant Details 
1_1 Penon conducting the follow up 
Please select the person conducting the survey. 
r V'llyisw:a Mildred Mboll..Ulbl [:: 
1.2 om 
Please enter the date when referral ¥;as tradmd. 
1.3 P.UC~nt 10 number 
Is the participant lD number indtided on the Jetter? 
r Yes (lj 
C No (2] 
fA Pricip•tiDNamber - ~ptvre 
Please insert the participant lD number as seen on the Jetter. 
En:ec::s a ·o~a: l id C:Sl iC:e::1tJ:~r (ri:quire.d) 
t..!ii Gender-
Please enter the participants gender. 
E:>. pe:t;; a sirt;:!e cption r'!!spc;~se (requir-ed) 
C MUe [li 
C Female [2] 
Is the participant's age available? 
E--I= ~Ctl a sir!;l-i! cpt ior. respor,se (required) 
r: Yes [1j 
L No (2] 
Prer~q_uisi~~ . 
Skip ..,l ,!!.n P3_rtkipanr .Age Available (1.6) N-:Jt E'!']ual 'Yes [1]' 
1.7 Porticip;lnl ...... 
Please enter the participant's age. 
Is the date when 1be home-based testing was done available? 
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P ~·e:r•:=:q._.i.:;;it~s 
·?. <ip ·, · ~r £:..?"'.~ cf J"-;•: .~i: :,-i·• .. :~_:::;;.:.:' T•2.Et,'::·.;....., .. :· .. E·=''1.1' •. ':?! (1. -~-: :, 'ii':·t E-=1u:z.l ··y,=$' [1~' 
1..9 Date o f lHome-bilsed Testing 
\\i'hat v.-ras the original date of the home-based testing? 
Section 2. Categories 
2_1 Category Selection 
Please select the followilng calleg:ories you would. like to answer. 
Exp,ec:.s mu:tipl.e. '.Se"e.tt-e.d options (rrequired) 
C First Visit Debjls [1] 
C CD4 count [:!] 
C A.R.VliteJ:acy [3] 
C A.R.V :in:illation [ 4 j 
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Section 3- First Visit Details 
r. . --~ ;-,;;qt:i.;;i~.~~_;; 
'2 ' ~· ·.,.r ·=-~-.:z,oori· Sc::'ecio;l (..:. . .1) Exduc:~s First \'i.:" il D.:{;.:·fL.z C'lr 
3 .1 Clinic Nilme 
Please select the Clinic whlll'e the referral letter was fuund. 
r Sihleu Clinic [:] 
r Lourdes Clinic : 2: 
C' GoWDelu clinic [3] 
C I-tvoti Cliaic [ ~·: 
r ST Marg.al"ets Clinic (5) 
C Guprmi cli1ic: [<5] 
L lbisi Clinic: [ 7 J 
C ltietvlei HospiUl {81 
C ST M;oquets H<>spiu.l [9] 
C ST. Alldrews Hospit .. l { 10 
C EG usher Memorial Hospittl [! !f 
C other [ 12. 
P.re.requisoit~ 
Skip''·"~" Categor)• Se!ect:Jon (21) Excludes 'First Visit Detaifs [1}' 
Skip '"11En Clinic Name (3.1:} Not EqmoJ 'Olh"r [12]' 
32 Clinic tUme- otbe.-
Please specify. 
Er.~e:ts a sing I_;! line te:-:t response (n~qui.n::·d)• [ ____ _ 
11-re:requisites 
Skip •.·lnen C.a-tegar,- Se!ectfan (.2.1) Exdudes 'First Vis<t Detaits [ 1]' 
3.3 Awar~ of Date 
Do you know the date when the participant visited the clinic? 
E"'::~ects a s ir gle cpt:ar. rez._;:~orse (required") 
C Yes [ 1 ] 
C No [2] 
Branches 
If res~>onse Equ"ls 'No [2T the·, skip to Cfient Ref erred (arSeJ•viO!!S p ·.s) 
Prerequisites 
Skip ·.·~ -,en C'.a:tegory Selectfan (2.1) Exdudes •First Visit Oetai:Fs- [1]" 
3.A. Dab!o Client Visbd CliruC 
Please enter in the date that the participant visited the clinic. 
E:!! !=e:t s a date n:s-f:om:a (required; 
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(::c,J·:::·r·J ~:t.:::.E 
S· !: ··.r :: ·:;;(..·:-'"~· S ~!:::-~'"ti:.1 ~::: !i Exd:·~·.:::; ' Ft ;:;=t 1/h;lt C·;;~ ifs- [lT 
3...5 C6ent Referr-ed for Services 
Please-select which services the client was referred to. 
r TB screeDillC [1] 
r STI scree-nine :~1 
r J:";amily pl.l:D.n..i.n~;: :J:: 
r HIV fol1ow up servi~es : .j, : 
P"ceri!qul!:: ib:s 
S~·iF •.-n.::n Cat~gory Si!!~cticm {Ll) EX£1udes 'Fi rst Vi:s:it D;:taits [1J' 
Skip ·· ~"'·::n Cli~t Ri:.ferr.:;..J for Senlic.as (3.5) Exdu ~.s tTB screening [1]' 
W;~S the client diagnosed with TB at the facility? 
E.:ot pe'"ts a s lrg l·e cptior respon:;:e: (required)' 
C Yes [1) 
C Na [.2] 
C I>aa't bun• [3-
Pl'e:r~quisltes 
Ski p: \·men Category Sel~ction (2.1 } Excludes 'First Visit OetaHs [ 1]" 
S ki p- ~-~h~n client" REferred forServfc-=-..s (3~5) Excludes •sn SO""&e.ning [2]' 
3_7 Diagnased sn 
W;~S the client diagnosed with any SITs at the facility? 
E;c.;: t: e::ts a sir.gle c-o:icn re:sponse· (required) 
C Yes [l] 
C Na [2] 
r I>aa'thcnor [3 ! 
Pre:re.qujsftes 
Skfp \', .-,en CJtegOI')I Select:ior; {21) Exclud-es 'Rrst Vlsi t Oetaifs [1)" 
Skfp· '.-nEn Client Rf!:ferr~d (orSerotices (3,.$) Excludes 'Family planning [.3]' 
3..1 Famrty Planning 
Was the client started on fAmily planning? 
E:;1=e:ts a s ir.gle cptior; .rasp0'"1$e- (r€!quired) 
C YoS [ l] 
C Na [2] 
C I>aa' tkDow [J: 
Prel'equls:ites 
Skip ~·•.;en C:rtegory Selection (2.1) Exch.nfi!S "First Visit Detaifs [1]' 
Skip ...,:,en Client Refer-red for SErvia?S (3.5) Excludes 't=.m.ily planning {3]' 
Skip ·.-~ :..,en Family Pl;;;nning (.3~8) NolEquc:l 'Yes [1)" 
3..9 Fa111ily Planning Method 
Which methods of fAmily planning are being used? 
c n. pill [1] 
c Depo Proven. ~2] 
r: Nar.istente ( 3] 
r M~ll! condoml!s [ .;.] 
r Female co11.dom.s [ ~ J 
r Othu :s: 
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f. r :r '· .-:•..1 ~.:;it.::; 
s-:~ --:;r ~~:;t;;.;-~ ~· :;,-';,';:::-:;~·n 1 .? • .:) E-vd~l::':o..O c:r.F.. ".r-:t o~:.:'l'fs- [f!' 
3.10 Cfmic&l CJQrt loc~ted 
Clients <linical Chart Located, ID number recorded 
rYes ~;.: 
r No (2j 
f•e::-.;:;ui!Jto 
·;: .. ;: · ·ur C3t.:>JC:"i:Sc.>;: :t;.::--;-, (.l.1) Ex:d~d~ 'fir;:;t \!i:;it C:!~c;&;. [1]' 
3.11 Loc~ted ia p~RT n!gister 
Oient located in pre-ART register, ID number recorded 
r Yes j) j 
f:' No [2] 
Prere!(UisH~ 
Ski p '."¥"'1i!n CarEgory'SeleaiOI'I (2~1) Excludes 'Fi.-st Visit (letait:. [1]' 
S Up w-: en CUnical Chart l:ccated (3.10) £qu31ls •y25 ~1]' 
S~i p · ... ,en Loc:iiit.ad inpr-~ARTregi:;tcr(3.11) Equals Yc.s [1]' 
3.12 C·OIIfinn Botla. Na 
Please confirm that neither the Clinical chart nor the eniiy in the pre-ART register could be found. Select the 'Bad' option to make changes in the 
event data was incorrectly captured. 
C Neitbu soarce doc:amu.t r:ould. be fouad. [ 1] 
Section 4- CD4 Count 
Prerequisites 
Skip vi,en C-ato:goryS'eleaion (2.1} Exdud.as 'C:D4 count [2]' 
4_1 em count o• 
On what date was the CD4 mont done? 
E>~J:lects a d;;t~ response (required) 
P.re~reCJ,uisit-<!5 
S kip •tmen Ci?:tegol'}• Se!ectirm (2.1.) Exdur:fes 'C04 cnunt [2]' 
42 Pncipmts CD' Count Clinic Card 
Wha;t is the clients CD4 Count? 
'Expec~s a r..um:;:-;c r-e:pon.se (required) 
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Section 5- ARV Literacy 
S.l ARV Ulet-acy f 
Did the client complete ARV literacy 1? 
r No [2] 
Prerequisites 
Ski~ 1·1.1~n Category Selection (2.~) Ex dudes 'ARV literacy [3]' 
Skip ~., ;,e n ARV Uter.;;cy 1 (5.1) Nd E<1ual 'YK [lY 
S2 ARV Uleracy I Dale 
Please enter the date AKV Literacy 1 was completed 
P.-e~:equisi t-es: 
Skip r.rn:n C-ategory 5e!ectio.'l (2.1) Ex.dudes "ARV lit~ racy [3]' 
5.3 ARV Uleracy2 
Did the client complete ARV literacy 2? 
C Yes [1j 
C No [~] 
C Doll' t !mow [3] 
P'rerequisit-es 
Skip ~·J:-• .:n Categcr;~Siae;:;tioo (.2..1 ) Exdud6 "ARV literacy [3]' 
Skip ~th.:n ARV Lit:er;aqr 2 (5.3) Not Equal 'Yes [1]' 
SA ARV Uleracy 2 Dale 
Please enter the date ARV Literacy 2 was completed. 
L ____ ........ _ .. ________ J 
Prer ii!C{Uisites 
Skip •n:; oE:n Citcgvry Selection (2.1) Exdudi!S 'ARV lit"!racy [3]' 
S.S ARV Uleney 3 
Did the client completeARVliteracy 3? 
E...,_pa:::;;; a s irgle cpticn ; esp':ir Sii!· (re~uired) 
C YeS [lj 
C No [2] 
L Doll' t !mow [3] 
Prereq.uisit.:cs 
Skip •o,.""'en Category S~..lcctioo (2.1) Ex dudes "AR\' literacy [3]' 
Skip v~-;o, r. ARV Lit&'llC}' 3 (5.5) N.:ot Equal 'Yes [1]" 
Please enter the date ARV Literacy 3 was completed. 
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5.7 Confirm No ARV l..it:2rilcv 
Please confirm that the participant bas not completed any ARV literacy sessions. If the participant has completed an ARV literacy session, select 
back to change your response. 
r The p;utieip.intll.u not ~ompleted u.y AR.Vliteruy sessions. [: ) 
P:r.lr>:!quisi te:> 
S !..~ p ·.; ·,~;. n Ca te;pr; 'Si!l~;cticn (.::!.1) Exdud.:!s 'ARV litcr3c.y [Jl' 
s ~: p v; "l:?O C1.1ntirm Na ..... RV !itu~q~ (5]) E-=:uats "The particfp.ar:t has not .t::crnpfe'.:cd any AAV ~f.:erncy se.;:sicr.s. [ tj' 
5.8 ARV Literacy Sessioos 
Where did the ment attend the sessions? 
C siklu• cli.U< [ 1] 
C Lovde.s clioi~ [ 2} 
r: G<lWllt!lU. Cllni~ (3J 
C MToti cl.iai~ (4) 
[} 5T HUJ::Uf!ts Clini~: (5) 
C Gurwilli cli.Aie [S] 
1: Ibisi cliD..ic [7] 
C JtietTIU Cliai~ [Cj 
C ST M.a.q:uets Bospit.il) [9] 
C Printe doctor {:!.0_ 
C OtlLn C9~} 
Prl!req_uisites 
Skip w.,'!n Ca-t~OI'V SeJection (2.1) Exdud'!S 'ARV lit~Jmcy [3}' 
Skip h~en ARVUt!!racy Sessions (5.8) Exdudes •{stl1er [ 95) ' 
S..9 ARV Session Loc4ion other 
Please Specify: 
E...,..pe::t a s.ingl~ line teXt n::~f: :mse {r:equir e:d} 
L_ ---- ---·------··-----·------· 
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Section 6. ARV Initiation 
6 .1 Initiated ARVs 
Has the client initiated ARVs? 
r Yes l 
I":- No [2] 
r DDn't Jmow c 3 r 
Prerequisites 
5 kip ,,.,;-,.,n Ca-tegory Select:ian (2.1) Ex d'udes 'ARV initiatl<>n [ of]' 
Skip •.·/'-.en Initiated ARVs (6.1) t~ot :Equal 'Y€5 [ :1 ]" 
62 Date ARV lnitiirted 
What date did the dientinitiatedARVs? 
Prerequis-Jtes 
Skip .,, e;n Category Select:f~n (2.1) Exdudes 'ARV in:itiat<on [4]' 
Skip,.,. en InitiatedARVs (6.1)· Not :Equal 'Ve.s [:1.]' 
6.3 Where Initiate ARV.s 
Where did the client initiate ARVs? 
Expec:"""..s a single a;=~tic.r re5"c.rse. (requir<iad) 
C Sihlen CliD.i<: [! ] 
C LOu:rdes Clioi<: [2:l 
C G-aw:a.ele;o. Clinic: [ 3 J 
C Mvoti Clinic [ 4 I 
C ST Mugarets Clinic: [5] 
C G111:Wini Clinic [6) 
L Jhisi CliD.ic: f7 
C ltietvlei Clinic [S] 
C ST Maq;uets H<>spital [9] 
C PJ:ivate doc:tor [10] 
C othn :ss; 
P.rel"equisites 
Skip ·ci'oen Ca~egcrr/ Selection (2.1) Exdudes 'ARV initiation [ 4]' 
Skip •.,'-,.;;on lnitiat<id ARVs (6.:!} Not Equal 'Yes L<]' 
S~ip •.i'->-=n Whereinithtte·ARVs(<>.3) f i:OtEqua f 'Other [95]' 
&A ARV Loc;otion Other 
Please Specify: 
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P--:::·e..:}tlh;i"':::s 
:;,. r: ·. - !r C.:,t:::r·.?J·~ ':.;:•'?rt:-:.-r:• : .... ::) Ex::fJ.d~.: 'l~ ....... i:::ti~tU c· r l [ -:-J' 
6.5 HIV- Related Services 
Has the client been referred to another facility for additio·nal HIV-related services? 
r No [:) 
r Do:rt't ~ow :3J 
r Not ;appl ic.able •: 4: 
Prerequisites 
S ki p 1ho=n .category Se!eal;.w (2.1) Exdmfe:s '<'RV initiaticm [4]" 
Skip· ... ,:nen HTV- Related Services (6.5) Not Equa l 'Yes [1J' 
Which facility has the client been referred to? 
C Rietvlei Hospi1:al Il] 
C ST Margarets Hospital [ 2 ] 
C ST. Alldrews Hospi1:al _3 ] 
C EG Usber Mem.o:rial Hospiul [.;: 
C Other LS] 
Pr~requi,;ites _ . . . _ _ _ 
Sktp '·men Category.Se!ertrr:m (.2..1) Exdudes 'ARV m1tiatum [4]' 
Skip whom HIV- Rehtterl Services (6.5) .Not Eq~.~al 'Yes [1]' 
Skip •.-hen R£fer:red "Facility (6.6) Not Equal 'Other [Sf 
6.7 Referred Facility othtS 
Please Specify 
E'•pe::ts a si ng l e l ine ta:-:t n:sponse {n:quired) 
·------·--··---.. -·-----·--·------
Section 7- End 
7 .1 End Instruction 
You have reached. the end of the survey. Select Next to store.. 
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Appendix 6. 
Client Outcome Survey 
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Client Outcome Survey 
Last Modified by: Mobenzi Support o n 26 Oct 2011 09:56:08 Revision number. 303 Fie ld Count: 60 
Section 1. Background 
1.1 PID 
PID: 
1.2 Cfuster 
Please select the cluster name. 
Ex:>e,:ts a sin~ I~ option response (rclJUired ) 
0 Mvoti [1] 
n Pbu m amuncu (2] 
0 Caead u [ 3) 
[J Vulr.a [4 ] 
[j Mthwa na [5) 
n Senti [6) 
n James [7] 
n Mantuzeleni [8] 
c Mfulamhle [9 ] 
n Matsheni [10) 
0 Sphaleni [1 1) 
0 Gcebeni [ 12] 
n Summerfield (13] 
n Neamb ele (14) 
0 Readsdale (15] 
0 Dnmisa [16] 
n St. Barna b as f 1 7) 
n Mahobe (JS] 
n Skulu (20] 
1.3 lflD 
HIDD: 
En ,ects C! :~ume ric. response (r-equi red) 
! 
..1 
1.4 GBUR 
Gender: 
E .J.:t.::t~ ~ tir;l: o.Jt •cn r':?!.:llcn ::. (required) 
r Male c'] 
r Female ·, 
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1.5 CONSENT 
Did the client give consent for medical record review at the time of testing? 
r Yes !!j 
r Unkno"'·n {Consent missing) [:::: 
1.6 Sought c.,.. 
Had this client known their status previously but not sought care? 
fi Yes fl) 
f"i No [e] 
1.7 CONTACT 
Does this person have a phone number? 
E:•pi:!cts a single opt1on respo n!>: (re.qulrt"!d) 
n Ye• [l) 
0 No [2) 
1.8 INPERSON 
How many in-person follow up visits, including interviews, did thls person have? 
E/.p'!cts a numeric rt:!;par.se (required) 
1.9 FONECALL 
How many follow up phone calls did this person receive? 
L 
1.10 TCONTACT 
What is the total number of follow up contacts the client received? 
c.~ peels a numenc response {required) 
! _____________________ _ 
1.11 LASTFU 
What was the date of the last follow up contact? 
IH 
1.12 MOVED 
Did this person ever move out of the study area? 
n v .. [l) 
n No [e] 
1.13 llEFUSEF 
Did this person ever refuse follow up visits? 
r Ycs uJ 
r No ~~~ 
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1.14 DISCLOSE 
Has the client disclosed his/her status? 
t Yes :JJ 
r No 1" · 
t Unknown [?.: 
f:.rc:t·tLes 
if .- ,,~,~~;:.-~n;;;~.: f~ot Equ~ l 'Y(.'S [1]' t-·~er skip t.c Di5CDA'TE: (1 .. :!.8.) 
1.15 DISCWHO 
To whom did the client disclose? 
E;.·pe o:ts multtp; E:.- sel::!ded opt~on s (re rau 'ire d ) 
D Marital partner [ l) 
£"": Other partner [2] 
[J Parent (s) [3 ] 
[J Sibling(s) [ 4 } 
[i Cbild(ren) ( 5] 
D Other family member [6] 
D Friend/Neighbor [ 7 ] 
[J Religious leader [8] 
[J Other [9 J 
P re:req.uisites 
s;cip when DIS CW HO (1.15) Excludes 'Other (9]' 
1.16 DISCWHO Other 
Please specify: 
Expect s .;; s ingle line t e.-:. t r-?spons:e ( required ) 
I _ 
1.17 DISCWHBt 
Which is the fu-st visit date when disclosure is noted (including cross sectional interview date)? 
E;~p: e cts a d2te n~sponse {required) 
I_ ---------- ---- -----------
Prerequis ites 
SkJp ~:d1en DIS CJ.OSE (J.14) Not Equai 'N:u [2.]' 
1.18 OlSCDATE 
What is the last date when disclosure information is available? 
1.19 LETTER 
Was the actual referral letter found at the clinic? 
t Yes [ l] 
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1.21! ffiDIAG 
Was this client diagnosed with TB? 
I Yes [:) 
I No ::: 
r Unkno wn [ :] 
1.21 OlJTCOME 
What was the final CD4 outcome for this person? 
r Died [1.) 
0 Obtilined C04, verified l:!J 
0 Obtained CD4, unverified [3j 
[J Had not obt01.ined a C04 at lut point of contact [4) 
£1 No outcome information available [SJ 
n £.%eluded [6] 
BrO?!m .. hes 
Jf r,;,sponse Equals 'Obtained C04., verified [2]' then .skip to lNFOS~'lCE (1.1.4) 
If re~,pc..ns'3 Equal5 'Obtilined CD4, unverifie:rl [3}' then skip tc lNfOSnCEU/'iVECOUNT (l.25) 
If r£:spons:e Equt~ls 'No CJutr.orne infonuation availt~ ble [ 5]' then ~:;kip to NOJNfO (.1.2:Z) 
If resoon!.'= EqtJais 'Exduded [6]" th.:n skip to EXCLUSION (1 . 23} 
If respom:•::! Equa ls 'Ui.\d nrJt obtained i\ CD4 ill last polutof contact (4]' then zldp to HC REAS!J (1.58) 
If f'?.:>pons'3 Equa!s 'Died [1]' then ;ld;J to End (:1 • .1} 
Prerequisites 
S":.:i p wh'.!n OUTCOME (1.21) Not Equal · so outconu."! information available (5)' 
1.22 N<»>FO 
Why is no information available for this person? 
Expect5 a sing!~ option response (re.quirl!d} 
n Moved 1 unreachable ( 1] 
0 Refused follow up visits 1 unreachable [2:] 
0 Uncontilctable a.fter seven.l attempts ['3] 
[] Other [4] 
Cram.:hes 
If H:sponse EfJUi1iS 'Other (4.]' U)en sbp t.o NOINFO Other(2.1) 
If r~sponse Not ECIU\li'Ol'he-r (4]' then sbp to End {2.3) 
Prerequisites • 
Sio'ip when OUTCOME {1 • .1.1} Not Equai-EXc.luded: [6)' 
1.23 EXCWSION 
Why was this person excluded? 
E:.;p2cts a sing! .a option rf:~pon'Jie { required) 
n K.new they were posltive prior to HBHCT (1] 
n Claim to h<~ve rete.sted n egative [2) 
n Initially indetermina te'~ not given final results [3] 
fl Ini ti ally refused results (·;] 
n Other (51 
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i· ·~·t ··•1 .P:.i:', !.' 
.J·;rc·-: .• : tz.;.: !) lt.:.t £c:u:JI ':)bt~~it' ~~ ·:r; .; , •!di--'J (~:1' 
1.24 tlFOSRCE 
What is the source of verified CD4 information? 
r Clinic: records l-) 
I Laboratory report ;.?: 
r CHent's clinic: cud t3 ; 
1·· '"H ;:;:-n! ~. f:ctu<Jb '(lin it t•n:nd~; [ 1]' tiH~., !.ki;, r.v f.;.~JO\'.'lM 1'E {1..27} 
lf ~.:.:: ~-:.n.::~ F.quiils 'labc-;,IJ}rv r<:port i1:i' tl~~n :> km to l:f!VI!..'DATL; ( 121) 
Pn!r~Quisitns 
Si•ip \'1·1en OIJfC:OME (1.2.1} Not Equal 'Obtained t.D4, unverified [3 ]' 
1.25 tjFQSRCEUNVECOUNT 
What is the source of unverified CD4 count and date information? 
n Self report [ l] 
~ Refernlletter fonnd {2] 
Prerequisite~ 
SKip t'"hen OUTCOME (1.21} Not [f~ual 'Obtjjhll"d CD4, unverified (3 ]' 
1.26 SET Skip CD4FDAT 
Numeric 
Thi'i fiei•J is not di!.'pl.w~d on .:he de\lic:e {optirw~ l ), Dt!f~ult: _ {SET(60707,1)}_ 
1.21 KHOWDATE 
Is the CD4 date known? 
E;.;p!<':t9 a stngl~ option res;J·Jnse (required) 
0 Yes [l] 
0 No j2] 
If r~stoc.ns~ EQUill5 'No [2]' tllf:!r. skip to CD.f FOAT (1.30) 
Prerettuisites 
s :~ip Wh(:l'l KNOWOAif (1.27} Equ.1l:>o 'No [ 2]' 
1.28 C04 DATE 
What date did the client receive a CD4? 
E;;p~ct~ a dat~ re~por1~e {rcqu ir~d) 
·. :-: .. 
1.29 Skip CO.FDAT 
Numeric 
Th1s f:~l\:1 is not· displayed on the de ~rice (option31), DefGult: 0 
rn,.re,tui,.il~s 
S '• ip W~H:O Sfdp CD4FOAT (.1.29) Equnls '0' 
1.30 CD4 FDAT 
If self reported date, what is the first date wheri CD4 was noted as being done? 
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1.31 KNOWCD4 
Is the CD4 count known? 
rYes :: 
r No 
f." r~: fr>:"IU ' sitr~5 
:- 1-: iJ ·,·, ~, -:1 KNOl"..'C[)4 (1.31) Etltmls To [2j" 
1.32 CD4CT 
What is the client's CD4 count? 
1.33 CUNIC 
Where did the client receive a CD4? 
Expects a rinole opl1~n response (r-<!:qui red) 
c Sihleza Clinic ( 1] 
c Lourdes Clinic [ 2 J 
r Gowan Lea Clinic [3] 
r: Mvoti Clinic [4) 
r: St. Margaxet's Clinic or Hospital [5] 
r Gur;wini Clinic ( 6] 
r: Ibisi Clinic [7 1 
r: Rietvlei Clinic or Hospit~l [8] 
r St. Andrews Hospital [9 ] 
r Umzimkulo Clinic [10] 
r Ixopo Clinic [ 1 1 ) 
r Kolc.stad - any (12} 
c Mvubukazi Clinic [13] 
r: Priv~te doctor (14] 
c Other, inside district [15] 
r::: Other, outside district[ 16] 
r Missing, no info [99] 
Prerequisites 
Sk!p ~·1h en CI. IN.CC (l .33) Not Equai'Other. in'>ide d 'fs.t rict ['JS]' 
1.34 CLINIC Other Inside 
Please specify: 
Exp.r:cts a sin~le hn-= text response (required} 
Prerequisites 
Ski p wh~r~ CLIN! C ( 1.33) Not !:Quai 'Orh~: r, outside d:-str;ct {16]' 
1.35 CLINIC Other Outside 
Please specify: 
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1.36 RESULT 
Had the client received their CD4 count results at the last point of contact? 
l Yes ,1; 
I No . :!._" 
r Unknown L:.: 
1.37 ARYL SRC 
What is the source of the ARV literacy information? 
I Self report i 1 i 
r Clinic records [2.] 
I Client's clinic c~rd [3J 
1.38 ARV1 
Did the client complete ARV literacy 1? 
Expects a sinQie op tion r-espans~ {required) 
[j YeS (l] 
[j No [Z j 
Branche s 
[f res po r. 5:~ Ectuals 'No [2)' then sk i tJ t fJ DElAY(l .55) 
1.39 ARV1DATE1 
Does the client know what date did they complete ARV literacy 1? 
E_:..,pects. z. sir.gle or;tiDn _ re~pcnse (required ) 
0 Yes [l] 
0 No [2 ] 
Prerequisites 
S ~ i p w hen ARV1DATE1 (1r39) [quil ls 'No [2' ]' 
1.40 ARV1DATE 
What date did the client complete ARV literacy t? 
Expect~ a c- ate r espC;nse (required} 
1 . 
1.41 ARV2 
Did the client complete ARV literacy 2? 
[j Yes [1) 
[i No [2 ] 
B:runch~s 
rf respor. se [qu-ills ' r.fo [2]' th~n ski p t·:.. DELAY (1 .55) 
1.42 ARII2DATE2 
Does the client know what date did they comple1e ARV literacy 2? 
I Yes •·; ; 
l No .. 
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fr :::-\':fi'J::; :i t!'..i 
- .:ip • -. .,., ,tr:~'l'!..lA!£1 ( 1.42} EritE;b ' !Jo PJ' 
1.43 AR\12DATE 
What date did the client complete ARV literacy 2? 
1.44 ARVJ 
Did the client complete ARV literacy 3? 
n Yes [ l] 
n No [2) 
if r ~spor;~,·~ EtlUllls 'Nn [2]' then s1: jp to DELAY (155) 
1.45 ARVJDATEJ 
Does the client know what date did they complete ARV literacy 3? 
n Yes [l) 
n No [>) 
Pr-erequisite~ 
Sl-."1p wlh:n AflVJD/iTE3 (1 .. </5) Equals "No [21' 
1.46 ARVJDATE 
What date did the client complete ARV literacy 3? 
E'i pF:r:ts ;: d-3te r:s p nse (ren:ulr~d ) 
I ._.--·----·--·--··------·- ·-----··· 
1.47 RX INIT 
Did the client initiate ART? 
E.~ pecis a smo le option respo nse: (required) 
n Yes [l] 
n No [>.) 
Brant.hes 
lf re 3por:se [quais 'No [2]' then ::;;..]JJ to DElAY(1.55) 
1.48 RXSRCE 
What is the source of information for ART initiation and date? 
E;:.pHt:> a ~i n g le option r.::s;c.•nJ>e (reraulrcd ) 
0 Selfreport [ 1] 
n Clinie records [2 J 
n Client's clinic cud [ 3] 
1.49 RXKNDATE 
Is the date of ART initiation known? 
n Y•s [ l] 
n NO [ ' . 
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1.50 RXDATE 
What date did the client initiate ART? 
J· :-.:.t·': '.l tl ;~i~·:•s 
::-, ;J · i·,~·#• 1?.XKifll.H£: {J.~ ~J Cqtnl5 'W.>5[: J' 
1.51 RXFDATE 
If no date or self reported date, what is the first contact date when treatment was noted as having started? 
1.52 RX CUNIC 
Where did the client initiate ART? 
ExpP.cts a single- option response (required ) 
n Mvoti Clinic [!J 
n St. Marguet's Hospital !2] 
n R.ietvlei Hospitiill (3] 
n St. Andrews Hospital [ 41 
n lbisi Clinic [5) 
[j GoWiln Lea Clinic (61 
n bopo Clinic p] 
n :Koltstiild- any [6] 
D Private doctor ['9 J 
n Other, inside district [:!0] 
n Other, outside district [11] 
[i Missing, no info [99] 
Pre.renu isite.s 
Skip wh•::,1 nx CLTfJlC {1.52) Not Equal 'Othe-r, inside district [10]' 
1.53 RX CLINIC Other Inside 
Please specify: 
Exp~ct.s a sinQ.Ie line text response (required) 
I -- -~----- _, _ _ ____ _J 
Prere<lU isites 
S%i p wh<:!n ftX CUrJIC (1.5:/) Not Equal 'OtJrer, outsidf~ dls-trir:t {lJ]' 
1.54 RX CUNIC Other- Outside 
Please specify: 
E:xpN.t:.:: <1 si n g!-~ line teH r~sponsl3 (required) 
L- ---------·- -----·-------·-·-- -------· ·-
1.55 DB.AY 
Was there a delay in seeking care? 
E:-.pects a !> i ngl~ opti on r.:..st:Dn~ ~ {n•quired) 
r Yes Ltl 
Er.:!nche s 
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f·:, .. :-f!Wli:'iitfo!~i 
if. . · ·: :~ t-EL.·,~· ll55) l::,tlt"il5 'r{,) !.21' 
1.56 DBAYREA 
What are the reasons for any delay in seeking health care services? (Tick all that apply) 
r No time/busy :·] 
r Haven't disclosed yet [~~ 
r Financial limitations :::!J 
r Dish.nce to the clinic [·1-1 
r Fear of status becoming len own f 5J 
r Just don't , ... ·ant to go [6] 
I Feeling strong/healthy ! 7) 
[ Believe in traditional medicine lS] 
r. Went to the clinic, but had a problem there [9] 
r Lack of confidentiality at the clinic [10] 
C Feel scared/afraid to go [11 j 
r Lost the referral letter [ 12] 
C Didn't believe results (13] 
r Claim to have retested negative [.H:] 
C No reilson given [15 ] 
f:" Other {l5] 
Prerequisites 
s:.:.ip ·...- h ~n OFI.AYREI\ (1.56) Excludes 'Othe: r ( 16]' 
1.57 DElAYREA Other 
Please specify: 
E ~~P~<ts a ~ingl.e line t.exl: rf:!sr.onse (rcquked) 
L 
Prerequ isites. 
SXw wr.~n O!J"TCOME (1.21) Not. Equal ' Had not obtained a CD·~ il l l.:1st point of contac t [4]' 
1.58 HC REASN 
\'/bat are the reasons why the client did not obtain health care services at all? 
L No time/busy f! ] 
r: Haven't disclosed yet [2] 
C Finilnciallimitations [3] 
["" Dist;ance to the clin ic ( 4] 
f'":" F~u of status becoming known [5] 
r. Just don't want to go r 6] 
r Feeling s t r ong/hnlthy [7] 
C Believe in tnditionill medicine l3] 
L Went to the clinic, but had a problem there [9] 
r Laek of confident iality at the clinic [ 1 0] 
r Feel sca.redfafraid to go {1.1] 
r Lost the refe rral letter [ 11] 
r Didn't believe results [ 13] 
r Claim to have retested oegatjve [ t~i} 
r No reason given (:~: 
r Other ~-·· 
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:"~l!rr,;:.l :lto.._S 
·, • . ;: ·, f.1ti;C!).'-:£:. (1 .. "i.1) 1-Jti~ E:Jil."!l H":.d v;.t •.•b~ ... -::il .... "~ ~~ CC•4 r.o:~ l·;.~;t 1-"•iht (•~ \c.;·,tal1 [-1]' 
IC r:U;~;f,' u.:i!i} E.:.r!t'l.k.:-; "JO:rn ["1 -:.r 
1.59 HC REASN- Olher 
Please specify: 
Pr;?r•.:t:!· _-c;. it<:".s 
;:. -:~- .'. ·,.;;:; ;-;E.f.Wf.ll ilA) E(]llt!IS '[·' i!ll! OJ' 
1.60 PREGNANT 
Did this person ever report being pregnant during the study period? 
I Yes [l) 
I No [2) 
Omndu!s 
If ,..espons-"! Equals 'f-lo ("2]" thf!n si:ip to Sac:ial .Servlcvs (1.ti4) 
Prerequisites 
s;·io -... hen GEf.IDEil (.I A) E<waTs 'f.1ille [ "1)' 
1.61 PIITCT 
Did the mother receive PMTCf drugs? 
El"P".:! Ct.-; a bir,gl~ o;>tion responf.'!! (r~qulred) 
I Yes [t] 
C No [2] 
r: Uoknowo [3] 
Prer(!cjuisites 
Skb w:. • .e n GENOER {.l.4) [QU;Jis ' f·1~10 [ t]' 
1.62 BPMTCT 
Did the baby receive PMTCf drugs? 
E:~pecls a singl-e option res pons"' {n:.quir(~tl ) 
f":" Yes [t) 
I No [2) 
I Uoknow1> [3] 
Prerequisites 
S~i:> ·,•-lhlf:n G"END£n (lA) EQUilf.s. 'Male [1]' 
1.63 BABYTEST 
Did the baby get tested for HIV? 
I Yes [l] 
I No [2] 
r Unlmown (1] 
1.64 Social Services 
Was the client ever asked about social services? 
f":" Yes [l) 
I No [2] 
Br.-.nr.hcs 
h ~-:::: o-;.~ Cqu.:.tl!, "No [1'j' ;:-i·•:'n ~-. ;.p ~-:1 t:ml (:Z.3) 
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1.65 last Date Asked About Socia l Services 
What is the last date when the client was asked about having received social services? 
1.66 SUPPGRP 
Did the client join an HIV support group? 
r Yes (1) 
r No [2] 
r Unknown [3) 
1.67 HBC 
Did the client receive home based care? 
E:·~p ects •J sing!!'! option resp >JnS'-'! (required) 
rYes (!] 
(; No [2] 
C Unknown [3] 
1.68 !WI 
Did the client receive support from a social worker? 
E:<pects a single option response (rC()Uirc-d) 
r: Yes [1] 
r: No [2) 
r: Unknown (J] 
1.69 NGO 
Did the client receive support from an NGO? 
Expects a single option response (r equ ired) 
C Yes [1] 
C No (2] 
r Unknown [3] 
1. 70 DISGRA/fl 
Did the client apply for a disability grant? 
E.·..:pects ;a sing!~ ontion rasporu;~ (r equired) 
C Yes (1) 
C No [2] 
C Unknown (3] 
Pr~requlsites 
S!~IP Wh'?n DTSGRANT (1.70) Not ECJUi'JI 'Yes [1]' 
1.71 RECGRAHT 
Did the client receive a social disability grant? 
r Yes ( 1} 
r No :::~ 
r Unknown "j 
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1.n SPIRITUAl 
Received support from a spiritual/religious leader? 
I Yes 1) 
I No [ 
I Unknown [",] 
1.73 COMMGRP 
Received support from a community group? 
f' Yes [ !] 
!J No [2] 
!J Unknown [3] 
1.7 4 TRACHEAL 
Received support/treatment from a traditional healer? 
E..-p.ect; a single oplton r~sp,Jn~e (requir~.d ) 
0 Yes [1] 
!J No (2] 
0 Unknown (3] 
1.75 SS NOT OBTAINED 
Did the respondent say they did not receive any of the above services? 
E:-:p;;:cts ;::; sing!~ option response (required) 
!J Yes (!] 
0 No [2] 
Or<Jnches 
If re~t:Dns~~ Equals 'No [2]' then skip t-:1 Sochtl Sentlces (1~64) 
1.76 SSREAS 
Reasons why any social services not obtained {Tick all that apply) 
E;-:pect!i r.~ultipls s2l~ded optlons (required) 
n Don't see a need for the service [ 11 
0 Service not available [2] 
0 No reason given [3] 
rJ Haven't yet received a CD4 count (5} 
rJ Haven't disclosed their status broadly [6] 
0 Don't want others to know their status [7] 
0 Not ready for a support group [8] 
0 Other (4} 
J'•rerif(JUisites 
Skip ,•,h:-'1 S:.S: REAS (1 .76) Ext tudes 'Other [ 4r 
1.77 SS REAS Othe.-
Please specifY: 
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Section 2. End 
r·' '!-~qu;.- ~._,:. 
~ =: ···:i!tl.'"·.i (:; ;;;) c.-t ~~:~~.- c,;:oi.:t .-~i· 
2.1 NOINFO Other 
Please specify: 
llrer{'_quisllcs 
::;·,i.1 •:, )'; ~n EXCLUSJC1N {1.]:!) No: [QlWI 'Ott1Cf (5]' 
2.2 EXCLUSION Othe< 
Please specify: 
2.3 End 
Thank you for conducting the survey. Please select BACK if you wish to review the questions. Alternatively, select NEXT to complete the survey. 
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Appendix 7. 
Cross-sectional Survey 
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Cross-Sectional Survey 
This questionnaire has different sections and I will be explaining each one as we come to it, for example I 
will start with identifYing particulars, your life situation etc/ Lemibuzo equlethwe apha yahlukahlukene 
ngokwezigaba ezithile, umzekelo imibuzo yokuqala imayelana nokwazi ngawe, eminye imayelana nesimo 
sakho sentlalo njalo, njalo. 
SECTION 1. Identification and Background Characteristics 
I am now going to ask for basic information and background characteristics. These questions will help us 
get all the responses from people and group this information in categories that indicate age, gender, level 
of education etc.Ngoku ndizakukubuza imibuzo ezakufuna inkcukacha mayelana nokuba ungubani. 
Lemibuzo izakusinceda ekubeni sikwazi ukuthatha zonke iimpendulo esizakuzifumana ebantwini bonke 
sizibeke ngokwezigaba zokuba umntu uneminyaka emingaphi, usisini, ufunde waphelaphi njalo, njalo. 
1.1 HH ID 
1.2 Participant ID 
1.3 Cluster 
1.4 Age in years/Uzalwe ngeyiphi inyanga? Uneminyaka 
emingaphi kula nyaka? 
1.5 
1.6 
1.7 
(as of that daylngolosuku) 
Gender/lsini 
What is your current relationship status?/Sithini isimo 
sakho kubudlelwane bezothando? 
What is the highest level of schooling that you have 
completed?/Ukhe waya esikolweni? Ukuba ewe, . 
leliphi elona banga uligqibile)la? 
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I= Mvoti 
2 = Phumamuncu 
3 = Cacadu 
4=Vuka 
5 = Mthwana 
6 =Senti 
7 =James 
8 = Mantuzeleni 
9 = Mfulamhle 
IO = Matsheni 
II = Sphahleni 
I2 = Gcebeni 
I3 = Summerfield 
14 = Readsdale 
I5 = Dumisa 
I= Male 
2 =Female 
l = Single!Akatshatanga 
2 = Married!Utshatile 
I I 
3 = Have a long term partner; don't live 
together/ Unomntu othandana naye 
ixesha elide; kodwa ongahlali naye 
4 = Living together/living as 
married!Unomntu othanda naye 
ohlalisana naye 
5 = Separated!Divorced!Wahlukene 
nomyeni/nenkosikazi yakho 
6 = Widowed/ Umhlolokazi/ Umhlolo 
I = Never attended school!zange ndaya 
esikolweni 
2 = Some_£rimary!o~agczibanga 
amabanga aphantsi 
(R - GR 6) 
3 =Completed primary 
schooVuwagqibile amabanga aphantsi 
(complete GR7) 
4 =Some high schooVangawagqibanga 
amabanga aphezulu (GR 8- II) 
5 = Completed high schooVuwagqibile 
amabanga aphezulu (completed GR I2) 
6 = Completed tertiary!Ugqibile 
ukufundela ukusebenza 
7 = Unknown/ andazi 
1.8 What is your religion?/Ukhonza phi? 1 = Christian only/Ukholelwa kuKrestu 
kuphela 
2 = Christian plus Traditional 
Beliefs/UngumKrestu okholelwa kubantu 
abadala 
3 = Muslim/ Sulumane 
4 = Shembe/ Usonta kwaShembe 
5 =None/ Akanankolo 
6 = Other!Unenye inkolo 
1.9 Please specify if religion is Other 
SECTION 2. Life Circumstances 
I am now going to ask you questions about your life circumstances./ Ngoku ndizakubuza umibu~o 
emayelana nesimo sakho sentlalo. 
2.1 How many sources of livelihood do you 1 =One 
have?/Zingaphi indlela okwazi okuphilangazo? 2 = More than one 
3 =None (Skip to 2.6) 
2.2 What is your current source of livelihood?/Uphi/a 1 = Job in a formal business, farm, 
ngantoni? organization, or agency!Usebenza 
(ungandixelela zonke iindlela owenza ngazo imali) kwishishini lakho, e farm a, intlangano 
2 = Work in the informal sector for 
Tick all that apply!Ungakhetha ngaphezu someone else (including domestic 
kwempendulo enye service, oddjobs)!Ndiyatorhoza 
(usebenza emakitshini, ubamba amatorho 
njalo, njalo) 
3 = Self-employed (formal or informal; 
vending, spaza owner, seamstress, 
hairdresser, renting out 
services!equipment)l(itorho; ukuthengisa 
iveg nezinye izinto, emphakathini, une 
spaza, uyathunga, wenza iinwele, ulimela 
abantu okanye uqeshisa ngemishini 
yakho). 
4 = Subsistence farming (fann to 
eat)/Ulimela ukutya 
5 = Receive a grant!Ufumana umrholo 
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kuRhulumente 
6 = No source ofincome!Awundlela 
yokuphila 
7 = Retired (elder)/Utya umhlala phantsi 
8 = Other (specify)/ Enye (cacisa) 
2.3 Please specify if current source of livelihood is Other 
2.4 Which source of livelihood gives you the most 1 = Job in a formal business, farm, 
income?/Y eyiphi eyona ekunika imali eninzi? organization, or agency!Usebenza 
kwishishini lakho, e farm a, intlangano 
2 = Work in the informal sector for 
someone else (including domestic 
service, odd jobs)/Ndiyatorhoza 
(usebenza emakitshini, ubamba amatorho 
njalo, njalo) 
3 = Self-employed (formal or informal; 
vending, spaza owner, seamstress, 
hairdresser, renting out 
services!equipment)/ (itorho; ukuthengisa 
iveg nezinye izinto, emphakathini, une 
spaza, uyathunga, wenza iinwele, ulimela 
abantu okanye uqeshisa ngemishini 
yakho). 
4 = Subsistence farming (farm to 
eat)/Ulimela ukutya 
5 =Receive a grant/Ufumana umrholo 
kuRhulumente 
6 =No source ofincome!Awundlela 
yokuphila 
7 = Retired (elder)/Utya umh/ala phantsi 
8 =Other (specify)/ Enye (cacisa) 
2.5 How would you describe the regularity of your main 1 = Regular/ Rhoqo 
source ofincome?/Ungathi mhlambi uyifumana 2 = Irregular/Nge/oxesha 
kangaphi? 3 = No income!Andiyifumani 
2.6 Which of the following would you say best describes 1 = We don't have enough money for 
your home situation? /Xa unokuchaza isimo salapha food!Akukho mali yaneleyo yokuthenga 
ekhaya ucinga ukuba sesiphi isimo esingqinelana ukutya 
neselikhaya kwezi zilandelayo 2 =We have enough money for food, but 
not for other essential items such as 
clothes/lkhona imali eyaneleyo yokutya, 
kodwa ayikho eyokuthenga ezinye 
izidingo ezibalulekileyo njengempah/a. 
3 =We have money for essentials like 
food and clothes but are very short of 
many other things/Jkhona imali 
yokuthenga izidingo ezinjengo kutya 
nempahla, kodwa kuyashota kwezinye 
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izinto ezininzi 
4 = We have most important things, but 
few luxury goods/Zikhona izinto 
ezibalulekileyo, kodwa azikho izinto 
zokungcebeleka/zobukhazikhazi. 
5 = We have money for luxury goods and 
extra things/Ikhona imali yezinto 
zokungcebeleka nobukhazikhazi, nako 
konke 
8 =Refuse to Answer/A kafuni 
kuphendula 
2.7 Thinking about your spouse, children, 1 = None/A bekho 
nieces/nephews, elderly parents, etc, for how many 2=0NE/Mnye 
people living inside and outside your household 3 = TWO/Babini 
would you say that you are fmancially responsible? 4 = THREE/Bathathu 
(To clarify, ask Who are those people that you have 5 = FOUR/ Bane 
mentioned?)/ 6 = FIVE/Bahlanu 
7 =More than 5/Bangaphezu kwesihlanu 
Cinga ngomlingani, abantwana, abatshana, 
abanakwenu, abazali bakho abadala, bangaphi 
abantu abahlala apha ekhaya nangaphandle 
kwelikhaya abaxhomekeke kuwe ngokwesimo semali? 
(Buza ukuba ngobani abo bantu,kwaba obabalileyo?) 
2.8 Thinking about your spouse, children, 1 = None/Abekho 
nieces/nephews, elderly parents, etc., for how many 2=0NE/Mnye 
people living inside and outside your household 3 = TWO/Babini 
would you say that rely on you for something other 4 = THREE/Bathathu 
than money? (To clarify, ask Who are those people 5 = FOUR/Bane 
that you have mentioned?)/ Cinga ngomlingane, 6 = FIVE/Bahlanu 
abantwana, abatshanalabaza/a, abanakwenu, abazali 7 = More than 5/Bangaphezu kwesihlanu 
bakho abadala, bangaphi abantu abahlala apha 
ekhaya nangaphandle kwelikhaya obanekekelayo 
abaphantsi kweliso lakho ngaphandle kokubanikeza 
imali? (Buza ukuba ngobani abo bantu,kwaba 
ababalileyo?) 
2.9 Do you participate regularly (at least once a month) 1 =Yes/Ewe 
in any community or civil society groups or 2 = No/Hayi (Skip to Q2.12) 
activities? (If response is initially no, probe using 
responses from Q2.10)//Jngaba uyazibandakanya 
isikhathi esininzi iindibano zamphakathi nemicimbi 
esemphakathini?(Ukuba uphendule ngo hayi,buza 
uqhabalake ujonge ku Q2.10). 
2.10 If YES to Q2.9, which type of groups do you _Church or other religious group/Icawe, 
participate in? (tick all that apply)/Ukuba EWE namanye amaqembu enkolo 
kulemibuzo engesentla, ngawaphi amaqembu _ Hobby, sport, art, or other leisure 
ozibandakanya nawo kula alandelayo? group/Izinto ozithandayo 
njengezemidlalo, umculo, amaqembu 
oms ina 
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2.11 Please specify if groups are Other 
2.12 How would you say your health is at the 
moment?/Ungathi isimo sakho sempilo sinjani 
njengangoku? 
2.13 How much time have you spent away from home 
in the last year?/Zingaphi intsuku ozichithe kude 
nekhaya kulonyaka udlulileyo (buzisisa kusukela 
kunyaka odlulile ngalesikhathi kuzotsho manje)? 
Section 3. Experience of home-based testing 
_ Political or advocacy 
group/ Ezopolitiko 
_ Community service group/ Intlangano 
zomphakathi 
_ Youth group!Intlangano zolutsha 
_ Women's/men's group!Jntlangano 
zoo mama 
_Income generating project!Iprojekti 
eyenza inzuzo 
_Course or educational 
programme!Uhle!o lokuzithuthukisa 
ngezemfundo 
_Some other type of group 
(specify)/Ezinye iint!elo zamaqembu 
(Cacisa) 
_Question sk.ippedluma utsibile apha 
cacisa 
1 =Very poor/Sibucayi kakhulu 
2 = Poor/Sibucayi 
3 = Fair/Singconywana 
4 = Good!Sihle 
5 = Excellent!Sih!e kakhulu 
1 =Never away/Angikaze 
2 = Away one month or less 
3 =Away 2-4 months 
4 = Away for 5-6 months 
5=Most times, I'm not at this 
home!Jxesha elininzi andihlali apha 
(away for more than 6 months) 
I will now ask you questions that relate to your experience of being counselled and tested at home./ Ngoku 
ndizakukubuza imibuzo emayelana nendlela o!ubone ngayo uhlelo lokwelulekwa nokuhlolwa ekhaya. 
3.1 There are many reasons why someone might decide 
to take an HIV test. Why did you decide to test when 
the Good Start counsellor visited you? (PROBE if 
client initially chooses 13) 
Zininzi izizathu ezingenza umntu ahlole. Yintoni 
ek:Yvenze uvume ukuhlolela ekhaya ngelixesha 
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1 = It seemed like a good thing to 
do!Kubonakale kuyinto entle ukuba 
ndiyenze 
2 = I felt pressured/difficult to say 
no!Uzive unobunzima bokwala, okanye 
uzive unyanzelekile. 
3 = Motivated because others in the home 
umeluleki ka Good Start ebekuvakashele? were testing!Uye wakhuthazeka ngokuba 
(Phandisisa ukuba ukhetha impendulo 13: Mhlambi ubona abanye behlola ekhaya. 
kukhona isizathu esithe phecelezi esenza ukuthi ufune 4 = The counsellor convinced me it was 
ukwazi isimo sakho sempilo) important!Umeluleki undenze ndabona 
ukubaluleka kokwazi isimo sempilo yam. 
5 = I fe lt more comfortable testing at 
home than at a clinic/Uzive ukhululekile 
ukuhlolela ekhaya kunase kliniki 
6 = I have been involved in risky 
behavior and was concerned about my 
status/Bendizibandakanye nezinto 
ezinobungozi bokundibeka 
emngciphekweni wokusuleleka, ndaza 
ndafuna ukuzazi isimo sam sempi/o. 
7 = I have been feeling sick and was 
concerned about my status!Bendihlala 
ndiziva ndingaphilanga, ngoku ndafuna 
ukuzazi isimo sam sempilo. 
8 = My partner or family member 
encouraged me to test!Umndeni wam 
okanye umlingane wam yibona 
abandikhuthaze ukuba ndihlole 
9 = I have been sexually 
abused!Ndandike ndahlukunyezwa 
ngokocantsi. 
10 =I'm suspicious about my partner's 
behaviorlstatus/Bendinokusola okuthi/e 
ngendlela umlingane wam abeziphethe 
ngayo nangesimo sakhe sempilo 
11 = My partner passed away and I know 
or suspect that slhe died of 
HIV /Umlingane wam washona kwaye 
ndiyazi okanye ndisola ukuba wabulawa 
ligciwane 
12 =I need it for insurance or other 
offical purposes/Bendidinga ukwazi isimo 
sam sempilo ngezizathu ze mshwalents 
okanye izidingo zempepha 
13= I just wanted to know my 
status!Bendifuna nje ukwazi isimo sam 
sempilo 
14= Other, specifiy/Enye (Cacisa) 
3.2 Specify reason for testing if Other 
3.3 Did you feel more or less comfortable taking an HIV 1 = I felt a lot more comfortable at 
test at home than you would have felt in a health home/Ndizive ndikhululeke ngaphezulu 
facility?/Uzive ukhululekile ngokuhlolela isandule/a ekhaya 
ngculaza ekhaya kunokuhlolela ekliniki? 2 = I felt a little more comfortable at 
home/Ndizive ndinako ukukhululeka 
okuthile ekhaya 
3 =Same, doesn't make a 
difference/Kuya.fana, akukho mahluko 
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4 = I would have felt a little more 
comfortable at the clinic!Ndicinga 
ngendizive ndinokukhululeka 
okungaphezulu ekliniki 
5 = I would have felt a lot more 
comfortable at the clinic/ Ndicinga 
ngendizive ndikhululeke kakhulu ekliniki 
3.4 If the Good Start counselor hadn't visited you, would 1 =Yes/Ewe 
you have gone elsewhere for an HIV test within that 2 = Possibly/maybe/ 
same month?/ Ukubangaba umeluleki ka Good Start Kungenzeka/Mhlambi 
ebengakuvakashelanga ingabe ngewuye kwenye 3 ~No/Hayi 
indawo yokuh/olela isandule/a ngculaza 4 =Don't know/can't say!Andazi, 
kwakulenyanga? andinakutsho 
3.5 How comfortable did you feel with the level of 1 =Very comfortable/Bendikhululekile 
knowledge and skills that the Good Start counsellor kakhulu 
who visited you demonstrated?/Uzive ukhululeke 2 = Generally 
kangakanani ngolwazi nekhono umaluleki ka Good comfortable!Bendikhululekile 
Start a/ubonisile ngenkathi ekuvakashela? 3 =Very 
uncomfortable/ Bendingakhululekanga 
kakhulu 
4 = Generally 
uncomfortable/ Bendingakhululekanga 
3.6 Do you feel that the counsellor gave you enough 1 =Yes, Definitely/Ewe, 
information about where to seek help for follow-up ngokuqinisekileyo 
services at other health facilities?/Uva ukuthi 2 =Yes, in a way/Ewe, kana 
umaluleki ukunikeze iminingwane eyaneleyo ngokuba 3 =No, not at aWZange, konke, konke 
ungalufumana phi uneeda kulandelelwa kumanye 
amaziko ezempilo? 
3.7 Did you trust/believe the results of the HIV test you 1 =Yes/Ewe 
took at home?/Uye wazithemba/wazikholelwa 2 = No/Hayi 
iziphumo zokuhlolelwa isandulela ngculaza ozithole 3 =Not sure!Andiqinisekanga 
ekhaya? 
3.8 What was your overall impression of the home-based 1 = It was excellent/lbint/e kakhulu 
counselling and testing session?!Uyibone njani xa 2 =It was good!Ibintle 
iyonke inkqubo yokwelulekwa nokuhlolelwa ekhaya? 3 =It was okay!Bekungekho nto itheni 
4 =It was poor/Ibimbi 
5 =It was very poor!bimbi kakhulu 
Section 4. Barriers to Accessing Health Care. 
Many different factors can prevent people from getting medical advice or treatment. Now I would like to 
ask you some questions about getting medical care for yourself. These questions are about the problems 
you might face when you are sick and want to get medical advice or treatment. For each one, I would like 
you to tell me whether it is a big problem, small problem, or not a problem at all for you? 
Zininzi izinto ezibangela ukuba abantu bangalufumani unyango okanye ingcebiso ngezempilo. Ngoku 
ndizakukubuza imibuzo emayelana nokunakekelwa kl-vempilo yakho. Lemibuzo imbalwa ndizakukubuza 
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yona imayelana neengxaki onokudibana nazo xa ugula ufuna unyango okanye ingcebiso ngezempilo. 
Kumbuzo ngamnye endizakukubuza wona ndicela ucacise ukuba yingxaki enkulu encinci, okanye 
ayiyongxaki kwaphela. 
4.1 Is getting money needed for transport a 1 =BIG PROBLEMIYINGXAKI ENKULU 
problem?/Kuyingxaki ukufumana imali yokukhwela? 2=SMALL PROBLEMIYINGXAKI 
ENCINCI 
3=NOT A PROBLEMIAKUYONGXAKI 
4.2 Is getting money needed for treatment a problem? 1 =BIG PROBLEMIYINGXAKI ENKULU 
!Kuyingxaki ukufumana imali amayeza? 2=SMALL PROBLEMIYINGXAKI 
ENCINCI 
3=NOT A PROBLEMIAKUYONGXAKI 
4.3 Is the distance to the health facility a 1=BIG PROBLEMIYINGXAKI ENKULU 
problem?/Uyingxaki umgama oya emtholampilo? 2=SMALL PROBLEMIYINGXAKI 
ENCINCI 
3=NOT A PROBLEMIAKUYONGXAKI 
4.4 Is availability of transport a problem?/Ingaba 1 =BIG PROBLEMIYINGXAKI ENKUL U 
kuyingxaki na ubukho bezithutho? 2=SMALL PROBLEMIYINGXAKI 
ENCINCI 
3=NOT A PROBLEMIAKUYONGXAKI 
4.5 Is finding time to go to the health facility a 1 =BIG PROBLEMIYINGXAKI ENKULU 
problem?!Ingaba kuyingxaki ukufumana ixesha 2=SMALL PROBLEMIYINGXAKI 
lokuya emtholampilo? ENCINCI 
3=NOT A PROBLEMIAKUYONGXAKI 
4.6 Is getting permission/approval from a spouse/family l=BIG PROBLEMIYINGXAKI ENKULU 
member to go to a health facility a problem?!Ingaba 2=SMALL PROBLEMIYINGXAKI 
kuyingxaki ukufumana imvume yokuya emtholampilo ENCINCJ 
kumlingane wakho okanye umndeni? 3=NOT A PROBLEMIAKUYONGXAKI 
Section 5. Perceptions of the Health Care System 
Now I am going to ask you questions about your experiences of seeking health care at a health care 
facility/Ngoku ndizakukubuza imibuzo emayelana nendlela okuthole ngayo ukufuna unakekelo lwempilo 
emtholampilo. 
5.1 The last time you visited a clinic, hospital, or doctor, 1 = SIHLEZA CLINIC . 
where did you go?!Ngesikhathi ugcina ukuya 2 = LOURDES CLINIC 
emtholempilo, udokotela, noma esibhedlela, waya 3 = GOWNELEA CLINIC 
kuphi? 4 = MVOTI CLINIC 
5 = ST MARGARETS CLINIC 
6 = GUGWINI CLINIC 
7 = IBISI CLINIC 
8 = RIETVLEI HOSPITAL 
9 = ST MARGARETS HOSPITAL 
10 =PRIVATE DOCTOR 
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11 =E.G. USHER HOSPITAL 
(KOKSTAD) 
12 = ST. ANDREWS 
(HARDING) 
13 = Malenge Clinic 
14 = Sphamandla Clinic 
15 =Harding Clinic 
16 = Umzimkulu Clinic 
17 = Mvubukazi Clinic 
18 =Other, specify 
19 =Never sought health care/ kaze afune 
ncedo lwezempilo)- (skip to Q6.1) 
Specify if last clinic was Other 
5.3 Based on your experiences, would you say that the 1 -ALWAYS AVAILABLE/ Bah/ala 
health care staff at (name of facility) are always bekhona ngamaxesha onke 
available? /Ngokwamava akho ungathi mhlawumbi 2 =MOSTLY AV AILABLE!Bakhona 
abasebenzi base (ig.ama le kliniki) bah/ala bekhona? amaxesha amaninzi 
3 = SOMETIMES 
A V AILABLE/Bakhona ngamanye 
amaxesha 
4 =RARELY AVAILABLE!Kunqabile 
ukuba babekhona 
5 =NEVER A V AILABLE!Abaze 
babekhona 
9 =Question skipped/Uma utsibile apha 
cacisa 
5.4 How were you treated by the staff the last time you 1 =VERYBADLYIKAKUBI 
sought treatment at (name offacility)?/Bakuphatha KAKHULU 
njani abasebenzi base (igama lomtholampilo) 2 = BADLYIKAKUBI 
ukugqibela kwakho ukuya khona uyofuna uneeda? 3 = FAIRLYIPHAKATHI NAPHAKATHI 
(NJEE) 
4 = WELLIKAKUKHLE 
5 =VERYWELLIKAKUHLE 
KAKHULU 
9 =Question skipped/Uma utsibile apha 
cacisa 
5.5 In general, how would you rate the services offered at 1 =VERY POOR!Lubi kakhulu 
(name offacility)?/Ngokokubona kwakho ungathi 2 = POOR!Lubi 
lunjani unakekelo lwempilo olufumana kulo 3 = F AIR!phakathi-naphakathi (njeee) 
mtholampilo? 4 = GOOD!luhle 
5 = VERY GOOD!Luhle kakhulu 
9 =Question skipped!Uma utsibile apha 
cacisa 
5.6 Based on your experiences, are drugs and supplies 1 =NEVER A V AILABLE/Z4NGE 
usually available at (name offacility)?!Ngokokwazi YABAKHONA 
lnvakho ingaba amapilisi okanye imishanguzo ihlezi 2 =RARELY AVAILABLE/AYJFANE 
218 
ukubakhona kulp mtholampilo? JBEKHONA 
3 =SOMETIMES AVAILABLE/ 
KWESINYE JSJKHATHI IBAKHONA 
4 =MOSTLY A V AILABLEIJSIKHATHJ 
ESJNINZJ IBAKHONA 
5 =ALWAYS AVAILABLE/ JHLALA 
IKHONA 
6 = DON'T KNOW/ANDAZJ 
9 =Question skipped/Uma utsibile apha 
cacisa 
5.7 How much do you trust that the health care workers 1 = COMPLETELY TRUST 
at (name of facility) will keep information about you THEMINDIYABATHEMBA 
confidential?/ NGOKUPHELELEYO 
Uthemba kangakanani ukuba abasebenzi bezempilo 2 = TRUST THEM 
abalapha kulomtholampilo bangakwazi ukugcina SOMEWHA T/NDINAKO 
inkcukacha ngawe iyimfihlo? UKUBATHEMBA 
3 =DON'T TRUST THEM AT 
ALLIANDIBATHEMBI NJE 
KWAPHELA 
4 =NOT SUREIANDIQINISEKANGA 
9 =Question skipped/Uma utsibile apha 
cacisa 
5.8 How much do you trust that the health care workers 1 = COMPLETELY TRUST 
at (name of facility) have the knowledge and skills to THEMINDJYABATHEMBA 
address your health problems?/ Uthemba NGOKUPHELELEYO 
kangakanani ukuba abasebenzi bezempilo aba/apha 2 =TRUST THEM 
kulomtholampilo ukuba banolwazi nokhono SOMEWHA TINDINAKO 
olupheleleyo ukuba bangakwazi ukukusiza UKUBATHEMBA 
kwiinkinga zakho zempilo? 3 =DON'T TRUST THEM AT 
ALLIANDIBATHEMBI NJE 
KWAPHELA 
4 =NOT SUREIANDIQINISEKANGA 
9 =:oQuestion skipped/Uma utsibile apha 
cacisa 
5.9 Is (name of facility) the nearest one to your home? l =YES/EWE (Skip to Q6.1) 
(If yes, skip to Q6.1 ; If no, continue)/Jngaba 2=NOIHAYI 
lomtholampilo ngowona oseduze kwalapho uhlala 9 =Question skipped/Uma utsibile apha 
khona? (Ukuba ewe, tsiba uye ku 47, ukuba hayi, cacisa 
qhubeka) 
5.10 Which is the nearest health facility to your 1 = SIHLEZA CLINIC 
home?/Ngowuphi umtholampilo ongowona oseduze 2 = LOURDES CLINIC 
nalapho uhlala khona? 3 = GOWNELEA CLINIC 
4 = MVOTI CLINIC 
5 = ST MARGARETS CLINIC 
6 = GUGWINI CLINIC 
7 = IBISI CLINIC 
8 = RIETVLEI HOSPITAL 
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9- ST MARGARETS HOSPITAL 
10 =PRIVATE DOCTOR 
11 =E.G. USHERHOSPITAL 
(KOKSTAD) 
12 = ST. ANDREWS (HARDING) 
13 = Malenge Clinic 
14 = Sphamandla Clinic 
15 =Harding Clinic 
16 = Umzimkulu Clinic 
17 = Mvubugazi Clinic 
18 = Other, specify 
99 =Question skipped/Uma utsibile apha 
eacisa 
5.11 Specify if nearest facility is other 
5.12 Have you ever sought treatment or other health 1 =Yes/EWE 
services at (name offaci1ity)? (If no, skip to Q6.1; If 2 =No/HAY/(Skip to Q6.1) 
yes, continue) 9 =Question skipped/Uma utsibile apha 
!Kukhana uneeda lwemishanguza akanye a/unye eaeisa 
uneeda ngezempila awake walufuna 
kulamthalampilo? (Ukuba hayi, tsiba ku Q6.1; ukuba 
ewe, qhubeka) 
5.13 Based on your experiences, would you say that the 1 = ALWAYS AVAILABLE/ Bah/ala 
health care staff at (name of facility) are always bekhona ngamaxesha anke 
available? /Ngakwamava akho ungathi mhlawumbi 2 =MOSTLY AVAILABLE!Bakhana 
abasebenzi base (igama le kliniki) bah/a/a bekhana? amaxesha amaninzi 
3 = SOMETIMES 
A V AILABLE!Bakhona ngamanye 
amaxesha 
4 =RARELY AV AILABLE!Kunqabile 
ukuba babekhona 
5 =NEVERAVAILABLE/A baze 
babekhana 
9 =Question skipped/Uma utsibile apha 
eaeisa 
5.14 How were you treated by the staff the last time you 1 =VERY BADLY/KAKUBI 
sought treatment at (name offacility)?/Bakuphatha KAKHULU 
njani abasebenzi base (igama lomthalampilo) 2 =BADLYIKAKUBI 
ukugqibela kwakha ukuya khana ukuyofuna uneeda? 3 =FAIRLYIPHAKATHI NAPHAKATHI 
(NJEE) 
4 = WELL/ KAKUKHLE 
5 =VERY WELLIKAKUHLE 
KAKHULU 
9 =Question skipped/Uma utsibile apha 
eaeisa 
5.15 In general, how would you rate the services offered at 1 = VERY POOR!Lubi kakhulu 
(name of facility) that is nearest to your 2 = POOR!Lubi 
home?/Ngakakubona kwakha ungathi lunjani 3 = F AIR/phakathi-naphakathi (rljeee) 
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unakekelo lwempilo owalufumana kulo mtholampilo? 4 = GOOD/luhle 
5 =VERY GOOD!Luhle kakhulu 
9 =Question skipped/Uma utsibile apha 
cacisa 
5.16 Based on your experiences, are drugs and supplies 1 =NEVER A V AILABLEIZANGE 
usually available at (name offacility)?/Ngokolnvazi YABAKHONA 
kwakho ingaba amapilisi okanye imishanguzo 2 =RARELY AVAILABLE/ AYIFANE 
ijwayele ukubakhona kulo mtholampilo? IBEKHONA 
3 =SOMETIMES AVAILABLE/ 
KWESINYE ISIKHATHI IBAKHONA 
4 =MOSTLY AVAILABLE/ISIKHATHI 
ESININZJ IBAKHONA 
5 =ALWAYS AVAILABLEIIHLALA 
IKHONA 
6 =DON'T KNOW!ANDAZI 
9 =Question skipped/Uma utsibile apha 
cacisa 
5.17 How much do you trust that the health care workers 1 - COMPLETELY TRUST 
at (name offaci1ity) will keep information about you THEM!NDIYABATHEMBA 
confidential? NGOKUPHELELEYO 
Uthemba kangakanani ukuba abasebenzi bezempilo 2 = TRUST THEM 
abalapha kulomtholampilo bangakwazi ukugcina SOMEWHATINDINAKO 
inkcukacha ngawe iyimfihlo? UKUBATHEMBA 
3 =DON'T TRUST THEM AT 
ALLIANDIBATHEMBI NJE 
KWAPHELA 
4 =NOT SUREIANDIQINISEKANGA 
9 =Question skipped!Uma utsibile apha 
cacisa 
5.18 How much do you trust that the health care workers 1 = COMPLETELY TRUST 
at (name of facility) have the knowledge and skills to THEM!NDJYABATHEMBA 
address your health problems?/Uthemba kangakanani NGOKUPHELELEYO 
ukuba abasebenzi bezempilo abalapha 2 = TRUST THEM 
kulomtholampilo ukuba banolwazi nekhono SOMEWHA TINDINAKO 
olupheleleyo ukuba bangakwazi ukukusiza UKUBATHEMBA 
kwiinkinga zakho zempilo? 3 =DON'T TRUST THEM AT 
ALLIANDIBATHEMBI NJE 
KWAPHELA 
4 =NOT SUREIANDIQINISEKANGA 
9 =Question skipped!Uma utsibi/e apha 
cacisa 
Section 6. Knowledge and Beliefs about IDV/AIDS and ARVS 
Now I'd like to ask you about your views on HIV/AIDS and ARVS. I'm going to read you some 
statements and would like for you to tell me whether you agree or disagree or are unsure about the 
statement./ Ngoku ndizakubuza imibuzo ngeembono zakho malunga nesandulela ngculaza nengculaza 
kunye nemishanguzo yayo. Ndizakukufundela inkulumo, ndingathanda ukuthi undixelele ukuba 
uyavumelana inkulumo, okanye awuvumelani, okanye awuqinisekan~a. 
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6.1 There is no cure for AIDS/ Alikho ikhambi 1- Agree!Uyavuma 
leNgculaza 2 = Disagree!Awuvumi 
3 = Don 't know/Not 
sure/ Awazi! Awuqinisekanga 
6.2 A person with HIV I AIDS may not look or feel sick 1 - Agree!Uyavuma 
for many years/Umuntu onesandulela ngculaza 2 = Disagree!Awuvumi 
angangabukeki egula iminyaka eminingi 3 =Don't know/Not 
sure/ Awazil Awuqinisekanga 
6.3 ARVs for HIV almost always improves the lives of 1 = Agree/ Uyavuma 
those taking thern!lsikhathi esiningi lmishanguzo 2 = Disagree!Awuvumi 
yesandulela ngculaza ibenza ngcono ubomi balabo 3 =Don't know/Not 
abayithathayo sure!Awazi/ Awuqinisekanga 
6.4 People who stay in this community are able to access 1 = Agree/Uyavuma 
ARVs readily.!Abantu abahlala kulendawo 2 = Disagree!Awuvumi 
bayakwazi ukuthola imishanguzo yesandulela 3 =Don't know/Not 
ngculaza kalula sure!Awazi/Awuqinisekanga 
6.5 If you're not feeling sick, you don't need ARVs/ Xa 1 = Agree!Uyavuma 
uziva ungaguli awudingi ukuthatha imishanguzo 2 = Disagree!Awuvumi 
yesandulela ngculaza 3 =Don't know/Not 
sure!Awazi/Awuqinisekanga 
6.6 A person's CD4 count determines whether a person 1 = Agree/ Uyavuma 
can get ARVs./Ukuqala komntu imishanguzo 2 = Disagree!Awuvumi 
yesandulela ngculaza kuxhomekeke kwinani 3 =Don't know/Not 
lamasotsha omzimba wakhe. sure/Awazi!Awuqinisekanga 
6.7 Once you start taking ARVs, you have to take them 1 = Agree/ Uyavuma 
for the rest of your life./Xa ukhe waqala imishanguzo 2 = Disagree!Awuvumi 
yesandulela ngculaza uyisebenzisa ubomi bakho 3 =Don't know/Not 
bonke. sure!Awazi/Awuqinisekanga 
6.8 ARVs can make you feel sick.!Imishanguzo 1 = Agree/Uyavuma 
yesandulela ngculazaingakwenza ugule. 2 = Disagree/Awuvumi 
3 =Don' t know/Not 
sure/ Awazi/ Awuqinisekanga 
6.9 ARV Treatment is very expensive for 1 = Agree/Uyavuma 2 = Disagree/Awuvumi 
patients!Imishanguzo yesandulela ngculaza iyabiza 3 = Don't know/Not kakhulu kwiziguli. 
sure/ Awazi/ Awuqinisekanga 
6.10 Taking ARV treatment is not simple/Ukuthatha 1 = Agree!Uyavuma 2 = Disagree/Awuvumi imishanguzo yengculaza akuyona into elula 3 = Don't know/Not 
sure/Awazi!Awuqinisekanga 
6.11 Traditional medicine can cure HIV/AIDS/ Amayeza 1 = Agree!Uyavuma 
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esintu angaselapha isandulela ngculaza kunye 2 = Disagree/Awuvumi 
nengculaza 3 =Don't know/Not 
sure!Awazi/Awuqinisekanga 
6.12 Traditional medicine is better than ARVs/Amayeza 1 = Agree/ Uyavuma 
esintu angcono kunemishanguzo yesandulela 2 = Disagree/Awuvumi 
ngculaza 3 =Don't know/Not 
sure/Awazi/Awuqinisekanga 
6. 13 It is too difficult to take drugs your whole 1 = Agree/ Uyavuma 
life/ Kunzima kakhu/u ukuthatha imishanguzo imp i/o 2 = Disagree!Awuvumi 
yakhoyonke 3 =Don't know/Not 
sure/ Awazi/ Awuqinisekanga 
6.14 You know where/how to fmd resources such as 1 = Agree!Uyavuma 
support groups, social workers, and NGOs who can 2 = Disagree!Awuvumi 
help you deal with your illness./Uyazi ukuba 3 =Don't know/Not 
ungalufomana phi futhi kanjani uneeda olunjenge sure!Awazi/Awuqinisekanga 
ntlangano ezinika inxaso, oonontlalo-ntle, 
neentlangano ezingandinceda ukuthi ukwazi 
ukume/ana nesimo sakho sokugu/a. 
6. 15 When you have HIV, it makes it difficult for your 1 = Agree!Uyavuma 
body to fight other illnesses and infections such as 2 = Disagree!Awuvumi 
TB/Xa unesandulela ngculaza kwenza kube nzima 3 =Don't know/Not 
ukuba umzimba wakho ulwe nezinye izifo sure!Awazi/ Awuqinisekanga 
ezinjengesifo sephepha nezinye izigulo 
Section 7. Fear and Stigma 
The next couple of sections will include questions about your experience ofbeing HIV-positive/ For the 
section now, I'm going to read you some statements about how it might feel to be HIV -positive. For each 
one, please tell me how strongly you agree. If any of these questions make you feel uncomfortable and 
you do not want to answer please let me know) Lemibuzo elandelayo izakuquka imibuzo emalunga 
namava akho okuba nesandule/a-ngculaza.Ngoku ndizakukufundela inkuluma echaza ukuba kunjani 
ukuba nesandulela ngculaza. Umbuza nombuzo ndizakuce/a ukuba undixelele ukuba uqiniseke 
kangakanani na ngawa. Ukuba eminye yalemibuzo ikwenza uzive ungakhululekanga ungathandi 
ukuphendula, ndicela undazise. 
7.1 You feel that other people might blame you for being I =Strongly agree!Uvumelana kakhulu 
HIV-positive./Jngaba uzizwa engathi abantu 2 =Somewhat agree/Unaka ukuvumelana 
abaningi banyakusala ngoba unesandulela ngculazi 3 = Agree/Uyavumelana 
4 = Disagree/Andivumelani 
5 = Somewhat disagree/Unaka 
ukungavumelani 
6 =Strongly disagree/Awuvumelani 
ntlaba 
8 =Refuse to answer/Uyala ukuphendula 
7.2 You feel ashamed ofyour illness (HIVIAIDS)/lngaba 1 =Strongly agree/Uvumelana kakhulu 
uziva uneentloni ngcJkugula kwakha (yisifo 2 =Somewhat agree/Unaka ukuvume/ana 
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sesandulela ngculazi) 3 = Agree/Uyavumelana 
4 = Disagree!Andivumelani 
5 = Somewhat disagree/Unaka 
ukungavumelani 
6 = Strongly disagree!Awuvumelani 
ntlaba 
8 = Refuse to answer/Uyala ukuphendula 
7.3 It is difficult to tell people in your community that 1 = Strongly agree/Uvume/ana kakhulu 
you have HIV!AIDS.!Kunzima ukuxelela abantu 2 = Somewhat agree/Unaka ukuvumelana 
emphakathini ahlala kuwa ukuba unegciwane 3 = Agree!Uyavumelana 
lesandulela ngculaza? 4 = Disagree!Andivumelani 
5 = Somewhat disagree/Unaka 
ukungavumelani 
6 =Strongly disagree/Awuvumelani 
ntlaba 
8 = Refuse to answer!Uyala ukuphendula 
7.4 You see your illness (HIV) as a punishment for things 1 = Strongly agree/Uvumelana kakhulu 
you've done!Ubana ukugula kwakha engathi 2 =Somewhat agree/Unaka ukuvumelana 
sisijezisa sendlela awawuziphethe ngaya 3 = Agree!Uyavumelana 
4 = Disagree!Andivumelani 
5 =Somewhat disagree/Unaka 
ukungavumelani 
6 = Strongly disagree/Awuvumelani 
ntlaba 
8 =Refuse to answer!Uyala ukuphendula 
7.5 You feel that you might lose your job if someone 1 =Strongly agree/Uvumelana kakhulu 
fmds out about your illness./Uziva ngathi 2 = Somewhat agree/Unaka ukuvumelana 
ungaphulukana namsebenzi wakha ukuba kungakha 3 = Agree/Uyavumelana 
angazi ukuba unesandulela ngculazi. 4 = Disagree!Andivumelani 
5 = Somewhat disagree/Unaka 
ukungavumelani 
6 =Strongly disagree/Awuvumelani 
ntlaba 
7 =Not applicable 
8 = Refuse to answer!Uyala ukuphendula 
9 = N/A (No job) 
7.6 You may have to change the place you live because 1 =Strongly agree!Uvumelana kakhulu 
of your HIV status.!Kungenzeka utshintshe indawa 2 =Somewhat agree/Unaka ukuvumelana 
a hi ala kuya ngenxa yesima sakha sempila 3 = Agree/Uyavumelana 
4 = Disagree!Andivumelani 
5 =Somewhat disagree/Unaka 
ukungavumelani 
6 =Strongly disagree!Awuvumelani 
ntlaba 
8 =Refuse to answer!Uyala ukuphendula 
7.7 You would avoid getting treatment or services 1 = Strongly agree/Uvumelana kakhulu 
because someone might find out about your HIV 2 =Somewhat agree/Unaka ukuvumelana 
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status./Kungenzeka ukubalekele ukuthola 3 = Agree!Uyavumelana 
imishanguzo noma uneeda uma kungenzeka 4 = Disagree/Andivumelani 
kubekhona ongazi ngesimo sakho sempilo 5 = Somewhat disagree/Unaka 
ukungavume/ani 
6 = Strongly disagree!Awuvumelani 
.,.- ntlobo 
8 =Refuse to answer/Uya/a ukuphendula 
7.8 You fear that people might hurt your family if they 1 = Strongly agree/Uvumelana kakhulu 
learn about your illness./Wesaba ukuba abantu 2 = Somewhat agree/Unaka ukuvume/ana 
bangenzaka/isa umndeni wakho xa bengeva ukuba 3 = Agree/Uyavumelana 
unesandulela ngculaza 4 = Disagree/Andivume/ani 
5 = Somewhat disagree/Unaka 
ukungavumelani 
6 = Strongly disagree/A wuvume/ani 
ntlobo 
8 =Refuse to answer/Uyala ukuphendula 
7.9 You fear that you will lose your friends if they learn 1 = Strongly agree/Uvumelana kakhulu 
about your HIV status.!Wesaba ukuba 2 = Somewhat agree/Unaka ukuvumelana 
ungaphulukana nabahlobo bakho xa bengeva ukuba 3 = Agree/Uyavumelana 
unesandulela ngculaza 4 = Disagree/Andivumelani 
5 = Somewhat disagree/Unaka 
ukungavumelani 
6 = Strongly disagree!Awuvumelani 
ntlobo 
8 =Refuse to answer/Uyala ukuphendula 
7.10 You fear your family will reject you if they learn 1 =Strongly agree/Uvumelana kakhulu 
about your illness./Wesaba ukuba umndeni wakho 2 =Somewhat agree/Unaka ukuvumelana 
unga kulahlela izandla xa ungeva ukuba 3 = Agree/Uyavumelana 
unesandulela ngculaza. 4 = Disagree/Andivumelani 
5 = Somewhat disagree/Unaka 
ukungavumelani 
6 =Strongly disagree/Awuvumelani 
ntlobo 
8 = Refuse to answer/Uyala ukuphendula 
Section 8. Social Support and Disclosure 
This next section is about your experiences of social support and telling others about your 
statusJLemibuzo ilandelayo imalunga nenxaso oyifumana kwabanye abantu, kunye nokuthetha ngesimo 
sakho kwabanye abantu. 
8.1 Thinking about friends, family members, religious 1 = None/ Namnye 
leaders, or community members, who would you say 2 = 1 or 2 
are the people you usually confide in when you're 3 = A few (3-4)/Bambalwa (3-4) 
experiencing difficulties in life?(Remember to count 4 = Many (5 or more)/Baninzi (5 
the people and mark the response) 1/Cabanga nangaphezulu) 
ngabangane, umndeni, abantu becawe, nabantu 
bomphakathi, ngobani abantu onokuthi uyalavazi 
ukubavulela isifuba xa uhlangana nobunzimq 
ebomini? (Khumbula ukubabala, ubhale phantsi 
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inani !abo) 
8.2 Have you told anyone about your HIV status?/ 1 =Yes/ Ewe 
Ukhona umntu osele umxelele ngesimo sakho sokuba 2 = No/Hayi (Skip to Q8 .7) 
nesandulela ngculaza? 
(If no, skip to Q8.7; if yes, continue)/ (Ukuba Hayi, 
tsiba ku Q8. 7; Ukuba Ewe, qhubeka) 
8.3 How many people have you told?/Bangaphi abantu 1 =One 
osele ubaxelele ngesimo sakho? 2=Two 
3 =Three 
4 =Four 
5 =Five 
6 =More than five 
9 =Question skipped!Uma utsibile apha 
cacisa 
8.4 Thinking about the people inside your household, 1 = None!Namnye 
how many people would you say are supportive or 2 =One 
accepting of you as a person with HIV/AIDS?/Xa 3=Two 
ucinga ngabantu ohlala nabo apha ekhaya bangaphi 4 =Three 
mhlambi ongathi bayakuxhasa futhi bakwamkele 5 =Four 
njengomntu ophila nesandulela ngculaza okanye 6 =Five 
ingculaza? 7 =More than five/ Ngaphezu kwe 5 
8 =Nobody in the household knows my 
status/ Akho namnye ekhayeni endihlala 
kulo osaziyo isimo sam 
9 = I live alone/ndihlala ndedwa 
99 =Question skipped/Uma utsibile apha 
cacisa 
8.5 Thinking about the people outside your household, 1 - None/Namnye 
including family members, how many people would 2=0ne 
you say are supportive or accepting of you as a 3 =Two 
person with HIV/AIDS?/ Xa ucinga ngabantu 4 =Three 
abangaphandle kwekhaya lakho, ukuquka umndeni 5 =Four 
wakho, bangaphi mhlambi ongathi bayakuxhasafuthi 6 =Five 
bakwamkele njengomntu ophila nesandulela 7 = More than five/ Ngaphezu kwe 5 
ngculaza okanye ingculaza? 8 = Nobody outside the household knows 
my status/Akho namnye ongaphandle 
kwekhaya endihlala kulo osaziyo isimo 
sam 
9 =Question skipped/Uma utsibile apha 
cacisa 
8.6 Has anyone that you've told about your HIV status, 1 = Yes/Ewe (SKIP to 8.8) 
reacted negatively to ~he news that you are HIV- 2 = No/Hayi (SKIP to 8.8) 
positive?/Kukhona wtzntu okhe wamxelela ngesimo 9 =Question skipped!Uma utsibile apha 
sakho sempilo wakhombisa ukungasamkeli? cacisa 
8.7 Are you planning to tell anyone about your 1 = Yes 
status?!Jngaba uzimisele ukuba nomntu ozakumxelela 2=No 
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ngesimo sakho sempilo? 3 = Maybe /Not sure/ Mhlambil 
Andiqinisekanga 
9 =Question skipped/Uma utsibile apha 
cacisa 
8.8 Do you personally know anyone who has 1 =Yes/Ewe 
HIV/AIDS?/Ingaba ukhona umntu omaziyo 2 = No/Hayi 
onesandulela ngculaza okanye ingculaza? 
8.9 Do you know anyone who has died ofHTV/AIDS?/ 1 =Yes/Ewe 
Jngaba kukhona umntu omaziyo owatshona ngenxa 2 =No/Hayi 
yesandulela ngculaza okanye ingculaza? 
8.10 Do you have any friends or family who are taking 1 =Yes/Ewe 
ARVs?/ Ingaba unaye umngani okanye umndeni 2 =No/Hayi 
othatha imishanguzo yesandulela ngculaza? 3 =Don't know/Andazi 
8.11 Do you know anyone who has gotten healthier 1 =Yes/Ewe 
because of ARVS?/ Ukhona umntu omaziyo owaba 2 =No/Hayi 
ngcono empilweni ngenxa yemishanguzo yesandulela 3 =Don't know!Andazi 
ngculaza? 
8.12 Do you know anyone who died after starting ARVs?/ 1 =Yes/Ewe 
Ingaba ukhona umntu omaziyo owashona ngemva 2 =No/Hayi 
kokuqala imishanguzo yesandulela ngculaza? 3 =Don't know/Andazi 
Section 9. Mental Health 
I am now going to ask you questions related to how you have been feeling in the past 3 months, and since 
you've learnt about your HIV status. Think about the past 3 months, as well as the time since you learnt 
about your HIV status. Have you experienced any of the following? I Ngoku ndizakukubuza imibuzo 
emalunga nendlela obowuziva ngayo kwezinyanga ezintathu ezidlulileyo, nangemva kokuva ngesimo 
sakho sesandulela ngculaza. Xa ucinga ngezinyanga ezintathu zidlulileyo, kwakunye nasemva kokuva 
ngeziphumo zakho zesandulela ngculaza, ingaba ukhe waziva na ezizinto zilandelayo? 
In the Past 3 Months/ Since learning 
Kwezinyanga zintathu mvstatus/ 
zidluliye Ukusukela mhla 
weva iziphumo 
zakho 
zesandulela 
J!g_culaza 
9.1 Have you often had headaches?/Ungumntu 1 =Yes/Ewe I= Yes/Ewe 
9.2 obehlala ehlutshwa yintloko? 2 =No/Hayi 2 =No/Hayi 
9.3 Has your appetite been poor?/ Umdla wakho 1 =Yes/Ewe 1 =Yes/Ewe 
9.4 wokutya ingaba wehlile? 2 = No/Hayi 2 = No/Hayi 
9.5 Have you had difficulties sleeping at night? I= Yes/Ewe I= Yes/Ewe 
9.6 !Uziva kunzima ukulala ebusuku? 2 =No/Hayi 2 =No/Hayi 
9.7 Have you felt nervous, tense, or worried?/ 1 =Yes/Ewe 1 =Yes/Ewe 
9.8 Bowuziva ungakhululekanga, unexhala? 2 =No/Hayi 2 = No/Hayi 
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9.9 Have you had trouble thinking clearly?/ l =Yes/Ewe 1 =Yes/Ewe 
9.10 Bewungxaki yokucingisisa kakuhle okanye 
ing_qondo ithatha ibeka? 
2 =No/Hayi 2 =No/Hayi 
9.11 Have you felt unhappy?/Bewuziva I- Yes/Ewe I= Yes/Ewe 
9.12 ukhathazekile? 2 = No/Hayi 2 =No/Hayi 
9.13 Have you cried more than usual?/ lngaba ukhe 1 =Yes/Ewe 1 =Yes/Ewe 
9.14 wakhala ngaphezu kwesiqhelo? 2 =No/Hayi 2 =No/Hayi 
9.15 Have you found it difficult to enjoy your daily 1 =Yes/Ewe 1 =Yes/Ewe 
9.16 activities?/Uzive kunzima ukonwabela izinto 
obewuzenza ? 
2 =No/Hayi 2 =No/Hayi 
9.17 Have you found it difficult to make 1 =Yes/Ewe I= Yes/Ewe 
9.18 decisions?/Ukufumanise kunzima ukwenza 
izinqumo? 
2 =No/Hayi 2 =No/Hayi 
9.19 Has your daily work suffered?/lngaba 1 =Yes/Ewe I= Yes/Ewe 
9.20 umsebenzi wakho wantsuku zonke ukhe wano 2 =No/Hayi 2 = No/Hayi 
kungahambi kakuhle? 
9.21 Have you lost interest in things you usually 1 =Yes/Ewe I= Yes/Ewe 
9.22 enjoy?llngaba awusenamdla kwizinto obudla 
nf{okuzonwabela? 
2 =No/Hayi 2 =No/Hayi 
9.23 Has the thought of ending your life been on 1 =Yes/Ewe I= Yes/Ewe 
9.24 your mind?/ Ingaba ukhe wanazo iingcinga 2 =No/Hayi 2 =No/Hayi 
zokuthatha ubomi bakho? 
9.25 Have you felt tired all the time?/Bowuziva 1 =Yes/Ewe I= Yes/Ewe 
9.26 ukhathele lonke ixesha? 2 = No/Hayi 2 =No/Hayi 
Section 10. Alcohol Use 
This section is concerned with questions on alcohol use./ Lemibuzo e/andelayo izakubuza imibuzo 
ema/unga notywala. 
10.1 Do you ever drink alcohol?/ Ukhe ubuse/e utywala? I =Yes/ Ewe 
2 =No/ Hayi (Skip to Q11.1) 
(If Yes, continue; IfNo, Skip to Q11.1) 
10.2 Think about the past 3 months. In the past 3 months, I = Everyday/zonke iintsuku 
how often did you usually have at least one drink- 2 =Nearly every daylphantse zonke 
everyday, nearly everyday, three to four days a week, iintsuku 
one to two days a week, one to three days a month, or 3 = 3-4 days per week/3-4 days ngeveki 
less than once a month? 4 = 1-2 days per week/ I-2 days ngeveki 
5 = I-3 days per month/ 1-3 days 
Cinga ngezinyanga zintathu zidlulileyo. K wezinyanga ngenyanga 
zintathu zidlulileyo, kukangaphi mhlarnbe apho ubukhe 6 = Less than once a month/ ngaphantsi 
usele nokuba yikomityi enye yotywala - yonke imihla, kwakanye ngenyanga -
phantse zonke iintsuku, kathathu okanye kane ngeveki, 7 = Did not drink in past 3 
usuku olunye ukuya kwezimbini ngeveki, usuku months/Andiphuzanga ngezinyanga 
olunye ukuya kwezintathu ngenyanga, okanye kanye zintathu zidlulileyo 
nangaphantsi ngenyanga? 8 =Don't know/Andazi 
9 =Refused/ Walile ukuphendula 
99 =Question skipped!Uma utsibile 
apha cacisa 
10.3 How often in the past 3 months did you have 5 or more l = Everyday!zonke iintsuku 
drinks in a single day - everyday, nearly everyday, 2 = Nearly every day/phantse zonke 
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three to four days a week, one to two days a week, one iintsuku 
to three days a month, or less than once a month? 3 = 3-4 days per week/3-4 days ngeveki 
4 = 1-2 days per week/ I -2 days ngeveki 
Kukangaphi kwezinyanga ezintathu ezidlulile apho uye 5 = 1-3 days per month/ I -3 days 
waphuza khona noba ziinkomityi ezintlanu ngenyanga 
nangaphezulu ngosuku olunye - yonke imihla, phantse 6 =Less than once a month/ ngaphantsi 
zonke iintsuku, kathathu okanye kane ngeveki, usuku kwakanye ngenyanga 
olunye ukuya kwezimbini ngeveki, usuku olunye 7 = Did not drink in past 3 
ukuya kwezintathu ngenyanga, okanye kanye months/ Andiphuzanga ngezinyanga 
nangaphantsi ngenyanga? zintathu zidlulileyo 
8 =Don'tknow/Andazi 
9 =Refused/ Walile ukuphendula 
99 =Question skipped!Uma utsibile 
apha cacisa 
10.4 How often in the past 3 months did you drink enough 1 = Everyday/zonke iintsuku 
to feel intoxicated or drunk- either you felt unsteady 2 =Nearly every daylphantse zonke 
on your feet, or your vision was blurred, or your speech iintsuku 
was slurred-- everyday, nearly everyday, three to 3 = 3-4 days per week/3-4 days ngeveki 
four days a week, one to two days a week, one to three 4 = 1-2 days per week/ 1-2 days ngeveki 
days a month, or less than once a month? 5 = 1-3 days per month/ 1-3 days 
ngenyanga 
Kukangaphi kwezinyanga zintathu zidlulileyo apho 6 =Less than once a month/ ngaphantsi 
uye waphuza kangangoba waziva unxilile okanye kwakanyengenyanga 
udakiwe -mhlambi ubuxakwa nakukuma, okanye 7 = Did not drink in past 3 
ubungabonisisi kakuhle, okanye nokuthetha kwakho months!Andiphuzanga ngezinyanga 
kungavakali - yonke imihla, phantse zonke iintsuku, zintathu zidlulileyo 
kathathu okanye kane ngeveki, usuku olunye ukuya 8 =Don't know!Andazi 
kwezimbini ngeveki, usuku olunye ukuya kwezintathu 9 =Refused/ Walile ukuphendula 
ngenyanga, kanye okanye nangaphantsi ngenyanga? 99 =Question skipped/Uma utsibile 
apha cacisa 
Section 11. Contact Interviewer 
11.1 Would you be willing to participate in another 1 =Yes/Ewe 
interview with someone from Good Start?!Ingaba 2 =No/Hayi 
ungathanda ukuba nengxoxo nomunye wabasebenzi 
bakwa Good Start? 
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Appendix 8. 
Cross-sectional Survey Consent Form 
(English and Zulu/Xhosa Versions) 
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Good start Q~know "ystatus 
RESEARCH CONSENT FORM 
Information Sheet and Written Informed Consent Form - Cross Sectional Survey 
H-29141 -LET'S MAKE IT WORK: EMPOWERING HIV-POSITIVE CLIENTS OF 
HOME-BASED HIV COUNSELING AND TESTING TO RECEIVE CARE AND 
TREATMENT 
Background 
Hello, I am Ms/Mrs!Mr (interviewer name). I am an 
interviewer fi:orn the University of the Western Cape and the Medical Research Council. I 
am meeting with you today because you said you were interested in being in a study that 
is part of the Good Start project. I would like to describe this part ofthe study to you so 
you can decide if you would like to be in it. 
The South Mrican Medical Research Council, the University of the Western Cape, and 
Boston University in the United States are doing a study to learn what makes HIV 
positive people seek the HIV services they do and how quickly they seek them after 
testing HIV -positive in the horne. 
The Good Start project and the study are happening in many areas of the Urnzimkulu 
sub-district and we are inviting all people who tested HIV -positive at horne to be in this 
study. We expect this study to last about one year. 
We are giving you this information sheet to tell you more about the study. After you have 
learned more about the study, you can decide if you want to participate in this study. If 
you do want to take part, we will ask you to sign a separate consent form. Your decision 
to be or not be in the study will not affect the HIV care you'll receive or your access to 
care at the healthcare facility. 
Purpose 
The home-based counselling and testing we are offering in the Good Start Project is 
something new for South Africa. If we find that people in this community like it, the 
government may expand it so that more people can benefit. To be successful, they will 
need to know how to improve the project. They will need to know if people want to take 
a test at home and why some people who test positive at horne don't get HIV care. 
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What Happens In This Research Study 
You will be one of approximately 400 subjects to be asked to participate in this study. 
All or part of this research study will take place in the Umzimkulu Sub-District, Sisonke 
District, South Africa. 
Being in the study involves answering questions about yourself and your views. I am a 
trained interviewer and will be asking these questions. I will ask these questions in a 
private place where you would like. The questions will ask about your family and about 
your views and experiences about home-based HIV testing, the health care system, 
HIV I AIDS and HIV treatment, stigma around HIV I AIDS, social support and disclosure, 
mental health, and alcohol use. 
I will be entering your answers into a cell phone, which will send them to a computer in 
our office. The answers the study team will see will not include your name or other · 
identifiers so they will not know who you are. 
Being in this study is voluntary. No one outside the research team will know whether or 
not you were in the study. Your answers will be kept confidential. 
Risks and Discomforts 
There are a few possible risks to being in the study. First, while the interview will be 
conducted in private and we will not tell anyone else in the community about the 
interview, someone might guess what the study is about or will ask you why you were in 
it. To protect you, members of our study team will be visiting all members of this 
community for different purposes so being visited by me doesn't necessarily reveal your 
status. Moreover, at the same time we interview you, we will also ask permission to 
conduct an interview with other members of your household, who may have similar or 
different HIV test results than you. 
Second you may be asked questions that could make you feel distressed, uncomfortable, 
or sad. You do not have to answer any questions and you can leave the study at any time 
if you do not want to continue. I would be glad to discuss any concerns you have as we 
go through the interview. 
Third, it is possible that information collected in this study may accidentally become 
known to others outside the study team. We think this risk is very small. To try to prevent 
this, names will never be written in any reports or documents from the study. No one 
outside the researchers will ever see the answers to the questions or see your medical 
record. 
There may be unknown risks/discomforts involved. Study staff will update you in a 
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timely way on any new information that may affect your health, welfare, or decision to 
stay in this study 
Potential Benefits 
The benefits of participating in this study may be: that the questions we will ask you and 
other participants will help us to learn why people may not get HIV care after testing in 
the home. This will help the government make changes to the home-based testing 
program so that it will help more people get the HIV care they need .. However, you may 
not receive any benefit from participating. 
Alternatives 
Your alternative is to not participate in the study. 
Subject Costs and Payments 
There are no costs to you for participating in this research study. You will receive 2.5 kg 
maize meal, 2.5 kg sugar, lkg beans, and 750ml oil for participating in this study. 
Confidentiality 
Any records relating to your participation in the study and your answers to the questions 
will remain confidential. Information will be collected from you on a cell phone and 
coded with a confidential study ID number. The information will be sent to a computer in 
our office, which nobody outside the study team can access. 
Representatives of the South Mrican Medical Research Council, the University of the 
Western Cape, Boston University School ofPublic Health, the Boston University 
Medical Center Institutional Review Board, and the U.S. Office of Human Research 
Protections in the U.S. may review records as part of their responsibility to oversee 
research. No other person or organization will have access to the records or to any 
individual information about you and your family. 
Subject's Rights 
Right to Refuse or Withdraw 
Taking part in this study is voluntary. You have the right to refuse to take part in this 
study. If you decide to be in the study and then change your mind, you can withdraw 
from the research. Your participation is completely up to you. Your decision will not 
affect your being able to get health care at this institution or payment for your health care. 
It will not affect your emollment in any health plan or benefits you can get. 
If you choose to take part, you have the right to stop at any time. If there are any new 
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findings during the study that may affect whether you want to continue to take part, you 
will be told about them as soon as possible. 
The investigator may decide to discontinue your participation without your permission 
because he/she may decide that staying in the study will be bad for you, or the sponsor 
may stop the study. 
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Good start Q~know "y status 
CONSENT FORM 
StudyiD __________________________ ___ 
LET'S MAKE IT WORK: EMPOWERING HIV-POSITIVE CLIENTS OF HOME-BASED HIV 
COUNSELING AND TESTING TO RECEIVE CARE AND TREATMENT 
Researcher: ______________ (Interviewer's name) 
Research conducted by: University of the Western Cape and Medical Research Council 
Mr/Ms/Mrs _______________ has explained what is involved and I agree 
to take part. 
My questions have been answered. 
_ I agree to participate in the interview 
I understand that I can withdraw at any time without giving a reason and without it affecting the 
care I or my family receive. 
Participant Name 
Participant signature or thumbprint Date 
Person obtaining consent (signature and printed name) Date 
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Good start Q~know "ystatus 
RESEARCH CONSENT FORM 
Information Sheet and Written Informed Consent Form- Cross Sectional Study (Zulu/Xhosa) 
Intsusa 
Ndingu Umnu/nkos (igama lomphandi). Ndingumphandi ovela e 
dyunivesiti yase Ntshona-koloni. Ndihlangene nawe namhlanje njengoko ubonakalise umdla 
koluphando oluyingxenye no Goodstart. Ndingathanda ukuchaza esisigaba sophando kuwe ukuze 
uthathe isinqumo sokuba ungathanda na ukuthatha inxaxheba. 
I MRC ne Dyunivesithi yase Ntshonakoloni,I Dyunivesithi yase Boston E Melika benza lolu 
cwaningo ukwazi kabanzi ukuthi yini eyenza abantu abanegciwane basukume bayofuna uncedo, 
nokuthi balufumana ngokushesha okungakanani emva kokuba bezazile isimo sabo sempilo 
emakhayeni abo. 
Uphando luka Goodstart lwenzeka kwingxenye yezindawo ezithile zase Mzimkhulu, kwaye simema 
bonke abatholakele benegciwane emakhayeni abo ukuba babeyingxenye yaloluphando. Silindele 
ukuthi loluphando lungathatha unyaka. 
Sikunikeza lelipheshana lolwazi ukuze wazi kabanzi ngocwaningo lwethu.Masele wazi kabanzi 
ngophando lwethu, ungasithatha isinqumo sokuqhubeka. Uma ufuna, singacela ukuba usayine 
ipheshana elisecaleni lesivumelwano.isinqumo sakho sokuvuma okanye ukwala ukuba yingxenye 
yaloluphando ngeke kuchaphazele indlela oyophatheka ngayo kuwo nawu phi na umtholampilo. 
lnjongo 
Ukweluleka nokuhlolela ekhaya okunikezwa ngu Goodstart kuyinto entsha la e Mzantsi Africa. Ukuba 
sifumanisa ukuba abantu abaninzi kulemiphakathi bayayithakazelela le nkqubo urhulumeni 
angayandisa ukuze babebaninzi abantu abangaxhamla. Ukuze kubeyimpumelelo, sifuna ukwazi ukuba 
singayiphucula njani indlela esenza ngayo uphando. Sifuna ukwazi ukuba abantu bayakuthanda na 
ukuhlolelwa emakhayeni abo, nokuthi zeziphi izizathu ezikhokelela ukuthi umuntu onegciwane aye 
emtholampilo afumane ukulandelelwa okanye angayi. 
Okwenzekayo kulolucwaningo 
Ukuba yingxenye yaloluphando kuzobandakanya ukuba uphendule imibuzo emalunga nawe nemibono 
onayo. Ndingumphandi oqeqeshiweyo, ozokubuza le mibuzo. Ndizokuyibuza endaweni esesithe, 
ekhethwe nguwe.lmibuzo izobandakanya ukubuzwa ngomndeni wakho, imibono yakho namava 
onawo ngohlelo ukukwelulekwa nokuhlolelwa ekhayeni lakho, ezempilo ngokubanzi, amachiza 
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abandakanya isandulela-ngculazi nengculazi, ukucwaswa okuzungeze isifo sengculazi,ukuxhaswa 
ngezentlala-kahle nokuphumela obala, okubandakanya ukugula ngengqondo,nophuzo oludakanayo. 
Zonke izimpendulo zakho ndizobe ndizifaka kwi Cell phone, yona ke izisa kwi Computer kuma ofisi 
ethu. Izimpendulo zakho ngekhe zilifake igama lakho ngakho ke ngekhe zaziwe izimpendulo ukuba 
zisuka kuwe, nokuba bowungubani. 
Ukuba kulolucwaningo kungothando lwakho. Akakho ongaphandle kwalelithimba lophando ongazi 
ukuba bowuyingxenye yaloluphando. Izimpendulo zakho zogcinakala ziyimfihlo kuthi. 
Ubungozi nokungaphatheki kahle 
Bumbalwa kakhulu ubungozi bokuba yingxenye yaloluphando. Okokuqala njengoko imibuzo izawube 
ibuzelwa ekhusini singeke saxelela muntu emphakathini nemibuzo esiyibuzileyo. Abanye abantu 
bangasola ukuba lungani ucwaningo, mhlawumbe baze babuze ukuthi kungani ungenelile. 
Ukukukhusela, Iqembu locwaningo lwethu luzobe luvakashela wonke umphakathi ngezizathu 
ezahlukene ngakho ke, ukuza kwam kuwe akusidaluli isimo sakho sempilo. Ngaphandle koko, 
ngaxeshanye sibuza wena, sizocela imvume yokubuza imibuzo kwamanye amalungu omndeni wakho 
anganazo izimo ezifanayo noma ezihlukile mhlawumbe kwi sandulela ngculazi negciwane lalo. 
Okwesibini, mhlawumbe kungakhona imibuzo engangakuphathi kakuhle, ikuxakanise,ungaphatheki 
kakuhle, okanye ikudakumbise. Uselungelwenilokungayiphenduli lo mibuzo. Kananjalo unalo 
ilungelo lokuyeka ukuzibandakanya rna ungasathandi ukuba yingxenye. Ndingathanda ukuzixazulula 
zonke izinkinga onganazo ngesikhathi sisobabini. 
Okwesithathu, kungenzeka ulwazi osuluqokelele kuwe luputshukele kwizandla ezingezizo, sicinga 
ubungozi bungabuncane kakhulu. Ukuyikhusela leyonto ukuze ingenzeki, amagama awabhalwa 
nakuyiphina ingxelo yophando. Akukho namnye ongaphandle kwethimba lophando ongazibona 
izimpendulo zemibuzo okanye abone ingxelo ngobume bakho bempilo. 
Zingakhona mhlawumbe izimo zobungozi noma ezinokungakuphathi kahle ezingaziwa. Ithimba 
lophando luzokusoloko njalo lukwazisa njalonjalo ngazo zonke izinto ezintsha ezingabandakanya 
impilo yakho, ezentlalakahle, nesinqumo sokuhlala koluphando. 
Okubalulekileyo Ongakuzuza 
Inzuzo yokuzibandakanya kolucwaningo: Imibuzo esizoyibuza nabanye abazibandakanyayo ingasisiza 
sifunde kabanzi ngokuba kungani abantu bengakuthandi ukulandelelwa emveni kokuhlolelwa 
emakhayeni abo. Loku kungasiza urhulumeni enze ushintsho kwizindlela zokuqhuba uhlelo 
lokuvakashela nokuhlola emakhaya ukuze isize abantu abaningi bathole usizo abaludingayo 
ngokuphathelene nesandulela ngculazi negciwane. Ngokunjalo ungangazuzi lutho ngokuzibandakanya 
kwakho. 
Kungenjalo 
Ungangazibandakanyi ntlobo kuloluphando. 
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Umgomo wexabiso noma intlawulo 
Akukho ntlawulo yokungenela kwakho kulolucwaningo. Uthola u2.5 kg wempuphu, 2.5 kg 
woshukela, lkg ubhontsisi, 750ml amafutha ngokungenela kolucwaningo. 
Imlthlo 
Yonke imiqulu ephathelene nokuzibandakanya kwakho kulolucwaningo nezimpendulo zakho kohlala 
kuyimfihlo. Imininingwane izocoshwa kuwe nge selula ingenagama bese inikezwa inombolo 
eyimfihlo yocwaningo. Inkcukacha zizozothunyelwa kumakhompuyutha ethu kuma ofisi ethu, apho 
kungekho namnye wangaphandle onganelungelo kuwo. 
Abamele u Medical Reseach Council, Dyunivesiti yase Ntshona-koloni, Dyunivesithi yase Boston, 
Boston Dyunivesithi Medical Center Institutional Review Board kanye ne U.S .Office yeHuman 
Research Protection e U.S. bangawabheka amabhuku njengengxenye yomsebenzi wabo ukuhlola 
ngokuphelele lolucwaningo. Akakho omnye umuntu okanye intlangano enelungelo kulamabhuku 
noma inkcukacha ngawe noma umndeni wakho. 
Amalungelo Ozibandakanyayo 
Ukuthatha inxaxheba kolucwaningo kungokuzikhethela. Unelungelo lokwala ukuthatha inxaxheba 
nangasiphi na isikhathi. Uma ugqiba ekubeni uyangenela kolu cwaningo bese ujika umqondo, 
ungayeka noma kunini. 
Isigqibo sakho ngeke sibandakanye ukuthola kwakho unakekelo olufanelekile ku Nompilo wethu 
noma ku chaphazele noma kuthinte okutholayo kumanye amaziko ekuhlaleni. Ngeke ikuthintele 
ekuzibandakanyeni nezinye izintlelo zezempilo, nenzuzo ongayithola. 
Ngokuvuma ukuba yingxenye yaloluphando akukuvimbeli amalungelo akho. Ukunikeza imvume 
kusho nje kuphela ukuthi uzwile kwaye ufundile ngalo lucwaningo ngoko ke uyavuma 
ukuzibandakanya. Uzonikezwa okuzosala kuwena ngalokhu ozokugcina. 
Ukuba ngalo nangaliphi na ixesha ufisa ukurhoxa kulolucwaningo ngeke uhlawuliswe lutho okanye 
ulahlekelwe lutho obeluzoba yinzuzo kuwena. 
Uma unombuzo okanye okunye nje okusemqondweni wakho mayelana naloluphando noma 
nezentlalakahle njengozibandakanyayo noma ulimele bewuzibandakanya, siza fowunela u Ms 
Weliswa Binza Umgqugquzeli walo luhlelo. Kulezi no. 039 4332532. Umgqugquzeli noma elinye 
ilungu lesigungu Jingawuphendula umbuzo Kanjalo ungathola eminye imininingwane engeminye 
ngoku fonela u Njingalwazi Danie du Toit kwi MRC Ethics Committee kule nombolo 021-938-0341 
noma umthumele iimeyili ethi: adri.labuschagne@mrc.ac.za. 
Siyacela uthathe isikhathi ucabangisise kahle ukuba ungathanda noma awuthandi ukuba yingxenye 
yalolucwaningo. 
Uma uyavuma, ndingacela usayine isivumelwana ngezantsi. Uma futhi ungathandi ukuba yingxenye, 
ngiyabonga ngokuba sikwazise ngokubanzi ngocwaningo lwethu. 
Imvume Yokwala Noma Ukurhoxa 
Ukuthatha inxaxheba kuloluphando kungokuzithandela. Unelungelo lokwala ukuba yingxenye. Uma 
unquma ukuba yingxenye bese ushintsha umqondo, uvumelekile ukurhoxa kulolucwaningo. 
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Ukuzibandakanya kukuwe ngokupheleleyo. Isinqumo sakho ngeke sichaphazelwe indlela 
ozonakekelwa ngayo kwezempilo kweliziko okanye kube yindlela okhokhela ngayo impilo yakho. 
Ngeke futhi ichaphazele ukufakwa kuluhlu lwawo wonke amacebo nawo onke amalungelo ongathi 
uwathole. 
Uma ukhetha ukungenela, unalo ilungelo lokuyeka nangasiphi na isikhathi ufuna.Uma kukhona 
okutsha esikufumanayo uyakuxelelwa ngokukhulu ukukhawuleza. 
Abaphandi banganquma ukukuyekisa ukuthatha inxaxheba koluphando ngaphandle kwemvume yakho 
uma mhlawumbi bengabona kungakhona ubungozi obungakhona ngakwicala lakho noma abaxhasi 
benga misa uxhaso lwabo kolucwaningo. 
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Good start Q~ kriow "ystatus 
CONSENT FORM 
Study PID ____________ Cluster!HHID _________ _ 
LET'S MAKE IT WORK: EMPOWERING HIV-POSITIVE CLIENTS OF HOME-BASED HIV 
COUNSELING AND TESTING TO RECEIVE CARE AND TREATMENT 
Researcherllgama lomphandi: Celiwe Ngidi (Interviewer' s name) 
Research conducted by!Uphando luqhutywa: 
University of the Western Cape and Medical Research Council I Idyunivesiti yasentshona-Koloni 
bebambisene no Medical Research Council. 
Ms. Celiwe Ngidi has explained what is involved and I agree to take part!Nkos ucacisile 
okubandakanyekayo kwaye nam ndiyavuma ukuthatha inxaxheba. 
_(Tick) My questions have been answered/ Imibuzo yam iphendulekile 
_(Tick) I agree to participate in the interview/ Ndiyavuma ukuthatha inxaxheba 
kolucwaningo 
I understand that I can withdraw at any time without giving a reason and without it affecting the 
care I or my family receive./Ndiyaqonda ukuba ndingarhoxa nangasiphi na isikhathi ngaphandle 
kokunika isizathu nangaphandle kokuchaphazela unakekelo nomndeni warn. 
Participant Namellgama lozibandakanyayo 
Participant signature or thumbprint/Ozibandakanyayo(tyikitya noma ubeke uthupha) 
Date/Umhla: __________ _ __________ _ _ ___ _ 
Person obtaining consent (signature and printed name)/Umuntu othola imvume (tyikitya 
bese ubhale igama eligcwele) 
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Appendix 9. 
Unadjusted Hazard Ratios 
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Unadjusted Hazard Ratios and 95% confidence intervals for all variables explored {n=l96) 
(*denotes variables significant at a level ojpSO.l) 
Variable N (%)HIV- Unadjusted p-
positive Hazard Ratio value 
HBHCT (95% C.l.) 
clients who 
obtained a 
CD4 
1. *Adult household members 0.0081 
<3 90/123 (62.8) I 
2:3 46/73 (37.2) 0.62 (0.43- 0.89) 0.010 
2. Gender 0.7799 
Male 26/40 (65.0) 1 
Female 110/156 (70.5) 1.06 (.69 - 1.6) 0.781 
3. *Age group 0.0006 
16-24 14/30 (33.3) .41 (.23- .73) 
25+ 123/166 (74.1) 1 0.002 
4. Marital status 0.1622 
Single 44/73 (60.3) 1 
Married/co-habitating 65/89 (73.0) 1.4 (.95 - 2.1) 0.090 
Widowed/divorced/separated 27/34 (79.4) 1.4 (.90 - 2.3) 0.131 
5. *Ever bad an HIV test prior to HBHCT 0.0755 
Yes 57/88 (64.8) 1 
No 79/108 (73.2) 1.4 (.97- 1.9) 0.078 
6. *Level of schooling 0.0033 
Never attended/some primary/completed primary 
Some high school/completed high school/tertiary 77/96 (80.2) 1 
59/100 (59.0) 0.6 (.43 -.85) 0.004 
7. Religion 0.5707 
Christian only 9/14 (64.3) 1 
Christian + traditional beliefs 111/161 (68.9) 1.3 (.63 - 2.6) 0.493 
Shembe 5/8 (62.5) 1.1 (.35 - 3.3) 0.904 
None 11/13 (84.6) 1.9 (.74 - 4 .6) 0.186 
8. *Number of income sources 0.0380 
0 19/34 (55.9) 1 
1 73/107 (68.2) 1.4 (.85 - 2.3) 0.186 
2+ 44/55 (80.0) 2.0 (1.1 - 3.4) 0.015 
9. *# people for whom financially responsible 0.0653 
0-2 54/88 (61.4) 1 
3+ 82/108 (75.9) 1.4 (.98 - I .9) 0.068 
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IO. *# people for whom a caregiver 0.023I 
0-3 I3/27 ( 48.2) I 
4+ I23/169 (72.8) 1.8 (1.0- 3.3) 0.036 
II. Perception of health status 0.1458 
Poor/very poor 68/92 (73.9) 1 
Fair/good/excellent 68/104 (65.4) 0. 78 (.55 - 1.1) 0.145 
12. *Time spent away from home 0.0789 
Never away - away up to 4months/year I 06/146 (72. 6) 1 
A way 5+ months/year 30/50 (50.0) 0.70 (.46- 1.1) 0.089 
13. *Reason for testing 0.0123 
Suspicion of illness 69/86 (80.2) I 
Other reason 67/110 (60.9) 0.65 (.46- .91) 0.012 
14. Comfort testing at home 0.7920 
A lot/little more at home 112/159 (70.4) 1 
Same as clinic 19/29 (65.5) 0.92 (.56- 1.5) 0.727 
A lot/little more at clinic 5/8 (62.5) .76 (.31- 1.9) 0.556 
15. Tested if counsellor hadn't visited 0.8171 
No 74/109 (67.9) 1 
Maybe/not sure 16/22 (72.7) 1.0 (.59 - 1.8) 0.914 
Yes 46/65 (70.8) 1.1 (.78- 1.6) 0.524 
16. Comfort with counsellor's skills 0.2028 
Very/generally comfortable 135/192 (70.3) 1 
Very/generally uncomfortable 1/4 (25.0) 0.32 (.04- 2.3) 0.255 
17. *Received enough information about follow up 0.0947 
Yes 131/191 (68.6) 1 
No 5/5 (100.0) 2.4 (.97- 5.8) 0.058 
18. *Believed HBHCT results 0.0000 
Yes 112/141 (79.4) 1 
No/not sure 24/55 (43.6) 0.37 (.24 - .58) 0.000 
19. Impression of HBHCT 0.2294 
Excellent/good 125/177 (70.6) 1 
Okay/poor/very poor 11/19 (57.9) 0.70 (.38- 1.3) 0.253 
20. Barriers to care- is money for transport a 0.2605 
problem? 
Not a problem 53/73 (72.6) 1 
Big/small problem 83/123 (67.5) 0.82 (.58 - 1.2) 0.257 
21. Barriers to care- is money for treatment a 0.4916 
problem? 
Not a problem 48/67 (71.6) I 
Big/small problem 88/129 (68.2) 0.88 (.62 - 1.3) 0.489 
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22. Barriers to care- is distance to facility a 0.9219 
problem? 
Not a problem 48/71 (67.6) 1 
Big/small problem 88/125 (70.4) 1.0 (.71 - 1.5) 0.922 
23. Barriers to care- is availability of transport a 0.8434 
problem? 
Not a problem 82/122 (67.2) 1 
Big/small problem 54/74 (73.0) 1.0 (.73 - 1.5) 0.20 
24. *Barriers to care - is finding time to go to the 0.0074 
facility a problem? 
Not a problem 114/155 (73 .6) 1 
Big/small problem 22/41 (53.7) 0.56 (.35 - .88) 0.012 
25. Barriers- is getting permission to go a 0.5665 
problem? 
Not a problem 131/190 (69.0) 1 
Big/small problem 5/6 (83 .3) 1.3 (.54- 0.60 
3.21215) 
26. Perceptions of HC system - are staff 0.6841 
available? 
Always/mostly 126/176 (71.6) 1 
Sometimes/rarely/never. . 7/10 (70.0) 0.86 (.40- 1.8) 0.691 
27. Perceptions of HC system - how were you 0.9866 
treated last time? 
Very badly/badly/fairly 13/17 (76.5) 1 
Very well/well 120/169 (71.0) 1.0 (.56- 1.8) 0.987 
28. *Perceptions of HC system -how would you 0.0072 
rate services? 
Very poor/poor 19/30 (63 .3) 1 
Very good/good/fair 114/156 (73.1) 1.5 (.95 - 2.5) 0.083 
Never been to clinic 3/10 (30.0) 0.42 (.13- 1.4) 0.167 
29. *Perceptions ofHC system- are 0.0078 
drugs/supplies available? 
Never/rarely/sometimes 21/40 (52.5) 1 
Mostly/always 80/104 (76.9) 2.0 (1.3 - 3.3) 0.004 
Don't know/never been to clinic 35/52 (67.3) 1.8 (1.1 - 3.2) 0.027 
30. Perceptions of HC system- trust 0.4764 
confidentiality 
Completely/somewhat 79/1 15 (68.7) 1 
Not a.t all 26/40 (65 .0) 0.75 (.48- 1.2) 0.201 
Not sure/never been to clinic 31/41 (75.6) 0.92 (.61 - 1.4) 0.716 
31. Perceptions of HC system -trust skills 0.7294 
Completely/somewhat 104/146 (71.2) 1 
Not at all 10/17 (58.8) 0.77 (.40- 1.5) 0.43 8 
Not sure 22/33 (66.7) 0.89 (.56- 1.4) 0.616 
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32. Knowledge- there is no cure for AIDS 0.4149 
Agree 72/104 (69.2) 0.87(.62- 1.2) 0.414 
Disagree/don ' t know 64/92 (69.6) 1 
33. Knowledge- a person with AIDS may not look 0.8833 
or feel sick for many years 
Agree 88/124 (71.0) 1.0 (.72- 1.5) 0.883 
Disagree/don't know 48/72 (66.7) 1 
34. Knowledge- person's CD4 determines 0.4133 
whether they get ARVs 
Agree 100/138 (72.5) 1.2 (.80- 1.7) 0.419 
Disagree/don't know 36/58 (62.1) 1 
35. Knowledge- you must take ARVs your whole 0.4429 
life 
Agree 1011140 (72.1) 1.2 (.79- 1.7) 0.448 
Disagree/don't know 35/56 (62.5) 1 
36. Knowledge -IITV/AIDS makes it difficult for 0.2333 
your body to fight other illnesses 
Agree 66/91 (72.5) 1.2 (.88 - 1. 7) 0.232 
Disagree/don 't know 70/105 (66.7) 1 
37. Limiting belief- ARVS almost always improve 0.3769 
the lives of those taking them 
Agree 107/148 (72.3) 1 
Disagree/don' t know 29/48 (60.4) 0.83 (.55 - 1.3) 0.385 
38. Limiting belief- people in this community can 0.2618 
readily access ARVS 
Agree 64/84 (76.2) 1 
Disagree/don't know 72/112 (64.3) 0.82 .(56 - 1.2) 0.260 
39. Limiting belief- if you're not feeling sick you 0.4138 
don't need ARVs 
Agree/don' t know 57/87 (65.5) 0.87 (.62- 1.2) 0.416 
Disagree 79/109 (72.5) 1 
40. *Limiting belief- ARVs can make you feel 0.0482 
sick 25/40 (62.5) 0.65 (0.42 - 1.02) 0.059 
Agree 1111156 (71.2) 1 
Disagree/don't know 
41. *Limiting belief- ARVs are very expensive 0.0084 
Agree 18/21 (85 .7) 2.1(1.3 -3 .5) 0.004 
Disagree/don' t know 118/175 (67.4) 1 
42. Limiting belief- ARV treatment is not simple 0.1691 
Agree 37/59 (62.7) 0.77(.53- 1.1) 0.177 
Disagree/don't know 99/137 (72.3) 1 
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43. Limiting belief- traditional medicine can cure 0.2352 
HIV 
Agree 12/19 (63.2) 0.71 (0.39- 1.3) 0.257 
Disagree/don 't know 1241177 (70.1) 1 
44. *Limiting belief- traditional medicine is 0.0468 
better than ARVs 
Agree/don' t know 49/84 (58.3) 1 
Disagree 87/ 112 (77. 7) 1.4 (1.0- 2.0) 0.050 
45 . *Limiting belief- It is too difficult to take 0.0327 
ARVS for life 
Agree 34/56 (60.7) 0.66 (.45 - .98) 0.038 
Disagree/don't know 102/140 (72.9) 1 
46. Limiting belief- you know where to find 0.8375 
resources to help deal with illness 
Agree 74/108 (68.5) 1 
Disagree/don 't know 62/88 (70.5) 1.0 (.74- 1.5) 0.837 
47. Fear/Stigma -other people might blame you 0.4268 
for being HIV-positive 
Strongly/somewhat/agree 33/44 (75.0) 1.2 (.79- 1.7) 0.420 
Strongly I somewhat/ disagree 100/149 (67.1) 1 
48. Fear/Stigma- feel ashamed of your illness 0.2041 
Strongly/somewhat/agree 55/83 (66.3) .80 (.57- 1.1) 0.207 
Strongly I somewhat/ disagree 81/113 (71.7) 1 
49. Fear/Stigma -difficult to tell people that you 0.7809 
have HIV I AIDS 
Strongly/somewhat/agree 115/166 (69.3) 1.1 (.67- 1.7) 0.782 
Strongly/somewhat/disagree 21/30 (70.0) 1 
50. Fear/Stigma -you see your illness as a 0.7842 
punishment for things you've done 
Strongly I somewhat/ agree 52/73 (71.2) 1.0 (.74- 1.5) 0.784 
Strongly/somewhat/disagree 83/121 (68.6) 1 
51. Fear/Stigma -you feel you may have to move 0.1248 
because of your HIV status 
Strongly/somewhat/agree 9/19 (47.4) .61 (.31 - 1.2) 0.153 
Strongly/somewhat/disagree 127/177 (71.8) 1 
52. *Fear/Stigma -you would avoid getting 0.1048 
treatment or services because someone might 
find out about your HIV status 
Strongly/somewhat/agree 10/20 (50.0) .61 (.32- 1.2) 0.131 
Strongly/somewhat/disagree 126/176 (71.6) 1 
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53 . Fear/Stigma- you fear people might hurt your 0.5782 
family if they learn about your status 
Strongly/somewhat/agree 54176 (71.1) l.l (.78- 1.6) 0.577 
Strongly/somewhat/disagree 82/120 (68.3) 1 
54. Fear/Stigma- you fear you will lose your 0.2810 
friends if they learn about your HIV status 
Strongly/somewhat/agree 74/113 (65.5) .83 (.59 - 1.2) 0.279 
Strongly/somewhat/disagree 62/83 (74.7) 1 
55. *Familiarity- do you know anyone with 0.0281 
HIV/AIDS? 
Yes 114/152 (75.0) 1.6 (1.0- 2.6) 0.037 
No 22/44 (50.0) 1 
56. *Familiarity- do you know anyone who has 0.0557 
died of H1V I AIDS 
Yes 93/124 (75 .0) 1 
No 43172 (59.7) .70 (.49- 1.0) 0.061 
57. Familiarity- do you have any friends/family 0.3867 
taking ARVs? 
Yes 58/79 (73.4) 1.2 (.83 - 1.6) 0.385 
No/Don't know 78/117 (66.7) 1 
58. Familiarity- do you know anyone who's 0.1227 
gotten healthier because of ARVs? 
Yes 86/115 (74.8) 1.3 (.93 - 1.9) 0.127 
No/Don't know 50/81 (61.7) 1 
59. Familiarity- do you know anyone who died 0.5508 
after starting ARVs? 
Yes 21/30 (70.0) 1 
No 1151166 (69.3) .87 (.54 - 1.4) 0.544 
60. *Total mental health symptoms before 0.0250 
HBHCT . 75/119(63.0) - 1 
0 61177 (79.2) 1.5 (1.1- 2.1) 0.024 
1+ 
61. *Total mental health symptoms after HBHCT 0.0281 
1-2 18/35 (51.4) 1 
3+ 118/161 (73.3) 1.7 (1.0- 2.8) 0.039 
62. *Ever drink alcohol 0.0591 
Yes 33/56 (58.9) 1 
No 103/140 (73.6) 1.4 (.97- 2.1) 0.067 
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Appendix 10. 
Qualitative Study Consent Form 
(English & Zulu/Xhosa Versions) 
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Good start Q~know "y status 
RESEARCH CONSENT FORM 
Information Sheet and Written Informed Consent Form - Qualitative Study 
H-29141- LET'S MAKE IT WORK: EMPOWERING HIV-POSITIVECLIENTS OF 
HOME-BASED HIV COUNSELING AND TESTING TO RECEIVE CARE AND 
TREATMENT 
Background 
Hello, I am Ms/Mrs/Mr (interviewer name). I am an 
interviewer from the University of the Western Cape and the Medical Research Council. I 
am meeting with you today because you said you were interested in being in a study that 
is part of the Good Start project. I would like to take a few minutes to describe this part of 
the study in more detail so that you can decide again if you would like to participate. 
The South African Medical Research Council, the University of the Western Cape, and 
Boston University in the United States are doing a study to learn what helps people who 
have tested HIV -positive at home get follow up health and social support services, or 
what difficulties they might face in trying to get these services. 
The Good Start project and this study are happening in many areas of the Urnzimkulu 
sub-district. 
We are giving you this information sheet to tell you more details about the research 
study. After you have learned more about the study, you can decide if you would like to 
take part. If you do want to take part, we will ask you to sign a separate consent form. 
Your decision to participate or not participate in the study will not affect the support and 
follow up visits that you'll receive from your counselor, or affect the services that you can 
get from the health facility or other organizations. 
Purpose 
The home-based counselling and testing that we are offering as part of the Good Start 
Project is something new for South Africa. If we find that people in this community like 
it, the government may want to expand it so that more people can benefit. To be 
successful, they will need to know whether people want to take a test at home, and why 
some people do and do not get the health and social services they need after testing 
positive. 
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What Happens In This Research Study 
You will be one of approximately 25 subjects to be asked to participate in this study. 
All or part of this research study will take place in the Umzimkulu Sub-District, Sisonke 
District, South Africa. 
If you are in this study, we ask that you have an open discussion with me about your 
experiences since the time you tested positive during the home-based counselling and 
testing session. I am a trained interviewer and will be asking questions and taking notes 
about your responses. Some of the questions may be quite personal and might make you 
feel uncomfortable. For example, I will ask you about your feelings about having HIV. 
You do not have to answer these questions if you don't want to. Please tell me if any of 
our discussions make you feel uncomfortable and we can stop or discuss other topics. 
If you agree, I will also tape-record our discussion, so that the study team can hear your 
responses and learn from them. When the study is finished, these tapes will be destroyed. 
I will conduct the interview in a private location of your choosing. The interview may last 
about 1 hour. 
The study team will not know your name or any other personal information about you, so 
they will not be able to identify you. Your responses will only be linked to a unique ID 
number. 
Being in this study is completely voluntary. No one outside the research team will know 
whether or not you participated. Your responses to the questions will be kept 
confidential. 
Risks and Discomforts 
There are a few possible risks to being in the study. First, while the interview will be 
conducted in private and we will not tell anyone else in the community about the 
interview, someone might guess what the study is about or will ask you why you were in 
it. To protect you, members of our study team will be visiting all members of this 
community for different purposes so being visited by me doesn't necessarily reveal your 
status. 
Second you may be asked questions that could make you feel distressed, uncomfortable, 
or sad. You do not have to answer any questions and·you can leave the study at any time 
if you do not want to continue. I would be glad to discuss any concerns you have as we 
go through the interview. 
Third, it is possible that information collected in this study may accidentally become 
known to others outside the study team. We think this risk is very small. To try to prevent 
this, names will never be written in any reports or documents from the study. No one 
outside the researchers will ever see the answers to the questions or see your clinic 
record. 
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There may be unknown risks/discomforts involved. Study staff will update you in a 
timely way on any new information that may affect your health, welfare, or decision to 
stay in this study 
Potential Benefits 
The benefits of participating in this study may be: that the information that we will get 
from you and other participants will help us to understand the reasons why people may 
have a difficult time getting health and social services after testing HIV -positive in the 
home. This information will assist the government to change the home-based testing 
project so that when it is taken to other areas, it will not only help people to get tested, 
but also help clients like you receive the care and treatment that they need .. However, 
you may not receive any benefit from participating. 
Alternatives 
Your alternative is to not participate in the study. 
Subject Costs and Payments 
There are no costs to you for participating in this research study. You will receive 2.5 kg 
maize meal, 2.5 kg sugar, I kg beans, and 750ml oil for participating in this study. 
Confidentiality 
Records relating to your participation in the study and your answers to the questions will 
remain confidential. We will not record your name or any other personally identifying 
information. Information collected from you either on tape or written on paper will be 
coded with a confidential study ID number. 
Representatives of the South African Medical Research Council, the University of the 
Western Cape, Boston University School of Public Health, the Boston University 
Medical Center Institutional Review Board, and the U.S. Office of Human Research 
Protections in the U.S. may review records as part of their responsibility to oversee 
research. No other person or organization will have access to the records or to any 
individual information about you and your family. 
Subject's Rights 
Taking part in this study is voluntary. You have the right to refuse to ·take part. If you 
decide to be in the study and then change your mind, you can stop at any time. Your 
decision will not affect your being able to get support from your counselor or affect the 
services you get from any other institutions in the area. It will not affect your enrollment 
in any health plan or benefits you can get. 
By consenting to be in this study you do not waive any of your legal rights. Giving 
consent means that you have heard or read the information about this study and that you 
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agree to participate. You will be given a copy of this form to keep. 
If at any time you withdraw from this study you will not suffer any penalty or lose any 
benefits to which you are entitled. 
If you have any questions or concems about the research or about your welfare as a 
research pruiicipant or any injury related to the study, please contact the Project 
Coordinator Ms. Weliswa Binza at Tel: 039-433-2532. The Coordinator or a member of 
the research team will try to answer all of your questions. You may obtain more 
information about your rights as a research subject by contacting ProfDanie du Toit of 
the MRC Ethics Committee at: Tel: 021-938-0341; email: adri.labuschagne@mrc.ac.za. 
Please take as much time as you would like now to decide whether you agree to 
participate in the study. 
If you agree, I would like you sign the consent form below. If you do not agree to 
participate, thank you for letting us tell you about the research study. 
Right to Refuse or Withdraw 
Taking part in this study is voluntary. You have the right to refuse to take part in this 
study. If you decide to be in the study and then change your mind, you can withdraw 
from the research. Your participation is completely up to you. Your decision will not 
affect your being able to get health care at this institution or payment for your health care. 
It will not affect your emollment in any health plan or benefits you can get. 
If you choose to take part, you have the right to stop at any time. If there are any new 
findings during the study that may affect whether you want to continue to take part, you 
will be told about them as soon as possible. 
The investigator may decide to discontinue your participation without your permission 
because he/she may decide that staying in the study will be bad for you, or the sponsor 
may stop the study. 
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Good start Q~know "ystatus 
CONSENT FORM 
StudyiD __________________________ __ 
LET'S MAKE IT WORK: EMPOWERING IDV-POSITIVE CLIENTS OF HOME-BASED IDV 
COUNSELING AND TESTING TO RECEIVE CARE AND TREATMENT 
Researcher: (Interviewer's name) 
----------------------------
Research conducted by: University of the Western Cape and Medical Research Council 
Mr/Ms/Mrs _____________________________ has explained what is involved and I agree 
to take part. 
My questions have been answered. 
_ I agree to participate in the interview . 
_I agree to have my responses to the interview questions tape-recorded 
I understand that I can withdraw at any time without giving a reason and without it affecting the 
care I or my family receive. 
Participant Name 
Participant signature or thumbprint Date 
Person obtaining consent (signature and printed name) Date 
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Good start Q~know "ystatus 
Information Sheet and Written Informed Consent Form - Qualitative Study 
(Zulu/Xhosa) 
H-29141- LET'S MAKE IT WORK: EMPOWERING HIV-POSITIVE CLIENTS OF 
HOME-BASED HIV COUNSELING AND TESTING TO RECEIVE CARE AND 
TREATMENT 
Background 
Hello, ndingu nkosazane/nkosikazi/mnumzane (igama 
lomcwaningi). Ndingumcwaningi wase dyunivesithi yase Ntshonalanga Kapa ne Medical 
Research Council. Ndidibana nawe namhlanje ngoba wawuthe ungathanda ukuthatha 
inxaxheba ocwaningweni lakwa Good Start project. Ndingathanda ukuthatha ixesha 
elincinci ukuchaza lengxenye yocwaninigo kabanzi ukuze ucingisise okokubana uyafuna 
yini futhi ukuthatha inxaxheba. 
!South African Medical Research Council, idyunivesithiyase Ntshonalanga Kapa, 
idyunivesithi yase Boston e-United States benza ucwaningo ukuze bafunde ukuthi yini 
esiza abantu abahlolele ekhaya bathola ukuthi banentsholongwane kagawulayo bathole 
ukulandelwa ngezempilo nenxaso, nokuthi zintoni iingxaki abanokudibana nazo xa 
bezama ukufumana oluncedo nenxaso. 
I Good Start project nalolucwaningo lwenzeka ezindaweni eziningi kwingxenye yo 
Mzimkhulu 
Sikunikeza lelipheshana lolwazi ukukunikeza imininingwane ethe vetshe ngocwaningo. 
Emva kokuba usufunde kabanzi ngocwaningo, ungakhetha ukuthi uyathanda yini 
ukuthatha inxaxheba ocwaningweni. Uma ungathanda ukuthatha inxaxheba, sizokucela 
ukuthi usayine imvumelwano eseceleni. Isinqumo sakho sokuthatha inxaxheba noma 
sokungayithathi ngeke kube nomthelela ekuxhasweni nokulandelwa okwenziwa 
ngumeluleki wakho, noma izinsiza ozifumana emtholampilo nanoma kuziphi 
izinhlangano. 
Intloso 
Ukwelulekwa nokuhlolelwa ekhaya esikunikeza njengengxenye ye Good Start Project 
yinto entsha eNingizimu Afrika. Uma sithola ukuthi lomphakathi uyayithanda , 
urhulumente angathanda ukuyelula ukuze abantu abanintsi basizakale. Ukuze 
baphumelele, bazodinga ukwazi ukuthi abantu bayathanda yini ukuhlolelwa emakhaya, 
nokuthi kungani abanye abantu bethola okanye bengatholi ukusizakala kwizidingo 
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ngezempilo nezenhlalo emuva kokuba emuva kokuba behlolile bathola ukuthi 
banentsholongwane kagawulayo. 
Kwenzekani kulolucwaningo 
Uzokuba ngomnye wabangu 25 abazocelwa ukuthi bathathe inxaxheba kulolucwaningo. 
Lonke noma ingxenye yalolucwaningo izokwenziwa e- Umzimkulu Sub-District, Sisonke 
District, eNingizimu Afrika. 
Uma ukulolucwaningo, ndicela ukuthi ube nengxoxo evulelekile nami malunga namava 
obenawo seloko wahlolwa ekhaya watholwa unesandulela ngculaza. Ngingumcwaningi 
oqeqeshiwe ngizobe ngibuza imibuzo kukhona nendikuqobelela phantsi ngezimpendulo 
zakho. Eminye imibuzo izobe ibuza ngawe ngqo futhi ingakwenza uzizwe 
ungakhululekile. Umzekelo, ngizokubuza ngemizwa yakho ngokuba nesandulela 
ngculaza. Akumele uphendule lemibuzo uma ungafuni ukuyiphendula. Ndicela ungazise 
uma ingxoxo yethu ikwenza uzizwe ungakhululekile sizokuma noma sixoxe ngezinye 
izihloko. 
Uma uvuma, ngizoqopha ingxoxo yethu, ukuze ithimba locwaningo lizwe izimpendulo 
zakho futhi bafunde kuzo. Uma ucwaningo seluphelile, ingxoxo eqoshiwe iyohlahlwa. 
N gizokwenza ingxoxo endaweni enemfihlo ezokhethwa nguwe. Ingxoxo ingacishe 
ithathe ihora elilodwa. 
Ithimba locwaningo ngeke lilazi igama lakho nanoma iluphi ulwazi oluqondene nawe, 
ngaleyondlela ngeke bakwazi ukukukhomba. Izimpendulo zakho ziyoqondaniswa 
nenombolo yakho yocwaningo eqondene nawe. 
Ukuthatha inxaxheba kulolucwaningo kuxhomekeke kuwe. Akekho ongekho 
ocwaningweni ozokwazi ukuthi ubambe iqhaza noma cha. Izimpendulo zakho 
emibuzweni ziyogcinwa ziyimfihlo. 
Ubungozi nokungaphatheki kahle 
Kunobungozi obuncinci obungaba khona ngokuthi ube socwaningweni. Okokuqala noxa 
ucwaningo luzobe lwenziwa endaweni eyimfihlo futhi singeke sitshele muntu elalini 
ngengxoxo, omunye angaqagela ukuthi ucwaningo lungani noma abuze okokubana 
yingani ukulo. Ukukuvikela, amalungu ocwaningo lwethu azovakashela onke amalungu 
alelali ngezizathu ezahlukene ngalokho ukuvakashelwa ndim akukhuphi isimo sempilo 
yakho. 
Okwesibini ungabuzwa imibuzo ezokwenza uzizwe ukhathazekile, ungonwabanga, 
ungakhululekile noma ujalile. Akudingeki ukuthi uphendule imibuzo futhi ungashiya 
ocwaningweni nganoma yiliphi ixesha uma ungasafuni ukuqhubeka. Ndingavuya 
ukuxoxa nganoma ngawaphi amaxhala onawo ngokuya siqhubeka nengxoxo. 
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Okwesithathu, kunganzeka ulwazi esiluqoqe kulolucwaningo luphume ngephutha 
lwaziwe ngabantu abangeyona ingxenye yethimba locwaningo. Sicinga okokubani 
lengozi incinci kakhulu. l)kuzama ukuvikela lokhu, amagama ngeke abhalwe kuma 
report noma imiqulu ephuma kulolucwaningo. Akekho omnye ngaphandle 
kwabacwaningi oyobona izimpendulo zemibuzo noma abone irecord lakho 
lasemtholampilo. 
Kungaba nobungozi /ukungaphatheki kahle obungaziwa obungaba khona. Abacwaningi 
bayokwazisa ngexesha elililo uma kukhona ulwazi olusha olungachaphazela impilo 
yakho, inhlalo, noma isinqumo sokuba socwaningweni. 
Ongase ukuzuze 
Inzuzo yokuthatha inxaxheba ocwaningweni kungaba: ukuthi ulwazi esizoluthola kuwe 
nabanye ababambe iqhaza luzosinceda ukuqonda izizathu zokuthi kungani abantu 
bengathola ubunzima ekutholeni izibonelelo zempilo nezenhlalo emuva kokuba.behlole 
ekhaya bathola ukuthi banentsholongwane kagawulayo. Lolulwazi luzonceda 
urhulumente okokubani atshintshe iproject yokuhlola ekhaya ukuze uma isiyiswa 
kwezinye iindawo incede abantu ukuthi bahlolwe, futhi incede abantu abafana nawe 
bathole unakekelo nokuphathwa abakudingayo. Noma kunjalo kungenzeka kungabikho 
nzuzo oyihlolayo ngokubamba iqhaza. 
Okunyeokwakwenza 
Okunye ongakwenza ukuthi ungalibambi iqhaza ocwaningweni. 
lzindleko nenkokhelo 
Azikho izindleko kuwe ngothatha inxaxheba kulolucwaningo. Uzothola 2.5 kg impuphu, 
2.5 kgiushukelalkg iimbotyi, no 750ml amafutha ngokuthatha inxaxheba 
kulolucwaningo. 
Imfihlo 
Amarekhodi amalunga nokuthatha kwakho inxaxheba ocwaningweni nezimpendulo 
zakho emibuzweni kuyoba yimfihlo. Ngekhe sirekhode igama lakho noma ulwazi 
oluqondene nawe ngqo. Ulwazi oluqoqwe kuwe nge tape noma olubhalwe ephepheni 
luyobhalwa ngekhodi eqondene nawe yocwaningo. 
Abamele iSouth African Medical Research Council,Idyunivesithi yase Ntshonalanga 
Kapa, idyunivesithi yaseBoston School of Public Health, idyunivesithi yaseBoston 
Medical Center Institutional Review Board, ne U.S. Office of Human Research 
Protections eU.S. bangabheka amabhukui njengenye yomsebenzi wabo wokubheka 
ucwaningo. Akekho omnye umuntu noma intlangano eyokwazi ukuthola lamarekhodi 
noma ulwazi ngawe noma ngosapho lwakho. 
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Amalungelo othathe inxaxheba 
Ukuthatha inxaxheba ocwaningweni kuwukuzinikela. Unelungelo lokunqaba ukuthatha 
inxaxheba. Uma ukhetha ukuthatha inxaxheba ocwaningweni bese ushintsha ingqondo, 
ungama nganoma ngasiphi isikhathi. Ukunqaba kwakho ngeke kube nomthelela 
ekutholeni ukwesekwa umeluleki wakho noma kUbe nomthelela ekutholeni usizo 
ezikhungweni zalendawo .. Ngeke kube nomthelela ekubhalisweni ezinhlelweni 
zezempilo noma ongakuxhamla. 
Ngokuvuma ukuthi ube kulolucwaningo awunikezeli ngawo namaphiamalungelo akho. 
Ukunika imvume kuthetha ukuthi uvile noma ufundile inkcukacha ngalolucwaningo 
nokuthi uyavuma ukuthatha inxaxheba. Uzonikezwa ikopi yalelifomu ukuthi uligcine. 
Uma nganoma ngasiphi isikhathi uphuma kulolucwaningo angeke ujeziswe noma 
ulahlekelwe imixhamlo ekufanele. 
Uma unemibuzo ngocwaningo noma ngenhlalo yakho njengothathe inxaxheba 
ocwaningweni noma ukulimala okuhlobene nocwaningo, sicela uthine u Project 
Coordinator Ms. Weliswa Binza ku: 039-433-2532. UCoordinator noma ilungu lethimba 
locwaningo liyozama ukuphendula yonke imibuzo yakho. Ungathola ulwazi vetshe 
ngokuthinta uProfDanie du Toit weMRC Ethics Committee kul: 021-938-0341; email: 
adri.labuschagne@mrc.ac.za. 
N gicela uthathe ixesha ongathanda ukulithatha ucinge okokubana uyavuma yini 
ukuthatha inxaxheba ocwaningweni. 
Uma uvuma, ndingathanda okokubani usayine lefomu engezansi. Uma ungavumi 
siyabonga ngokuthi usivumele sikuxelele ngocwaningo. 
Ilungelo lokwala noma lokuphuma 
Ukuthatha inxexheba kulolucwaningo kuwukuzinikela. Unelungelo lokwala ukuthatha 
inxexheba kulolucwaningo. Uma ukhetha ukuba socwaningweni uphinde ushintshe 
umqondo, ungaphuma ocwaningweni. Ukuthatha kwakho inxexheba ocwaningweni 
kuwukuthanda kwakho. Isinqumo sakho ngeke siphazamise ukuthola kwakho usizo 
kulesisikhungo noma ukukhokhelwa kokunakekelwa kwakho kwezempilo. Ngeke 
kuvimbe ukubhaliswa kwakho ezinhlelweni zezempilo noma imixhamlo ongayithola. 
Uma ukhetha ukuthatha inxexheba, unelungelo lokuma noma ngaliphi ixesha. Uma 
kukhona okusha okufumanekayo ngesikhathi socwaningo okungaphazamisa ukuthi 
uyaqhubeka nokuthatha inxexheba, uyokwaziswa ngakho ngokushesha. 
Umcwaningi omkhulu angakhetha ukumisa ukuthatha kwakho inxaxheba ngaphandle 
kwemvume yakho ngemuva uma ebona ukuthi ukuthatha kwakho inxaxheba kungaba 
nobungozi kuwe, noma umxhasi amise ucwaningo. 
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Good start Q~know "ystatus 
CONSENT FORM 
StudyiD __________________________ ___ 
LET'S MAKE IT WORK: EMPOWERING HIV-POSITIVE CLIENTS OF HOME-BASED HIV 
COUNSELING AND TESTING TO RECEIVE CARE AND TREATMENT 
Umcwaningi: ______________ (Igama lomcwaningi) 
Ucwaningo lwenziwa i: yaseNtshona Koloni ne Medical Research Council 
Mnu/Nksz/Nkk usechazile ukuthi kwenziwani futhi 
·----------------
ndiyavuma ukubamba iqhaza. 
Imibuzo yami isiphenduliwe. 
_ Ndiyavuma ukuthatha inxaxheba engxoxweni 
_Ndiyavuma okukubana izimpendulo zami engxoxweni ziqoshwe 
Ndiyaqonda okokubani ndingaphuma namona ngaliphi ixesha ngaphandle kokunikeza 
unobangela nanokuthi ndingahlukumezeki onakekelweni mina nomndeni wami esilufumanayo. 
Igama lothathe inxaxheba 
Ukusayina kothathe inxaxheba noma isithupha Usuku 
Ofumana imvume (signature and printed name) Usuku 
258 
Appendix 11. 
In-depth Interview Guide 
259 
In-depth Interview Guide 
Today I'd like to discuss your experiences with the home-based HIV counseling and 
testing session you had with a Good Start counselor, as well as your experiences 
following that counseling session. I would like to understand how you 've been coping 
with your illness, whether or not you've accesses needed health care services, and the 
challenges that you might have faced in accessing them. As a member of the Good Start 
Study Team, I have access to the records that were kept during your ongoing counseling 
visits and if you don 't mind, I will be asking you questions about some of that 
information. Please feel free to be open and honest about your experiences. The purpose 
of this interview is to learn from you so that we can make improvements to the home-
based counseling and testing intervention. Any information you can give will be very 
helpful. 
*Note to interviewer: Please review the client profile thoroughly before starting the 
interview. Make sure to refer to the client profile throughout the interview and 
probe about specific issues as necessary. 
To get started, can you tell me a little bit about your life and circumstances. 
Possible probes: 
• How do you usually spend your days? Describe a typical day. 
• Who are the other people that stay with you or depend upon you? Can you tell me 
a little bit about your relationship with them? 
• What things, if any, in your life make you feel happy and excited? 
• What things, if any, in your life make you feel sad, frustrated, or anxious? 
Now think back to the time the Good Start counselor approached you in your home 
and you decided to take an IDV test. Can you tell me a little bit about the 
counselor's visit and the testing session? 
Possible probes: 
• How did you feel when you were approached by the counselor? 
• What made you decide to take an HIV test that day? 
• How did you feel about the way the counseling and testing was conducted? 
• What are your views about the ongoing counseling that you received from the 
counselor? 
Mter you found out you were HIV-positive, how did you initially react? 
Possible probes: 
• What were the emotions you felt? 
• Did you tell anyone? If so, who? 
• How did people react to tllis news? 
260 
It has now been a few months since you found out you were HIV-positive, how have 
you been managing your illness? 
Possible probes: 
• What are the feelings you have now? 
• Who all have you told about your illness? 
• Do you feel that you have support from others in your life that is helping you 
manage your illness? If yes, please describe what this support looks like. If no, 
can you explain further. 
• What all have you done to cope with or address your illness? 
Have you sought any HEALTH CARE related to your HIV diagnosis? 
(Interviewer should review client profile to see which services have and haven 't been 
sought) 
Possible probes: 
• Can you tell me about your experiences seeking these services? 
• (If the client profile shows that any other services were sought that the client 
hasn't mentioned, the interviewer should probe about these). What about X 
service? Can you tell me a little bit about seeking that service? (Repeat for each 
omitted service) 
• (Looking at the client profile, the client should probe about services that were not 
sought at all). What about X service? Can you tell me a little bit about why you 
didn't seek this type of service? Is there anything that might have made it difficult 
to obtain this service? 
• Now think about all of the health services that we have talked about. For those 
that you did seek out, can you tell me a little bit about what might have helped 
you or made it easier to get those services? (Interviewer should review the client 
profile outlining key characteristics from the cross-sectional survey and ask about 
any relevant issues if they don't come up naturally). 
• If you have visited a health care facility recently, can you tell me a little bit about 
your experience there? 
• Which facility did you visit? 
• How did you get there? 
• What, if any, challenges did you experience in getting there? 
• How long did you spend at the facility? 
• How do you feel about the services that you received? 
• What type of attitude did the health care staff have toward you? 
• Did you discuss your HIV status? 
• Did you understand the services and if anything, what you needed to do next? 
If no, what was unclear? 
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Have you sought any SOCIAL SERVICES related to your IDV diagnosis? (The 
interviewer may have to give afew examples of the types of services she is referring to) 
Possible probes: 
• Can you tell me about your experiences seeking these services? 
• (If the client profile shows that any other services were sought that the client 
hasn 't mentioned, the interviewer should probe about these). What about X 
service? Can you tell me a little bit about seeking that service? (Repeat for each 
omitted service) 
• (Looking at the client profile, the client should probe about services that were not 
sought at all). What about X service? Can you tell me a little bit about why you 
didn't seek this type of service? Is there anything that might have made it difficult 
to obtain this service? 
• Now think about all of the health services that we have talked about. For those 
that you did seek out, can you tell me a little bit about what might have helped 
you or made it easier to get those services? (Interviewer should review the client 
profile outlining key characteristics from the cross-sectional survey and ask about 
any relevant issues if they don 't come up naturally). 
• If you have sought any social services, can you tell me a little bit about your 
experience there? 
• Which organization did you visit? 
• How did you get there? 
• What, if any, challenges did you experience in getting there? 
• How long did you spend at the facility? 
• How do you feel about the services that you received? 
• What type of attitude did the organization staffhave toward you? 
• Did you understand the services and if anything, what you needed to do next? 
If no, what was unclear? 
I would also like to ask you about some other issues related to HIV/AIDS. What are 
your beliefs about treatment for AIDS? 
Possible probes: 
• Is treatment available in this community? 
• In which ways, if any, is treatment helpful? 
• In which ways, if any, is treatment harmful? 
• What, if any, are the challenges related to obtaining treatment? 
• What are your plans regarding seeking treatment for AIDS? 
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N 
0\ 
.j:>. 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
CODEBOOK 
Assessing the linkage to care following home-based HIV counseling and testing 
I 
I 
CODE CODE NAME CODE DESCRIPTION 
Life Life Any general description of life circumstances including finances, 
circumstances mobility, household membership, daily activities, existence of marital or 
other romantic relationships, difficulties, or supportive situations, etc. 
Health Health status Any description of the client's perception of current health status or 
description of physical symptoms 
MHealth Mental health Any mention of sadness/depression or descriptions of depression-related 
status symptoms, or other mental health conditions 
Alcohol Alcohol use Any mention of alcohol use/non-use 
HIVAIDS Knowledge Any description about information/knowledge (or misinformation) the 
about HIV/AIDS client has about HIV I AIDS and the source of that infmmation 
Know HIV Know someone Any description of knowing or not knowing someone with HIV I AIDS, 
with HIV/AIDS including those who may have died 
EverT est Ever tested for Any description of having tested for HIV prior to HBHCT, including 
HIV prior to those who had a positive diagnosis but did not seek care 
HBHCT 
N 
0'\ 
Vl 
8. 
9. 
10. 
11. 
12. 
13. 
14. 
15. 
Reason Test 
HBHCT 
Couple_Test 
Response 
Reason Believe 
HH_Support 
Referral 
Non _linkage 
Reasons and 
readiness for 
testing 
HBHCT 
expenence 
Couples testing 
Response to 
diagnosis 
Reason for 
belief/non-belief 
of results 
Household 
support 
Referral process 
Non-linkage 
Any description of why the person decided to test within HBHCT (e.g. I 
felt at risk, pressure from family, wanted at-shirt, etc) and their level of I 
readiness for testing (e.g. anxious, fearful) 
Any description of the HBHCT intervention or process of testing within 
the home 
Any description of having tested as a couple and possibly the impact on 
coping or care-seeking 
Any description ofthe client's immediate reaction to the results (e.g. 
acceptance, disbelief, sadness) and how they have been coping with the 
diagnosis (e.g. not thinking about it, feeling upset, suicidal thoughts, 
questioning how they got it) 
Any description of why the client did or did not believe the HIV test 
results 
Any mention of social or emotional support specifically within the 
household in regard to the client' s HIV status- can be either positive or 
negative. 
Any description of the referral process from HBHCT to facility-based 
care (e.g. counselor did or did not explain the process, refeiTalletter was 
or was not given) 
Any description of not linking to care, factors the client explicitly stated 
hindered linkage to care (e.g. no time, no money, other responsibilities, 
i waiting for partner, fear, feel healthy), and future plans regarding linkage I 
N 
0\ 
0\ 
16. 
17. 
18. 
19. 
20. 
21. 
22. 
23 . 
NoLink NoReason 
Linkage 
Exper _Linkage 
Treatment 
TradMed 
Disclosure 
Partner 
Stigma 
-
"Just didn' t go" 
Linkage 
Experience at 
linkage 
Treatment 
Traditional 
medicine 
Disclosure 
Partner 
relationship and 
interaction 
Stigma 
Tag any interviews where clients just couldn' t seem to identify or explain 
any barriers or reasons for non-linkage 
Any description of linking to care, factors that clients explicitly stated 
helped them link to care (e.g. counselor' s encouragement, motivation to 
be healthy, hospitalization, someone offering to go with them) 
Any description of what happened once the clients linked to care - could 
be either a positive or negative experience (e.g. had a problem at the 
facility) 
Any description about ART or other treatment for HIV, including 
perceptions about treatment and plans for taking or not taking it 
Any description about the views on or use/non-use of traditional medicine 
for HIV or other illnesses 
Any description about whether or not the client disclosed their status, who 
they disclosed to, and the other people' s reactions 
Any description of the marital or romantic partner relationship in eluding 
disclosure, communication, partner's reactions and level of support (e.g. 
husband is supportive, husband won't use condoms, husband is away so 
can' t tell him, etc.) 
Any description of experienced stigma, perceived stigma, fear of stigma, 
or actions that seem related to stigma (e.g. not taking the food parcel, 
refusing follow up visits) 
I 
I 
N 
0\ 
-.....) 
24. 
25. 
26. 
27. 
28. 
29. 
HC_System 
Followup 
Mobility 
Social_ support 
Case_Study 
Operational 
General views 
and experiences 
related to the 
local healthcare 
system 
Views on follow 
up visits 
Mobility 
Social support 
services 
Case study 
HBHCT 
Operational 
Issues 
Any general description of experiences or views of the local health 
facilities when not specifically related to linkage to care (e.g. attitude of 
staff, quality of care, availability of drugs, distance, waiting time, etc) 
Any description about clients' experiences, perceptions and views on 
follow up visits (e.g. find them helpful, don't like the visits because they 
raise suspicions) 
Any description of travel or not being home that seems it could affect 
linkage 
Any mention of availability, interest in, views about, or access to social 
support services for PL WHA (e.g. support groups, social worker, getting 
an ID, other NGOs) 
Tag any interviews that could be used as an illustrative case study 
Tag any issues that may be important to address practically within a 
training or when planning implementation of HBHCT 
REFERENCES 
1. Schechter MT, Craib KJ, Gelmon KA, Montaner JS, Le TN, O'Shaughnessy MV. 
HIV-1 and the aetiology of AIDS. Lancet. 1993; 341(8846): 658-9. 
2. San Francisco AIDS Foundation. AIDS Basics. 2012 [cited 2012 August 17]; 
Available from: http://www.sfaf.org/hiv-info/basics/. 
3. National Institutes of Allergy and Infectious Diseases. HIV/AIDS. 2011 [cited 
2012 August 17]; Available from: 
http://www.niaid.nih.gov/topics/hivaids/Pages/Default.aspx 
4. Montaner JS, Reiss P, Cooper D, Vella S, Harris M, Conway B, et al. A 
randomized, double-blind trial comparing combinations of nevirapine, didanosine, 
and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, 
Canada and Australia Study. JAMA: The Journal ofthe American Medical 
Association. 1998; 279(12): 930-7. 
5. Hammer SM, Katzenstein DA, Hughes MD, Gundacker H, Schooley RT, Haubrich 
RH, et al. A trial comparing nucleoside monotherapy with combination therapy in 
HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. 
AIDS Clinical Trials Group Study 175 Study Team. New England Journal of 
Medicine. 1996; 335(15): 1081-90. 
6. Carpenter LM, Kamali A, Ruberantwari A, Malamba SS, Whitworth JA. Rates of 
HIV -1 transmission within marriage in rural Uganda in relation to the HIV sera-
status ofthe partners. AIDS. 1999; 13(9): 1083-9. 
7. Wood E, Hogg RS, Harrigan PR, Montaner JS. When to initiate antiretroviral 
therapy in HIV -!-infected adults: a review for clinicians and patients. Lancet 
Infectious Diseases. 2005; 5(7): 407-14. 
8. Cote HCF, Brumme ZL, Craib KJP, Alexander CS, Wynhoven B, Ting L, et al. 
Changes in Mitochondrial DNA as a Marker of Nucleoside Toxicity in HIV-
Infected Patients. New England Journal of Medicine. 2002; 346(11): 811-20. 
9. Gallant JE, DeJesus E, .Arribas JR, Pozniak AL, Gazzard B, Campo RE, et al. 
Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, larnivudine, and 
efavirenz for HIV. New England Journal of Medicine. 2006; 354(3): 251-60. 
10. Staszewski S, Morales-Ramirez J, Tashima KT, Rachlis A, Skiest D, Stanford J, et 
al. Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and 
indinavir plus zidovudine and lamivudine in the treatment ofHIV-1 infection in 
adults. New England Journal ofMedicine. 1999; 341(25): 1865-73. 
268 
11. van Leth F, Phanuphak P, Ruxrungtham K, Baraldi E, MillerS, Gazzard B, et al. 
Comparison of first-line antiretroviral therapy with regimens including nevirapine, 
efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label 
trial, the 2NN Study. Lancet. 2004; 363(9417): 1253-63. 
12. Avert.org. Introduction to HIV and AIDS Treatment. (cited 2012 August 17]; 
Available from: http://www.avert.org/treatment.htm 
13. Joint United Nations Programme on HIV/AIDS (UNAIDS). World AIDS Day 
Report; 2011. 
14. Joint United Nations Programme on HIV/AIDS (UNAIDS). Global Report: 
UNAIDS report on the global AIDS epidemic; 2010. 
15. United Nations News Center. Life expectancy in sub-Saharan Africa is lower now 
than 30 years ago: UN index. 2006. 
16. Beresford B. AIDS takes an economic and social toll: impact on households and 
economic growth most severe in Southern Africa. Africa Recovery. June 2001. 
17. Shisana 0 , Rehle T, Simbayi LC, Zuma K JS, Pillay-van-Wyk V, Mbelle N, et al. 
South African National HIV Prevalence, Incidence, Behaviour and Communication 
Survey, 2008: A turning tide among teenagers? Cape Town: HSRC Press; 2009. 
18. National Department of Health. Operational Plan for Comprehensive HIV and 
AIDS Care, Management and Treatment for South Africa; 2003. 
19. World Health Organization (WHO), Joint United Nations Programme on 
HIV/AIDS (UNAIDS), United Nations Children's Fund (UNICEF). Global 
HIV I AIDS Response: epidemic update and health sector progress towards universal 
access; 2011. 
20. Joint United Nations Programme on HIV/AIDS (UNAIDS), World Health 
Organization (WHO). UN AIDS/WHO Policy Statement on HIV Testing. 2004 
[cited 2009 April14]; Available from: 
http://www. who .int/hiv /pub/vet/statement/ en/ 
21. Joint United Nations Programme on HIV I AIDS (UN AIDS). The impact of 
voluntary counseling and testing: a global review of the benefits and challenges; 
2001. 
22. The Voluntary HIV -1 Counseling and Testing Efficacy Study Group. Efficacy of 
voluntary HIV -1 counselling and testing in individuals and couples in Kenya, 
Tanzania, and Trinidad: a randomised trial. Lancet. 2000; 356(9224): 103-12. 
269 
23. Denison JA, O'Reilly KR, Schmid GP, Kennedy CE, Sweat MD. HIV voluntary 
counseling and testing and behavioral risk reduction in developing countries: a 
meta-analysis, 1990--2005. AIDS and Behavior. 2008; 12(3): 363-73 . 
24. World Health Organization (WHO), Joint United Nations Programme on 
HIV/AIDS (UNAIDS), United Nations Children's Fund (UNICEF). Towards 
Universal Access: scaling up priority HIV I AIDS interventions in the health sector; 
2008. 
25. Liechty CA, Liechty CA. The evolving role ofHIV counseling and testing in 
resource-limited settings: HIV prevention and linkage to expanding HIV care 
access. Current HIV/AIDS Reports. 2004; 1(4): 181-5. 
26. Kalichman SC, Simbayi LC. HIV testing attitudes, AIDS stigma, and voluntary 
HIV counselling and testing in a black township in Cape Town, South Africa. 
Sexually Transmitted Infections. 2003 ; 79(6): 442-7. 
27. Morin SF, Khumalo-Sakutukwa G, Charlebois ED, Routh J, Fritz K, Lane T, et al. 
Removing barriers to knowing HIV status: same-day mobile HIV testing in 
Zimbabwe. Journal of Acquired Immune Deficiency Syndromes: Journal of 
Acquired Immune Deficiency Syndromes. 2006; 41(2): 218-24. 
28. Matovu J, Makumbi F. Expanding access to HIV voluntary counseling and testing 
in sub-Saharan Africa: alternative approaches for improving uptake, 2001-2007. 
Tropical Medicine & International Health. 2007; 12(11): 1315-22. 
29. WolffB, Nyanzi B, Katongole G, Ssesanga D, Ruberantwari A, Whitworth J, et al. 
Evaluation of a home-based voluntary counselling and testing intervention in rural 
Uganda. Health Policy & Planning. 2005; 20(2): 109-16. 
30. De Cock KM, Marum E, Mbori-Ngacha D. A sero-status based approach to 
HIV/AIDS prevention and care in Africa. Lancet. 2003; 362: 1847-9. 
31 . Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary 
HIV testing with immediate antiretroviral therapy as a strategy for elimination of 
HIV transmission: a mathematical model. Lancet. 2009; 373(9657): 48-57. 
32. Mbengashe T, Nevhutalu Z, Chipimo M, Chidarikire T, Diseko L. The national 
HIV counselling and testing campaign and treatment expansion in South Mrica: a 
return on investments in combination prevention. XIX International AIDS 
Conference; 2012; Washington D.C. ; 2012. 
33. IRIN/PlusNews. SOUTH AFRICA: National HIV testing campaign disappoints. 
2010. 
270 
34. De Cock KM, Bunnell R, Mermin J. Unfinished business--expanding HIV testing 
in developing countries. New England Journal of Medicine. 2006; 354(5): 440-2. 
35. Nieburg P, Cannell T, MmTison JS. Expanded HIV Testing: critical gateway to 
HIV treatment and prevention requires major resources, effective protections. 
Washington D.C. :Center for Strategic and International Studies; 2005. 
36. WHO. The Right to Know: new approaches to HIV testing and counseling. 
Geneva: World Health Organization; 2003. 
37. Bateganya MH, Abdulwadud OA, Kiene SM. Home-based HIV voluntary 
counseling and testing in developing countries. Cochrane Database of Systematic 
Reviews. 2008; 3. 
38. Family Health International. Service Delivery Models for HIV counseling and 
testing. 2008 [cited; Available from: 
http://www.fhi.org/en/HIV AIDS/pub/fact/ctmodels.htm 
39. Fylkesnes K, Siziya S. A randomized trial on acceptability of voluntary HIV 
counselling and testing. Tropical Medicine & International Health. 2004; 9(5): 566-
72. 
40. Sabapathy K, Van den Bergh R, Fidler S, Hayes R, Ford N. Uptake of Home-Based 
Voluntary HIV Testing in Sub-Saharan Africa: A Systematic Review and Meta-
Analysis. PLoS Medicine. 2012; 9(12): e1001351. 
41. Nuwaha F, Muganzi E, Kasasa S, Achorn M, Bunnel R, Kabetesi D, et al. District-
wide, door-to-door, home-based HIV voluntary counselling and testing in rural 
Uganda. 16th International AIDS Conference. Toronto, Canada; 2006. 
42. Mabirizi J., Kaleeba M., Kisambira E., Kironde S., Nsabagasani X. Increasing 
access using home-based confidential HIV counseling and testing: an innovative 
community-based program in Uganda XVI International AIDS Conference: 
Abstract no WEPE0364; 2006; Toronto, Canada. 2006. 
43. Matovu J, Kigozi G, Nalugoda F, Wabwire-Mangen F, Gray R. The Rakai Project 
counselling programme experience. Tropical Medicine & International Health. 
2002; 7(12): 1064-7. 
44. Were W, Mermin J, Bunnell R, Ekwaru JP, Kaharuza F, Were W, et al. Home-
based model for HIV voluntary counselling and testing.[comment]. Lancet. 2003; 
361(9368): 1569 0 
271 
45. Yoder S, Katahoire A, Kyaddondo D, Akol Z, Bunnell R, Kaharuza F. Home-based 
HIV Testing and Counseling in a Survey Context in Uganda. Calverton, Maryland, 
USA: ORC Macro; 2006. 
46. Helleringer S, Kohler HP, Frimpong JA, J. M. Increasing Uptake ofHIV Testing 
and Counseling Among the Poorest in Sub-Saharan Countries Through Home-
Based Service Provision. Journal of Acquired Immune Deficiency Syndromes. 
2009; 51(2): 185-93. 
47. Nuwaha F, Kasasa S, Wana G, Muganzi E, Tumwesigye E. Effect ofhome-based 
HIV counselling and testing on stigma and risky sexual behaviours: serial cross-
sectional studies in Uganda. Journal ofthe International AIDS Society. 2012; 
15(2): 17423. 
48. Naik R, Tabana H, Doherty T, Zembe W, Jackson D. Client characteristics and 
acceptability of a home-based HIV counselling and testing intervention in rural 
South Africa. BMC Public Health. 2012; 12(1): 824. 
49. Negin J, Wariero J, Mutuo P, Jan S, Pronyk P. Feasibility, acceptability and cost of 
home-based HIV testing in rural Kenya. Tropical Medicine and International 
Health. 2009; 14(8): 849-55. 
50. Menzies N, Abang B, Wanyenze R, Nuwaha F, Mugisha B, Coutinho A, et al. The 
costs and effectiveness of four HIV counseling and testing strategies in Uganda. 
AIDS. 2009; 23(3): 395-401. 
51. Mutale W, Michelo C, Jurgensen M, Fylkesnes K. Home-based voluntary HIV 
counselling and testing found highly acceptable and to reduce inequalities. BMC 
Public Health. 2010; 10: 347. 
52. Helleringer S, Kohler HP, Frimpong JA, Mkandawire J. Increasing uptake ofHIV 
testing and counseling among the poorest in sub-Saharan countries through home-
based service provision. Journal of Acquired Immune Deficiency Syndromes. 
2009; 51(2): 185-93. 
53. Tt.unwesigye E, Wana G, Kasasa S, Muganzi E, Nuwaha F. High uptake of home-
based, district-wide, HIV counseling and testing in Uganda. AIDS Patient Care and 
STDs. 2010; 24(11): 735-41. 
54. Sekandi JN, Sempeera H, List J, Mugerwa MA, Asiimwe S, Yin X, et al. High 
acceptance of home-based HIV counseling and testing in an urban community 
setting in Uganda. BMC Public Health. 2011 ; 11: 730. 
55. Were WA, Mermin JH, Wamai N, Awor AC, Bechange S, Moss S, et al. 
Undiagnosed HIV infection and couple HIV discordance among household 
272 
members ofHIV-infected people receiving antiretroviral therapy in Uganda. 
Joumal of Acquired Immune Deficiency Syndromes. 2006; 43(1): 91-5. 
56. Kigozi IM, Dobkin LM, Martin JN, Geng EH, Muyindike W, Emenyonu NI, et al. 
Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral 
therapy in Sub-Saharan Africa. Journal of Acquired Immune Deficiency 
Syndromes. 2009; 52(2): 280-9. 
57. April MD, Walensky RP, Chang Y, Pitt J, Freedberg KA, Losina E, et al. HIV 
testing rates and outcomes in a South African community, 2001-2006: implications 
for expanded screening policies. Journal of Acquired Immune Deficiency 
Syndromes. 2009; 51(3): 310-6. 
58. Keiser 0 , Anastos K, Schechter M, Balestre E, Myer L, Boulle A, et al. 
Antiretroviral therapy in resource-limited settings 1996 to 2006: patient 
characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and 
Latin America. Tropical Medicine and International Health. 2008; 13(7): 870-9. 
59. Cornell M, Grimsrud A, Fairall L, Fox MP, van Cutsem G, Giddy J, et al. 
Temporal changes in programme outcomes among adult patients initiating 
antiretroviral therapy across South Africa, 2002-2007. AIDS. 2010; 24(14): 2263-
70. 
60. May M, Boulle A, Phiri S, Messou E, Myer L, Wood R, et al. Prognosis of patients 
with HIV -1 infection starting antiretroviral therapy in sub-Saharan Africa: a 
collaborative analysis ofscale-up programmes. Lancet. 2010; 376(9739): 449-57. 
61. Ford N, Kranzer K, Hilderbrand K, Jouquet G, Goemaere E, Vlahakis N, et al. 
Early initiation of antiretroviral therapy and associated reduction in mortality, 
morbidity and defaulting in a nurse-managed, community cohort in Lesotho. AIDS. 
2010; 24(17): 2645-50. 
62. BrinkhofMW, Dabis F, Myer L, Bangsberg DR, Boulle A, Nash D, et al. Early 
loss ofHIV-infected patients on potent antiretroviral therapy programmes in lower-
income countries. Bulletin of the World Health Organization. 2008; 86(7): 559-67. 
63. Grinsztejn B R, H., Cohen MS, et al.,. Effects of early versus delayed initiation of 
antiretroviral therapy (ART) on HIV clinical outcomes: results from the HPTN 052 
randomized clinical trial. Sixth International AIDS Society Conference on HIV 
Pathogenesis, Treatment and Prevention. Rome, Italy; 2011. 
64. Badri M, Lawn SD, Wood R. Short-term risk of AIDS or death in people infected 
with HIV-1 before antiretroviral therapy in South Africa: a longitudinal study. 
Lancet. 2006; 368(9543): 1254-9. 
273 
65. Sabin CA, Smith CJ, Gumley H, Murphy G, Lampe FC, Phillips AN, et al. Late 
presenters in the era of highly active antiretroviral therapy: uptake of and responses 
to antiretroviral therapy. AIDS. 2004; 18(16): 2145-51. 
66. Antinori A, Johnson M, Moreno S, Rockstroh JK, Yazdanpanah Y. Introduction to 
late presentation for HIV treatment in Europe. Antiviral Therapy. 2010; 15 Suppl 
1: 1-2. 
67. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy 
N, et al. Prevention ofHIV-1 infection with early antiretroviral therapy. New 
England Journal of Medicine. 2011; 365(6): 493-505. 
68. Mills EJ, Bakanda C, Birungi J, Chan K, Ford N, Cooper CL, et al. Life expectancy 
of persons receiving combination antiretroviral therapy in low-income countries: a 
cohort analysis from Uganda. Annals oflnternal Medicine. 2011; 155(4): 209-16. 
69. Leisegang R, Cleary S, Hislop M, Davidse A, Regensberg L, Little F, et al. Early 
and late direct costs in a Southern African antiretroviral treatment programme: a 
retrospective cohort analysis. PLoS Medicine. 2009; 6(12): e1000189. 
70. Wachira J, Kimaiyo S, Ndege S, Mamlin J, Braitstein P. What Is the Impact of 
Home-Based HlV Counseling and Testing on the Clinical Status ofNewly Enrolled 
Adults in a Large HIV Care Program in Western Kenya? Clinical Infectious 
Diseases. 2012; 54(2): 275-81. 
71. Patel R, Kassaye S, Gore-Felton C, Wyshak G, Kadzirange G, Woelk G, et al. 
Quality of life, psychosocial health, and antiretroviral therapy among HIV -positive 
women in Zimbabwe. AIDS Care. 2009; 21(12): 1517-27. 
72. Beard J, Feeley F, Rosen S. Economic and quality oflife outcomes of antiretroviral 
therapy for HIV I AIDS in developing countries: a systematic literature review. 
AIDS Care. 2009; 21(11): 1343-56. 
73. Nakagawa F, Lodwick RK, Smith CJ, Smith R, Cambiano V, Lundgren JD, et al. 
Projected life expectancy of people with HIV according to timing of diagnosis. 
AIDS. 2012; 26(3): 335-43. 
74. Life expectancy of individuals on combination antiretroviral therapy in high-
income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008; 
372(9635): 293-9. 
75. HIV Prevention Trials Network (HPTN). Additional benefits of early HIV 
treatment revealed. Science Daily. 2012, July 26. 
274 
76. Donnell D, Baeten JM, Kiarie J, Thomas KK, Stevens W, Cohen CR, et al. 
Heterosexual HIV -1 transmission after initiation of antiretroviral therapy: a 
prospective cohmi analysis. Lancet. 2010; 375(9731): 2092-8. 
77. Eaton JW, Johnson LF, Salomon JA, Bamighausen T, B~ndavid E, Bershteyn A, et 
al. HIV Treatment as Prevention: Systematic Comparison of Mathematical Models 
of the Potential Impact of Antiretroviral Therapy on HIV Incidence in South 
Africa. PLoS Medicine. 2012; 9(7): e1001245. 
78. The HIV Modelling Consortium Treatment as Prevention Editorial Writing Group. 
HIV Treatment as Prevention: Models, Data, and Questions-Towards Evidence-
Based Decision-Making. PLoS Medicine. 2012; 9(7): e1001259. 
79. Granich R, Kahn JG, Bennett R, Holmes CB, Garg N, Serenata C, et al. Expanding 
ART for treatment and prevention ofHIV in South Africa: estimated cost and cost-
effectiveness 2011-2050. PLoS One. 2012; 7(2): e30216. 
80. Dieffenbach CW, Fauci AS. Universal voluntary testing and treatment for 
prevention ofHIV transmission. JAMA: The Journal of the American Medical 
Association. 2009; 301(22): 2380-2. 
81. Hayes R, Sabapathy K, Fidler S. Universal Testing and Treatment as an HIV 
Prevention Strategy: Research Questions and Methods. Current HIV Research. 
2011; 9(6): 429-45. 
82. Rosen S, Fox MP. Retention in HIV care between testing and treatment in sub-
Saharan Africa: a systematic review. PLoS Medicine. 2011; 8(7): e1001056. 
83. Wanyenze RK, Hahn JA, Liechty CA, Ragland K, Ronald A, Mayanja-Kizza H, et 
al. Linkage to HIV care and survival following inpatient HIV counseling and 
testing. AIDS and Behavior. 2011; 15(4): 751-60. 
84. Mugavero MJ, Norton WE, Saag MS. Health care system and policy factors 
influencing engagement in HIV medical care: piecing together the fragments of a 
fractured health care delivery system. Clinical Infectious Diseases. 2011; 52 Suppl 
2: S238-46. 
85. Assefa Y, Van Darnme W, Mariam DH, Kloos H. Toward universal access to HIV 
counseling and testing and antiretroviral treatment in Ethiopia: looking beyond 
HIV testing and ART initiation. AIDS Patient Care and STDs. 2010; 24(8): 521-5. 
86. Kranzer K, Zeinecker J, Ginsberg P, Orrell C, Kalawe NN, Lawn SD, et al. 
Linkage to HIV care and antiretroviral therapy in Cape Town, South Africa. PLoS 
One. 2010; 5(11): e13801. 
275 
87. Larson BA, Brennan A, McNamara L, Long L, Rosen S, Sanne I, et al. Lost 
opportunities to complete CD4+ lymphocyte testing among patients who tested 
positive for HIV in South Africa. Bulletin of the World Health Organization. 2010; 
88(9): 675-80. 
88 . Micek MA, Gimbel-Sherr K, Baptista AJ, Matediana E, Montoya P, Pfeiffer J, et 
al. Loss to follow-up of adults in public HIV care systems in central Mozambique: 
identifying obstacles to treatment. Journal of Acquired Immune Deficiency 
Syndromes. 2009; 52(3): 397-405. 
89. Mulissa Z, Jerene D, Lindtjorn B. Patients present earlier and survival has 
improved, but pre-ART attrition is high in a six-year HIV cohort data from 
Ethiopia. PLoS One. 2010; 5(10): el3268. 
90. Bassett IV, Wang B, Chetty S, Mazibuko M, Bearnot B, Giddy J, et al. Loss to care 
and death before antiretroviral therapy in Durban, South Africa. Journal of 
Acquired Immune Deficiency Syndromes. 2009; 51(2): 135-9. 
91. Losina E, Bassett IV, Giddy J, Chetty S, Regan S, Walensky RP, et al. The "ART" 
of linkage: pre-treatment loss to care after HIV diagnosis at two PEPF AR sites in 
Durban, South Africa. PLoS One. 2010; 5(3): e9538. 
92. Govindasamy D, van Schaik N, Kranzer K, Wood R, Mathews C, Bekker LG. 
Linkage to HIV care from a mobile testing unit in South Africa by different CD4 
count strata. Journal of Acquired Immune Deficiency Syndromes. 2011; 58(3): 
344-52. 
93. Bhagwanjee A, Peterson I, Akintola 0, George G. Bridging the gap between VCT 
and HIV/AIDS treatment uptake: perspectives from a mining-sector workplace in 
South Africa. African Journal of AIDS Research. 2008; 7(3): 271-9. 
94. Murray LK, Semrau K, McCurley E, Thea DM, Scott N, Mwiya M, et al. Barriers 
to acceptance and adherance of antiretroviral therapy in urban Zambian women: a 
qualitative study. AIDS Care. 2009; 21(1): 78-86. 
95. Posse M, Meheus F, van Asten H, van der VenA, Baltussen R. Barriers to access 
to antiretroviral treatment in developing countries: a review. Tropical Medicine and 
International Health. 2008; 13(7): 904-13. 
96. Larson BA, Brennan A, McNamara L, Long L, Rosen S, Sanne I, et al. Early loss 
to follow up after enrolment in pre-ART care at a large public clinic in 
Johannesburg, South Africa. Tropical Medicine and International Health. 2010; 15 
Suppl1: 43-7. 
276 
97. Otieno PA, Kohler PK, Bosire RK, BrownER, Macharia SW, John-Stewart GC. 
Determinants of failure to access care in mothers referred to HIV treatment 
programs in Nairobi, Kenya. AIDS Care. 2010; 22(6): 729-36. 
98. Luseno W, Wechsberg W, Middlesteadt-Ellerson R, W G. Linkages and barriers to 
care for high-risk South African women testing positive for HIV [abstract] . 
Abstract TUPE0209. XVII International AIDS Conference. Mexico City, Mexico; 
3-8 August, 2008. 
99. Ulett KB, Willig JH, Lin HY, Routman JS, Abroms S, Allison J, et al. The 
therapeutic implications of timely linkage and early retention in HIV care. AIDS 
Patient Care and STDs. 2009; 23(1): 41-9. 
100. Naidoo NP, Faal M, Venter WDF, Osih R. Patient retention-reasons why patients 
do or do not come back for care after HIV testing [abstract]. Abstract THPE0798. 
XVIII International AIDS Conference; 201 0; Vienna, Austria. 
101. Uganda Ministry of Health. Uganda National Policy Guidelines for HIV 
Counselling and Testing. 2005. 
102. World Health Organization. Planning, implementing, and monitoring, home-based 
HIV testing and counselling: a practical handbook for sub-Saharan Africa; 2012. 
103. Amolloh M, Medley A, Owuor P, Audi B, Sewe M, Muttai H, et al. Early uptake of 
HIV care and treatment services after testing HIV -positive during home-based 
testing and counselling in rural Western Kenya. 18th Conference on Retroviruses 
and Opportunistic Infections. Boston, Massachussetts; 28 February-3 March 2011. 
104. Barnabas R, van Rooyen H, Baeten J, Joseph P, Phakati Z, Krows M, et al. 
Significant decrease in.community viral load and increase in proportion with 
suppressed viral load six months after a program ofhomeDbased HIV counseling 
and testing and facilitated referral to HIV care (HBCT) in KwaZulu-Natal, South 
Africa Abstract#: A-452-0196-21333; Poster#: LBPE34. XIX International AIDS 
Conference 2012. Washington D.C .. 
105. Nakigozi G, Makurnbi F, Reynolds S, Galiwango R, Kagaayi J, Nalugoda F, et al. 
Non-enrollment for free community HIV care: :fmdings from a population-based 
study in Rakai, Uganda. AIDS Care. 2011; 23(6): 764-70. 
106. Hatcher AM, Turan JM, Leslie HH, Kanya LW, Kwena Z, Johnson MO, et al. 
Predictors of Linkage to Care Following Community-Based HIV Counseling and 
Testing in Rural Kenya. AIDS and Behavior. 2011. 
107. Lugada E, Levin J, Abang B, Mermin J, Mugalanzi E, Namara G, et al. Comparison 
of home and clinic-based HIV testing among household members of persons taking 
277 
antiretroviral therapy in Uganda: results from a randomized trial. J oumal of 
Acquired Immune Deficiency Syndromes. 2010; 55(2): 245-52. 
108. Mulogo EM, Abdulaziz AS, Guerra R, Baine SO. Facility and home based HIV 
Counseling and Testing: a comparative analysis of uptake of services by rural 
communities in southwestern Uganda. BMC Health Services Research. 2011; 11: 
54. 
109. Umzimkhulu Local Municipality. Reviewed Integrated Development Plan for 
2010/2011 Financial Year; 2010. 
110. Statistics South Africa. Community Survey 2007; 2007. 
111. Department of Health (South Africa). National Antenatal Sentinel HIV and Syphilis 
Prevalence Survey in South Africa, 2009; 2010. 
112. Tabana H, Doherty T, S S, Lombard C, Jackson D, Zembe W, et al. Knowledge of 
HIV status prior to a community HIV counseling and testing intervention in a rural 
district of South Africa: results of a community based survey. [Awaiting 
publication]; 2011. 
113. Department of Health (South Africa), Italian Cooperation. Evaluation of 
Antiretroviral Therapy Against HIV/AIDS in Kwazulu-Natal South Africa; 2008. 
114. Department of Health (South Africa), Monitoring and Evaluation Unit. National 
Comprehensive HIV and AIDS Plan Statistics. 2009. 
115. Department of Health (South Africa). National Antiretroviral treatment guidelines. 
2004. 
116. Department of Health (South Africa). The South African Antiretroviral treatment 
guidelines 2010. 2010. 
117. World Health Organization. Antiretroviral therapy for HIV infection in adults and 
adolescents: Recommendations for a public health approach, 2010 revision. 
Geneva; 2010. 
118. Department of Health (South Africa). HIV and AIDS and STI Strategic Plan for 
South Africa, 2007-2011; 2007. 
119. Pillay Y, Barron P. The Implementation ofPHC Re-engineering in South Africa 
120. Mobenzi Researcher. 2012 [cited 2012 October 17]; Available from: 
http:/ /www.mobenzi.com/researcher/ 
278 
121. Fox MP, Larson B, Rosen S. Defining retention and attrition in pre-antiretroviral 
HIV care: proposals based on experience in Africa. Tropical Medicine and 
International Health. 2012. 
122. Torian LV, Wiewel EW, Liu KL, Sackoff JE, Frieden TR. Risk factors for delayed 
initiation of medical care after diagnosis ofhuman immunodeficiency virus. 
Archives oflnternational Medicine. 2008; 168(11): 1181-7. 
123. Fitzgerald DW, Maxi A, Marcelin A, Johnson WD, Pape JW. Notification of 
positive HIV test results in Haiti: can we better intervene at this critical crossroads 
in the life of HIV -infected patients in a resource-poor country? AIDS Patient Care 
and STDs. 2004; 18(11 ): 658-64. 
124. Yeap AD, Hamilton R, Charalambous S, Dwadwa T, Churchyard GJ, Geissler PW, 
et al. Factors influencing uptake ofHIV care and treatment among children in 
South Africa- a qualitative study of caregivers and clinic staff. AIDS Care. 2010; 
22(9): 1101-7. 
125. Kagee A, Delport T. Barriers to adherence to antiretroviral treatment: the 
perspectives of patient advocates. Journal of Health Psychology. 2010; 15(7): 
1001-11. 
126. Sharkey A, Chopra M, Jackson D, Winch PJ, Minkovitz CS. Influences on 
healthcare-seeking during final illnesses of infants in under-resourced South 
African settings. Journal of Health, Population, and Nutrition. 2011; 29(4): 379-87. 
127. Public Service Commission. Consolidated report on inspections of primary health 
care delivery sites: deprutment ofhealth; 2010. 
128. Bakeera SK, Wamala SP, Galea S, State A, Peterson S, Pariyo GW. Community 
perceptions and factors influencing utilization ofhealth services in Uganda. 
International Journal for Equity in Health. 2009; 8: 25. 
129. Groh K, Audet CM, Baptista A, Sidat M, Vergara A, Vermund SH, et al. Barriers to 
antiretroviral therapy adherence in rural Mozambique. BMC Public Health. 2011; 
11: 650. 
130. Mazzilli C, Davis A. Health seeking behavior in Somalia: a literature review: 
UNICEF and the European Union; 2009. 
131. Musheke M, Ntalasha H, GariS, McKenzie 0, Bond V, Martin-Hilber A, et al. A 
systematic review of qualitative fmdings on factors enabling and deterring uptake 
ofHIV testing in Sub-Saharan Africa. BMC Public Health. 2013; 13: 220. 
279 
132. Weiser S, Wolfe W, Bangsberg D, Thior I, Gilbert P, Makhema J, et al. Barriers to 
antiretroviral adherence for patients living with HIV infection and AIDS in 
Botswana. Journal of Acquired Immune Deficiency Syndromes. 2003; 34(3): 281-
8. 
133. Parkes-Ratanshi R, Bufumbo L, Nyanzi-Wakholi B, Levin J, Grosskurth H, Lalloo 
DG, et al. Barriers to starting ART and how they can be overcome: individual and 
operational factors associated with early and late start of treatment. Tropical 
Medicine and International Health. 2010; 15(11): 1347-56. 
134. MallS, Middelkoop K, Mark D, Wood R, Bekker LG. Changing patterns in 
HIV/AIDS stigma and uptake of voluntary counselling and testing services: The 
results of two consecutive community surveys conducted in the Western Cape, 
South Africa. AIDS Care. 2012. 
135. Leserman J. Role of depression, stress, and trauma in HIV disease progression. 
Psychosomatic Medicine. 2008; 70(5): 539-45. 
136. Ownby RL, Jacobs RJ, Waldrop-Valverde D, Gould F. Depression care and 
prevalence in HIV -positive individuals. Neurobehavioral HIV Medicine. 201 0; 2: 
73-83. 
137. Cairns G. Help When You're Troubled: getting the right psychlogical support; 
Autumn 2011. 
138. Ferrando SJ. Managing Depression in HIV Disease, Viral Hepatitis, and Substance 
Abuse. In: Braun J, editor. PRN Notebook. New York City: Physicians Research 
Network; 2005. p. 19-23. 
139. Ammassari A, Antinori A, Aloisi MS, Trotta MP, Mlirri R, Bartoli L, et al. 
Depressive symptoms, neurocognitive impairment, and adherence to highly active 
antiretroviral therapy among HIV -infected persons. Psychosomatics. 2004; 45(5): 
394-402. 
140. Starace F, Ammassari A, Trotta MP, Murri R, De Longis P, Izzo C, et al. 
Depression is a risk factor for suboptimal adherence to highly active antiretroviral 
therapy. Journal of Acquired Immune Deficiency Syndromes. 2002; 31 Suppl3: 
S136-9. 
141. Hechter R, Wang J, Sidell M, Towner W. The impact of depression on retention in 
care and viral suppression in a large cohort of insured HIV -infected patients; Oral 
abstract FRLBD03; XIX International AIDS Conference. Washington D.C.; 2012. 
280 
142. Hendershot CS, Stoner SA, Pantalone DW, Simoni JM. Alcohol use and 
antiretroviral adherence: review and meta-analysis. Joumal of Acquired Immune 
Deficiency Syndromes. 2009; 52(2): 180-202. 
143. Chander G, Lau B, Moore RD. Hazardous alcohol use: a risk factor for non-
adherence and lack of suppression in HIV infection. Joumal of Acquired Immune 
Deficiency Syndromes. 2006; 43( 4): 411-7. 
144. Baum MK, Rafie C, Lai S, Sales S, Page JB, Campa A. Alcohol use accelerates 
HIV disease progression. AIDS Research and Human Retroviruses. 2010; 26(5): 
511-8. 
145. Neuman MG, Schneider M, Nanau RM, Parry C. Alcohol Consumption, 
Progression of Disease and Other Comorbidities, and Responses to Antiretroviral 
Medication in People Living with HIV. AIDS Research and Treatment. 2012; 
2012: 751827. 
146. VanderHoeven M, Kruger A, GreeffM. Differences in health care seeking 
behaviour between rural and urban communities in South Africa. International 
Joumal for Equity in Health. 2012; 11: 31 . 
147. Zachariah R, Harries AD, Manzi M, Gomani P, Teck R, Phillips M, et al. 
Acceptance of anti-retroviral therapy among patients infected with HIV and 
tuberculosis in rural Malawi is low and associated with cost of transport. PLoS 
One. 2006; 1: e121. 
148. Kagee A, Remien RH, Berkman A, Hoffman S, Campos L, Swartz L. Structural 
barriers to ART adherence in Southem Africa: Challenges and potential ways 
forward. Global Public Health. 2011; 6(1): 83-97. 
149. Reda AA, Biadgilign S. Determinants of Adherence to Antiretroviral Therapy 
among HIV-Infected Patients in Africa. AIDS Research and Treatment. 2012; 
2012: 574656. 
150. Mukolo A, Villegas R, Aliyu M, Wallston KA. Predictors of Late Presentation for 
HIV Diagnosis: A Literature Review and Suggested Way Forward. AIDS and 
Behavior. 2013; 17(1): 5-30. 
151. Wallston KA, Wallston BS. Health locus of control scales. New York: Academic 
Press; 1981. 
152. Jewkes RK, Dunkle K, Nduna M, ShaiN. Intimate partner violence, relationship 
power inequity, and incidence ofHIV infection in young women in South Africa: a 
cohort study. Lancet. 2010; 376(9734): 41-8. 
281 
153. Amaro H, Raj A. On the margin: power and women's HIV risk reduction strategies. 
Sex Roles. 2000; 42(7 /8): 723-49. 
154. Ware NC, Wyatt MA, Geng EH, Kaaya SF, Agbaji 00, Muyindike WR, et al. 
Toward an Understanding of Disengagement from HIV Treatment and Care in Sub-
Saharan Africa: A Qualitative Study. PLoS Medicine. 2013; 10(1): e1001369. 
155. Project Inform. TLC+:Testing and Linkage to Care Plus; 2010. 
156. Government Notice R.401 National Health Act (61/2003): Regulations: Withdrawal 
of blood from a living person for testing. South Africa: South African National 
Department of Health, Gazette #33188; 2010. 
157. Thompson MA, Mugavero MJ, Amico KR, Cargill VA, Chang L W, Gross R, et al. 
Guidelines for improving entry into and retention in care and antiretroviral 
adherence for persons with HIV: evidence-based recommendations from an 
International Association of Physicians in AIDS Care panel. Annals of Internal 
Medicine. 2012; 156(11): 817-33, W-284, W-5, W-6, W-7, W-8, W-9, W-90, W-
91, W-92, W-93, W-94. 
158. Zachariah R, Teck R, Buhendwa L, Fitzerland M, Labana S, Chinji C, et al. 
Community support is associated with better antiretroviral treatment outcomes in a 
resource-limited rural district in Malawi. Transactions of the Royal Society of 
Tropical Medicine and Hygiene. 2007; 101(1): 79-84. 
159. Apinundecha C, Laohasiriwong W, Cameron MP, Lim S. A community 
participation intervention to reduce HIV/AIDS stigma, Nakhon Ratchasima 
province, northeast Thailand. AIDS Care. 2007; 19(9): 1157-65. 
160. Rollnick S, Miller W, Butler C. Motivational interviewing in health care: helping 
patients change behavior New York City: Guilford Press; 2008. 
161. HillS, Kavookjian J. Motivational interviewing as a behavioral intervention to 
increase HAART adherence in patients who are HIV-positive: a systematic review 
of the literature. AIDS Care. 2012; 24(5): 583-92. 
162. Mbuagbaw L, Y e C, Thabane L. Motivational interviewing for improving outcomes 
in youth living with HIV. Cochrane Database of Systematic Reviews. 2012; 9: 
CD009748. 
163. Naar-King S, Outlaw A, Green-Jones M, Wright K, Parsons JT. Motivational 
interviewing by peer outreach workers: a pilot randomized clinical trial to retain 
adolescents and young adults in HIV care. AIDS Care. 2009; 21(7): 868-73. 
282 
164. Evangeli M, Engelbrecht SK, Swartz L, Turner K, Forsberg L, Soka N. An 
evaluation of a brief motivational interviewing training course for HIV I AIDS 
counsellors in Westem Cape Province, South Africa. AIDS Care. 2009; 21(2): 189-
96. 
165. Evangeli M, Longley M, Swartz L. No reductions and some improvements in South 
African lay HIV I AIDS counsellors' motivational interviewing competence one year 
after brieftraining. AIDS Care. 2011 ; 23(3): 269-73. 
166. Dewing S, Mathews C, Schaay N, Cloete A, Louw J, Simbayi L. Behaviour change 
counselling for ARV adherence support within primary health care facilities in the 
Westem Cape, South Africa. AIDS and Behavior. 2012; 16(5): 1286-94. 
· 167. World Health Organization. Guidance on couples HIV testing and counseling 
including antiretroviral therapy for treatment and prevention in serodiscordant 
couples: recommendations for a public health approach 2012. 
168. Mundell JP, Visser MJ, Makin JD, Kershaw TS, Forsyth BW, Jeffery B, et al. The 
impact of structured support groups for pregnant South African women recently 
diagnosed HIV positive. Women & Health. 2011; 51(6): 546-65. 
169. Wouters E, van Loon F, van Rensburg D, Meulemans H. Community support and 
disclosure ofHIV serostatus to family members by public-sector antiretroviral 
treatment patients in the Free State Province of South Africa. AIDS Patient Care 
and STDs. 2009; 23(5): 357-64. 
170. Wouters E, Van Darnme W, van Rensburg D, Masquillier C, Meulemans H. Impact 
of community-based support services on antiretroviral treatment programme 
delivery and outcomes in resource-limited countries: a synthetic review. BMC 
Health Services Research. 2012; 12: 194. 
171. Integrated Access to Care and Treatment. Facilitate. [cited 2013 March 8]; 
Available from: http:/ /www.iactsupport.org/index.php/how-we-work/facilitate 
172. Khumalo-Sakutukwa G, Morin SF, Fritz K, Charlebois ED, van Rooyen H, 
Chingono A, et al. Project Accept (HPTN 043): a community-based intervention to 
reduce HIV incidence in populations at risk for HIV in sub-Saharan Africa and 
Thailand. Joumal of Acquired Iinmune Deficiency Syndromes. 2008; 49(4): 422-
31. 
173. LeeS, Li L, Lamsirithawom S, Nasungnun B. Development of family-focused HIV 
disclosure intervention in Thailand [Abstract WEPE398]. XIX International AIDS 
Conference; 2012; Washington D.C.; 2012. 
283 
174. Greene K, Carpenter A, Catona D, Magsamen-Conrad K. The Brief disclosure 
intervention (BDI): facilitating African Americans' disclosure ofHIV. Journal of 
Communication 2013; 63: 138-58. 
175. United Nations Joint Programme on HIV and AIDS. KwaZulu Natal adopts a 
holistic approach to HIV. 2011. 
176. West E. South Africa: Motsoaledi endorses 'KwaZulu-Natal approach' to HIV 
fight. Business Day Live; 2012. 
177. Jani IV, Sitoe NE, Alfai ER, Chongo PL, Quevedo JI, Rocha BM, et al. Effect of 
point -of-care CD4 cell count tests on retention of patients and rates of antiretroviral 
therapy initiation in primary health clinics: an observational cohort study. Lancet. 
2011; 378(9802): 1572-9. 
178. Grundy CL, Medina AL, Winogron D, Croucher AP, Batz HG, Hallett TB, et al. 
Point-of-care CD4 tests can increase life-years saved with reduced costs compared 
to flow cytometric CD4 counting; Oral abstract MOAD0105. 6th International 
AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention; Rome, 
Italy; 2011. 
179. Larson BA, Schnippel K, Ndibongo B, Xulu T, Brennan A, Long L, et al. Rapid 
Point-of-Care CD4 Testing at Mobile HIV Testing Sites to Increase Linkage to 
: Care: An Evaluation of a Pilot Program in South Africa. Journal of Acquired 
Immune Deficiency Syndromes. 2012; 61(2): e13-7. 
180. Manabe YC, Wang Y, Elbireer A, Auerbach B, Castelnuovo B. Evaluation of 
portable point-of-care CD4 counter with high sensitivity for detecting patients 
eligible for antiretroviral therapy. PLoS One. 2012; 7(4): e34319. 
181. Save the Children. Partnership defined quality: a tool book for community and 
health provider collaboration for quality improvement; 2003. 
182. Project Inform. TLC+: Best Practices to Implement Enhanced HIV Test, Link-to-
Care, Plus Treat (TLC-Plus) Strategies in Four U.S. Cities. San Francisco; 2011. 
284 
K          
 
  
   
   
         
     
   
 
   
 
 
 
     
     
       
     
      
       
 
         
     
     
      
 
    
          
    
        
      
    
   
 
   
        
     
      
 
  
 
  
       
 
    
     
   
    
  
  
   
     
    
       
         
     
      
     
    
 
  
         
       
    
 
       
         
    
   
     
 
  
        
 
  
      
     
        
   
     
   
    
  
     
  
    
     
 
 
    
     
 
  
 
         
    
          
     
      
  
 
       
         
    
      
       
     
   
   
  
  
 
 
